General Information of This Antigen (ID: TAR0THKZD)
Antigen Name
Receptor tyrosine-protein kinase erbB-2 (HER2)
Gene Name
HER2
Gene ID
2064
Synonym
HER2; MLN19; NEU; NGL; Metastatic lymph node gene 19 protein;Proto-oncogene Neu;Proto-oncogene c-ErbB-2;Tyrosine kinase-type cell surface receptor HER2;p185erbB2;CD340
Sequence
MELAALCRWGLLLALLPPGAASTQVCTGTDMKLRLPASPETHLDMLRHLYQGCQVVQGNL
ELTYLPTNASLSFLQDIQEVQGYVLIAHNQVRQVPLQRLRIVRGTQLFEDNYALAVLDNG
DPLNNTTPVTGASPGGLRELQLRSLTEILKGGVLIQRNPQLCYQDTILWKDIFHKNNQLA
LTLIDTNRSRACHPCSPMCKGSRCWGESSEDCQSLTRTVCAGGCARCKGPLPTDCCHEQC
AAGCTGPKHSDCLACLHFNHSGICELHCPALVTYNTDTFESMPNPEGRYTFGASCVTACP
YNYLSTDVGSCTLVCPLHNQEVTAEDGTQRCEKCSKPCARVCYGLGMEHLREVRAVTSAN
IQEFAGCKKIFGSLAFLPESFDGDPASNTAPLQPEQLQVFETLEEITGYLYISAWPDSLP
DLSVFQNLQVIRGRILHNGAYSLTLQGLGISWLGLRSLRELGSGLALIHHNTHLCFVHTV
PWDQLFRNPHQALLHTANRPEDECVGEGLACHQLCARGHCWGPGPTQCVNCSQFLRGQEC
VEECRVLQGLPREYVNARHCLPCHPECQPQNGSVTCFGPEADQCVACAHYKDPPFCVARC
PSGVKPDLSYMPIWKFPDEEGACQPCPINCTHSCVDLDDKGCPAEQRASPLTSIISAVVG
ILLVVVLGVVFGILIKRRQQKIRKYTMRRLLQETELVEPLTPSGAMPNQAQMRILKETEL
RKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSP
YVSRLLGICLTSTVQLVTQLMPYGCLLDHVRENRGRLGSQDLLNWCMQIAKGMSYLEDVR
LVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESILRRRFT
HQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLEKGERLPQPPICTIDVYMIMVKCWM
IDSECRPRFRELVSEFSRMARDPQRFVVIQNEDLGPASPLDSTFYRSLLEDDDMGDLVDA
EEYLVPQQGFFCPDPAPGAGGMVHHRHRSSSTRSGGGDLTLGLEPSEEEAPRSPLAPSEG
AGSDVFDGDLGMGAAKGLQSLPTHDPSPLQRYSEDPTVPLPSETDGYVAPLTCSPQPEYV
NQPDVRPQPPSPREGPLPAARPAGATLERPKTLSPGKNGVVKDVFAFGGAVENPEYLTPQ
GGAAPQPHPPPAFSPAFDNLYYWDQDPPERGAPPSTFKGTPTAENPEYLGLDVPV

    Click to Show/Hide
Family
Tyr protein family
Function
Protein tyrosine kinase that is part of several cell surface receptor complexes, but that apparently needs a coreceptor for ligand binding. Essential component of a neuregulin-receptor complex, although neuregulins do not interact with it alone. GP30 is a potential ligand for this receptor. Regulates outgrowth and stabilization of peripheral microtubules (MTs). Upon ERBB2 activation, the MEMO1-RHOA-DIAPH1 signaling pathway elicits the phosphorylation and thus the inhibition of GSK3B at cell membrane. This prevents the phosphorylation of APC and CLASP2, allowing its association with the cell membrane. In turn, membrane-bound APC allows the localization of MACF1 to the cell membrane, which is required for microtubule capture and stabilization.

    Click to Show/Hide
Uniprot Entry
ERBB2_HUMAN
HGNC ID
HGNC:3430
KEGG ID
hsa:2064
Each Antibody-drug Conjugate and Its Component Related to This Antigen
Full List of The ADC Related to This Antigen
The Numbers of ADCs, Their Three Components, Payload Targets, and Corresponding Diseases for This Antigens
ADC Name Payload Target Linker ADC Info
WO2024105205A1 11e-1015a [1]
KSPI6-1
Undisclosed
Undisclosed
ADC Name Payload Target Linker ADC Info
39860260 2Rs15d-H3KH6-MMAE [2]
Monomethyl auristatin E
Microtubule (MT)
DBCO-PEG4-Val-Cit-PABC
4D5 HC A118C
ADC Name Payload Target Linker ADC Info
CN106714844B ADC-101 [3]
PNU-159682
DNA topoisomerase 2-alpha (TOP2A)
CN106714844B-ADC-101-linker
CN106714844B ADC-103 [3]
PNU-159682
DNA topoisomerase 2-alpha (TOP2A)
CN106714844B-ADC-103-linker
CN106714844B ADC-111 [3]
PNU-159682
DNA topoisomerase 2-alpha (TOP2A)
Undisclosed
CN106714844B ADC-112 [3]
PNU-159682
DNA topoisomerase 2-alpha (TOP2A)
Undisclosed
CN106714844B ADC-119 [3]
PNU-159682
DNA topoisomerase 2-alpha (TOP2A)
CN106714844B-ADC-119-linker
CN106714844B ADC-131 [3]
PNU-159682
DNA topoisomerase 2-alpha (TOP2A)
Undisclosed
4D5 HC A140C
ADC Name Payload Target Linker ADC Info
CN106714844B ADC-128 [3]
PNU-159682
DNA topoisomerase 2-alpha (TOP2A)
Undisclosed
4D5 LC A149C
ADC Name Payload Target Linker ADC Info
CN106714844B ADC-129 [3]
PNU-159682
DNA topoisomerase 2-alpha (TOP2A)
Undisclosed
4D5 LC S121C
ADC Name Payload Target Linker ADC Info
CN106714844B ADC-132 [3]
PNU-159682
DNA topoisomerase 2-alpha (TOP2A)
Undisclosed
4D5 LC V205C
ADC Name Payload Target Linker ADC Info
CN106714844B ADC-130 [3]
PNU-159682
DNA topoisomerase 2-alpha (TOP2A)
Undisclosed
7.16.4_msIgG2a
ADC Name Payload Target Linker ADC Info
EP4489789A1 7.16.4_msIgG2a Conjugate 4 [4]
Undisclosed
Undisclosed
Undisclosed
7C2 HC A118C
ADC Name Payload Target Linker ADC Info
CN106714844B ADC-107 [3]
PNU-159682
DNA topoisomerase 2-alpha (TOP2A)
Undisclosed
CN106714844B ADC-114 [3]
PNU-159682
DNA topoisomerase 2-alpha (TOP2A)
Undisclosed
7C2 HC K118C
ADC Name Payload Target Linker ADC Info
CN106714844B ADC-140 [3]
PNU-159682
DNA topoisomerase 2-alpha (TOP2A)
Ethylmaleimide linker
7C2 LC K149C
ADC Name Payload Target Linker ADC Info
CN106714844B ADC-108 [3]
PNU-159682
DNA topoisomerase 2-alpha (TOP2A)
Undisclosed
CN106714844B ADC-109 [3]
PNU-159682
DNA topoisomerase 2-alpha (TOP2A)
CN106714844B-ADC-109-linker
CN106714844B ADC-116 [3]
PNU-159682
DNA topoisomerase 2-alpha (TOP2A)
Undisclosed
CN106714844B ADC-134 [3]
PNU-159682
DNA topoisomerase 2-alpha (TOP2A)
CN106714844B-ADC-134-linker
CN106714844B ADC-135 [3]
PNU-159682
DNA topoisomerase 2-alpha (TOP2A)
CN106714844B-ADC-135-linker
CN106714844B ADC-136 [3]
PNU-159682
DNA topoisomerase 2-alpha (TOP2A)
Undisclosed
CN106714844B ADC-137 [3]
PNU-159682
DNA topoisomerase 2-alpha (TOP2A)
Ethylmaleimide linker
CN106714844B ADC-138 [3]
PNU-159682
DNA topoisomerase 2-alpha (TOP2A)
Ethylmaleimide linker
Ab0001-LCCTL-HC
ADC Name Payload Target Linker ADC Info
LC301-1-1 (2) [5]
Dxd-1
Undisclosed
LA301-1-1 linker
LC301-1-1 (4) [5]
Dxd-1
Undisclosed
LA301-1-1 linker
LC301-2-1 (2) [5]
Dxd-1
Undisclosed
LA301-1-1 linker
LC301-2-1 (4) [5]
Dxd-1
Undisclosed
LA301-1-1 linker
LC301-3-1 (4) [5]
Dxd-1
Undisclosed
LA301-3-1 linker
LC301-4-1 (6) [5]
Dxd-1
Undisclosed
LA301-4-1 linker
LC301-5-1 (8) [5]
Dxd-1
Undisclosed
LA301-5-1 linker
LC302-1-1 (2) [5]
Dxd-1
Undisclosed
LA302-1-1 linker
LC302-1-1 (4) [5]
Dxd-1
Undisclosed
LA302-1-1 linker
LC302-1-4 (2) [5]
Dxd-1
Undisclosed
LA302-1-4 linker
LC302-1-4 (4) [5]
Dxd-1
Undisclosed
LA302-1-4 linker
LC302-2-1 (4) [5]
Dxd-1
Undisclosed
LA302-2-1 linker
LC302-2-4 (4) 4 [5]
Dxd-1
Undisclosed
LA302-2-4 linker
LC302-3-1 (6) [5]
Dxd-1
Undisclosed
LA302-3-1 linker
LC302-3-4 (6) [5]
Dxd-1
Undisclosed
LA302-3-4 linker
LC302-4-1 (8) [5]
Dxd-1
Undisclosed
LA302-3-1 linker
LC302-4-4 (8) [5]
Dxd-1
Undisclosed
LA302-3-4 linker
ADAPT6-ABD
ADC Name Payload Target Linker ADC Info
ADAPT6-ABD-mcDM1 [6]
Mertansine DM1
Microtubule (MT)
Maleimidocaproyl (Ser3-Gly)3
Anbenitamab
ADC Name Payload Target Linker ADC Info
Anbenitamab-ADC-Tb3-1 [7]
Anbenitamab-ADC-Tb3-1 payload
Undisclosed
Anbenitamab-ADC-Tb3-1 linker
Anbenitamab-ADC-Tb3-2 [7]
Anbenitamab-ADC-Tb3-2 payload
Undisclosed
Anbenitamab-ADC-Tb3-2 linker
Anbenitamab-ADC-Tb3-3 [7]
Anbenitamab-ADC-Tb3-3 payload
Undisclosed
Anbenitamab-ADC-Tb3-3 linker
Anbenitamab-ADC-Tb3-4 [7]
Anbenitamab-ADC-Tb3-4 payload
Undisclosed
Anbenitamab-ADC-Tb3-4 linker
Anbenitamab-ADC-Tb3-5 [7]
Anbenitamab-ADC-Tb3-5 payload
Undisclosed
Anbenitamab-ADC-Tb3-5 linker
Anbenitamab-ADC-Tb3-6 [7]
Anbenitamab-ADC-Tb3-6 payload
Undisclosed
Anbenitamab-ADC-Tb3-6 linker
Anbenitamab-ADC-Tb3-7 [7]
Anbenitamab-ADC-Tb3-7 payload
Undisclosed
Anbenitamab-ADC-Tb3-7 linker
Anbenitamab-ADC-Tb3-8 [7]
Anbenitamab-ADC-Tb3-8 payload
Undisclosed
Anbenitamab-ADC-Tb3-8 linker
Anbenitamab-ADC-Tb3-9 [7]
Anbenitamab-ADC-Tb3-9 payload
Undisclosed
Anbenitamab-ADC-Tb3-9 linker
Anbenitamab-ADC-Tb3-10 [7]
Anbenitamab-ADC-Tb3-10 payload
Undisclosed
Anbenitamab-ADC-Tb3-10 linker
ADC Name Payload Target Linker ADC Info
An2-anti-HER2-Doxetaxel [8]
Docetaxel
Microtubule (MT)
Undisclosed
Anti-HER2 1-alpha-hydroxyvitamin-D5-HER-2 Anti-ody conjugate mAb
ADC Name Payload Target Linker ADC Info
Alpha-hydroxyvitamin-D5-HER2 antibody conjugate [9]
Vitamin D
Undisclosed
Sulfosuccinimidyl 6-4 azido nitrophenylamido hexanode (SANPAH)
anti-Her2 114 (H- (A114C)) and 183 (H- (kK183C)) mAb
ADC Name Payload Target Linker ADC Info
H- (C)-#10 [10]
Undisclosed
Undisclosed
Undisclosed
CD33-11A1-v1417 (C)-#39 [10]
CD33-11A1-v1417 (C)-#39 Payload
Undisclosed
CD33-11A1-v1417 (C)-#39 Linker
Anti-HER2 7C2 mAb
ADC Name Payload Target Linker ADC Info
HER2-5 ADC [11]
GNE-987 (R)
Bromodomain-containing protein 4 (BRD4)
Dolaflexin polymer
Anti-HER2 antibody
ADC Name Payload Target Linker ADC Info
BB-1701
Eribulin
Microtubule (MT)
Mal-PEG2-Val-Cit-PABC
BAT8010
Exatecan
DNA topoisomerase 1 (TOP1)
A cleavable linker
SMP-656
Eribulin
Microtubule (MT)
SuperHydraTM linker
BL-M17D1
WA-00
Microtubule (MT)
Undisclosed
GB251
Monomethyl auristatin E
Microtubule (MT)
BiM-Val-Cit-PABC
GQ1007
TLR7/8 agonist
Toll-like receptor 7 (TLR7); Toll-like receptor 8 (TLR8)
Stable linker
SIBP-A17
DXd
DNA topoisomerase 1 (TOP1)
Mc-VASGFG
SYS6045
TOP1 inhibitor
DNA topoisomerase 1 (TOP1)
Undisclosed
Anti-HER2 antibody 20507
ADC Name Payload Target Linker ADC Info
WO2015095301A2 ADC-28 [12]
WO2015095301A2 ADC-28 payload
Undisclosed
WO2015095301A2 ADC-28 linker
WO2015095301A2 ADC-29 [12]
WO2015095301A2 ADC-29 payload
Undisclosed
WO2015095301A2 ADC-29 linker
WO2015095301A2 ADC-30 [12]
WO2015095301A2 ADC-30 payload
Undisclosed
WO2015095301A2 ADC-30 linker
WO2015095301A2 ADC-31 [12]
WO2015095301A2 ADC-31 payload
Undisclosed
WO2015095301A2 ADC-31 linker
WO2015095301A2 ADC-32 [12]
WO2015095301A2 ADC-32 payload
Undisclosed
WO2015095301A2 ADC-32 linker
WO2015095301A2 ADC-33 [12]
WO2015095301A2 ADC-33 payload
Undisclosed
WO2015095301A2 ADC-33 linker
WO2015095301A2 ADC-34 [12]
WO2015095301A2 ADC-34 payload
Undisclosed
WO2015095301A2 ADC-34 linker
WO2015095301A2 ADC-35 [12]
WO2015095301A2 ADC-35 payload
Undisclosed
WO2015095301A2 ADC-35 linker
WO2015095301A2 ADC-36 [12]
WO2015095301A2 ADC-36 payload
Undisclosed
WO2015095301A2 ADC-36 linker
WO2015095301A2 ADC-37 [12]
WO2015095301A2 ADC-37 payload
Undisclosed
WO2015095301A2 ADC-37 linker
WO2015189791A1 ADC-27 [13]
WO2015189791A1 ADC-27 payload
Undisclosed
WO2015189791A1 ADC-27 linker
WO2015189791A1 ADC-28 [13]
WO2015189791A1 ADC-28 payload
Undisclosed
WO2015189791A1 ADC-28 linker
WO2015189791A1 ADC-29 [13]
WO2015189791A1 ADC-29 payload
Undisclosed
WO2015189791A1 ADC-29 linker
WO2015189791A1 ADC-30 [13]
WO2015189791A1 ADC-30 payload
Undisclosed
WO2015189791A1 ADC-30 linker
WO2015189791A1 ADC-31 [13]
WO2015189791A1 ADC-31 payload
Undisclosed
WO2015189791A1 ADC-31 linker
WO2015189791A1 ADC-32 [13]
WO2015189791A1 ADC-32 payload
Undisclosed
WO2015189791A1 ADC-32 linker
WO2015189791A1 ADC-33 [13]
WO2015189791A1 ADC-33 payload
Undisclosed
WO2015189791A1 ADC-33 linker
WO2015189791A1 ADC-34 [13]
WO2015189791A1 ADC-34 payload
Undisclosed
WO2015189791A1 ADC-34 linker
WO2015189791A1 ADC-35 [13]
WO2015189791A1 ADC-35 payload
Undisclosed
WO2015189791A1 ADC-35 linker
WO2015189791A1 ADC-36 [13]
WO2015189791A1 ADC-36 payload
Undisclosed
WO2015189791A1 ADC-36 linker
WO2015189791A1 ADC-37 [13]
WO2015189791A1 ADC-37 payload
Undisclosed
WO2015189791A1 ADC-37 linker
WO2015189791A1 ADC-40 [13]
WO2015189791A1 ADC-40 payload
Undisclosed
WO2015189791A1 ADC-40 linker
WO2015189791A1 ADC-61 [13]
WO2015189791A1 ADC-61 payload
Undisclosed
WO2015189791A1 ADC-61 linker
WO2015189791A1 ADC-63 [13]
WO2015189791A1 ADC-63 payload
Undisclosed
WO2015189791A1 ADC-63 linker
WO2015189791A1 ADC-64 [13]
WO2015189791A1 ADC-64 payload
Undisclosed
WO2015189791A1 ADC-64 linker
Anti-HER2 antibody 2H9-A121C
ADC Name Payload Target Linker ADC Info
2H9-A121C-BMPEO-DM1 [14]
Maytansinoid DM1
Microtubule (MT)
2H9-A121C-BMPEO-DM1 linker
anti-HER2 antibody mAb-1
ADC Name Payload Target Linker ADC Info
WO2023232144A1ADC-1 [15]
WO2023232144A1, ADC-1, Payload
Microtubule (MT)
WO2023232144A1, ADC-1, linker
WO2023232144A1ADC-2 [15]
WO2023232144A1, ADC-2, Payload
DNA topoisomerase I (TOP1)
WO2023232144A1, ADC-2, linker
Anti-HER2 DVD-Fab
ADC Name Payload Target Linker ADC Info
Anti-HER2 DVD-Fab_MMAF [16]
Monomethyl auristatin F
Microtubule (MT)
Dibromomaleimide-PEG4
Anti-HER2 DVD-Fab-h38c2-K99C
ADC Name Payload Target Linker ADC Info
Anti-HER2 DVD-Fab-h38c2-K99C_MMAF [16]
Monomethyl auristatin F
Microtubule (MT)
Dibromomaleimide-PEG4
Anti-HER2 DVD-IgG1
ADC Name Payload Target Linker ADC Info
Anti-HER2 DVD-IgG1_MMAF [16]
Monomethyl auristatin F
Microtubule (MT)
Dibromomaleimide-PEG4
Anti-HER2 DVD-IgG1-Tiancimycin [17]
Tiancimycin
Microtubule (MT)
DVD-PEG4-Triazol
Anti-HER2 DVD-IgG1-H38c2-K99C
ADC Name Payload Target Linker ADC Info
Anti-HER2 DVD-IgG1-h38c2-K99C_MMAF [16]
Monomethyl auristatin F
Microtubule (MT)
Dibromomaleimide-PEG4
Anti-HER2 DVD-IgG1-h38c2-K99C Fluorescein [16]
Fluorescein derivative
Undisclosed
MS-PODA
Anti-HER2 DVD-IgG1-h38c2-K99C TAMTA 3 [16]
5(6)-Carboxytetramethylrhodamine
Undisclosed
Dibromomaleimide-PEG3
Anti-HER2 DVD-IgG1-h38c2-K99C TAMTA 2 [16]
5(6)-Carboxytetramethylrhodamine
Undisclosed
Monobromomaleimide-PEG3
Anti-HER2 DVD-IgG1-h38c2-K99C TAMTA 1 [16]
5(6)-Carboxytetramethylrhodamine
Undisclosed
Mal-PEG3
Anti-HER2 Fab
ADC Name Payload Target Linker ADC Info
Fab-SN38 [18]
Active metabolite of irinotecan SN38
DNA topoisomerase 1 (TOP1)
LPETGGG-PEG3-Azide BCN-AVC
Anti-HER2 IgG1(GH2-20)
ADC Name Payload Target Linker ADC Info
IgG1 (GH2-20)-vc-MMAE [19]
Monomethyl auristatin E
Microtubule (MT)
Mc-Val-Cit-PABC
Anti-HER2 IgG1(GH2-20) scFv
ADC Name Payload Target Linker ADC Info
ScFv(GH2-20)-PE38KDEL [19]
Pseudomonas exotoxin PE38
Eukaryotic elongation factor 2 kinase (EEF2K)
Undisclosed
Anti-HER2 IgG1(GH2-20)-AL1
ADC Name Payload Target Linker ADC Info
IgG1 (GH2-20)-AL1-MMAE [19]
Monomethyl auristatin E
Microtubule (MT)
Undisclosed
Anti-HER2 IgG1(GH2-61)
ADC Name Payload Target Linker ADC Info
IgG1 (GH2-61)-vc-MMAE [19]
Monomethyl auristatin E
Microtubule (MT)
Mc-Val-Cit-PABC
Anti-HER2 IgG1(GH2-61) scFv
ADC Name Payload Target Linker ADC Info
ScFv(GH2-61)-PE38KDEL [19]
Pseudomonas exotoxin PE38
Eukaryotic elongation factor 2 kinase (EEF2K)
Undisclosed
Anti-HER2 IgG1(GH2-61)-AL1
ADC Name Payload Target Linker ADC Info
IgG1 (GH2-61)-AL1-MMAE [19]
Monomethyl auristatin E
Microtubule (MT)
Undisclosed
Anti-HER2 IgG1(GH2-75)
ADC Name Payload Target Linker ADC Info
IgG1 (GH2-75)-vc-MMAE [19]
Monomethyl auristatin E
Microtubule (MT)
Mc-Val-Cit-PABC
Anti-HER2 IgG1(GH2-75) scFv
ADC Name Payload Target Linker ADC Info
ScFv(GH2-75)-PE38KDEL [19]
Pseudomonas exotoxin PE38
Eukaryotic elongation factor 2 kinase (EEF2K)
Undisclosed
Anti-HER2 IgG1(GH2-75)-AL1
ADC Name Payload Target Linker ADC Info
IgG1 (GH2-75)-AL1-MMAE [19]
Monomethyl auristatin E
Microtubule (MT)
Undisclosed
Anti-HER2 IgG1(H32)
ADC Name Payload Target Linker ADC Info
IgG1 (H32)-vc-MMAE [19]
Monomethyl auristatin E
Microtubule (MT)
Mc-Val-Cit-PABC
Anti-HER2 IgG1(H32) scFv
ADC Name Payload Target Linker ADC Info
ScFv(H32)-PE38KDEL [19]
Pseudomonas exotoxin PE38
Eukaryotic elongation factor 2 kinase (EEF2K)
Undisclosed
Anti-HER2 IgG1(H32)-AL1
ADC Name Payload Target Linker ADC Info
IgG1 (H32)-AL1-MMAE [19]
Monomethyl auristatin E
Microtubule (MT)
Undisclosed
Anti-HER2 mAb
ADC Name Payload Target Linker ADC Info
ADC2202 [20]
Undisclosed
Undisclosed
Undisclosed
Anti-HER2 ADC 12-3.1 [21]
Anti-HER2 ADC 12-3 payload
Undisclosed
Anti-HER2 ADC 12-3 linker
Alpha-HER2-Duo 405 [21]
Duocarmycin 405
Human Deoxyribonucleic acid (hDNA)
Undisclosed
Anti-HER2 ADC 2-7 [21]
Anti-HER2 ADC 2-7 payload
Undisclosed
Anti-HER2 ADC 2-7 linker
Anti-HER2 ADC 3-4 [21]
Anti-HER2 ADC 3-4 payload
Undisclosed
Anti-HER2 ADC 3-4 linker
Anti-HER2 ADC 4-3 [21]
Anti-HER2 ADC 4-3 payload
Undisclosed
Anti-HER2 ADC 4-3 linker
Anti-HER2 ADC 5-3 [21]
Anti-HER2 ADC 5-3 payload
Undisclosed
Anti-HER2 ADC 5-3 linker
Anti-HER2 ADC 6-2 [21]
Anti-HER2 ADC 6-2 payload
Undisclosed
Anti-HER2 ADC 6-2 linker
Anti-HER2 ADC 7-1 [21]
Anti-HER2 ADC 7-1 payload
Undisclosed
Anti-HER2 ADC 7-1 linker
Anti-HER2 ADC 8-5 [21]
Anti-HER2 ADC 8-5 payload
Undisclosed
Anti-HER2 ADC 8-5 linker
Anti-HER2 ADC 9-4 [21]
Anti-HER2 ADC 9-4 payload
Undisclosed
Anti-HER2 ADC 9-4 linker
Anti-HER2 ADC 10-1 [21]
Anti-HER2 ADC 10-1 payload
Undisclosed
Anti-HER2 ADC 10-1 linker
Anti-HER2 ADC 11-5 [21]
Anti-HER2 ADC 11-5 payload
Undisclosed
Anti-HER2 ADC 11-5 linker
Anti-HER2 ADC 12-3.2 [21]
Anti-HER2 ADC 12-3 payload
Undisclosed
Anti-HER2 ADC 12-3 linker
Anti-HER2 ADC 13-7 [21]
Anti-HER2 ADC 13-7 payload
Undisclosed
Anti-HER2 ADC 13-7 linker
Anti-HER2 ADC 14-5 [21]
Anti-HER2 ADC 14-5 payload
Undisclosed
Anti-HER2 ADC 14-5 linker
Anti-HER2 ADC 15-5 [21]
Anti-HER2 ADC 15-5 payload
Undisclosed
Anti-HER2 ADC 15-5 linker
Anti-HER2 ADC 16-5 [21]
Anti-HER2 ADC 16-5 payload
Undisclosed
Anti-HER2 ADC 16-5 linker
Anti-HER2 ADC 17-2 [21]
Anti-HER2 ADC 17-2 payload
Undisclosed
Anti-HER2 ADC 17-2 linker
Anti-HER2 ADC 18-3 [21]
Anti-HER2 ADC 18-3 payload
Undisclosed
Anti-HER2 ADC 18-3 linker
Anti-HER2 ADC 19-5 [21]
Anti-HER2 ADC 19-5 payload
Undisclosed
Anti-HER2 ADC 19-5 linker
Anti-HER2 ADC 20-5 [21]
Anti-HER2 ADC 20-5 payload
Undisclosed
Anti-HER2 ADC 20-5 linker
Anti-HER2 ADC 21-5 [21]
Anti-HER2 ADC 21-5 payload
Undisclosed
Anti-HER2 ADC 21-5 linker
HER2-HC-H-SS-PBD [22]
SG2000
Human Deoxyribonucleic acid (hDNA)
H-disulfide linker
HER2-LC-H-SS-PBD [22]
SG2000
Human Deoxyribonucleic acid (hDNA)
H-disulfide linker
HER2-HC-Me-SS-PBD [22]
SG2000
Human Deoxyribonucleic acid (hDNA)
Me-disulfide linker
HER2-LC-Me-SS-PBD [22]
SG2000
Human Deoxyribonucleic acid (hDNA)
Me-disulfide linker
Anti-HER2 mAb-Compound 9 [23]
Mertansine DM1
Microtubule (MT)
Anti-HER2 mAb-Compound 9 linker
Anti-HER2 mAb-Compound 17 [23]
Mertansine DM4
Microtubule (MT)
Anti-HER2 mAb-Compound 17 linker
Anti-HER2 mAb-Compound 25 [23]
Monomethyl auristatin E
Microtubule (MT)
Anti-HER2 mAb-Compound 25 linker
Anti-HER2 mAb-Compound 31 [23]
Auristatin 0101
Microtubule (MT)
Anti-HER2 mAb-Compound 31 linker
Anti-HER2 mAb-Compound 36 [23]
Monomethyl auristatin E
Microtubule (MT)
Anti-HER2 mAb-Compound 36 linker
Anti-HER2 mAb-Compound 43 [23]
PBD dimer
Human Deoxyribonucleic acid (hDNA)
Anti-HER2 mAb-Compound 43 linker
Anti-HER2 mAb-Compound 49 [23]
PBD dimer
Human Deoxyribonucleic acid (hDNA)
Anti-HER2 mAb-Compound 49 linker
Anti-HER2 mAb-Compound 55 [23]
Mertansine DM1
Microtubule (MT)
Anti-HER2 mAb-Compound 55 linker
Anti-HER2 mAb-Compound 59 [23]
Mertansine DM4
Microtubule (MT)
Anti-HER2 mAb-Compound 59 linker
Anti-HER2 mAb-Compound 64 [23]
Monomethyl auristatin E
Microtubule (MT)
Anti-HER2 mAb-Compound 64 linker
Anti-HER2 mAb-Compound 69 [23]
Monomethyl auristatin E
Microtubule (MT)
Anti-HER2 mAb-Compound 69 linker
Anti-HER2 mAb-Compound 74 [23]
PBD dimer
Human Deoxyribonucleic acid (hDNA)
Anti-HER2 mAb-Compound 74 linker
Anti-HER2 mAb-Compound 75 [23]
Monomethyl auristatin E
Microtubule (MT)
Anti-HER2 mAb-Compound 75 linker
Anti-HER2 mAb-Compound 76 [23]
Monomethyl auristatin E
Microtubule (MT)
Anti-HER2 mAb-Compound 76 linker
Anti-HER2 mAb-Compound 77 [23]
Mertansine DM1
Microtubule (MT)
Anti-HER2 mAb-Compound 77 linker
Anti-HER2 mAb-Compound 78 [23]
Auristatin 0101
Microtubule (MT)
Anti-HER2 mAb-Compound 78 linker
Anti-HER2 mAb-Compound 79 [23]
Auristatin 0101
Microtubule (MT)
Anti-HER2 mAb-Compound 79 linker
Anti-HER2 mAb-Compound 80 [23]
Mertansine DM4
Microtubule (MT)
Anti-HER2 mAb-Compound 80 linker
CN110997010A ADC-1 [24]
CN110997010A ADC-1 payload
Undisclosed
CN110997010A ADC-1 linker
CN110997010A ADC-2 [24]
CN110997010A ADC-2 payload
Undisclosed
CN110997010A ADC-2 linker
CN110997010A ADC-3 [24]
CN110997010A ADC-3 payload
Undisclosed
CN110997010A ADC-3 linker
CN110997010A ADC-4 [24]
CN110997010A ADC-4 payload
Undisclosed
CN110997010A ADC-4 linker
CN110997010A ADC-5 [24]
CN110997010A ADC-5 payload
Undisclosed
CN110997010A ADC-5 linker
CN110997010A ADC-6 [24]
CN110997010A ADC-6 payload
Undisclosed
CN110997010A ADC-6 linker
CN110997010A ADC-7 [24]
CN110997010A ADC-7 payload
Undisclosed
CN110997010A ADC-7 linker
CN110997010A ADC-8 [24]
CN110997010A ADC-8 payload
Undisclosed
CN110997010A ADC-8 linker
CN110997010A ADC-9 [24]
Undisclosed
Undisclosed
CN110997010A ADC-9 linker
CN110997010A ADC-10 [24]
Undisclosed
Undisclosed
CN110997010A ADC-10 linker
CN110997010A ADC-11 [24]
Undisclosed
Undisclosed
CN110997010A ADC-11 linker
CN110997010A ADC-12 [24]
Undisclosed
Undisclosed
CN110997010A ADC-12 linker
CN110997010A ADC-13 [24]
Undisclosed
Undisclosed
CN110997010A ADC-13 linker
CN110997010A ADC-14 [24]
Undisclosed
Undisclosed
CN110997010A ADC-14 linker
CN110997010A ADC-15 [24]
Undisclosed
Undisclosed
CN110997010A ADC-15 linker
CN110997010A ADC-16 [24]
Undisclosed
Undisclosed
CN110997010A ADC-16 linker
CN110997010A ADC-17 [24]
Undisclosed
Undisclosed
CN110997010A ADC-17 linker
CN110997010A ADC-18 [24]
Undisclosed
Undisclosed
CN110997010A ADC-18 linker
CN110997010A ADC-19 [24]
Undisclosed
Undisclosed
CN110997010A ADC-19 linker
CN110997010A ADC-20 [24]
Undisclosed
Undisclosed
CN110997010A ADC-20 linker
CN110997010A ADC-21 [24]
Undisclosed
Undisclosed
CN110997010A ADC-21 linker
CN110997010A ADC-22 [24]
Undisclosed
Undisclosed
CN110997010A ADC-22 linker
CN110997010A ADC-23 [24]
Undisclosed
Undisclosed
CN110997010A ADC-1 linker
CN110997010A ADC-24 [24]
Undisclosed
Undisclosed
CN110997010A ADC-3 linker
CN110997010A ADC-25 [24]
Undisclosed
Undisclosed
CN110997010A ADC-3 linker
CN110997010A ADC-26 [24]
Undisclosed
Undisclosed
CN110997010A ADC-26 linker
CN110997010A ADC-27 [24]
Undisclosed
Undisclosed
CN110997010A ADC-5 linker
CN110997010A ADC-28 [24]
Undisclosed
Undisclosed
CN110997010A ADC-6 linker
CN110997010A ADC-29 [24]
Undisclosed
Undisclosed
CN110997010A ADC-7 linker
CN110997010A ADC-30 [24]
Undisclosed
Undisclosed
CN110997010A ADC-8 linker
CN110997010A ADC-31 [24]
Undisclosed
Undisclosed
CN110997010A ADC-31 linker
CN110997010A ADC-32 [24]
Undisclosed
Undisclosed
CN110997010A ADC-32 linker
CN110997010A ADC-33 [24]
Undisclosed
Undisclosed
CN110997010A ADC-33 linker
CN110997010A ADC-34 [24]
Undisclosed
Undisclosed
CN110997010A ADC-34 linker
HMBD-802
Exatecan; ATR inhibitor
ATR+DNA topoisomerase 1 (TOP1)
A cleavable linker
Anti-HER2 mAb A114N
ADC Name Payload Target Linker ADC Info
A114N-Mc-Val-Cit-PABC-MMAE [25]
Monomethyl auristatin E
Microtubule (MT)
Mc-Val-Cit-PABC
Anti-HER2 mAb A114N NNAS
ADC Name Payload Target Linker ADC Info
A114N NNAS-Mc-Val-Cit-PABC-MMAE [25]
Monomethyl auristatin E
Microtubule (MT)
Mc-Val-Cit-PABC
Anti-HER2 mAb glutamine 295 (Q295)
ADC Name Payload Target Linker ADC Info
VCit ADC 3a [26]
Monomethyl auristatin F
Microtubule (MT)
DBCO-PEG-VCit-PABC
EVCit ADC 3c [26]
Monomethyl auristatin F
Microtubule (MT)
DBCO-PEG-EVCit-PABC
Anti-HER2 mAb H-1
ADC Name Payload Target Linker ADC Info
H-1-vcMMAE [27]
Monomethyl auristatin E
Microtubule (MT)
Mc-Val-Cit-PABC
Anti-HER2 mAb H-3
ADC Name Payload Target Linker ADC Info
H-3-vcMMAE [27]
Monomethyl auristatin E
Microtubule (MT)
Mc-Val-Cit-PABC
Anti-HER2 mAb H-4
ADC Name Payload Target Linker ADC Info
H-4-vcMMAE [27]
Monomethyl auristatin E
Microtubule (MT)
Mc-Val-Cit-PABC
Anti-HER2 mAb H32
ADC Name Payload Target Linker ADC Info
H32-DM1_3.0 [28]
Mertansine DM1
Microtubule (MT)
Succinimidyl-4-(N-maleimidomethyl)cyclohexane-1-carboxylate (SMCC)
H32-DM1_3.3 [28]
Mertansine DM1
Microtubule (MT)
Succinimidyl-4-(N-maleimidomethyl)cyclohexane-1-carboxylate (SMCC)
H32-DM1_3.7 [28]
Mertansine DM1
Microtubule (MT)
Succinimidyl-4-(N-maleimidomethyl)cyclohexane-1-carboxylate (SMCC)
H32-DM1_3.8 [28]
Mertansine DM1
Microtubule (MT)
Succinimidyl-4-(N-maleimidomethyl)cyclohexane-1-carboxylate (SMCC)
H32-VCMMAE_2.1 [28]
Monomethyl auristatin E
Microtubule (MT)
Mc-Val-Cit-PABC
H32-VCMMAE_3.2 [28]
Monomethyl auristatin E
Microtubule (MT)
Mc-Val-Cit-PABC
H32-VCMMAE_3.8 [28]
Monomethyl auristatin E
Microtubule (MT)
Mc-Val-Cit-PABC
H32-VCMMAE_6.6 [28]
Monomethyl auristatin E
Microtubule (MT)
Mc-Val-Cit-PABC
Anti-HER2 mAb NNAS
ADC Name Payload Target Linker ADC Info
NNAS-Mc-Val-Cit-PABC-MMAE [25]
Monomethyl auristatin E
Microtubule (MT)
Mc-Val-Cit-PABC
Anti-HER2 mAb S298N/T299A/Y300S
ADC Name Payload Target Linker ADC Info
HER2 S298N/T299A/Y300S-Mc-Val-Cit-PABC-MMAE [25]
Monomethyl auristatin E
Microtubule (MT)
Mc-Val-Cit-PABC
Anti-HER2 mAb WT
ADC Name Payload Target Linker ADC Info
HER2 WT-Mc-Val-Cit-PABC-MMAE [25]
Monomethyl auristatin E
Microtubule (MT)
Mc-Val-Cit-PABC
Anti-HER-AO-Cys-MC-VC-PABC-MMAE [25]
Monomethyl auristatin E
Microtubule (MT)
Anti-HER-AO-Cys-MC-VC-PABC-MMAE linker
Anti-HER-MC-VC-PABC-PEG8-Dol10 [25]
Anti-HER-MC-VC-PABC-PEG8-Dol10 payload
Undisclosed
Anti-HER-MC-VC-PABC-PEG8-Dol10 linker
Anti-HER-AO-Cys-MC-VC-PABC-PEG8-Dol10 [25]
Anti-HER-AO-Cys-MC-VC-PABC-PEG8-Dol10 payload
Undisclosed
Anti-HER-AO-Cys-MC-VC-PABC-PEG8-Dol10 linker
Anti-HER2 scFv-Fc (Ser396Sec)
ADC Name Payload Target Linker ADC Info
Anti-HER2 scFv-Fc (Ser396Sec)-CN29 [29]
Monomethyl auristatin F derivative peptide (CN29)
Microtubule (MT)
Lodoacetamido-caproyl
Anti-Her2 WT
ADC Name Payload Target Linker ADC Info
Anti-HER-MC-VC-FABC-MMAE [30]
Monomethyl auristatin E
Microtubule (MT)
Aminooxy-Cys linker
AntiHER-AO-Cys-MC-VC-FABC-MMAE [30]
Monomethyl auristatin E
Microtubule (MT)
Aminooxy-Cys linker
Anti-HER-MC-VC-FABC-FEG8-DollO [30]
DollO
Undisclosed
Aminooxy-Cys linker
Anti-HER-AO-Cys-MC-VC-FABC-FEG8- DollO [30]
DollO
Undisclosed
Aminooxy-Cys linker
Anti-HER2-D265C
ADC Name Payload Target Linker ADC Info
Anti-HER2-D265C-30.2060 [31]
Amanitin 30.206
DNA-directed RNA polymerase II subunit RPB2 (POLR2B); DNA-directed RNA polymerase III subunit RPC7 (POLR3G)
Mc-Val-Ala-PABC
Anti-HER2-D265C-30.2115 [31]
Amanitin 30.2115
DNA-directed RNA polymerase II subunit RPB2 (POLR2B); DNA-directed RNA polymerase III subunit RPC7 (POLR3G)
Mc-Val-Ala-PABC
Anti-HER2-D265C-30.2347 [31]
Amanitin 30.2347
DNA-directed RNA polymerase II subunit RPB2 (POLR2B); DNA-directed RNA polymerase III subunit RPC7 (POLR3G)
Mc-Val-Ala-PABC
Anti-HER2-D265C-30.1699 [31]
Amanitin 30.1699
DNA-directed RNA polymerase II subunit RPB2 (POLR2B); DNA-directed RNA polymerase III subunit RPC7 (POLR3G)
Mc-Val-Ala-PABC
Anti-HER2-D265C-30.2371 [31]
Amanitin 30.2371
DNA-directed RNA polymerase II subunit RPB2 (POLR2B); DNA-directed RNA polymerase III subunit RPC7 (POLR3G)
Mc-Val-Ala-PABC
Anti-HER2-D265C-30.0880 [31]
Amanitin 30.088
DNA-directed RNA polymerase II subunit RPB2 (POLR2B); DNA-directed RNA polymerase III subunit RPC7 (POLR3G)
Maleimido-caproyl
Anti-HER2-D265C-30.2867 [31]
Amanitin 30.2867
DNA-directed RNA polymerase II subunit RPB2 (POLR2B); DNA-directed RNA polymerase III subunit RPC7 (POLR3G)
Maleimido-caproyl
Anti-HER2/neu mAb 4D5
ADC Name Payload Target Linker ADC Info
4D5-AF (CUAAC) [32]
Auristatin F
Microtubule (MT)
N6-(2-azidoethoxy)carbonyl-L-lysine
Anti-Her2Fab
ADC Name Payload Target Linker ADC Info
TWI852077B-J8 [33]
Undisclosed
Undisclosed
Undisclosed
TWI852077B-J13 [33]
Undisclosed
Undisclosed
Undisclosed
Anti-Her2Fab'
ADC Name Payload Target Linker ADC Info
TWI852077B-J6 [33]
Monomethyl auristatin E
Microtubule (MT)
TWI852077B-C1-linker
Anti-human HER2 mAb
ADC Name Payload Target Linker ADC Info
HER2-EC4 DAR7.8 [34]
NAMPT inhibitor 5
Nicotinamide phosphoribosyltransferase (NAMPT)
Open-chain glycine maleimide
HER2-EC5 [34]
NAMPT inhibitor 6
Nicotinamide phosphoribosyltransferase (NAMPT)
Open-chain glycine maleimide-PEG
HER2-EC4 DAR2.7 [34]
NAMPT inhibitor 5
Nicotinamide phosphoribosyltransferase (NAMPT)
Open-chain glycine maleimide
HER2-EC3 [34]
NAMPT inhibitor 4
Nicotinamide phosphoribosyltransferase (NAMPT)
Mc-Val-Ala
HER2-EC1 [34]
NAMPT inhibitor 4
Nicotinamide phosphoribosyltransferase (NAMPT)
Maleimido-caproyl
Anvatabart
ADC Name Payload Target Linker ADC Info
Anvatabart opadotin
Amberstatin 269 (AS269)
Microtubule (MT)
Hydroxylamine-PEG4
Anvatabart pactil [35]
Undisclosed
Undisclosed
Undisclosed
Az-LacNAc-Tras Ab7
ADC Name Payload Target Linker ADC Info
HER2-gsADC-41 [36]
Monomethyl auristatin E
Microtubule (MT)
Bicyclononyne derivative 6e
HER2-gsADC-42 [36]
Monomethyl auristatin E
Microtubule (MT)
PEGylation linker 6l
HER2-gsADC-43 [36]
Monomethyl auristatin E
Microtubule (MT)
PEGylation linker 6m
HER2-gsADC-44 [36]
Monomethyl auristatin E
Microtubule (MT)
Noncleavable linker 6s
HER2-gsADC-45 [36]
Monomethyl auristatin E
Microtubule (MT)
Noncleavable linker 6t
Azido-tagged trastuzumab (Ab2)
ADC Name Payload Target Linker ADC Info
HER2-gsADC-5 [36]
Monomethyl auristatin E
Microtubule (MT)
Azadibenzocylooctyne-amine derivative 6d
HER2-gsADC-6 [36]
Monomethyl auristatin E
Microtubule (MT)
Bicyclononyne derivative 6e
HER2-gsADC-7 [36]
Monomethyl auristatin E
Microtubule (MT)
PEGylation linker 6m
HER2-gsADC-8 [36]
Monomethyl auristatin E
Microtubule (MT)
Glycosyl PEGylation linker 6r
Azido-tagged trastuzumab (Ab3)
ADC Name Payload Target Linker ADC Info
HER2-gsADC-9 [36]
Monomethyl auristatin E
Microtubule (MT)
Linear alkyne 6f
HER2-gsADC-10 [36]
Monomethyl auristatin E
Microtubule (MT)
PEGylation linker 6g
HER2-gsADC-11 [36]
Monomethyl auristatin E
Microtubule (MT)
PEGylation linker 6h
HER2-gsADC-12 [36]
Monomethyl auristatin E
Microtubule (MT)
PEGylation linker 6i
HER2-gsADC-13 [36]
Monomethyl auristatin E
Microtubule (MT)
PEGylation linker 6j
HER2-gsADC-14 [36]
Monomethyl auristatin E
Microtubule (MT)
PEGylation linker 6k
HER2-gsADC-15 [36]
Monomethyl auristatin E
Microtubule (MT)
PEGylation linker 6l
HER2-gsADC-16 [36]
Monomethyl auristatin E
Microtubule (MT)
PEGylation linker 6m
HER2-gsADC-17 [36]
Monomethyl auristatin E
Microtubule (MT)
Noncleavable linker 6t
Azido-tagged trastuzumab (Ab5)
ADC Name Payload Target Linker ADC Info
HER2-gsADC-22 [36]
Monomethyl auristatin E
Microtubule (MT)
Linear alkyne 6f
HER2-gsADC-23 [36]
Monomethyl auristatin E
Microtubule (MT)
PEGylation linker 6g
HER2-gsADC-24 [36]
Monomethyl auristatin E
Microtubule (MT)
PEGylation linker 6h
HER2-gsADC-25 [36]
Monomethyl auristatin E
Microtubule (MT)
PEGylation linker 6i
HER2-gsADC-26 [36]
Monomethyl auristatin E
Microtubule (MT)
PEGylation linker 6j
HER2-gsADC-27 [36]
Monomethyl auristatin E
Microtubule (MT)
PEGylation linker 6k
HER2-gsADC-28 [36]
Monomethyl auristatin E
Microtubule (MT)
PEGylation linker 6l
HER2-gsADC-29 [36]
Monomethyl auristatin E
Microtubule (MT)
PEGylation linker 6m
HER2-gsADC-30 [36]
Monomethyl auristatin E
Microtubule (MT)
Glycosyl PEGylation linker 6o
HER2-gsADC-31 [36]
Monomethyl auristatin E
Microtubule (MT)
Glycosyl PEGylation linker 6p
HER2-gsADC-32 [36]
Monomethyl auristatin E
Microtubule (MT)
Glycosyl PEGylation linker 6q
HER2-gsADC-33 [36]
Monomethyl auristatin E
Microtubule (MT)
Glycosyl PEGylation linker 6r
Azido-tagged trastuzumab (Ab6)
ADC Name Payload Target Linker ADC Info
HER2-gsADC-34 [36]
Monomethyl auristatin E
Microtubule (MT)
Linear alkyne 6f
HER2-gsADC-35 [36]
Monomethyl auristatin E
Microtubule (MT)
PEGylation linker 6g
HER2-gsADC-36 [36]
Monomethyl auristatin E
Microtubule (MT)
PEGylation linker 6h
HER2-gsADC-37 [36]
Monomethyl auristatin E
Microtubule (MT)
PEGylation linker 6i
HER2-gsADC-38 [36]
Monomethyl auristatin E
Microtubule (MT)
PEGylation linker 6j
HER2-gsADC-39 [36]
Monomethyl auristatin E
Microtubule (MT)
PEGylation linker 6k
HER2-gsADC-40 [36]
Monomethyl auristatin E
Microtubule (MT)
PEGylation linker 6l
ADC Name Payload Target Linker ADC Info
B2-MMAE [37]
Monomethyl auristatin E
Microtubule (MT)
Mc-Val-Cit-PABC
BA-130-00-01
ADC Name Payload Target Linker ADC Info
LC A032D/HC [38]
LC A032D/HC payload
Undisclosed
LC A032D/HC linker
BA-130-03-02
ADC Name Payload Target Linker ADC Info
LC A032D/HC Y052K [38]
LC A032D/HC Y052K payload
Undisclosed
LC A032D/HC Y052K linker
BA-130-03-05
ADC Name Payload Target Linker ADC Info
LC A032D/HC G056K [38]
LC A032D/HC G056K payload
Undisclosed
LC A032D/HC G056K linker
BA-130-03-06
ADC Name Payload Target Linker ADC Info
LC A032D/HC T058D [38]
LC A032D/HC T058D payload
Undisclosed
LC A032D/HC T058D linker
BA-130-03-07
ADC Name Payload Target Linker ADC Info
LC A032D/HC A106E [38]
LC A032D/HC A106E payload
Undisclosed
LC A032D/HC A106E linker
BA-130-03-08
ADC Name Payload Target Linker ADC Info
LC A032D/HC S119E [38]
LC A032D/HC S119E payload
Undisclosed
LC A032D/HC S119E linker
ADC Name Payload Target Linker ADC Info
Trastuzumab pamirtecan
P1003
DNA topoisomerase 1 (TOP1)
Mc-Gly-Gly-Phe-Gly
ADC Name Payload Target Linker ADC Info
BAT8001
Batansine
Microtubule (MT)
Maleimido-caproyl
ADC Name Payload Target Linker ADC Info
HER2 KSP-ADC 1.1 [39]
Pyrrole based kinesin spindle protein inhibitor
Kinesin-like protein KIF11 (KIF11)
Kinesin spindle protein inhibitor (KSPi)-ADC linker 1
HER2 KSP-ADC 1.2 [39]
Pyrrole based kinesin spindle protein inhibitor
Kinesin-like protein KIF11 (KIF11)
Kinesin spindle protein inhibitor (KSPi)-ADC linker 2
HER2 KSP-ADC 1.3 [39]
Pyrrole based kinesin spindle protein inhibitor
Kinesin-like protein KIF11 (KIF11)
Kinesin spindle protein inhibitor (KSPi)-ADC linker 3
HER2 KSP-ADC 1.4 [39]
Pyrrole based kinesin spindle protein inhibitor
Kinesin-like protein KIF11 (KIF11)
Kinesin spindle protein inhibitor (KSPi)-ADC linker 4
HER2 KSP-ADC 2.1 [39]
Pyrrole based kinesin spindle protein inhibitor
Kinesin-like protein KIF11 (KIF11)
Kinesin spindle protein inhibitor (KSPi)-ADC linker 5
HER2 KSP-ADC 2.2 [39]
Pyrrole based kinesin spindle protein inhibitor
Kinesin-like protein KIF11 (KIF11)
Kinesin spindle protein inhibitor (KSPi)-ADC linker 6
ADC Name Payload Target Linker ADC Info
BB02E-MMAE [40]
Monomethyl auristatin E
Microtubule (MT)
Mc-Val-Cit-PABC
ADC Name Payload Target Linker ADC Info
BB03E-MMAE [40]
Monomethyl auristatin E
Microtubule (MT)
Mc-Val-Cit-PABC
ADC Name Payload Target Linker ADC Info
BB03E-A-MMAE [40]
Monomethyl auristatin E
Microtubule (MT)
Mc-Val-Cit-PABC
ADC Name Payload Target Linker ADC Info
BB04E-MMAE [40]
Monomethyl auristatin E
Microtubule (MT)
Mc-Val-Cit-PABC
ADC Name Payload Target Linker ADC Info
BB05E-MMAE [40]
Monomethyl auristatin E
Microtubule (MT)
Mc-Val-Cit-PABC
BCN-trastuzumab tras-v1a-145
ADC Name Payload Target Linker ADC Info
Trast-v1a-145-PF03 [41]
Undisclosed
Undisclosed
Undisclosed
Trast-v1a-145-PF09 [41]
Undisclosed
Undisclosed
Undisclosed
Trast-v1a-145-PF12 [41]
Undisclosed
Undisclosed
Undisclosed
Trast-v1a-145-PF13 [41]
Undisclosed
Undisclosed
Undisclosed
Trast-v1a-145-PF17 [41]
Undisclosed
Undisclosed
Undisclosed
Tras-v1a-145-PF19 [41]
Undisclosed
Undisclosed
Undisclosed
Trast-v1a-145-PF21 [41]
Undisclosed
Undisclosed
Undisclosed
bis-azido-trastuzumab tras-v1a
ADC Name Payload Target Linker ADC Info
Tras-v1a-PF29 [41]
Undisclosed
Undisclosed
Undisclosed
bis-azido-trastuzumab trast-v1a
ADC Name Payload Target Linker ADC Info
Trast-v1a-PF22 [41]
Undisclosed
Undisclosed
Undisclosed
Rit-v1a-145-PF22 [41]
Undisclosed
Undisclosed
Undisclosed
Trast-v1a-PF23 [41]
Undisclosed
Undisclosed
Undisclosed
Trast-v1a- (PF07)2 [41]
Undisclosed
Undisclosed
Undisclosed
Trast-v1a- (PF10)2 [41]
Undisclosed
Undisclosed
Undisclosed
Trast-v1a- (PF11)2 [41]
Undisclosed
Undisclosed
Undisclosed
Trast-v1a- (PF14)2 [41]
Undisclosed
Undisclosed
Undisclosed
Trast-v1a- (PF15)2 [41]
Undisclosed
Undisclosed
Undisclosed
Trast-v1a-145-PF27 [41]
Undisclosed
Undisclosed
Undisclosed
Trast-v1a- (PF20)2 [41]
Undisclosed
Undisclosed
Undisclosed
CHO-G2F-Tras (Ab4)
ADC Name Payload Target Linker ADC Info
HER2-gsADC-18 [36]
Monomethyl auristatin E
Microtubule (MT)
ThioPz linker 6a
HER2-gsADC-19 [36]
Monomethyl auristatin E
Microtubule (MT)
2-Aminobenzamide oxime
HER2-gsADC-20 [36]
Monomethyl auristatin E
Microtubule (MT)
Hydroxylamine derivative 6c
HER2-gsADC-21 [36]
Monomethyl auristatin E
Microtubule (MT)
PEGylation linker 6n
CHO-S2G2F-Tras (Ab1)
ADC Name Payload Target Linker ADC Info
HER2-gsADC-1 [36]
Monomethyl auristatin E
Microtubule (MT)
ThioPz linker 6a
HER2-gsADC-2 [36]
Monomethyl auristatin E
Microtubule (MT)
2-Aminobenzamide oxime
HER2-gsADC-3 [36]
Monomethyl auristatin E
Microtubule (MT)
Hydroxylamine derivative 6c
HER2-gsADC-4 [36]
Monomethyl auristatin E
Microtubule (MT)
PEGylation linker 6n
CN105828840B_ADC-102 antibody
ADC Name Payload Target Linker ADC Info
CN105828840B ADC-102 [42]
CN105828840B_ADC-102 payload
Undisclosed
CN105828840B_ADC-102 linker
CN105828840B_ADC-103 antibody
ADC Name Payload Target Linker ADC Info
CN105828840B ADC-103 [42]
CN105828840B_ADC-103 payload
Undisclosed
CN105828840B_ADC-103 linker
CN105828840B_ADC-105 antibody
ADC Name Payload Target Linker ADC Info
CN105828840B ADC-105 [42]
CN105828840B_ADC-105 payload
Undisclosed
CN105828840B_ADC-105 linker
CN105828840B_ADC-106 antibody
ADC Name Payload Target Linker ADC Info
CN105828840B ADC-106 [42]
CN105828840B_ADC-106 payload
Undisclosed
CN105828840B_ADC-106 linker
CN105828840B_ADC-107 antibody
ADC Name Payload Target Linker ADC Info
CN105828840B ADC-107 [42]
CN105828840B_ADC-107 payload
Undisclosed
CN105828840B_ADC-107 linker
CN105828840B_ADC-109 antibody
ADC Name Payload Target Linker ADC Info
CN105828840B ADC-109 [42]
CN105828840B_ADC-109 payload
Undisclosed
CN105828840B_ADC-109 linker
CN105828840B_ADC-112 antibody
ADC Name Payload Target Linker ADC Info
CN105828840B ADC-112 [42]
CN105828840B_ADC-112 payload
Undisclosed
CN105828840B_ADC-112 linker
CN105828840B_ADC-113 antibody
ADC Name Payload Target Linker ADC Info
CN105828840B ADC-113 [42]
CN105828840B_ADC-113 payload
Undisclosed
CN105828840B_ADC-113 linker
CN105828840B_ADC-114 antibody
ADC Name Payload Target Linker ADC Info
CN105828840B ADC-114 [42]
CN105828840B_ADC-114 payload
Undisclosed
CN105828840B_ADC-114 linker
CN105828840B_ADC-117 antibody
ADC Name Payload Target Linker ADC Info
CN105828840B ADC-117 [42]
CN105828840B_ADC-117 payload
Undisclosed
CN105828840B_ADC-117 linker
CN105828840B_ADC-118 antibody
ADC Name Payload Target Linker ADC Info
CN105828840B ADC-118 [42]
CN105828840B_ADC-118 payload
Undisclosed
CN105828840B_ADC-118 linker
CN105828840B_ADC-119 antibody
ADC Name Payload Target Linker ADC Info
CN105828840B ADC-119 [42]
CN105828840B_ADC-119 payload
Undisclosed
CN105828840B_ADC-119 linker
CN105828840B_ADC-121 antibody
ADC Name Payload Target Linker ADC Info
CN105828840B ADC-121 [42]
CN105828840B_ADC-121 payload
Undisclosed
CN105828840B_ADC-121 linker
CN105828840B_ADC-123 antibody
ADC Name Payload Target Linker ADC Info
CN105828840B ADC-123 [42]
CN105828840B_ADC-123 payload
Undisclosed
CN105828840B_ADC-123 linker
Coprelotamab
ADC Name Payload Target Linker ADC Info
Coprelotamab-ADC-Tb3-1 [7]
Coprelotamab-ADC-Tb3-1 payload
Undisclosed
Coprelotamab-ADC-Tb3-1 linker
Coprelotamab-ADC-Tb3-2 [7]
Coprelotamab-ADC-Tb3-2 payload
Undisclosed
Coprelotamab-ADC-Tb3-2 linker
Coprelotamab-ADC-Tb3-3 [7]
Coprelotamab-ADC-Tb3-3 payload
Undisclosed
Coprelotamab-ADC-Tb3-3 linker
Coprelotamab-ADC-Tb3-4 [7]
Coprelotamab-ADC-Tb3-4 payload
Undisclosed
Coprelotamab-ADC-Tb3-4 linker
Coprelotamab-ADC-Tb3-5 [7]
Coprelotamab-ADC-Tb3-5 payload
Undisclosed
Coprelotamab-ADC-Tb3-5 linker
Coprelotamab-ADC-Tb3-6 [7]
Coprelotamab-ADC-Tb3-6 payload
Undisclosed
Coprelotamab-ADC-Tb3-6 linker
Coprelotamab-ADC-Tb3-7 [7]
Coprelotamab-ADC-Tb3-7 payload
Undisclosed
Coprelotamab-ADC-Tb3-7 linker
Coprelotamab-ADC-Tb3-8 [7]
Coprelotamab-ADC-Tb3-8 payload
Undisclosed
Coprelotamab-ADC-Tb3-8 linker
Coprelotamab-ADC-Tb3-9 [7]
Coprelotamab-ADC-Tb3-9 payload
Undisclosed
Coprelotamab-ADC-Tb3-9 linker
Coprelotamab-ADC-Tb3-10 [7]
Coprelotamab-ADC-Tb3-10 payload
Undisclosed
Coprelotamab-ADC-Tb3-10 linker
Cys-mutant trastuzumab
ADC Name Payload Target Linker ADC Info
Cys-mutant trastuzumab-biotin [43]
Biotin
Undisclosed
Undisclosed
degly-ISOmAb
ADC Name Payload Target Linker ADC Info
Degly-ISOmAb-1-mc-vc-PAB-MMAE [44]
Monomethyl auristatin E
Microtubule (MT)
Mc-Val-Cit-PABC
degly-mAb1
ADC Name Payload Target Linker ADC Info
Degly-mAb1-1-mc-vc-PAB-MMAE [44]
Monomethyl auristatin E
Microtubule (MT)
Mc-Val-Cit-PABC
ADC Name Payload Target Linker ADC Info
177Lu-CHX-A"-DTPA-PODS-DVD [45]
Lutetium-177
Undisclosed
PODS-CHX-A"-DTPA
ADC Name Payload Target Linker ADC Info
DX126-262
Tub114
Microtubule (MT)
Mal-PEG10 based linker
Enfertuzumab
ADC Name Payload Target Linker ADC Info
Enfertuzumab-compound 1100 [46]
Undisclosed
Undisclosed
Undisclosed
Enfertuzumab-compound 1101 [46]
Undisclosed
Undisclosed
Undisclosed
Enfertuzumab-compound 1102 [46]
Undisclosed
Undisclosed
Undisclosed
Enfertuzumab-compound 1103 [46]
Undisclosed
Undisclosed
Undisclosed
Enfertuzumab-compound 1574 [46]
Undisclosed
Undisclosed
Undisclosed
Enfertuzumab-compound 1105 [46]
Undisclosed
Undisclosed
Undisclosed
Enfertuzumab-compound 1106 [46]
Undisclosed
Undisclosed
Undisclosed
Enfertuzumab-compound 1199 [46]
Undisclosed
Undisclosed
Undisclosed
Engineered trastuzumab
ADC Name Payload Target Linker ADC Info
Trastuzumab-C239I-SG3600 [47]
N10-beta-glucuronide SG3200
Human Deoxyribonucleic acid (hDNA)
Mal-PEG8-Val-Ala-PABC
Trastuzumab-C239I-SG3400 [47]
SG3200
Human Deoxyribonucleic acid (hDNA)
Mal-PEG8-Val-Ala-PABC
Engineered HER-SG3227 [48]
SG2219
Human Deoxyribonucleic acid (hDNA)
Acetamide-PEG4-Val-Ala-PABA
ADC Name Payload Target Linker ADC Info
FM2b-F-D2 [49]
Monomethyl auristatin E
Microtubule (MT)
Mc-Val-Cit-PABC
ADC Name Payload Target Linker ADC Info
FM2b-K-D2 [49]
Monomethyl auristatin E
Microtubule (MT)
Mc-Val-Cit-PABC
ADC Name Payload Target Linker ADC Info
FM2b-S-D2 [49]
Monomethyl auristatin E
Microtubule (MT)
Mc-Val-Cit-PABC
ADC Name Payload Target Linker ADC Info
FM2b-Y-D2 [49]
Monomethyl auristatin E
Microtubule (MT)
Mc-Val-Cit-PABC
Gancotamab
ADC Name Payload Target Linker ADC Info
Gancotamab-ADC-Tb3-1 [7]
Gancotamab-ADC-Tb3-1 payload
Undisclosed
Gancotamab-ADC-Tb3-1 linker
Gancotamab-ADC-Tb3-2 [7]
Gancotamab-ADC-Tb3-2 payload
Undisclosed
Gancotamab-ADC-Tb3-2 linker
Gancotamab-ADC-Tb3-3 [7]
Gancotamab-ADC-Tb3-3 payload
Undisclosed
Gancotamab-ADC-Tb3-3 linker
Gancotamab-ADC-Tb3-4 [7]
Gancotamab-ADC-Tb3-4 payload
Undisclosed
Gancotamab-ADC-Tb3-4 linker
Gancotamab-ADC-Tb3-5 [7]
Gancotamab-ADC-Tb3-5 payload
Undisclosed
Gancotamab-ADC-Tb3-5 linker
Gancotamab-ADC-Tb3-6 [7]
Gancotamab-ADC-Tb3-6 payload
Undisclosed
Gancotamab-ADC-Tb3-6 linker
Gancotamab-ADC-Tb3-7 [7]
Gancotamab-ADC-Tb3-7 payload
Undisclosed
Gancotamab-ADC-Tb3-7 linker
Gancotamab-ADC-Tb3-8 [7]
Gancotamab-ADC-Tb3-8 payload
Undisclosed
Gancotamab-ADC-Tb3-8 linker
Gancotamab-ADC-Tb3-9 [7]
Gancotamab-ADC-Tb3-9 payload
Undisclosed
Gancotamab-ADC-Tb3-9 linker
Gancotamab-ADC-Tb3-10 [7]
Gancotamab-ADC-Tb3-10 payload
Undisclosed
Gancotamab-ADC-Tb3-10 linker
GGG-IL15Ralpha-IL15 208
ADC Name Payload Target Linker ADC Info
BCN-PEG12-IL15Ralpha-IL15 [41]
Undisclosed
Undisclosed
Undisclosed
ADC Name Payload Target Linker ADC Info
WO2022228495A1 ADC-73 [50]
WO2022228495A1 ADC-73 payload
Undisclosed
WO2022228495A1 ADC-73 linker
H01L02-Dxd [51]
DX-8951 derivative (DXd)
DNA topoisomerase 1 (TOP1)
Mc-Gly-Gly-Phe-Gly
ADC Name Payload Target Linker ADC Info
H02L02-Dxd [51]
DX-8951 derivative (DXd)
DNA topoisomerase 1 (TOP1)
Mc-Gly-Gly-Phe-Gly
ADC Name Payload Target Linker ADC Info
H02L03-Dxd [51]
DX-8951 derivative (DXd)
DNA topoisomerase 1 (TOP1)
Mc-Gly-Gly-Phe-Gly
ADC Name Payload Target Linker ADC Info
H04L02-Dxd [51]
DX-8951 derivative (DXd)
DNA topoisomerase 1 (TOP1)
Mc-Gly-Gly-Phe-Gly
HER2 (L328C)
ADC Name Payload Target Linker ADC Info
anti-HER2 Ab (L328C)-vcMMAE [52]
Monomethyl auristatin E
Microtubule (MT)
Mc-Val-Cit-PABC
HER2-C Anti-ody
ADC Name Payload Target Linker ADC Info
HER2-C Antibody-Compound (X) [53]
HER2-C Antibody-Compound (X) payload
Undisclosed
HER2-C Antibody-Compound (X) linker
HER2-C Antibody-Compound (XI) [53]
HER2-C Antibody-Compound (XI) payload
Undisclosed
HER2-C Antibody-Compound (XI) linker
HER2-C Antibody-Compound (XIV) [53]
HER2-C Antibody-Compound (XIV) payload
Undisclosed
HER2-C Antibody-Compound (XIV) linker
HER2-C Antibody-Compound (XVIII) [53]
HER2-C Antibody-Compound (XVIII) payload
Undisclosed
HER2-C Antibody-Compound (XVIII) linker
HER2-C Antibody-Compound (Ie) [53]
HER2-C Antibody-Compound (Ie) payload
Undisclosed
HER2-C Antibody-Compound (Ie) linker
HER2-C Antibody-Compound (XIX) [53]
HER2-C Antibody-Compound (XIX) payload
Undisclosed
HER2-C Antibody-Compound (XIX) linker
HER2-C Antibody-Compound (Ii) [53]
HER2-C Antibody-Compound (Ii) payload
Undisclosed
HER2-C Antibody-Compound (Ii) linker
HER2-C Antibody-Compound (XLI) [53]
HER2-C Antibody-Compound (XLI) payload
Undisclosed
HER2-C Antibody-Compound (XLI) linker
HER2-C Antibody-Compound (XVI) [53]
HER2-C Antibody-Compound (XIX) payload
Undisclosed
HER2-C Antibody-Compound (XIX) linker
HER2-C Antibody-Compound (XL) [53]
HER2-C Antibody-Compound (XL) payload
Undisclosed
HER2-C Antibody-Compound (XL) linker
HER2-C Antibody-Compound (XLIII) [53]
HER2-C Antibody-Compound (XLIII) payload
Undisclosed
HER2-C Antibody-Compound (XLIII) linker
HER2-C Antibody-Compound (XLII) [53]
HER2-C Antibody-Compound (XLII) payload
Undisclosed
HER2-C Antibody-Compound (XLII) linker
HER2-C Antibody-Compound (XV) [53]
HER2-C Antibody-Compound (XV) payload
Undisclosed
HER2-C Antibody-Compound (XV) linker
Her2-PT-A114C-hGl
ADC Name Payload Target Linker ADC Info
Her2-PT-A114C-hGl- LP2 [54]
Undisclosed
Undisclosed
Undisclosed
Her2-PT-A114C-hGl-LP48 [54]
Undisclosed
Undisclosed
Undisclosed
Her2-PT-H16-K222R-hG1
ADC Name Payload Target Linker ADC Info
Her2-PT-H16-K222R- hG1-LP1 [54]
Undisclosed
Undisclosed
Undisclosed
Her2-PT-H16-K222R- hGl-LP13 [54]
Undisclosed
Undisclosed
Undisclosed
Her2-PT-H16-K222R- hGl-LP49 [54]
Undisclosed
Undisclosed
Undisclosed
Her2-PT-H16-K222R- hGl-LP19 [54]
Undisclosed
Undisclosed
Undisclosed
Her2-PT-H16-K222R-Hg1
ADC Name Payload Target Linker ADC Info
Her2-PT-H16-K222R- hG1-LP6 [54]
Undisclosed
Undisclosed
Undisclosed
Her2-PT-H7C-K222R-hGl
ADC Name Payload Target Linker ADC Info
Her2-PT-H7C-K222R- hGl-LP19 [54]
Undisclosed
Undisclosed
Undisclosed
Her2-PT-LCQ05- K222R-hGl
ADC Name Payload Target Linker ADC Info
Her2-PT-LCQ05- K222R-hGl-LP19 [54]
Undisclosed
Undisclosed
Undisclosed
Hertuzumab
ADC Name Payload Target Linker ADC Info
Disitamab vedotin
Monomethyl auristatin E
Microtubule (MT)
Mc-Val-Cit-PABC
Hertuzumab vedotin [55]
Monomethyl auristatin E
Microtubule (MT)
Mc-Val-Cit-PABC
Disitamab-ADC-Tb3-1 [7]
Disitamab-ADC-Tb3-1 payload
Undisclosed
Disitamab-ADC-Tb3-1 linker
Disitamab-ADC-Tb3-2 [7]
Disitamab-ADC-Tb3-2 payload
Undisclosed
Disitamab-ADC-Tb3-2 linker
Disitamab-ADC-Tb3-3 [7]
Disitamab-ADC-Tb3-3 payload
Undisclosed
Disitamab-ADC-Tb3-3 linker
Disitamab-ADC-Tb3-4 [7]
Disitamab-ADC-Tb3-4 payload
Undisclosed
Disitamab-ADC-Tb3-4 linker
Disitamab-ADC-Tb3-5 [7]
Disitamab-ADC-Tb3-5 payload
Undisclosed
Disitamab-ADC-Tb3-5 linker
Disitamab-ADC-Tb3-6 [7]
Disitamab-ADC-Tb3-6 payload
Undisclosed
Disitamab-ADC-Tb3-6 linker
Disitamab-ADC-Tb3-7 [7]
Disitamab-ADC-Tb3-7 payload
Undisclosed
Disitamab-ADC-Tb3-7 linker
Disitamab-ADC-Tb3-8 [7]
Disitamab-ADC-Tb3-8 payload
Undisclosed
Disitamab-ADC-Tb3-8 linker
Disitamab-ADC-Tb3-9 [7]
Disitamab-ADC-Tb3-9 payload
Undisclosed
Disitamab-ADC-Tb3-9 linker
Disitamab-ADC-Tb3-10 [7]
Disitamab-ADC-Tb3-10 payload
Undisclosed
Disitamab-ADC-Tb3-10 linker
HMA000352
ADC Name Payload Target Linker ADC Info
HMPL-A251
HM5041609
PI3K; PIKK
A cleavable linker
ADC Name Payload Target Linker ADC Info
WO2024140447A1 ADC 1 [56]
WO2024140447A1 ADC 1 Payload
Undisclosed
WO2024140447A1 ADC 1 Linker
WO2024140447A1 ADC 3
WO2024140447A1 ADC 1 Payload
Undisclosed
WO2024140447A1 ADC 3 Linker
WO2024140447A1 ADC 5
WO2024140447A1 ADC 1 Payload
Undisclosed
WO2024140447A1 ADC 4 Linker
WO2024140447A1 ADC 7
WO2024140447A1 ADC 1 Payload
Undisclosed
WO2024140447A1 ADC 7 Linker
WO2024140447A1 ADC 9
WO2024140447A1 ADC 1 Payload
Undisclosed
WO2024140447A1 ADC 9 Linker
WO2024140447A1 ADC 11
WO2024140447A1 ADC 1 Payload
Undisclosed
WO2024140447A1 ADC 11 Linker
WO2024140447A1 ADC 13
WO2024140447A1 ADC 13 Payload
Undisclosed
WO2024140447A1 ADC 13 Linker
WO2024140447A1 ADC 15
WO2024140447A1 ADC 13 Payload
Undisclosed
WO2024140447A1 ADC 15 Linker
WO2024140447A1 ADC 17
WO2024140447A1 ADC 13 Payload
Undisclosed
WO2024140447A1 ADC 17 Linker
WO2024140447A1 ADC 19
WO2024140447A1 ADC 13 Payload
Undisclosed
WO2024140447A1 ADC 3 Linker
WO2024140447A1 ADC 21
WO2024140447A1 ADC 13 Payload
Undisclosed
WO2024140447A1 ADC 21 Linker
WO2024140447A1 ADC 23
WO2024140447A1 ADC 13 Payload
Undisclosed
WO2024140447A1 ADC 23 Linker
WO2024140447A1 ADC 25
WO2024140447A1 ADC 1 Payload
Undisclosed
WO2024140447A1 ADC 25 Linker
WO2024140450A1 7-[N- (HS627-mc-Gly-Gly-Phe-Gly-ha-Ac), N- (S)-methoxyisopropyl]aminomethyl-10,11-methylenedioxycamptothecin [57]
Undisclosed
Undisclosed
Undisclosed
WO2024140450A1 7-[N- (HS627-Ac-PEG2-Val-Ala-PABC), N- (S)-methoxyisopropyl]aminomethyl-10,11-methylenedioxycamptothecin [57]
Undisclosed
Undisclosed
Undisclosed
WO2024140450A1 7-[N- (HS627-Ac-PEG2-Gly-Gly-Leu-Gly-ha-Ac), N- (S)-methyl-2-oxoethyl]-10,11-methylenedi-10,11-dihydroxycamptothecin [57]
Undisclosed
Undisclosed
Undisclosed
WO2024140450A1 7-[N- (HS627-Ac-PEG2-Val-Ala-PABC), N-methoxyethyl]aminoethyl-10,11-methylenedioxycamptothecin [57]
Undisclosed
Undisclosed
Undisclosed
WO2024140450A1 7-[N- (HS627-Ac-PEG2-Gly-Gly-Leu-Gly-ha-Ac), N-methoxyethyl]aminoethyl-10,11-methylenedi-6-mercaptopurine [57]
Undisclosed
Undisclosed
Undisclosed
WO2024140450A1 7-[N- (HS627-Ac-PEG2-Gly-Gly-Lys-Gly-ha-Ac), N- (S)-methylisopropyl]aminoethyl-10,11-methylenedi-10,11-ethenylhyerocytosine [57]
Undisclosed
Undisclosed
Undisclosed
WO2024140450A1 7-[N- (HS627-Ac-PEG2-Gly-Lys-PABC), N- (S)-methylisopropyl]aminoethyl-10,11-methylenedi-10,11-ethenylhydragranin 4.3 [57]
Undisclosed
Undisclosed
Undisclosed
HS627 ADC1 [58]
Undisclosed
Undisclosed
Undisclosed
HS627 ADC2 [58]
Undisclosed
Undisclosed
Undisclosed
HS627 ADC3 [58]
Undisclosed
Undisclosed
Undisclosed
CN116785448A ADC1 [59]
CN116785448A ADC1 payload
Undisclosed
CN116785448A ADC8 linker
CN116785448A ADC2 [59]
CN116785448A ADC2 payload
Undisclosed
CN116785448A ADC2 linker
CN116785448A ADC3 [59]
CN116785448A ADC5 payload
Undisclosed
CN116785448A ADC8 linker
CN116785448A ADC4 [59]
CN116785448A ADC4 payload
Undisclosed
CN116785448A ADC4 linker
CN116785448A ADC5 [59]
CN116785448A ADC5 payload
Undisclosed
CN116785448A ADC5 linker
CN116785448A ADC6 [59]
CN116785448A ADC6 payload
Undisclosed
CN116785448A ADC6 linker
CN116785448A ADC7 [59]
CN116785448A ADC7 payload
Undisclosed
CN116785448A ADC7 linker
CN116785448A ADC8 [59]
CN116785448A ADC8 payload
Undisclosed
CN116785448A ADC8 linker
HS627- (C1)2 [60]
undisclosed
Undisclosed
Undisclosed
HS627- (C1)4 [60]
undisclosed
Undisclosed
Undisclosed
(C6)4-HS627- (C1)2 [60]
undisclosed
Undisclosed
Undisclosed
HS627- (C2)2 [60]
undisclosed
Undisclosed
Undisclosed
HS627- (C4)4 3.8 [60]
undisclosed
Undisclosed
Undisclosed
(C0)4-HS627- (C2)2 [60]
undisclosed
Undisclosed
Undisclosed
HS627- (C3)2 [60]
undisclosed
Undisclosed
Undisclosed
HS627- (C3)4 [60]
undisclosed
Undisclosed
Undisclosed
(C0)4-HS627- (C3)2 [60]
undisclosed
Undisclosed
Undisclosed
HS627- (C4)2 [60]
undisclosed
Undisclosed
Undisclosed
HS627- (C4)4 3.7 [60]
undisclosed
Undisclosed
Undisclosed
(C6)4-HS627- (C4)2 [60]
undisclosed
Undisclosed
Undisclosed
HS627- (C5)2 [60]
undisclosed
Undisclosed
Undisclosed
HS627- (C5)4 [60]
undisclosed
Undisclosed
Undisclosed
(C0)4-HS627- (C5)2 [60]
undisclosed
Undisclosed
Undisclosed
HS627- (C6)2 [60]
undisclosed
Undisclosed
Undisclosed
HS627- (C6)4 [60]
undisclosed
Undisclosed
Undisclosed
(C0)4-HS627- (C6)2 [60]
undisclosed
Undisclosed
Undisclosed
HS627- (C7)2 [60]
undisclosed
Undisclosed
Undisclosed
HS627- (C7)4 [60]
undisclosed
Undisclosed
Undisclosed
(C6)4-HS627- (C7)2 [60]
undisclosed
Undisclosed
Undisclosed
HS627- (C8)2 [60]
undisclosed
Undisclosed
Undisclosed
HS627- (C8)4 [60]
undisclosed
Undisclosed
Undisclosed
(C0)4-HS627- (C8)2 [60]
undisclosed
Undisclosed
Undisclosed
ADC Name Payload Target Linker ADC Info
hSD5-vedotin [61]
Monomethyl auristatin E
Microtubule (MT)
Mc-Val-Cit-PABC
ADC Name Payload Target Linker ADC Info
XMT-2056
STING agonist
Stimulator of interferon genes protein (STING1)
Hydrophilic linker of XMT-2056
hu4DFabv7
ADC Name Payload Target Linker ADC Info
hu4DFabv7-BMPEO-DM1 [14]
Maytansinoid DM1
Microtubule (MT)
hu4DFabv7-BMPEO-DM1 linker
hu4DFabv8 (A121C)
ADC Name Payload Target Linker ADC Info
hu4DFabv8 (A121C)-BMPEO-DM1 [14]
Maytansinoid DM1
Microtubule (MT)
hu4DFabv8 (A121C)-BMPEO-DM1 linker
hu4DFabv8 (H-A175C)
ADC Name Payload Target Linker ADC Info
hu4DFabv8 (H-A175C)-BMPEO-DM1 [14]
Maytansinoid DM1
Microtubule (MT)
hu4DFabv8 (H-A175C)-BMPEO-DM1 linker
hu4DFabv8 (H-A40C)
ADC Name Payload Target Linker ADC Info
hu4DFabv8 (H-A40C)-BMPEO-DM1 [14]
Maytansinoid DM1
Microtubule (MT)
hu4DFabv8 (H-A40C)-BMPEO-DM1 linker
hu4DFabv8 (H-A88C)
ADC Name Payload Target Linker ADC Info
hu4DFabv8 (H-A88C)-BMPEO-DM1 [14]
Maytansinoid DM1
Microtubule (MT)
hu4DFabv8 (H-A88C)-BMPEO-DM1 linker
hu4DFabv8 (H-S119C)
ADC Name Payload Target Linker ADC Info
hu4DFabv8 (H-S119C)-BMPEO-DM1 [14]
Maytansinoid DM1
Microtubule (MT)
hu4DFabv8 (H-S119C)-BMPEO-DM1 linker
hu4DFabv8 (H-S122C)
ADC Name Payload Target Linker ADC Info
hu4DFabv8 (H-S122C)-BMPEO-DM1 [14]
Maytansinoid DM1
Microtubule (MT)
hu4DFabv8 (H-S122C)-BMPEO-DM1 linker
hu4DFabv8 (H-S179C)
ADC Name Payload Target Linker ADC Info
hu4DFabv8 (H-S179C)-BMPEO-DM1 [14]
Maytansinoid DM1
Microtubule (MT)
hu4DFabv8 (H-S179C)-BMPEO-DM1 linker
hu4DFabv8 (L-A144C)
ADC Name Payload Target Linker ADC Info
hu4DFabv8 (L-A144C)-BMPEO-DM1 [14]
Maytansinoid DM1
Microtubule (MT)
hu4DFabv8 (L-A144C)-BMPEO-DM1 linker
hu4DFabv8 (L-A43C)
ADC Name Payload Target Linker ADC Info
hu4DFabv8 (L-A43C)-BMPEO-DM1 [14]
Maytansinoid DM1
Microtubule (MT)
hu4DFabv8 (L-A43C)-BMPEO-DM1 linker
hu4DFabv8 (L-S168C)
ADC Name Payload Target Linker ADC Info
hu4DFabv8 (L-S168C)-BMPEO-DM1 [14]
Maytansinoid DM1
Microtubule (MT)
hu4DFabv8 (L-S168C)-BMPEO-DM1 linker
hu4DFabv8 (L-V15C)
ADC Name Payload Target Linker ADC Info
hu4DFabv8 (L-V15C)-BMPEO-DM1 [14]
Maytansinoid DM1
Microtubule (MT)
hu4DFabv8 (L-V15C)-BMPEO-DM1 linker
hu4DFabv8 (V110C)
ADC Name Payload Target Linker ADC Info
hu4DFabv8 (V110C)-BMPEO-DM1 [14]
Maytansinoid DM1
Microtubule (MT)
hu4DFabv8 (V110C)-BMPEO-DM1 linker
hu4DFabv8 (V110C)-MC-MMAF [14]
Monomethyl auristatin F
Microtubule (MT)
Maleimido-caproyl
hu4DFabv8 (V110C)-MC-MMAE [14]
Monomethyl auristatin E
Microtubule (MT)
Maleimido-caproyl
hu4DFabv8 (V110C)-MC-Val-Cit-PAB-MMAF [14]
Monomethyl auristatin F
Microtubule (MT)
Mc-Val-Cit-PABC
hu4DFabv8 (V110C)-MC-Val-Cit-PAB-MMAE [14]
Monomethyl auristatin E
Microtubule (MT)
Mc-Val-Cit-PABC
ADC Name Payload Target Linker ADC Info
WO2024140447A1 ADC 2
WO2024140447A1 ADC 1 Payload
Undisclosed
WO2024140447A1 ADC 1 Linker
WO2024140447A1 ADC 4
WO2024140447A1 ADC 1 Payload
Undisclosed
Undisclosed
WO2024140447A1 ADC 6
WO2024140447A1 ADC 1 Payload
Undisclosed
WO2024140447A1 ADC 4 Linker
WO2024140447A1 ADC 8
WO2024140447A1 ADC 1 Payload
Undisclosed
WO2024140447A1 ADC 7 Linker
WO2024140447A1 ADC 10
WO2024140447A1 ADC 1 Payload
Undisclosed
WO2024140447A1 ADC 9 Linker
WO2024140447A1 ADC 12
WO2024140447A1 ADC 1 Payload
Undisclosed
WO2024140447A1 ADC 11 Linker
WO2024140447A1 ADC 14
WO2024140447A1 ADC 13 Payload
Undisclosed
WO2024140447A1 ADC 13 Linker
WO2024140447A1 ADC 16
WO2024140447A1 ADC 13 Payload
Undisclosed
WO2024140447A1 ADC 15 Linker
WO2024140447A1 ADC 18
WO2024140447A1 ADC 13 Payload
Undisclosed
WO2024140447A1 ADC 17 Linker
WO2024140447A1 ADC 20
WO2024140447A1 ADC 13 Payload
Undisclosed
WO2024140447A1 ADC 3 Linker
WO2024140447A1 ADC 22
WO2024140447A1 ADC 13 Payload
Undisclosed
WO2024140447A1 ADC 21 Linker
WO2024140447A1 ADC 24
WO2024140447A1 ADC 13 Payload
Undisclosed
WO2024140447A1 ADC 23 Linker
WO2024140447A1 ADC 26
WO2024140447A1 ADC 1 Payload
Undisclosed
WO2024140447A1 ADC 25 Linker
WO2024140449A1 ADC2 [62]
WO2024140449A1+ADC1+payload
Undisclosed
Mc-Val-Cit
WO2024140449A1 ADC4 [62]
WO2024140449A1+ADC1+payload
Undisclosed
WO2024140449A1+ADC3+Linker
WO2024140449A1 ADC6 [62]
WO2024140449A1+ADC5+payload
DNA topoisomerase I (TOP1)
WO2024140449A1+ADC5+Linker
WO2024140449A1 ADC8 [62]
WO2024140449A1+ADC5+payload
DNA topoisomerase I (TOP1)
WO2024140449A1+ADC7+Linker
WO2024140449A1 ADC10 [62]
WO2024140449A1+ADC5+payload
DNA topoisomerase I (TOP1)
WO2024140449A1+ADC9+Linker
WO2024140449A1 ADC12 [62]
WO2024140449A1+ADC5+payload
DNA topoisomerase I (TOP1)
WO2024140449A1+ADC9+Linker
WO2024140449A1 ADC14 [62]
WO2024140449A1+ADC13+payload
Undisclosed
WO2024140449A1+ADC13+Linker
WO2024140449A1 ADC16 [62]
WO2024140449A1+ADC13+payload
Undisclosed
WO2024140449A1+ADC13+Linker
WO2024140449A1 ADC18 [62]
WO2024140449A1+ADC17+payload
Undisclosed
WO2024140449A1+ADC17+Linker
WO2024140449A1 ADC20 [62]
WO2024140449A1+ADC19+payload
Undisclosed
WO2024140449A1+ADC19+Linker
WO2024140449A1 ADC22 [62]
WO2024140449A1+ADC5+payload
DNA topoisomerase I (TOP1)
WO2024140449A1+ADC5+Linker
WO2024140450A1 7-[N- (IP140B-mc-Gly-Gly-Phe-Gly-ha-Ac), N- (S)-methoxyisopropyl]aminomethyl-10,11-methylenedioxycamptothecin [57]
Undisclosed
Undisclosed
Undisclosed
WO2024140450A1 7-[N- (1P140B-Ac-PEG2-Val-Ala-PABC), N- (S)-methylisopropyl]aminoethyl-10,11-methylenedioxycamptothecin [57]
Undisclosed
Undisclosed
Undisclosed
WO2024140450A1 7-[N- (IP140B-Ac-PEG2-Gly-Gly-Leu-Gly-ha-Ac), N- (S)-methylisopropyl]aminoethyl-10,11-methylenedi-10,11-ethenyl-10,11-dihydroxycamptothecin [57]
Undisclosed
Undisclosed
Undisclosed
WO2024140450A1 7-[N- (IP140B-Ac-PEG2-Val-Ala-PABC), N-methoxyethyl]aminoethyl-10,11-methylenedi-6,7-dihydroxystilbene [57]
Undisclosed
Undisclosed
Undisclosed
WO2024140450A1 7-[N- (IP140B-Ac-PEG2-Gly-Gly-Leu-Gly-ha-Ac), N-methoxyethyl]aminoethyl-10,11-methylenedi-6,7-ethenidinocamptothecin [57]
Undisclosed
Undisclosed
Undisclosed
WO2024140450A1 7-[N- (IP140B-Ac-PEGz-Gly-Gly-Lys-Gly-ha-Ac), N- (S)-methylisopropyl]aminoethyl-10,11-methylenedi-10,11-ethenylhyerocytosine [57]
Undisclosed
Undisclosed
Undisclosed
WO2024140450A1 7-[N- (HS627-Ac-PEG2-Gly-Lys-PABC), N- (S)-methylisopropyl]aminoethyl-10,11-methylenedi-10,11-ethenylhydragranin 4.6 [57]
Undisclosed
Undisclosed
Undisclosed
IP140B ADC1 [58]
Undisclosed
Undisclosed
Undisclosed
IP140B ADC2 [58]
Undisclosed
Undisclosed
Undisclosed
IP140B ADC3 [58]
Undisclosed
Undisclosed
Undisclosed
CN117159739A ADC1 [63]
undisclosed
Undisclosed
Undisclosed
CN117159739A ADC2 [63]
undisclosed
Undisclosed
Undisclosed
CN117159739A ADC5 [63]
undisclosed
Undisclosed
Undisclosed
Isoprenylated trastuzumab
ADC Name Payload Target Linker ADC Info
LCB-ADC3 [64]
Monomethyl auristatin F
Microtubule (MT)
Bridged PEG4-valine-alanine
LCB-ADC2 [64]
Monomethyl auristatin F
Microtubule (MT)
Isoprene-PEG3,3,3-beta-Glu-PABC
LCB-ADC1 [64]
Monomethyl auristatin F
Microtubule (MT)
Isoprene-PEG3-beta-Glu-PABC
LOL1-HER2 (L234A, L235A, L328C)
ADC Name Payload Target Linker ADC Info
LOL1-anti-HER2 Ab (L234A, L235A, L328C) [52]
Monomethyl auristatin E
Microtubule (MT)
Mc-Val-Cit-PABC
M30-H1-L4P
ADC Name Payload Target Linker ADC Info
WO2022099762A1 ADCa [65]
Camptothecin
DNA topoisomerase 1 (TOP1)
WO2022099762A1 10
WO2022099762A1 ADCb [65]
Camptothecin
DNA topoisomerase 1 (TOP1)
Mc-Gly-Gly-Phe-Gly
ADC Name Payload Target Linker ADC Info
IN202417103839A ADC-1 [66]
Undisclosed
Undisclosed
Undisclosed
ADC Name Payload Target Linker ADC Info
IN202417103839A ADC-2 [66]
Undisclosed
Undisclosed
Undisclosed
IN202417103839A ADC-3 [66]
Undisclosed
Undisclosed
Undisclosed
IN202417103839A ADC-4 [66]
Undisclosed
Undisclosed
Undisclosed
IN202417103839A ADC-5 [66]
Undisclosed
Undisclosed
Undisclosed
ADC Name Payload Target Linker ADC Info
IN202417103839A ADC-6 [66]
Undisclosed
Undisclosed
Undisclosed
ADC Name Payload Target Linker ADC Info
WO2024140927A1-ADC-A (DAR4) [67]
Monomethyl auristatin E
Microtubule (MT)
Mc-Val-Cit-PABC
WO2024140927A1-ADC-D (DAR6) [67]
Active metabolite of irinotecan SN38
DNA topoisomerase 1 (TOP1)
CL2A
WO2024140927A1-ADC-D (DAR2) [67]
Active metabolite of irinotecan SN38
DNA topoisomerase 1 (TOP1)
CL2A
WO2024140927A1-ADC-E (DAR6) [67]
Doxorubicin
DNA topoisomerase 2-alpha (TOP2A)
Succinimidyl-4- (N-maleimidomethyl)cyclohexane-1-carboxylate (SMCC)
WO2024140927A1-ADC-E (DAR2) [67]
Doxorubicin
DNA topoisomerase 2-alpha (TOP2A)
Succinimidyl-4- (N-maleimidomethyl)cyclohexane-1-carboxylate (SMCC)
WO2024140927A1-ADC-A (DAR6) [67]
Monomethyl auristatin E
Microtubule (MT)
Mc-Val-Cit-PABC
WO2024140927A1-ADC-A (DAR2) [67]
Monomethyl auristatin E
Microtubule (MT)
Mc-Val-Cit-PABC
ADC Name Payload Target Linker ADC Info
mAb1-mc-vc-PAB-MMAE [44]
Monomethyl auristatin E
Microtubule (MT)
Mc-Val-Cit-PABC
mAb1-MMAE [68]
Monomethyl auristatin E
Microtubule (MT)
Mc-Val-Cit-PABC
mAb1-MMAF [68]
Monomethyl auristatin F
Microtubule (MT)
Mc-Val-Cit-PABC
mAb1-DXd [68]
DX-8951 derivative (DXd)
DNA topoisomerase 1 (TOP1)
Mc-Gly-Gly-Phe-Gly
mAb1-Extecan [68]
Exatecan
DNA topoisomerase 1 (TOP1)
Mc-Gly-Gly-Phe-Gly
mAb1-DAR6-PB [68]
Undisclosed
Undisclosed
Undisclosed
mAb1-DAR6-HEPES [68]
Undisclosed
Undisclosed
Undisclosed
mAb1-DAR6-MES [68]
Undisclosed
Undisclosed
Undisclosed
mAb1-DAR6-Tris [68]
Undisclosed
Undisclosed
Undisclosed
mAb1-DAR6-MOPSO [68]
Undisclosed
Undisclosed
Undisclosed
mAb17-DM21 [68]
Undisclosed
Undisclosed
Undisclosed
mAb1-MMAF+MMAE [68]
Undisclosed
Undisclosed
Undisclosed
mAb1-MMAE+MMAF [68]
Undisclosed
Undisclosed
Undisclosed
mAb1-MMAE+DXd [68]
Undisclosed
Undisclosed
Undisclosed
mAb1-DXd+MMAE [68]
Undisclosed
Undisclosed
Undisclosed
mAb1-DXd+MMAE+MMAF [68]
Undisclosed
Undisclosed
Undisclosed
mAb1-MMAE+GGFG-DXd [68]
Undisclosed
Undisclosed
Undisclosed
MAb1-DAR6-HEPES-20mM [68]
Undisclosed
Undisclosed
Undisclosed
MAb1-DAR6-HEPES-40mM [68]
Undisclosed
Undisclosed
Undisclosed
MAb1-DAR6-HEPES-60mM [68]
Undisclosed
Undisclosed
Undisclosed
MAb1-DAR6-HEPES-80mM [68]
Undisclosed
Undisclosed
Undisclosed
mAb1-DAR6-1mg·mL-1 [68]
Undisclosed
Undisclosed
Undisclosed
mAb1-DAR6-2.5mg·mL-1 [68]
Undisclosed
Undisclosed
Undisclosed
mAb1-DAR6-5mg·mL-1 [68]
Undisclosed
Undisclosed
Undisclosed
mAb1-DAR6-10mg·mI-1 [68]
Undisclosed
Undisclosed
Undisclosed
mAb1-DAR6-15mg·mL-1 [68]
Undisclosed
Undisclosed
Undisclosed
mAb1-DAR6-20mg·mL-1 [68]
Undisclosed
Undisclosed
Undisclosed
mAb1-DAR6-4°C/10.00 TCEP [68]
Undisclosed
Undisclosed
Undisclosed
mAb1-DAR6-4°C/12.00 TCEP [68]
Undisclosed
Undisclosed
Undisclosed
mAb1-DAR6-4°C/14.00 TCEP [68]
Undisclosed
Undisclosed
Undisclosed
mAb1-DAR6-12°C/3.25 TCEP [68]
Undisclosed
Undisclosed
Undisclosed
mAb1-DAR6-12°C/3.75 TCEP [68]
Undisclosed
Undisclosed
Undisclosed
mAb1-DAR6-16°C/3.00 TCEP [68]
Undisclosed
Undisclosed
Undisclosed
mAb1-DAR6-16°C/3.25 TCEP [68]
Undisclosed
Undisclosed
Undisclosed
mAb1-DAR6-22°C/2.85 TCEP [68]
Undisclosed
Undisclosed
Undisclosed
mAb1-DAR6-22°C/3.00 TCEP [68]
Undisclosed
Undisclosed
Undisclosed
mAb1-DAR6-pH 6.8 [68]
Undisclosed
Undisclosed
Undisclosed
mAb1-DAR6-pH 7.0 [68]
Undisclosed
Undisclosed
Undisclosed
mAb1-DAR6-pH 7.4 [68]
Undisclosed
Undisclosed
Undisclosed
mAb1-DAR6-pH 8.0 [68]
Undisclosed
Undisclosed
Undisclosed
mAb1-Tween 20 [68]
Undisclosed
Undisclosed
Undisclosed
mAb1-Benzyl Alcohol [68]
Undisclosed
Undisclosed
Undisclosed
mAb1-Trehalose [68]
Undisclosed
Undisclosed
Undisclosed
mAb1-Extecan+MMAE [68]
Undisclosed
Undisclosed
Undisclosed
mAb1-DBM-MMAF [68]
Undisclosed
Undisclosed
Undisclosed
mAb1-STB-MMAE [68]
Undisclosed
Undisclosed
Undisclosed
mAb1-Bimaleimide-MMAE [68]
Undisclosed
Undisclosed
Undisclosed
WO2024118785A3 Lot2 [69]
Undisclosed
Undisclosed
Undisclosed
WO2024118785A3 Lot3 [69]
Undisclosed
Undisclosed
Undisclosed
WO2024118785A3 Lot5 [69]
Undisclosed
Undisclosed
Undisclosed
WO2024118785A3 Lot7 [69]
Undisclosed
Undisclosed
Undisclosed
WO2024118785A3 Lot10 [69]
Undisclosed
Undisclosed
Undisclosed
WO2024118785A3 Lot14 [69]
Undisclosed
Undisclosed
Undisclosed
WO2024118785A3 Lot18 [69]
Undisclosed
Undisclosed
Undisclosed
WO2024118785A3 Lot20 [69]
Undisclosed
Undisclosed
Undisclosed
WO2024118785A3 Lot21 [69]
Undisclosed
Undisclosed
Undisclosed
WO2024118785A3 Lot43 [69]
Undisclosed
Undisclosed
Undisclosed
WO2024118785A3 Lot48 [69]
Undisclosed
Undisclosed
Undisclosed
WO2024118785A3 Lot52 [69]
Undisclosed
Undisclosed
Undisclosed
Ab-AL-LP2 [70]
Pro-DHT
Undisclosed
DIBAC-PEG4-vcPAB
Ab-AL-LP3 [70]
Pro-DHT
Undisclosed
DIBAC-PEG4-EvcPAB linker
Ab-AL-LP7 [70]
Pro-DHT
Undisclosed
COT-PEG4-branch-PEG2-EvcPAB
Ab-AL-LP41 [70]
DHT
Undisclosed
COT-PEG4-VK-PABC
Ab-BL-LP7 [70]
Pro-DHT
Undisclosed
COT-PEG4-branch-PEG2-EvcPAB
Ab-LP3A [70]
Pro-DHT
Undisclosed
NH2-PEG4-EvcPAB
Ab-LP5A [70]
DHT
Undisclosed
NH2-PEG4-EvcPAB-NHCH2
Ab-LP44 [70]
DHT
Undisclosed
NH2-PEG4-vcPABC
Ab-LP33 [70]
Pro-DHT
Undisclosed
Mc-PEG4-EvcPAB
ADC Name Payload Target Linker ADC Info
Trastuzumab vedotin [71]
Monomethyl auristatin E
Microtubule (MT)
Mc-Val-Cit-PABC
Margetuximab
ADC Name Payload Target Linker ADC Info
Margetuximab-ADC-Tb3-1 [7]
Margetuximab-ADC-Tb3-1 payload
Undisclosed
Margetuximab-ADC-Tb3-1 linker
Margetuximab-ADC-Tb3-2 [7]
Margetuximab-ADC-Tb3-2 payload
Undisclosed
Margetuximab-ADC-Tb3-2 linker
Margetuximab-ADC-Tb3-3 [7]
Margetuximab-ADC-Tb3-3 payload
Undisclosed
Margetuximab-ADC-Tb3-3 linker
Margetuximab-ADC-Tb3-4 [7]
Margetuximab-ADC-Tb3-4 payload
Undisclosed
Margetuximab-ADC-Tb3-4 linker
Margetuximab-ADC-Tb3-5 [7]
Margetuximab-ADC-Tb3-5 payload
Undisclosed
Margetuximab-ADC-Tb3-5 linker
Margetuximab-ADC-Tb3-6 [7]
Margetuximab-ADC-Tb3-6 payload
Undisclosed
Margetuximab-ADC-Tb3-6 linker
Margetuximab-ADC-Tb3-7 [7]
Margetuximab-ADC-Tb3-7 payload
Undisclosed
Margetuximab-ADC-Tb3-7 linker
Margetuximab-ADC-Tb3-8 [7]
Margetuximab-ADC-Tb3-8 payload
Undisclosed
Margetuximab-ADC-Tb3-8 linker
Margetuximab-ADC-Tb3-9 [7]
Margetuximab-ADC-Tb3-9 payload
Undisclosed
Margetuximab-ADC-Tb3-9 linker
Margetuximab-ADC-Tb3-10 [7]
Margetuximab-ADC-Tb3-10 payload
Undisclosed
Margetuximab-ADC-Tb3-10 linker
EP4487874A1-1 [72]
EP4487874A1-1payload
Undisclosed
EP4487874A1-1linker
EP4487874A1-4 [72]
EP4487874A1-4payload
Undisclosed
EP4487874A1-3linker
MHES0488A
ADC Name Payload Target Linker ADC Info
RG6148
PBD dimer
Human deoxyribonucleic acid (hDNA)
A cleavable disulfide linker
ADC Name Payload Target Linker ADC Info
CN114605367B A-II-11C [73]
Undisclosed
Undisclosed
Undisclosed
CN114605367B A-II-12C [73]
A-II-12C Payload
Undisclosed
6-Maleimidocaproic acid
CN114605367B A-II-13C [73]
A-II-13C Payload
Undisclosed
6-Maleimidocaproic acid
CN114605367B A-II-14C [73]
A-II-14C Payload
Undisclosed
6-Maleimidocaproic acid
CN114605367B A-II-21-C [73]
Undisclosed
Undisclosed
Undisclosed
CN114605367B A-II-22-C [73]
A-II-22-C Payload
Undisclosed
6-Maleimidocaproic acid
CN114605367B A-II-23-C [73]
A-II-23-C Payload
Undisclosed
6-Maleimidocaproic acid
CN114605367B A-II-24-C [73]
A-II-24-C Payload
Undisclosed
6-Maleimidocaproic acid
CN114605367B A-III-11 [73]
Undisclosed
Undisclosed
Undisclosed
CN114605367B A-III-12 [73]
A-III-12 Payload
Undisclosed
6-Maleimidocaproic acid
CN114605367B A-III-13 [73]
A-III-13 Payload
Undisclosed
6-Maleimidocaproic acid
CN114605367B A-III-14 [73]
A-III-14 Payload
Undisclosed
6-Maleimidocaproic acid
CN114605367B A-III-21 [73]
Undisclosed
Undisclosed
Undisclosed
CN114605367B A-III-22 [73]
A-III-22 Payload
Undisclosed
6-Maleimidocaproic acid
CN114605367B A-III-23 [73]
A-III-23 Payload
Undisclosed
6-Maleimidocaproic acid
CN114605367B A-III-24 [73]
A-III-24 Payload
Undisclosed
6-Maleimidocaproic acid
CN114605367B IV-21 [73]
Undisclosed
Undisclosed
Undisclosed
CN114605367B IV-22 [73]
A-III-22 Payload
Undisclosed
6-Maleimidocaproic acid
CN114605367B IV-23 [73]
A-III-23 Payload
Undisclosed
6-Maleimidocaproic acid
CN114605367B IV-24 [73]
A-III-24 Payload
Undisclosed
6-Maleimidocaproic acid
CN114605367B IV-11 [73]
Undisclosed
Undisclosed
Undisclosed
CN114605367B IV-12 [73]
A-III-12 Payload
Undisclosed
6-Maleimidocaproic acid
CN114605367B IV-13 [73]
A-III-13 Payload
Undisclosed
6-Maleimidocaproic acid
CN114605367B IV-14 [73]
A-III-14 Payload
Undisclosed
6-Maleimidocaproic acid
ADC Name Payload Target Linker ADC Info
Mil40-12B [74]
Monomethyl auristatin E
Microtubule (MT)
Maleamic methyl ester-based linker 12B
Mil40-5 [75]
Active metabolite of irinotecan SN38
DNA topoisomerase 1 (TOP1)
Mc-Val-Ala-PABC
Mil40-6 [75]
Active metabolite of irinotecan SN38
DNA topoisomerase 1 (TOP1)
Mal-PEG2-Val-Ala-PABC
Mil40-7 [75]
Active metabolite of irinotecan SN38
DNA topoisomerase 1 (TOP1)
Mal-PEG4-Val-Ala-PABC
Mil40-8 [75]
Active metabolite of irinotecan SN38
DNA topoisomerase 1 (TOP1)
Mal-PEG8-Val-Ala-PABC
Mil40-12A [74]
Monomethyl auristatin E
Microtubule (MT)
Maleamic methyl ester-based linker 12A
Mil40-12C [74]
Monomethyl auristatin E
Microtubule (MT)
Maleamic methyl ester-based linker 12C
Mil40-11 (DAR=7.1) [75]
Active metabolite of irinotecan SN38
DNA topoisomerase 1 (TOP1)
Mc-PEG8-Val-Ala-PABC
Mil40-11 (DAR=3.8) [75]
Active metabolite of irinotecan SN38
DNA topoisomerase 1 (TOP1)
Mc-PEG8-Val-Ala-PABC
Mil40-12B [74]
Monomethyl auristatin E
Microtubule (MT)
Mc-Val-Cit-PABC
Cys-linker-MMAE-based ADC 11 [76]
Monomethyl auristatin E
Microtubule (MT)
Cys-11 ADC linker
Cys-linker-MMAE-based ADC 12 [76]
Monomethyl auristatin E
Microtubule (MT)
Cys-12 ADC linker
Cys-linker-MMAE-based ADC 13 [76]
Monomethyl auristatin E
Microtubule (MT)
Cys-13 ADC linker
Cys-linker-MMAE-based ADC 14 [76]
Monomethyl auristatin E
Microtubule (MT)
Cys-14 ADC linker
Cys-linker-MMAE-based ADC 15 [76]
Monomethyl auristatin E
Microtubule (MT)
Mc-PABC
Cys-linker-MMAE-based ADC 16 [76]
Monomethyl auristatin E
Microtubule (MT)
Mc-Val-Cit-PABC
ADC Mil40-6 [77]
Monomethyl auristatin E
Microtubule (MT)
Silyl ether-based linker
Mil40-15 [76]
Monomethyl auristatin E
Microtubule (MT)
Mc-PABC
Trastuzumab biosimilar mil40 12a [78]
Monomethyl auristatin E
Microtubule (MT)
Maleamic methyl ester-based Val-Ala-PABC linker 12a
Trastuzumab biosimilar mil40 12b [78]
Monomethyl auristatin E
Microtubule (MT)
Maleamic methyl ester-based Val-Ala-PABC linker 12b
Trastuzumab biosimilar mil40 12c [78]
Monomethyl auristatin E
Microtubule (MT)
Maleamic methyl ester-based Val-Cit-PABC linker 12c
ADC Name Payload Target Linker ADC Info
EP3838893B1-ADC-I [79]
Monomethyl auristatin E
Microtubule (MT)
Mm-C3-Val-Ala-PAB
EP3838893B1-ADC-II [79]
Monomethyl auristatin E
Microtubule (MT)
Mm-C6-Val-Ala-PAB
EP3838893B1-ADC-III [79]
Monomethyl auristatin E
Microtubule (MT)
Mm-C6-Val-Cit-PAB
EP3838893B1-ADC-IV [79]
Undisclosed
Undisclosed
Mm-C6-Val-Cit-PAB
EP3838893B1-ADC-A [79]
Monomethyl auristatin E
Microtubule (MT)
Mm-C6-PEG4-Val-Ala-PAB
EP3838893B1-ADC-B [79]
Monomethyl auristatin E
Microtubule (MT)
Mm-C6-PEG8-Val-Ala-PAB
EP3838893B1-ADC-C [79]
Monomethyl auristatin E
Microtubule (MT)
Mm-C6-PEG8'-Val-Ala-PAB
Su-C6-Val-Cit-PAB [79]
Monomethyl auristatin E
Microtubule (MT)
Mc-Val-Cit-PABC
Mm-C6-PEG4-Val-Ala-PAB-MMAE [79]
Monomethyl auristatin E
Microtubule (MT)
Mm-C6-PEG4-Val-Ala-PAB
Mm-C6-PEG8-Val-Ala-PAB-MMAE [79]
Monomethyl auristatin E
Microtubule (MT)
Mm-C6-PEG8-Val-Ala-PAB
Mm-C6-PEG8'-Val-Ala-PAB-MMAE [79]
Monomethyl auristatin E
Microtubule (MT)
Mm-C6-PEG8'-Val-Ala-PAB
Su-C3-VA [79]
Monomethyl auristatin E
Microtubule (MT)
PEG2-Val-Cit-PABC
Su-C6-VC [79]
Monomethyl auristatin E
Microtubule (MT)
Mc-Val-Cit-PABC
Su-C6-VA [79]
Monomethyl auristatin E
Microtubule (MT)
Mc-Val-Ala-PABC
Minibody (4 cys)
ADC Name Payload Target Linker ADC Info
Mb (4)-m- (b-PEG12)-VC-MMAE [80]
Monomethyl auristatin E
Microtubule (MT)
IgG (8)-m- (b-PEG12)-VC-MMAE
ADC Name Payload Target Linker ADC Info
NJH395
TLR7 agonist
Toll-like receptor 7 (TLR7)
A non-cleavable linker
Modified ZHER2:2891 protein (ZHER2)
ADC Name Payload Target Linker ADC Info
Pyro-Linker-ZHER2 [81]
Pyropheophorbide-a
Undisclosed
Pyro-Linker based linker
mouse anti-human HER2 Ab
ADC Name Payload Target Linker ADC Info
WO2023232144A1ADC34 [82]
WO2025015586A1, ADC34, Payload
Toll-like receptor 7 (TLR7); Toll-like receptor 8 (TLR8)
Mc-Val-Cit-PABC
WO2023232144A1ADC35 [82]
WO2025015586A1, ADC35, Payload
Toll-like receptor 7 (TLR7); Toll-like receptor 8 (TLR8)
Mc-Val-Cit-PABC
WO2023232144A1ADC36 [82]
WO2025015586A1, ADC34, Payload
Toll-like receptor 7 (TLR7); Toll-like receptor 8 (TLR8)
SMCC
WO2023232144A1ADC37 [82]
WO2025015586A1, ADC35, Payload
Toll-like receptor 7 (TLR7); Toll-like receptor 8 (TLR8)
SMCC
ADC Name Payload Target Linker ADC Info
NOV0712-Dxd [51]
DX-8951 derivative (DXd)
DNA topoisomerase 1 (TOP1)
Mc-Gly-Gly-Phe-Gly
Palivizumab_msIgG2a
ADC Name Payload Target Linker ADC Info
Palivizumab_msIgG2a Conjugate 3 [4]
Undisclosed
Undisclosed
Undisclosed
Patritumab
ADC Name Payload Target Linker ADC Info
WO2022228495A1 ADC-72 [50]
WO2022228495A1 ADC-72 payload
Undisclosed
WO2022228495A1 ADC-72 linker
Pertuzumab
ADC Name Payload Target Linker ADC Info
SHR-4602
ER300
Microtubule (MT)
Stable enzyme-cleavable linker
Pertuzumab zuvotolimod
Zuvotolimod
Toll-like receptor 8 (TLR8)
Mc-Val-Cit-PABC
ORM-5029 [83]
SMol006
CRBN×GSPT1
Mc-Val-Cit-PABC
WO2020063676A1 ADC-7 [84]
WO2020063676A1_ADC-7 payload
Undisclosed
WO2020063676A1_ADC-7 linker
WO2020063676A1 ADC-8 [84]
WO2020063676A1_ADC-8 payload
Undisclosed
WO2020063676A1_ADC-8 linker
WO2020063676A1 ADC-9 [84]
WO2020063676A1_ADC-9 payload
Undisclosed
WO2020063676A1_ADC-9 linker
Pertuzumab-ADC-Tb3-1 [7]
Pertuzumab-ADC-Tb3-1 payload
Undisclosed
Pertuzumab-ADC-Tb3-1 linker
Pertuzumab-ADC-Tb3-2 [7]
Pertuzumab-ADC-Tb3-2 payload
Undisclosed
Pertuzumab-ADC-Tb3-2 linker
Pertuzumab-ADC-Tb3-3 [7]
Pertuzumab-ADC-Tb3-3 payload
Undisclosed
Pertuzumab-ADC-Tb3-3 linker
Pertuzumab-ADC-Tb3-4 [7]
Pertuzumab-ADC-Tb3-4 payload
Undisclosed
Pertuzumab-ADC-Tb3-4 linker
Pertuzumab-ADC-Tb3-5 [7]
Pertuzumab-ADC-Tb3-5 payload
Undisclosed
Pertuzumab-ADC-Tb3-5 linker
Pertuzumab-ADC-Tb3-6 [7]
Pertuzumab-ADC-Tb3-6 payload
Undisclosed
Pertuzumab-ADC-Tb3-6 linker
Pertuzumab-ADC-Tb3-7 [7]
Pertuzumab-ADC-Tb3-7 payload
Undisclosed
Pertuzumab-ADC-Tb3-7 linker
Pertuzumab-ADC-Tb3-8 [7]
Pertuzumab-ADC-Tb3-8 payload
Undisclosed
Pertuzumab-ADC-Tb3-8 linker
Pertuzumab-ADC-Tb3-9 [7]
Pertuzumab-ADC-Tb3-9 payload
Undisclosed
Pertuzumab-ADC-Tb3-9 linker
Pertuzumab-ADC-Tb3-10 [7]
Pertuzumab-ADC-Tb3-10 payload
Undisclosed
Pertuzumab-ADC-Tb3-10 linker
Pertuzumab-Compound(la) [85]
NeoDegrader P1
Protein cereblon (CRBN)
Pertuzumab-Compound(la) linker
Pertuzumab-Compound (la) DAR 8 [85]
NeoDegrader P1
Protein cereblon (CRBN)
Pertuzumab-Compound (la) DAR 8 linker
Pertuzumab-Compound(lc) [85]
NeoDegrader P4
Protein cereblon (CRBN)
Pertuzumab-Compound(lc) linker
Pertuzumab-Compound (lc) DAR 8 [85]
NeoDegrader P4
Protein cereblon (CRBN)
Pertuzumab-Compound (lc) DAR 8 linker
Pertuzumab-Compound (le) [85]
NeoDegrader P1
Protein cereblon (CRBN)
Pertuzumab-Compound (le) linker
Pertuzumab-Compound (lf) [85]
NeoDegrader P6
Protein cereblon (CRBN)
Pertuzumab-Compound (lf) linker
Pertuzumab-Compound (lg) [85]
NeoDegrader P2
Protein cereblon (CRBN)
Pertuzumab-Compound (lg) linker
Pertuzumab-Compound (lh) [85]
NeoDegrader P13
Protein cereblon (CRBN)
Pertuzumab-Compound (lh) linker
Pertuzumab-Compound (li) [85]
NeoDegrader P1
Protein cereblon (CRBN)
Pertuzumab-Compound (li) linker
Pertuzumab-Compound (lj) [85]
NeoDegrader P1
Protein cereblon (CRBN)
Pertuzumab-Compound (lj) linker
Pertuzumab-Compound (lk) [85]
NeoDegrader P14
Protein cereblon (CRBN)
Pertuzumab-Compound (lk) linker
Pertuzumab-Compound (ll) [85]
NeoDegrader P14
Protein cereblon (CRBN)
Pertuzumab-Compound (ll) linker
Pertuzumab-Compound (lm) [85]
NeoDegrader P14
Protein cereblon (CRBN)
Pertuzumab-Compound (lm) linker
Pertuzumab-Compound (X) [53]
Pertuzumab-Compound (X) payload
Undisclosed
Pertuzumab-Compound (X) linker
Pertuzumab-Compound (XI) [53]
Pertuzumab-Compound (XI) payload
Undisclosed
Pertuzumab-Compound (XI) linker
Pertuzumab-Compound (XIV) [53]
Pertuzumab-Compound (XIV) payload
Undisclosed
Pertuzumab-Compound (XIV) linker
Pertuzumab-Compound (XVIII) [53]
Pertuzumab-Compound (XVIII) payload
Undisclosed
Pertuzumab-Compound (XVIII) linker
Pertuzumab-Compound (Ie) [53]
Pertuzumab-Compound (Ie) payload
Undisclosed
Pertuzumab-Compound (Ie) linker
Pertuzumab-Compound (XIX) [53]
Pertuzumab-Compound (XIX) payload
Undisclosed
Pertuzumab-Compound (XIX) linker
Pertuzumab-Compound (Ii) [53]
Pertuzumab-Compound (Ii) payload
Undisclosed
Pertuzumab-Compound (Ii) linker
Pertuzumab-Compound (XLI) [53]
Pertuzumab-Compound (XLI) payload
Undisclosed
Pertuzumab-Compound (XLI) linker
Pertuzumab-Compound (XVI) [53]
Pertuzumab-Compound (XIX) payload
Undisclosed
Pertuzumab-Compound (XIX) linker
Pertuzumab-Compound (XL) [53]
Pertuzumab-Compound (XL) payload
Undisclosed
Pertuzumab-Compound (XL) linker
Pertuzumab-Compound (XLIII) [53]
Pertuzumab-Compound (XLIII) payload
Undisclosed
Pertuzumab-Compound (XLIII) linker
Pertuzumab-Compound (XLII) [53]
Pertuzumab-Compound (XLII) payload
Undisclosed
Pertuzumab-Compound (XLII) linker
Pertuzumab-Compound (XV) [53]
Pertuzumab-Compound (XV) payload
Undisclosed
Pertuzumab-Compound (XV) linker
Pertuzumab-Compound 9 [23]
Mertansine DM1
Microtubule (MT)
Pertuzumab-Compound 9 linker
Pertuzumab-Compound 17 [23]
Mertansine DM4
Microtubule (MT)
Pertuzumab-Compound 17 linker
Pertuzumab-Compound 25 [23]
Monomethyl auristatin E
Microtubule (MT)
Pertuzumab-Compound 25 linker
Pertuzumab-Compound 31 [23]
Auristatin 0101
Microtubule (MT)
Pertuzumab-Compound 31 linker
Pertuzumab-Compound 36 [23]
Monomethyl auristatin E
Microtubule (MT)
Pertuzumab-Compound 36 linker
Pertuzumab-Compound 43 [23]
PBD dimer
Human Deoxyribonucleic acid (hDNA)
Pertuzumab-Compound 43 linker
Pertuzumab-Compound 49 [23]
PBD dimer
Human Deoxyribonucleic acid (hDNA)
Pertuzumab-Compound 49 linker
Pertuzumab-Compound 55 [23]
Mertansine DM1
Microtubule (MT)
Pertuzumab-Compound 55 linker
Pertuzumab-Compound 59 [23]
Mertansine DM4
Microtubule (MT)
Pertuzumab-Compound 59 linker
Pertuzumab-Compound 64 [23]
Monomethyl auristatin E
Microtubule (MT)
Pertuzumab-Compound 64 linker
Pertuzumab-Compound 69 [23]
Monomethyl auristatin E
Microtubule (MT)
Pertuzumab-Compound 69 linker
Pertuzumab-Compound 74 [23]
PBD dimer
Human Deoxyribonucleic acid (hDNA)
Pertuzumab-Compound 74 linker
Pertuzumab-Compound 75 [23]
Monomethyl auristatin E
Microtubule (MT)
Pertuzumab-Compound 75 linker
Pertuzumab-Compound 76 [23]
Monomethyl auristatin E
Microtubule (MT)
Pertuzumab-Compound 76 linker
Pertuzumab-Compound 77 [23]
Mertansine DM1
Microtubule (MT)
Pertuzumab-Compound 77 linker
Pertuzumab-Compound 78 [23]
Auristatin 0101
Microtubule (MT)
Pertuzumab-Compound 78 linker
Pertuzumab-Compound 79 [23]
Auristatin 0101
Microtubule (MT)
Pertuzumab-Compound 79 linker
Pertuzumab-Compound 80 [23]
Mertansine DM4
Microtubule (MT)
Pertuzumab-Compound 80 linker
ADC2122 [86]
Duostatin 5
Microtubule (MT)
Pip-Val-Cit linker
Per-2C [87]
Undisclosed
Undisclosed
Undisclosed
Per-5C [87]
Undisclosed
Undisclosed
Undisclosed
WO2024169913A1 ADC07-01-8 [89]
B19
Eukaryotic peptide chain release factor GTP-binding subunit ERF3A (GSPT1)
Mc-Val-Cit-PABC
WO2024169913A1 ADC07-01-4 [89]
B19
Eukaryotic peptide chain release factor GTP-binding subunit ERF3A (GSPT1)
Mc-Val-Cit-PABC
WO2024169913A1 ADC07-02-8 [89]
B19
Eukaryotic peptide chain release factor GTP-binding subunit ERF3A (GSPT1)
Mc-Val-Ala-PABC
WO2024169913A1 ADC07-02-4 [89]
B19
Eukaryotic peptide chain release factor GTP-binding subunit ERF3A (GSPT1)
Mc-Val-Ala-PABC
WO2024169913A1 ADC07-06-8 [89]
B63
Eukaryotic peptide chain release factor GTP-binding subunit ERF3A (GSPT1)
Mc-Val-Ala-PABC
WO2024169913A1 ADC07-06-4 [89]
B63
Eukaryotic peptide chain release factor GTP-binding subunit ERF3A (GSPT1)
Mc-Val-Ala-PABC
WO2024169913A1 ADC07-08-8 [89]
B19
Eukaryotic peptide chain release factor GTP-binding subunit ERF3A (GSPT1)
(Linker-03)SMCC-TAZ-PEG-VC-PAB
WO2024169913A1 ADC07-08-4 [89]
B19
Eukaryotic peptide chain release factor GTP-binding subunit ERF3A (GSPT1)
(Linker-03)SMCC-TAZ-PEG-VC-PAB
WO2024169913A1 ADC07-09-8 [89]
Smol006
Eukaryotic peptide chain release factor GTP-binding subunit ERF3A (GSPT1)
Mc-Val-Cit-PABC
WO2024169913A1 ADC07-09-4 [89]
Smol006
Eukaryotic peptide chain release factor GTP-binding subunit ERF3A (GSPT1)
Mc-Val-Cit-PABC
pertuzumab
ADC Name Payload Target Linker ADC Info
CN114306633A A-1 [88]
Monomethyl auristatin E
Microtubule (MT)
CN114306633A-A-1-linker
CN114306633A C-3 [88]
Monomethyl auristatin E
Microtubule (MT)
CN114306633A-C-3-linker
Pertuzumab-S239C
ADC Name Payload Target Linker ADC Info
HER2-A Antibody-Compound (X) [53]
HER2-A Antibody-Compound (X) payload
Undisclosed
HER2-A Antibody-Compound (X) linker
HER2-A Antibody-Compound (XI) [53]
HER2-A Antibody-Compound (XI) payload
Undisclosed
HER2-A Antibody-Compound (XI) linker
HER2-A Antibody-Compound (XIV) [53]
HER2-A Antibody-Compound (XIV) payload
Undisclosed
HER2-A Antibody-Compound (XIV) linker
HER2-A Antibody-Compound (XVIII) [53]
HER2-A Antibody-Compound (XVIII) payload
Undisclosed
HER2-A Antibody-Compound (XVIII) linker
HER2-A Antibody-Compound (Ie) [53]
HER2-A Antibody-Compound (Ie) payload
Undisclosed
HER2-A Antibody-Compound (Ie) linker
HER2-A Antibody-Compound (XIX) [53]
HER2-A Antibody-Compound (XIX) payload
Undisclosed
HER2-A Antibody-Compound (XIX) linker
HER2-A Antibody-Compound (Ii) [53]
HER2-A Antibody-Compound (Ii) payload
Undisclosed
HER2-A Antibody-Compound (Ii) linker
HER2-A Antibody-Compound (XLI) [53]
HER2-A Antibody-Compound (XLI) payload
Undisclosed
HER2-A Antibody-Compound (XLI) linker
HER2-A Antibody-Compound (XVI) [53]
HER2-A Antibody-Compound (XIX) payload
Undisclosed
HER2-A Antibody-Compound (XIX) linker
HER2-A Antibody-Compound (XL) [53]
HER2-A Antibody-Compound (XL) payload
Undisclosed
HER2-A Antibody-Compound (XL) linker
HER2-A Antibody-Compound (XLIII) [53]
HER2-A Antibody-Compound (XLIII) payload
Undisclosed
HER2-A Antibody-Compound (XLIII) linker
HER2-A Antibody-Compound (XLII) [53]
HER2-A Antibody-Compound (XLII) payload
Undisclosed
HER2-A Antibody-Compound (XLII) linker
Pertuzumab-S239C-Compound (XV) [53]
Pertuzumab-S239C-Compound (XV) payload
Undisclosed
Pertuzumab-S239C-Compound (XV) linker
ADC Name Payload Target Linker ADC Info
Ptz-SA vedotin [90]
Monomethyl auristatin E
Microtubule (MT)
Mc-Val-Cit-PABC
Rat IgG2a mAb ICR12
ADC Name Payload Target Linker ADC Info
Monoclonal antibody ICR12-CPG2 conjugate [91]
Carboxypeptidase G2 (CPG2)
Undisclosed
Undisclosed
ADC Name Payload Target Linker ADC Info
(RC48-vc-MMAE) [92]
Monomethyl auristatin E
Microtubule (MT)
Mc-Val-Ala-PABC
Rituximab
ADC Name Payload Target Linker ADC Info
CN119343374A ADC-RIT41C [93]
Undisclosed
Undisclosed
Undisclosed
S1 Trastuzumab glycovariants
ADC Name Payload Target Linker ADC Info
S1 Trastuzumab glycovariants ADC [94]
Monomethyl auristatin E
Microtubule (MT)
DBCO-PEG4-Val-Cit
S4 Trastuzumab glycovariants
ADC Name Payload Target Linker ADC Info
S4 Trastuzumab glycovariants ADC [94]
Monomethyl auristatin E
Microtubule (MT)
DBCO-PEG4-Val-Cit
S6 Trastuzumab glycovariants
ADC Name Payload Target Linker ADC Info
S6 Trastuzumab glycovariants ADC [94]
Monomethyl auristatin E
Microtubule (MT)
DBCO-PEG4-Val-Cit
Sacituzumab
ADC Name Payload Target Linker ADC Info
Anti-Her2- (Q295-mcValCitPABC-A6)- (mcMMAF) [95]
Monomethyl auristatin F
Microtubule (MT)
Undisclosed
Anti-Her2- (0295-mcA6)- (mcMMAF) [95]
Monomethyl auristatin F
Microtubule (MT)
Undisclosed
Anti-Her2- (0295-mcMMAF)- (mcValCitPABC-A6) [95]
Monomethyl auristatin F
Microtubule (MT)
Undisclosed
Anti-Her2- (0295-mcMMAF)- (mc-A6) [95]
Monomethyl auristatin F
Microtubule (MT)
Undisclosed
Her2-Saci- (mc-MMAF)- (McAsnAsn-A6) [95]
Monomethyl auristatin F
Microtubule (MT)
Undisclosed
Her2-Saci- (mc-MMAF)- (mc-A6) [95]
Monomethyl auristatin F
Microtubule (MT)
Undisclosed
SCAHer2 (1)xSCAHer (2)
ADC Name Payload Target Linker ADC Info
CN117337196A Compound88 [96]
Active metabolite of irinotecan SN38
DNA topoisomerase 1 (TOP1)
30kmPEG-Lys (PEG2 - Mal)-3 (Val-Cit-PAB-DEA)
SCAHer2 (1)xSCAHer2
ADC Name Payload Target Linker ADC Info
CN117337196A Compound86 [96]
Active metabolite of irinotecan SN38
DNA topoisomerase 1 (TOP1)
30kmPEG-Lys (PEG2 - Mal)-2 (Val-Cit-PAB-DEA)
T (kK183C+K290C)
ADC Name Payload Target Linker ADC Info
T (kK183C+K290C)-VC0101 ADC [97]
Auristatin 0101
Microtubule (MT)
Mc-Val-Cit-PABC
TCO-trastuzumab trast-v1a-XL11
ADC Name Payload Target Linker ADC Info
Trast-v1a-XL11-204 [41]
Undisclosed
Undisclosed
Undisclosed
Thio Anti-HER2 hu7C2 HC L177C
ADC Name Payload Target Linker ADC Info
WO2017059289A1 ADC-117 [98]
WO2017059289A1_ADC-117 payload
Undisclosed
WO2017059289A1_ADC-117 linker
Thio Anti-HER2 hu7C2 HC Y376C
ADC Name Payload Target Linker ADC Info
WO2017059289A1 ADC-119 [98]
WO2017059289A1_ADC-119 payload
Undisclosed
WO2017059289A1_ADC-119 linker
Thio Anti-HER2 hu7C2 LC K149C
ADC Name Payload Target Linker ADC Info
WO2017059289A1 ADC-101 [98]
WO2017059289A1_ADC-101 payload
Undisclosed
WO2017059289A1_ADC-101 linker
WO2017059289A1 ADC-102 [98]
WO2017059289A1_ADC-102 payload
Undisclosed
WO2017059289A1_ADC-102 linker
WO2017059289A1 ADC-104 [98]
WO2017059289A1_ADC-104 payload
Undisclosed
WO2017059289A1_ADC-104 linker
WO2017059289A1 ADC-106 [98]
WO2017059289A1_ADC-106 payload
Undisclosed
WO2017059289A1_ADC-106 linker
WO2017059289A1 ADC-108 [98]
WO2017059289A1_ADC-108 payload
Undisclosed
WO2017059289A1_ADC-108 linker
WO2017059289A1 ADC-109 [98]
WO2017059289A1_ADC-109 payload
Undisclosed
WO2017059289A1_ADC-109 linker
WO2017059289A1 ADC-201 [98]
WO2017059289A1_ADC-201 payload
Undisclosed
WO2017059289A1_ADC-201 linker
WO2017059289A1 ADC-203 [98]
WO2017059289A1_ADC-203 payload
Undisclosed
WO2017059289A1_ADC-203 linker
WO2017059289A1 ADC-205 [98]
WO2017059289A1_ADC-205 payload
Undisclosed
WO2017059289A1_ADC-205 linker
Thio Anti-HER2 hu7C2 LC K149C HC L177C
ADC Name Payload Target Linker ADC Info
WO2017059289A1 ADC-113 [98]
WO2017059289A1_ADC-113 payload
Undisclosed
WO2017059289A1_ADC-113 linker
Thio Anti-HER2 hu7C2 LC K149C HC L177C HC Y376C
ADC Name Payload Target Linker ADC Info
WO2017059289A1 ADC-114 [98]
WO2017059289A1_ADC-114 payload
Undisclosed
WO2017059289A1_ADC-114 linker
Thio Her2 7C2 HC:A140C
ADC Name Payload Target Linker ADC Info
CN118436801A PAC 5 [99]
undisclosed
Undisclosed
Mc-Val-Cit-PABC
Thio hu Anti-HER2 4D5-8 HC A118C
ADC Name Payload Target Linker ADC Info
WO2014159981A2 ADC-211 [100]
WO2014159981A2_ADC-211 payload
Undisclosed
WO2014159981A2_ADC-211 linker
WO2014159981A2 ADC-130 [100]
WO2014159981A2_ADC-130 payload
Undisclosed
WO2014159981A2_ADC-130 linker
WO2014159981A2 ADC-HER2-48 [100]
WO2014159981A2_ADC-HER2-48 payload
Undisclosed
WO2014159981A2_ADC-HER2-48 linker
WO2014159981A2 ADC-HER2-22 [100]
WO2014159981A2_ADC-HER2-22 payload
Undisclosed
WO2014159981A2_ADC-HER2-22 linker
Thio hu Anti-HER2 7C2 HC A140C
ADC Name Payload Target Linker ADC Info
WO2017214024A1 ADC-106 [101]
WO2017214024A1_ADC-106 payload
Undisclosed
WO2017214024A1_ADC-106 linker
Thio hu Anti-HER2 7C2 LC K149C
ADC Name Payload Target Linker ADC Info
WO2017214024A1 ADC-103 [101]
WO2017214024A1_ADC-103 payload
Undisclosed
WO2017214024A1_ADC-103 linker
Thio Hu Anti-Her2 7C2 LC K149C
ADC Name Payload Target Linker ADC Info
CN118436801A PAC 1 [99]
undisclosed
Undisclosed
Mc-Val-Cit-PABC
Thio Hu anti-Her2 7C2 LC:K149C
ADC Name Payload Target Linker ADC Info
CN118436801A PAC 3 [99]
undisclosed
Undisclosed
Mc-Val-Cit-PABC
Thio-Tmab
ADC Name Payload Target Linker ADC Info
Thio-Tmab-BMPEO-DM1 [14]
Maytansinoid DM1
Microtubule (MT)
Thio-Tmab-BMPEO-DM1 linker
Thio-Tr (A121C)
ADC Name Payload Target Linker ADC Info
Thio-Tr (A121C)-BMPEO-DM1 [14]
Maytansinoid DM1
Microtubule (MT)
Thio-Tr (A121C)-BMPEO-DM1 linker
Tigatuzumab
ADC Name Payload Target Linker ADC Info
Tigatuzumab-ADC-Tb3-1 [7]
Tigatuzumab-ADC-Tb3-1 payload
Undisclosed
Tigatuzumab-ADC-Tb3-1 linker
Tigatuzumab-ADC-Tb3-2 [7]
Tigatuzumab-ADC-Tb3-2 payload
Undisclosed
Tigatuzumab-ADC-Tb3-2 linker
Tigatuzumab-ADC-Tb3-3 [7]
Tigatuzumab-ADC-Tb3-3 payload
Undisclosed
Tigatuzumab-ADC-Tb3-3 linker
Tigatuzumab-ADC-Tb3-4 [7]
Tigatuzumab-ADC-Tb3-4 payload
Undisclosed
Tigatuzumab-ADC-Tb3-4 linker
Tigatuzumab-ADC-Tb3-5 [7]
Tigatuzumab-ADC-Tb3-5 payload
Undisclosed
Tigatuzumab-ADC-Tb3-5 linker
Tigatuzumab-ADC-Tb3-6 [7]
Tigatuzumab-ADC-Tb3-6 payload
Undisclosed
Tigatuzumab-ADC-Tb3-6 linker
Tigatuzumab-ADC-Tb3-7 [7]
Tigatuzumab-ADC-Tb3-7 payload
Undisclosed
Tigatuzumab-ADC-Tb3-7 linker
Tigatuzumab-ADC-Tb3-8 [7]
Tigatuzumab-ADC-Tb3-8 payload
Undisclosed
Tigatuzumab-ADC-Tb3-8 linker
Tigatuzumab-ADC-Tb3-9 [7]
Tigatuzumab-ADC-Tb3-9 payload
Undisclosed
Tigatuzumab-ADC-Tb3-9 linker
Tigatuzumab-ADC-Tb3-10 [7]
Tigatuzumab-ADC-Tb3-10 payload
Undisclosed
Tigatuzumab-ADC-Tb3-10 linker
ADC Name Payload Target Linker ADC Info
WO2024105206A1 30e-1015 1 [102]
Undisclosed
Undisclosed
Undisclosed
WO2024105206A1 32e-1015 1 [102]
Undisclosed
Undisclosed
Undisclosed
WO2024105206A1 30e-1015 2 [102]
22i-5657 Payload
Undisclosed
22i-5657 Linker
WO2024105206A1 32e-1015 2 [102]
Mdo-cpt
DNA topoisomerase I (TOP1)
32p-Avelu Linker
ADC Name Payload Target Linker ADC Info
Tra-CAST-MMAE [103]
Monomethyl auristatin E
Microtubule (MT)
Styrylboronic acid-Val-Cit-PAB
ADC Name Payload Target Linker ADC Info
Tras-VC-MMAE [104]
Monomethyl auristatin E
Microtubule (MT)
Mc-Val-Cit-PABC
trast-v1b
ADC Name Payload Target Linker ADC Info
Trast-v1b- (PF07)2 [41]
Undisclosed
Undisclosed
Undisclosed
Trast-v1b- (PF15)2 [41]
Undisclosed
Undisclosed
Undisclosed
ADC Name Payload Target Linker ADC Info
Trast-v2- (PF15)2 [41]
Undisclosed
Undisclosed
Undisclosed
ADC Name Payload Target Linker ADC Info
Trast-v3- (PF15)2 [41]
Undisclosed
Undisclosed
Undisclosed
Trast-v3- (PF07)2 [41]
Undisclosed
Undisclosed
Undisclosed
Trast-v3-PF27 [41]
Undisclosed
Undisclosed
Undisclosed
Trast-v3-PF22 [41]
Undisclosed
Undisclosed
Undisclosed
Trast-v3- (201)2 [41]
Undisclosed
Undisclosed
Undisclosed
trast-v5a
ADC Name Payload Target Linker ADC Info
Trast-v5b- (PF16)2 [41]
Undisclosed
Undisclosed
Undisclosed
Trast-v5b-PF28 [41]
Undisclosed
Undisclosed
Undisclosed
trast-v5b- (XL05)2
ADC Name Payload Target Linker ADC Info
Trast-v5b- (XL05-PF09)2 [41]
Undisclosed
Undisclosed
Undisclosed
trast-v5b-XL01
ADC Name Payload Target Linker ADC Info
Trast-v5b-XL01-PF19 [41]
Undisclosed
Undisclosed
Undisclosed
Trast-v5b-XL01-PF02 [41]
Undisclosed
Undisclosed
Undisclosed
Trast-v5b-XL01-PF09 [41]
Undisclosed
Undisclosed
Undisclosed
trast-v5b-XL02
ADC Name Payload Target Linker ADC Info
Trast-v5b-XL02-PF15 [41]
Undisclosed
Undisclosed
Undisclosed
trast-v5b-XL05
ADC Name Payload Target Linker ADC Info
Trast-v5b- (XL05)2 1 [41]
Undisclosed
Undisclosed
Undisclosed
Trast-v5b- (XL05-PF02)2 [41]
Undisclosed
Undisclosed
Undisclosed
ADC Name Payload Target Linker ADC Info
Trast-v6- (XL05-PF19)2 [41]
Undisclosed
Undisclosed
Undisclosed
Trast-v6- (PF16)2 [41]
Undisclosed
Undisclosed
Undisclosed
Trast-v6-PF28 [41]
Undisclosed
Undisclosed
Undisclosed
Trast-v6- (XL05)2
ADC Name Payload Target Linker ADC Info
Trast-v6- (XL05-PF02)2 [41]
Undisclosed
Undisclosed
Undisclosed
Trast-v6- (XL05-PF09)2 [41]
Undisclosed
Undisclosed
Undisclosed
trast-v6-XL01
ADC Name Payload Target Linker ADC Info
Trast-v6-XL01-PF19 1 [41]
Undisclosed
Undisclosed
Undisclosed
Trast-v6-XL01-PF02 [41]
Undisclosed
Undisclosed
Undisclosed
Trast-v6-XL01-PF09 [41]
Undisclosed
Undisclosed
Undisclosed
trast-v6-XL02
ADC Name Payload Target Linker ADC Info
Trast-v6-XL02-PF15 [41]
Undisclosed
Undisclosed
Undisclosed
trast-v6-XL03
ADC Name Payload Target Linker ADC Info
Trast-v6-XL03-PF15 [41]
Undisclosed
Undisclosed
Undisclosed
trast-v6-XL12
ADC Name Payload Target Linker ADC Info
Trast-v6-XL12-PF02 [41]
Undisclosed
Undisclosed
Undisclosed
Trast-v7-XL01
ADC Name Payload Target Linker ADC Info
Trast-v6-XL01-PF19 2 [41]
Undisclosed
Undisclosed
Undisclosed
trast-v7-XL01
ADC Name Payload Target Linker ADC Info
Trast-v7-XL01-PF02 [41]
Undisclosed
Undisclosed
Undisclosed
Trast-v7-XL01-PF09 [41]
Undisclosed
Undisclosed
Undisclosed
trast-v8-XL06
ADC Name Payload Target Linker ADC Info
Trast-v8-XL06-PF02 [41]
Undisclosed
Undisclosed
Undisclosed
Trast-v8-XL06-PF09 [41]
Undisclosed
Undisclosed
Undisclosed
ADC Name Payload Target Linker ADC Info
Trast-v9- (PF19)2, [41]
Undisclosed
Undisclosed
Undisclosed
Trastuzumab
ADC Name Payload Target Linker ADC Info
caxmotabart entudotin
Monomethyl auristatin F
Microtubule (MT)
β-glucuronide linker
CAN016
Exatecan; MMAE
DNA topoisomerase 1 (TOP1)+Microtubule (MT)
Undisclosed
Trastuzumab emtansine [105]
DM1
Microtubule (MT)
Succinimidyl-4-(N-maleimidomethyl)cyclohexane-1-carboxylate (SMCC)
Trastuzumab deruxtecan [106]
DXd
DNA topoisomerase 1 (TOP1)
Mc-Gly-Gly-Phe-Gly
Trastuzumab rezetecan [107]
SHR9265
DNA topoisomerase 1 (TOP1)
Mc-Gly-Gly-Phe-Gly
Trastuzumab envedotin
Monomethyl auristatin E
Microtubule (MT)
NH2-PEG3-Val-Cit-PABC
Trastuzumab duocarmazine
Seco-DUBA
Human deoxyribonucleic acid (hDNA)
Mal-PEG2-Val-Cit-PABA-Cyclization Spacer
Trastuzumab bultecan
NT1
DNA topoisomerase 1 (TOP1)
PODS-CHX-A"-DTPA
Trastuzumab brengitecan
Ed-04
DNA topoisomerase 1 (TOP1)
Gly-Mal-Gly-Gly-Phe-Gly
TAA-013
Mertansine DM1
Microtubule (MT)
Succinimidyl-4- (N-maleimidomethyl)cyclohexane-1-carboxylate (SMCC)
B-003
Mertansine DM1
Microtubule (MT)
Succinimidyl-4- (N-maleimidomethyl)cyclohexane-1-carboxylate (SMCC)
FDA022 [108]
DXd
DNA topoisomerase 1 (TOP1)
Mc-Val-Ala-PABC double self-immolative linker
SHR-A1201
Mertansine DM1
Microtubule (MT)
Succinimidyl-4- (N-maleimidomethyl)cyclohexane-1-carboxylate (SMCC)
BI-CON-02
Undisclosed
Undisclosed
Undisclosed
Trastuzumab-SYNtansine [109]
Ahx-maytansine
Microtubule (MT)
BCN-HydraSpace-Val-Cit-PABC
Trastuzumab-Gelonin [110]
Gelonin
Ribosome (RB)
N-succinimidyl 4-(2-pyridyldithio) butanoate (SPDB)
Anti-HER2_vc-1 [111]
TLR7 agonist-1
Toll-like receptor 7 (TLR7)
Mc-Val-Cit-PABC
Tmab-SPP-DM1 [112]
Mertansine DM1
Microtubule (MT)
N-succinimidyl 4-(2-pyridyldithio) pentanoate (SPP)
Tmab-SSNPP-DM3 [112]
Maytansinoid DM3
Microtubule (MT)
Sulfosuccinimidyl-N-succinimidyl-4-(5-nitro-2-pyridyldithio) pentanoate (SSNPP)
Tmab-SSNPP-DM4 [112]
Mertansine DM4
Microtubule (MT)
Sulfosuccinimidyl-N-succinimidyl-4-(5-nitro-2-pyridyldithio) pentanoate (SSNPP)
Trastuzumab-AJICAP-maytansinoid [113]
Mertansine DM1
Microtubule (MT)
AJICAP
Trastuzumab-C239I-SG3249 [114]
SG3199
Human Deoxyribonucleic acid (hDNA)
Mal-PEG8-Val-Ala-PABC
Tras-Gly5-EDA-Pnu [115]
PNU-159682
DNA topoisomerase 2-alpha (TOP2A)
Gly5-EDA
Trastuzumab DVD-ADC [116]
Monomethyl auristatin F
Microtubule (MT)
Hexapeptide linker ASTKGP
Trastuzumab-Man-beta-1,4GlcNAc-MMAE [117]
Monomethyl auristatin E
Microtubule (MT)
Man-beta-1,4-GlcNAc
Trastuzumab-Glc-beta-1,4GlcNAc-MMAE [117]
Monomethyl auristatin E
Microtubule (MT)
Glc-beta-1,4GlcNAc
Trastuzumab-Gal-beta-1,4GlcNAc-MMAE [117]
Monomethyl auristatin E
Microtubule (MT)
Gal-beta-1,4-GlcNAc
Trastuzumab-MMAE conjugate DAR2 [118]
Monomethyl auristatin E
Microtubule (MT)
Man-beta-1,4-GlcNAc-DBCO-PEG5-VC-PAB
Trastuzumab-MMAE conjugate DAR4 [118]
Monomethyl auristatin E
Microtubule (MT)
Man-beta-1,4-GlcNAc-DBCO-PEG5-VC-PAB
Trastuzumab-MMAE conjugate DAR6 [118]
Monomethyl auristatin E
Microtubule (MT)
Man-beta-1,4-GlcNAc-DBCO-PEG5-VC-PAB
Trastuzumab-MMAE conjugate DAR8 [118]
Monomethyl auristatin E
Microtubule (MT)
Man-beta-1,4-GlcNAc-DBCO-PEG5-VC-PAB
Trastuzumab-MMAE conjugate DAR12 [118]
Monomethyl auristatin E
Microtubule (MT)
Man-beta-1,4-GlcNAc-DBCO-PEG5-VC-PAB
Trastuzumab-RSL3-NH2 [119]
RSL3-NH2
Phospholipid hydroperoxide glutathione peroxidase (GPX4)
Mal-PEG4-DBCO-Ala-Val
Tras-Gly5-EDA-Dox [115]
Doxorubicin
DNA topoisomerase 2-alpha (TOP2A)
Gly5-EDA
Tras-Gly5-EDA-Nemo [115]
Nemorubicin
DNA topoisomerase 2-alpha (TOP2A)
Gly5-EDA
Tras-Gly3-Vakl-Cit-PAB-PNU-159682 [115]
PNU-159682
DNA topoisomerase 2-alpha (TOP2A)
Gly3-vcPAB
Tras-Gly5-May [115]
Mertansine DM1
Microtubule (MT)
Gly5
Trastuzumab-SG3227 [48]
SG2219
Human Deoxyribonucleic acid (hDNA)
Acetamide-PEG4-Val-Ala-PABA
HER-SG3249 [120]
SG3199
Human Deoxyribonucleic acid (hDNA)
Mal-PEG8-Val-Ala-PABC
Site-specific HER-SG3249 [120]
SG3199
Human Deoxyribonucleic acid (hDNA)
Mal-PEG8-Val-Ala-PABC
Trastuzumab-SG3600 high DAR [47]
N10-beta-glucuronide SG3200
Human Deoxyribonucleic acid (hDNA)
Mal-PEG8-Val-Ala-PABC
LIN-002 [121]
Undisclosed
Undisclosed
Undisclosed
Trastuzumab imbotolimod [122]
T785
Toll-like receptor 7 (TLR7); Toll-like receptor 8 (TLR8)
BG based linker
Trastuzumab-BCN-HydraSpace-Val-Cit-PABC-Gly-Calicheamicin [109]
Gly-calicheamicin
Human Deoxyribonucleic acid (hDNA)
BCN-HydraSpace-Val-Cit-PABC
HER2 targeted DEP conjugate [123]
Active metabolite of irinotecan SN38
DNA topoisomerase 1 (TOP1)
Undisclosed
Trastuzumab SG-3259 [124]
SG3312
Human Deoxyribonucleic acid (hDNA)
Mc-Val-Ala
Trastuzumab-SG3400 high DAR [47]
SG3200
Human Deoxyribonucleic acid (hDNA)
Mal-PEG8-Val-Ala-PABC
Tra-IR700 [125]
IRDye 700DX
Undisclosed
Undisclosed
Anti-HER2_vc-7 [111]
TLR7 agonist-7
Toll-like receptor 7 (TLR7)
Mc-Val-Cit-PABC
Anti-HER2_vc-2 [111]
TLR7 agonist-2
Toll-like receptor 7 (TLR7)
Mc-Val-Cit-PABC
Anti-HER2 antibody-drug conjugate (Spirea) [126]
Monomethyl auristatin E
Microtubule (MT)
Undisclosed
TTZ-Mc-NPV-MMAE [127]
Monomethyl auristatin E
Microtubule (MT)
Mc-Asn-Pro-Val-PABC
Adcitmer [128]
Monomethyl auristatin E
Microtubule (MT)
Pyridino-caproic-Val-Cit-PABC
Trastuzumab-BCN-HydraSpace-Val-Cit-PABC-MMAE [109]
Monomethyl auristatin E
Microtubule (MT)
BCN-HydraSpace-Val-Cit-PABC
MF-TTZ-MMAE [129]
Monomethyl auristatin E
Microtubule (MT)
Dibromomethyl pyridine-Val-Cit-PABC
FGM-TTZ-MMAE [129]
Monomethyl auristatin E
Microtubule (MT)
Mc-Val-Cit-PABC
NC-ADC [130]
Monomethyl auristatin E
Microtubule (MT)
Divinylpyrimidine-PEG4
C-ADC [130]
Monomethyl auristatin E
Microtubule (MT)
Divinylpyrimidine-PEG4-Val-Ala-PABC
Tmab-SPDP-DM1 [112]
Mertansine DM1
Microtubule (MT)
N-succinimidyl 4-(2-pyridyldithio) butanoate (SPDB)
T-K-F (DAR 3.9) [131]
Monomethyl auristatin F
Microtubule (MT)
Succinimidyl-4-(N-maleimidomethyl)cyclohexane-1-carboxylate (SMCC)
T-C-F (DAR 3.7) [131]
Monomethyl auristatin F
Microtubule (MT)
Maleimido-caproyl
Trastuzumab-PNU-159682 Antibody-Drug Conjugate [132]
PNU-159682
DNA topoisomerase 2-alpha (TOP2A)
Undisclosed
Trastuzumab-BCN-HydraSpace-Val-Cit-PABC-PNU-159682 [133]
PNU-159682
DNA topoisomerase 2-alpha (TOP2A)
BCN-HydraSpace-Val-Cit-PABC
Trastuzumab-G5-PNU [115]
PNU-159682
DNA topoisomerase 2-alpha (TOP2A)
Gly5-FITC
PRO-1102 [134]
Exatecan
DNA topoisomerase 1 (TOP1)
Cleavable hydrophilic linker
Tra-Exa-PSAR10 [135]
Exatecan
DNA topoisomerase 1 (TOP1)
Mal-Exa-PSAR10
Tra-Exa-PSAR0 [135]
Exatecan
DNA topoisomerase 1 (TOP1)
Mal-Exa-PSAR0
T-N-F (DAR 3.2) [131]
Aldehyde-tagged MMAF
Microtubule (MT)
Undisclosed
T-N-F (DAR 1.6) [131]
Aldehyde-tagged MMAF
Microtubule (MT)
Undisclosed
Tras-ALN [136]
Alendronate
Farnesyl pyrophosphate synthase (FDPS)
Bicyclo[6.1.0]nona-4-yne
Trastuzumab-ATAC [137]
Alpha-amanitin
DNA-directed RNA polymerase II subunit RPB2 (POLR2B); DNA-directed RNA polymerase III subunit RPC7 (POLR3G)
Undisclosed
CRD-5500 antibody-drug conjugate [138]
CRD5500
Stimulator of interferon genes protein (STING1)
Undisclosed
Trastuzumab-deBouganin [139]
DeBouganin
Microtubule (MT)
Undisclosed
Trastuzumab-BCN-HydraSpace-Val-Cit-PABC-Duocarmycin [109]
Duocarmycin Sa
Human Deoxyribonucleic acid (hDNA)
BCN-HydraSpace-Val-Cit-PABC
Trastuzumab-BCN-HydraSpace-Val-Cit-PABC-Calicheamicin [109]
N-acetyl-gamma-calicheamicin
Human Deoxyribonucleic acid (hDNA)
BCN-HydraSpace-Val-Cit-PABC
MYX2449 [140]
N-Myristolytransferase inhibitor (NMTi)
Glycylpeptide N-tetradecanoyltransferase 1 (NMT1)
Undisclosed
Trastuzumab-BCN-HydraSpace-Val-Ala-PABC-PBD dimer [109]
PBD dimer 2
Human Deoxyribonucleic acid (hDNA)
BCN-HydraSpace-Val-Ala-PABC
MI-130004 [141]
PM050489
Microtubule (MT)
6-(2,5-dioxopyrrol-1-yl)-N-Propylhexanamide
Trastuzumab-DNA mimic 4 [142]
Q Pho-DNA mimics
Human Deoxyribonucleic acid (hDNA)
Diphenyltio-Mal-Cap
ST8176AA1 [143]
ST7612AA1
Histone deacetylase 1 (HDAC1)
Maleimide-thiol linker
Trastuzumab-L3-TL [144]
Triptolide
Nuclear factor NF-kappa-B p105 subunit (NFKB1)
BVP-PEG3-carbamate-PEG4
Trastuzumab-L2-TL [144]
Triptolide
Nuclear factor NF-kappa-B p105 subunit (NFKB1)
BVP-PEG3-diamine
Trastuzumab-L1-TL [144]
Triptolide
Nuclear factor NF-kappa-B p105 subunit (NFKB1)
BVP-PEG3-carbamate
Trastuzumab-L6 [145]
MF-6
DNA topoisomerase 1 (TOP1)
Bridged PEG4-valine-alanine
ADC Trast-7 [146]
Monomethyl auristatin E
Microtubule (MT)
Undisclosed
ADC Trast-10 [146]
Monomethyl auristatin E
Microtubule (MT)
Bis-BCN-modified Val-Cit-PABC linker 10
ADC Trast-14 [146]
PBD dimer 3
Human Deoxyribonucleic acid (hDNA)
Undisclosed
ADC Trast-11 [146]
PBD dimer 3
Human Deoxyribonucleic acid (hDNA)
Bis-BCN-modified Val-Cit-PABC linker 10
Trastuzumab-MCC-CpG conjugate [147]
Differentiated TLR-9 agonist (T-CpG)
Toll-like receptor 9 (TLR9)
Succinimidyl-4-(N-maleimidomethyl)cyclohexane-1-carboxylate (SMCC)
Trastuzumab-T1000-exatecan [148]
Exatecan
DNA topoisomerase 1 (TOP1)
Undisclosed
Trastuzumab-NGM-PROTAC conjugate [149]
BRD4 PROTAC 3
Bromodomain-containing protein 4 (BRD4)
NGM based linker
Trastuzumab-iCME [150]
Membrane-impermable colchinolmethyl ether (iCME) cytotoxin
Microtubule (MT)
Pacific blue fluorophore-SH based linker
IgG1 (trastuzumab)-vc-MMAE [19]
Monomethyl auristatin E
Microtubule (MT)
Mc-Val-Cit-PABC
Trastuzumab-DNA conjugate [151]
DNA mimics
Human Deoxyribonucleic acid (hDNA)
Undisclosed
OHPAS ADC-1 [152]
Alpha-amanitin
DNA-directed RNA polymerase II subunit RPB2 (POLR2B); DNA-directed RNA polymerase III subunit RPC7 (POLR3G)
Ortho-hydroxy-protected aryl sulfate
OHPAS ADC-2 [152]
SG2000
Human Deoxyribonucleic acid (hDNA)
Ortho-hydroxy-protected aryl sulfate
OHPAS ADC-3 [152]
seco-CBI-indole
Human Deoxyribonucleic acid (hDNA)
Ortho-hydroxy-protected aryl sulfate
OHPAS ADC-4 [152]
CBI-dimer-beta-Gal
Human Deoxyribonucleic acid (hDNA)
Ortho-hydroxy-protected aryl sulfate
Trastuzumab/nab-paclitaxel [153]
Paclitaxel
Microtubule (MT)
Undisclosed
Docetaxel-trastuzumab [154]
Docetaxel
Microtubule (MT)
Undisclosed
Trastuzumab-PC4AP-DOX [155]
Doxorubicin
DNA topoisomerase 2-alpha (TOP2A)
Photocaged C4AP
Trastuzumab-PNUEDAGly5 [156]
PNU-159682
DNA topoisomerase 2-alpha (TOP2A)
LPETG-Gly5-EDA
T (Anti-HER2)-30.2060 [31]
Amanitin 30.206
DNA-directed RNA polymerase II subunit RPB2 (POLR2B); DNA-directed RNA polymerase III subunit RPC7 (POLR3G)
Mc-Val-Ala-PABC
T (Anti-HER2)-30.2867 [31]
Amanitin 30.2867
DNA-directed RNA polymerase II subunit RPB2 (POLR2B); DNA-directed RNA polymerase III subunit RPC7 (POLR3G)
Maleimido-caproyl
ADC2-2 [157]
ADC 2-2 payload
DNA topoisomerase 1 (TOP1)
ADC 2-2 linker
ADC2-4 [157]
ADC 2-4 payload
DNA topoisomerase 1 (TOP1)
ADC 2-4 linker
ADC2-6-2 [157]
ADC 2-6-2 payload
DNA topoisomerase 1 (TOP1)
ADC 2-6-2 linker
ADC2-7-2 [157]
ADC 2-7-2 payload
DNA topoisomerase 1 (TOP1)
ADC 2-7-2 linker
ADC2-9-1 [157]
ADC 2-9-1 payload
DNA topoisomerase 1 (TOP1)
ADC 2-9-1 linker
ADC2-9-2 [157]
ADC 2-9-2 payload
DNA topoisomerase 1 (TOP1)
ADC 2-9-2 linker
ADC2-10 [157]
ADC 2-10 payload
DNA topoisomerase 1 (TOP1)
ADC 2-10 linker
ADC2-11 [157]
ADC 2-11 payload
DNA topoisomerase 1 (TOP1)
ADC 2-11 linker
ADC2-22 [157]
ADC 2-22 payload
DNA topoisomerase 1 (TOP1)
ADC 2-22 linker
ADC2-23 [157]
ADC 2-23 payload
DNA topoisomerase 1 (TOP1)
ADC 2-23 linker
ADC2-24 [157]
ADC 2-24 payload
DNA topoisomerase 1 (TOP1)
ADC 2-24 linker
ADC2-25 [157]
ADC 2-25 payload
DNA topoisomerase 1 (TOP1)
ADC 2-25 linker
ADC2-26 [157]
ADC 2-26 payload
DNA topoisomerase 1 (TOP1)
ADC 2-26 linker
ADC2-27 [157]
ADC 2-27 payload
DNA topoisomerase 1 (TOP1)
ADC 2-27 linker
ADC2-29 [157]
ADC 2-29 payload
DNA topoisomerase 1 (TOP1)
ADC 2-29 linker
ADC2-30 [157]
ADC 2-30 payload
DNA topoisomerase 1 (TOP1)
ADC 2-30 linker
ADC2-31 [157]
ADC 2-31 payload
DNA topoisomerase 1 (TOP1)
ADC 2-31 linker
ADC2-32 [157]
ADC 2-32 payload
DNA topoisomerase 1 (TOP1)
ADC 2-32 linker
ADC2-33 [157]
ADC 2-33 payload
DNA topoisomerase 1 (TOP1)
ADC 2-33 linker
ADC2-34 [157]
ADC 2-34 payload
DNA topoisomerase 1 (TOP1)
ADC 2-34 linker
ADC2-35 [157]
ADC 2-35 payload
DNA topoisomerase 1 (TOP1)
ADC 2-35 linker
ADC2-36-1 [157]
ADC 2-36-1 payload
DNA topoisomerase 1 (TOP1)
ADC 2-36-1 linker
ADC2-36-2 [157]
ADC 2-36-2 payload
DNA topoisomerase 1 (TOP1)
ADC 2-36-2 linker
ADC2-37 [157]
ADC 2-37 payload
DNA topoisomerase 1 (TOP1)
ADC 2-37 linker
ADC2-38 [157]
ADC 2-38 payload
DNA topoisomerase 1 (TOP1)
ADC 2-38 linker
ADC2-39 [157]
ADC 2-39 payload
DNA topoisomerase 1 (TOP1)
ADC 2-39 linker
ADC2-40 [157]
ADC 2-40 payload
DNA topoisomerase 1 (TOP1)
ADC 2-40 linker
ADC2-41 [157]
ADC 2-41 payload
DNA topoisomerase 1 (TOP1)
ADC 2-41 linker
ADC2-42 [157]
ADC 2-42 payload
DNA topoisomerase 1 (TOP1)
ADC 2-42 linker
ADC2-42-RO [157]
ADC 2-42-RO payload
DNA topoisomerase 1 (TOP1)
ADC 2-42-RO linker
ADC2-43 [157]
ADC 2-43 payload
DNA topoisomerase 1 (TOP1)
ADC 2-43 linker
ADC2-44 [157]
ADC 2-44 payload
DNA topoisomerase 1 (TOP1)
ADC 2-44 linker
ADC2-45 [157]
ADC 2-45 payload
DNA topoisomerase 1 (TOP1)
ADC 2-45 linker
ADC2-46 [157]
ADC 2-46 payload
DNA topoisomerase 1 (TOP1)
ADC 2-46 linker
ADC2-47 [157]
ADC 2-47 payload
DNA topoisomerase 1 (TOP1)
ADC 2-47 linker
ADC2-48 [157]
ADC 2-48 payload
DNA topoisomerase 1 (TOP1)
ADC 2-48 linker
ADC2-49 [157]
ADC 2-49 payload
DNA topoisomerase 1 (TOP1)
ADC 2-49 linker
ADC2-50 [157]
ADC 2-50 payload
DNA topoisomerase 1 (TOP1)
ADC 2-50 linker
ADC2-51 [157]
ADC 2-51 payload
DNA topoisomerase 1 (TOP1)
ADC 2-51 linker
ADC2-53 [157]
ADC 2-53 payload
DNA topoisomerase 1 (TOP1)
ADC 2-53 linker
ADC2-54 [157]
ADC 2-54 payload
DNA topoisomerase 1 (TOP1)
ADC 2-54 linker
ADC2-55 [157]
ADC 2-55 payload
DNA topoisomerase 1 (TOP1)
ADC 2-55 linker
ADC2-56 [157]
ADC 2-56 payload
DNA topoisomerase 1 (TOP1)
ADC 2-56 linker
ADC2-57 [157]
ADC 2-57 payload
DNA topoisomerase 1 (TOP1)
ADC 2-57 linker
ADC2-58 [157]
ADC 2-58 payload
DNA topoisomerase 1 (TOP1)
ADC 2-58 linker
ADC2-59 [157]
ADC 2-59 payload
DNA topoisomerase 1 (TOP1)
ADC 2-59 linker
ADC2-60 [157]
ADC 2-60 payload
DNA topoisomerase 1 (TOP1)
ADC 2-60 linker
ADC2-61 [157]
ADC 2-61 payload
DNA topoisomerase 1 (TOP1)
ADC 2-61 linker
ADC-2-62-1 [157]
ADC 2-62-1 payload
DNA topoisomerase 1 (TOP1)
ADC 2-62-1 linker
ADC-2-62-2 [157]
ADC 2-62-2 payload
DNA topoisomerase 1 (TOP1)
ADC 2-62-2 linker
ADC-2-63-1 [157]
ADC 2-63-1 payload
DNA topoisomerase 1 (TOP1)
ADC 2-63-1 linker
ADC-2-63-2 [157]
ADC 2-63-2 payload
DNA topoisomerase 1 (TOP1)
ADC 2-63-2 linker
ADC-2-64-1 [157]
ADC 2-64-1 payload
DNA topoisomerase 1 (TOP1)
ADC 2-64-1 linker
ADC-2-64-2 [157]
ADC 2-64-2 payload
DNA topoisomerase 1 (TOP1)
ADC 2-64-2 linker
ADC-2-65-1 [157]
ADC 2-65-1 payload
DNA topoisomerase 1 (TOP1)
ADC 2-65-1 linker
ADC-2-65-2 [157]
ADC 2-65-2 payload
DNA topoisomerase 1 (TOP1)
ADC 2-65-2 linker
ADC3-1 [157]
ADC 3-1 payload
DNA topoisomerase 1 (TOP1)
ADC 3-1 linker
ADC3-2 [157]
ADC 3-2 payload
DNA topoisomerase 1 (TOP1)
ADC 3-2 linker
ADC3-3 [157]
ADC 3-3 payload
DNA topoisomerase 1 (TOP1)
ADC 3-3 linker
ADC3-4 [157]
ADC 3-4 payload
DNA topoisomerase 1 (TOP1)
ADC 3-4 linker
ADC3-5 [157]
ADC 3-5 payload
DNA topoisomerase 1 (TOP1)
ADC 3-5 linker
ADC2-A [157]
ADC 2-A payload
DNA topoisomerase 1 (TOP1)
ADC 2-A linker
ADC2-B [157]
ADC 2-B payload
DNA topoisomerase 1 (TOP1)
ADC 2-B linker
ADC2-12 [157]
ADC 2-12 payload
DNA topoisomerase 1 (TOP1)
ADC 2-12 linker
HER2-ADC-01 (DAR8) [7]
HER2-ADC-01(DAR8) payload
Undisclosed
HER2-ADC-01(DAR8) linker
HER2-ADC-02 (DAR8) [7]
HER2-ADC-02(DAR8) payload
Undisclosed
HER2-ADC-02(DAR8) linker
HER2-ADC-03 (DAR8) [7]
HER2-ADC-03(DAR8) payload
Undisclosed
HER2-ADC-03(DAR8) linker
HER2-ADC-04 (DAR8) [7]
HER2-ADC-04(DAR8) payload
Undisclosed
HER2-ADC-04(DAR8) linker
HER2-ADC-05 (DAR8) [7]
HER2-ADC-05(DAR8) payload
Undisclosed
HER2-ADC-05(DAR8) linker
HER2-ADC-06 (DAR8) [7]
HER2-ADC-06(DAR8) payload
Undisclosed
HER2-ADC-06(DAR8) linker
HER2-ADC-07 (DAR8) [7]
HER2-ADC-07(DAR8) payload
Undisclosed
HER2-ADC-07(DAR8) linker
HER2-ADC-08 (DAR8) [7]
HER2-ADC-08(DAR8) payload
Undisclosed
HER2-ADC-08(DAR8) linker
HER2-ADC-09 (DAR8) [7]
HER2-ADC-09(DAR8) payload
Undisclosed
HER2-ADC-09(DAR8) linker
HER2-ADC-10 (DAR8) [7]
HER2-ADC-10(DAR8) payload
Undisclosed
HER2-ADC-10(DAR8) linker
WO2020063676A1 ADC-1 [84]
WO2020063676A1_ADC-1 payload
Undisclosed
WO2020063676A1_ADC-1 linker
WO2020063676A1 ADC-2 [84]
WO2020063676A1_ADC-2 payload
Undisclosed
WO2020063676A1_ADC-2 linker
WO2020063676A1 ADC-3 [84]
WO2020063676A1_ADC-3 payload
Undisclosed
WO2020063676A1_ADC-3 linker
WO2020063676A1 ADC-4 [84]
WO2020063676A1_ADC-4 payload
Undisclosed
WO2020063676A1_ADC-4 linker
WO2020063676A1 ADC-5 [84]
WO2020063676A1_ADC-5 payload
Undisclosed
WO2020063676A1_ADC-5 linker
WO2020063676A1 ADC-6 [84]
WO2020063676A1_ADC-6 payload
Undisclosed
WO2020063676A1_ADC-6 linker
WO2020063676A1 ADC-10 [84]
WO2020063676A1_ADC-10 payload
Undisclosed
WO2020063676A1_ADC-10 linker
WO2020063676A1 ADC-11 [84]
WO2020063676A1_ADC-11 payload
Undisclosed
WO2020063676A1_ADC-11 linker
WO2020063676A1 ADC-12 [84]
WO2020063676A1_ADC-12 payload
Undisclosed
WO2020063676A1_ADC-12 linker
WO2020063676A1 ADC-13 [84]
WO2020063676A1_ADC-13 payload
Undisclosed
WO2020063676A1_ADC-13 linker
WO2020063676A1 ADC-14 [84]
WO2020063676A1_ADC-14 payload
Undisclosed
WO2020063676A1_ADC-14 linker
WO2020063676A1 ADC-15 [84]
WO2020063676A1_ADC-15 payload
Undisclosed
WO2020063676A1_ADC-15 linker
WO2020063676A1 ADC-16 [84]
WO2020063676A1_ADC-16 payload
Undisclosed
WO2020063676A1_ADC-16 linker
WO2020063676A1 ADC-17 [84]
WO2020063676A1_ADC-17 payload
Undisclosed
WO2020063676A1_ADC-17 linker
WO2020063676A1 ADC-18 [84]
WO2020063676A1_ADC-18 payload
Undisclosed
WO2020063676A1_ADC-18 linker
WO2020063676A1 ADC-19 [84]
WO2020063676A1_ADC-19 payload
Undisclosed
WO2020063676A1_ADC-19 linker
WO2020063676A1 ADC-20 [84]
WO2020063676A1_ADC-20 payload
Undisclosed
WO2020063676A1_ADC-20 linker
WO2020063676A1 ADC-21 [84]
WO2020063676A1_ADC-21 payload
Undisclosed
WO2020063676A1_ADC-21 linker
WO2020063676A1 ADC-22 [84]
WO2020063676A1_ADC-22 payload
Undisclosed
WO2020063676A1_ADC-22 linker
WO2020063676A1 ADC-23 [84]
WO2020063676A1_ADC-23 payload
Undisclosed
WO2020063676A1_ADC-23 linker
WO2020063676A1 ADC-24 [84]
WO2020063676A1_ADC-24 payload
Undisclosed
WO2020063676A1_ADC-24 linker
Trastuzumab-Compound (la) DAR 1.6 [85]
NeoDegrader P1
Protein cereblon (CRBN)
Trastuzumab-Compound (la) DAR 1.6 linker
Trastuzumab-Compound (la) DAR 8 [85]
NeoDegrader P1
Protein cereblon (CRBN)
Trastuzumab-Compound (la) DAR 8 linker
Trastuzumab-Compound (Ib) DAR1.5 [85]
NeoDegrader P3
Protein cereblon (CRBN)
Trastuzumab-Compound (Ib) DAR1.5 linker
Trastuzumab-Compound (lc) [85]
NeoDegrader P4
Protein cereblon (CRBN)
Trastuzumab-Compound (lc) linker
Trastuzumab-Compound (lc) DAR 8 [85]
NeoDegrader P4
Protein cereblon (CRBN)
Trastuzumab-Compound (lc) DAR 8 linker
Trastuzumab-Compound (ld) DAR 1.6 [85]
NeoDegrader P1
Protein cereblon (CRBN)
Trastuzumab-Compound (ld) DAR 1.6 linker
Trastuzumab-Compound (le) [85]
NeoDegrader P1
Protein cereblon (CRBN)
Trastuzumab-Compound (le) linker
Trastuzumab-Compound (lf) [85]
NeoDegrader P6
Protein cereblon (CRBN)
Trastuzumab-Compound (lf) linker
Trastuzumab-Compound (lg) [85]
NeoDegrader P2
Protein cereblon (CRBN)
Trastuzumab-Compound (lg) linker
Trastuzumab-Compound (lh) [85]
NeoDegrader P13
Protein cereblon (CRBN)
Trastuzumab-Compound (lh) linker
Trastuzumab-Compound (li) [85]
NeoDegrader P1
Protein cereblon (CRBN)
Trastuzumab-Compound (li) linker
Trastuzumab-Compound (lj) [85]
NeoDegrader P1
Protein cereblon (CRBN)
Trastuzumab-Compound (lj) linker
Trastuzumab-Compound (lk) [85]
NeoDegrader P14
Protein cereblon (CRBN)
Trastuzumab-Compound (lk) linker
Trastuzumab-Compound (ll) [85]
NeoDegrader P14
Protein cereblon (CRBN)
Trastuzumab-Compound (ll) linker
Trastuzumab-Compound (lm) [85]
NeoDegrader P14
Protein cereblon (CRBN)
Trastuzumab-Compound (lm) linker
WO2017089895A1 ADC1 [158]
Monomethyl auristatin E
Microtubule (MT)
WO2017089895A1_ADC1 linker
WO2017089895A1 ADC2 [158]
Monomethyl auristatin F
Microtubule (MT)
WO2017089895A1_ADC2 linker
WO2017089895A1 ADC3 [158]
Monomethyl auristatin E
Microtubule (MT)
WO2017089895A1_ADC3 linker
WO2017089895A1 ADC4 [158]
Monomethyl auristatin F
Microtubule (MT)
WO2017089895A1_ADC4 linker
WO2017089895A1 ADC5 [158]
Monomethyl auristatin E
Microtubule (MT)
WO2017089895A1_ADC5 linker
WO2017089895A1 ADC6 [158]
Monomethyl auristatin F
Microtubule (MT)
WO2017089895A1_ADC6 linker
WO2017089895A1 ADC7 [158]
Monomethyl auristatin E
Microtubule (MT)
WO2017089895A1_ADC7 linker
WO2017089895A1 ADC8 [158]
Monomethyl auristatin F
Microtubule (MT)
WO2017089895A1_ADC8 linker
WO2017089895A1 ADC9 [158]
Monomethyl auristatin E
Microtubule (MT)
WO2017089895A1_ADC9 linker
WO2017089895A1 ADC10 [158]
Monomethyl auristatin E
Microtubule (MT)
WO2017089895A1_ADC10 linker
WO2017089895A1 ADC11 [158]
Monomethyl auristatin E
Microtubule (MT)
WO2017089895A1_ADC11 linker
WO2017089895A1 ADC12 [158]
Monomethyl auristatin E
Microtubule (MT)
WO2017089895A1_ADC12 linker
WO2017089895A1 ADC13 [158]
Monomethyl auristatin E
Microtubule (MT)
WO2017089895A1_ADC13 linker
WO2017089895A1 ADC14 [158]
Monomethyl auristatin F
Microtubule (MT)
WO2017089895A1_ADC14 linker
WO2017089895A1 ADC15 [158]
Monomethyl auristatin E
Microtubule (MT)
WO2017089895A1_ADC15 linker
WO2017089895A1 ADC16 [158]
Monomethyl auristatin F
Microtubule (MT)
WO2017089895A1_ADC16 linker
WO2017089895A1 ADC17 [158]
Monomethyl auristatin E
Microtubule (MT)
WO2017089895A1_ADC17 linker
WO2017089895A1 ADC18 [158]
Monomethyl auristatin F
Microtubule (MT)
WO2017089895A1_ADC18 linker
WO2017089895A1 ADC19 [158]
Monomethyl auristatin E
Microtubule (MT)
WO2017089895A1_ADC19 linker
WO2017089895A1 ADC20 [158]
Monomethyl auristatin F
Microtubule (MT)
WO2017089895A1_ADC20 linker
WO2017089895A1 ADC86 [158]
Monomethyl auristatin F
Microtubule (MT)
WO2017089895A1_ADC86 linker
WO2017089895A1 ADC87 [158]
Monomethyl auristatin E
Microtubule (MT)
WO2017089895A1_ADC87 linker
WO2017089895A1 ADC23 [158]
Monomethyl auristatin F
Microtubule (MT)
WO2017089895A1_ADC23 linker
WO2017089895A1 ADC24 [158]
Monomethyl auristatin E
Microtubule (MT)
WO2017089895A1_ADC24 linker
WO2017089895A1 ADC25 [158]
Monomethyl auristatin E
Microtubule (MT)
WO2017089895A1_ADC25 linker
WO2017089895A1 ADC26 [158]
Monomethyl auristatin E
Microtubule (MT)
WO2017089895A1_ADC26 linker
WO2017089895A1 ADC27 [158]
Monomethyl auristatin E
Microtubule (MT)
WO2017089895A1_ADC27 linker
WO2017089895A1 ADC28 [158]
Monomethyl auristatin E
Microtubule (MT)
WO2017089895A1_ADC28 linker
WO2017089895A1 ADC29 [158]
Monomethyl auristatin E
Microtubule (MT)
WO2017089895A1_ADC29 linker
WO2017089895A1 ADC30 [158]
Monomethyl auristatin E
Microtubule (MT)
WO2017089895A1_ADC30 linker
WO2017089895A1 ADC31 [158]
Monomethyl auristatin E
Microtubule (MT)
WO2017089895A1_ADC31 linker
WO2017089895A1 ADC32 [158]
Monomethyl auristatin E
Microtubule (MT)
WO2017089895A1_ADC32 linker
WO2017089895A1 ADC33 [158]
Monomethyl auristatin E
Microtubule (MT)
WO2017089895A1_ADC33 linker
WO2017089895A1 ADC34 [158]
Monomethyl auristatin F
Microtubule (MT)
WO2017089895A1_ADC34 linker
WO2017089895A1 ADC35 [158]
Monomethyl auristatin E
Microtubule (MT)
WO2017089895A1_ADC35 linker
WO2017089895A1 ADC36 [158]
Monomethyl auristatin E
Microtubule (MT)
WO2017089895A1_ADC36 linker
WO2017089895A1 ADC37 [158]
Monomethyl auristatin E
Microtubule (MT)
WO2017089895A1_ADC37 linker
WO2017089895A1 ADC38 [158]
Monomethyl auristatin F
Microtubule (MT)
WO2017089895A1_ADC38 linker
WO2017089895A1 ADC39 [158]
Monomethyl auristatin E
Microtubule (MT)
WO2017089895A1_ADC39 linker
WO2017089895A1 ADC40 [158]
Monomethyl auristatin F
Microtubule (MT)
WO2017089895A1_ADC40 linker
WO2017089895A1 ADC41 [158]
Monomethyl auristatin E
Microtubule (MT)
WO2017089895A1_ADC41 linker
WO2017089895A1 ADC42 [158]
Monomethyl auristatin F
Microtubule (MT)
WO2017089895A1_ADC42 linker
WO2017089895A1 ADC43 [158]
Monomethyl auristatin E
Microtubule (MT)
WO2017089895A1_ADC43 linker
WO2017089895A1 ADC44 [158]
Monomethyl auristatin F
Microtubule (MT)
WO2017089895A1_ADC44 linker
WO2017089895A1 ADC45 [158]
Monomethyl auristatin E
Microtubule (MT)
WO2017089895A1_ADC45 linker
WO2017089895A1 ADC46 [158]
Monomethyl auristatin F
Microtubule (MT)
WO2017089895A1_ADC46 linker
WO2017089895A1 ADC47 [158]
Monomethyl auristatin E
Microtubule (MT)
WO2017089895A1_ADC47 linker
WO2017089895A1 ADC48 [158]
Monomethyl auristatin F
Microtubule (MT)
WO2017089895A1_ADC48 linker
WO2017089895A1 ADC49 [158]
Monomethyl auristatin E
Microtubule (MT)
WO2017089895A1_ADC49 linker
WO2017089895A1 ADC50 [158]
Monomethyl auristatin F
Microtubule (MT)
WO2017089895A1_ADC50 linker
WO2017089895A1 ADC51 [158]
Monomethyl auristatin E
Microtubule (MT)
WO2017089895A1_ADC51 linker
WO2017089895A1 ADC52 [158]
Monomethyl auristatin E
Microtubule (MT)
WO2017089895A1_ADC52 linker
WO2017089895A1 ADC53 [158]
Monomethyl auristatin F
Microtubule (MT)
WO2017089895A1_ADC53 linker
WO2017089895A1 ADC54 [158]
Monomethyl auristatin F
Microtubule (MT)
WO2017089895A1_ADC54 linker
WO2017089895A1 ADC55 [158]
Monomethyl auristatin F
Microtubule (MT)
WO2017089895A1_ADC55 linker
WO2017089895A1 ADC76 [158]
Monomethyl auristatin F
Microtubule (MT)
WO2017089895A1_ADC76 linker
WO2017089895A1 ADC88 [158]
Monomethyl auristatin F
Microtubule (MT)
WO2017089895A1_ADC88 linker
WO2017089895A1 ADC89 [158]
Monomethyl auristatin F
Microtubule (MT)
WO2017089895A1_ADC89 linker
WO2017089895A1 ADC90 [158]
Monomethyl auristatin F
Microtubule (MT)
WO2017089895A1_ADC90 linker
WO2017089895A1 ADC91 [158]
Monomethyl auristatin E
Microtubule (MT)
WO2017089895A1_ADC91 linker
WO2017089895A1 ADC60 [158]
Monomethyl auristatin F
Microtubule (MT)
WO2017089895A1_ADC60 linker
WO2017089895A1 ADC61 [158]
Monomethyl auristatin E
Microtubule (MT)
WO2017089895A1_ADC61 linker
WO2017089895A1 ADC62 [158]
Monomethyl auristatin F
Microtubule (MT)
WO2017089895A1_ADC62 linker
WO2017089895A1 ADC63 [158]
Monomethyl auristatin E
Microtubule (MT)
WO2017089895A1_ADC63 linker
WO2017089895A1 ADC77 [158]
Monomethyl auristatin F
Microtubule (MT)
WO2017089895A1_ADC77 linker
WO2017089895A1 ADC21 [158]
Alpha-amanitin
DNA-directed RNA polymerase II subunit RPB2 (POLR2B); DNA-directed RNA polymerase III subunit RPC7 (POLR3G)
WO2017089895A1_ADC21 linker
WO2017089895A1 ADC22 [158]
Alpha-amanitin
DNA-directed RNA polymerase II subunit RPB2 (POLR2B); DNA-directed RNA polymerase III subunit RPC7 (POLR3G)
WO2017089895A1_ADC22 linker
WO2017089895A1 ADC56 [158]
Alpha-amanitin
DNA-directed RNA polymerase II subunit RPB2 (POLR2B); DNA-directed RNA polymerase III subunit RPC7 (POLR3G)
WO2017089895A1_ADC56 linker
WO2017089895A1 ADC57 [158]
Alpha-amanitin
DNA-directed RNA polymerase II subunit RPB2 (POLR2B); DNA-directed RNA polymerase III subunit RPC7 (POLR3G)
WO2017089895A1_ADC57 linker
WO2017089895A1 ADC58 [158]
Alpha-amanitin+Monomethyl auristatin F
Undisclosed
WO2017089895A1_ADC58 linker
WO2017089895A1 ADC59 [158]
Alpha-amanitin+Monomethyl auristatin F
Undisclosed
WO2017089895A1_ADC59 linker
HER2-B Antibody-Compound (X) [53]
HER2-B Antibody-Compound (X) payload
Undisclosed
HER2-B Antibody-Compound (X) linker
HER2-B Antibody-Compound (XI) [53]
HER2-B Antibody-Compound (XI) payload
Undisclosed
HER2-B Antibody-Compound (XI) linker
HER2-B Antibody-Compound (XIV) [53]
HER2-B Antibody-Compound (XIV) payload
Undisclosed
HER2-B Antibody-Compound (XIV) linker
HER2-B Antibody-Compound (XVIII) [53]
HER2-B Antibody-Compound (XVIII) payload
Undisclosed
HER2-B Antibody-Compound (XVIII) linker
HER2-B Antibody-Compound (Ie) [53]
HER2-B Antibody-Compound (Ie) payload
Undisclosed
HER2-B Antibody-Compound (Ie) linker
HER2-B Antibody-Compound (XIX) [53]
HER2-B Antibody-Compound (XIX) payload
Undisclosed
HER2-B Antibody-Compound (XIX) linker
HER2-B Antibody-Compound (Ii) [53]
HER2-B Antibody-Compound (Ii) payload
Undisclosed
HER2-B Antibody-Compound (Ii) linker
HER2-B Antibody-Compound (XLI) [53]
HER2-B Antibody-Compound (XLI) payload
Undisclosed
HER2-B Antibody-Compound (XLI) linker
HER2-B Antibody-Compound (XVI) [53]
HER2-B Antibody-Compound (XIX) payload
Undisclosed
HER2-B Antibody-Compound (XIX) linker
HER2-B Antibody-Compound (XL) [53]
HER2-B Antibody-Compound (XL) payload
Undisclosed
HER2-B Antibody-Compound (XL) linker
HER2-B Antibody-Compound (XLIII) [53]
HER2-B Antibody-Compound (XLIII) payload
Undisclosed
HER2-B Antibody-Compound (XLIII) linker
HER2-B Antibody-Compound (XLII) [53]
HER2-B Antibody-Compound (XLII) payload
Undisclosed
HER2-B Antibody-Compound (XLII) linker
Trastuzumab-Compound (XV) [53]
Trastuzumab-Compound (XV) payload
Undisclosed
Trastuzumab-Compound (XV) linker
WO2013055987A1 Tmab-101 [159]
SG2000
Human Deoxyribonucleic acid (hDNA)
WO2013055987A1_Tmab-101 linker
WO2013055987A1 Tmab-102 [159]
SG2000
Human Deoxyribonucleic acid (hDNA)
WO2013055987A1_Tmab-102 linker
WO2013055987A1 Tmab-104 [159]
SG2000
Human Deoxyribonucleic acid (hDNA)
WO2013055987A1_Tmab-104 linker
WO2013055987A1 Tmab-110 [159]
SG2000
Human Deoxyribonucleic acid (hDNA)
WO2013055987A1_Tmab-110 linker
WO2014159981A2 ADC-110 [100]
WO2014159981A2_ADC-110 payload
Undisclosed
WO2014159981A2_ADC-110 linker
WO2014159981A2 ADC-120 [100]
WO2014159981A2_ADC-120 payload
Undisclosed
WO2014159981A2_ADC-120 linker
ADC-II-1 [160]
ADC-II-1 payload
Undisclosed
ADC-II-1 linker
ADC-II-5 [160]
ADC-II-5 payload
Undisclosed
ADC-II-5 linker
ADC-II-9 [160]
ADC-II-9 payload
Undisclosed
ADC-II-9 linker
ADC-II-13 [160]
ADC-II-13 payload
Undisclosed
ADC-II-13 linker
ADC-I-1 [160]
ADC-I-1 payload
Undisclosed
ADC-I-1 linker
ADC-III-1 [160]
ADC-III-1 payload
Undisclosed
ADC-III-1 linker
ADC-III-9 [160]
ADC-III-9 payload
Undisclosed
ADC-III-9 linker
WO2022078260A1 ADC-1 [161]
Ln-D9
DNA topoisomerase 1 (TOP1)
WO2022078260A1_ADC-1 linker
WO2022078260A1 ADC-2 [161]
Ln-D1
DNA topoisomerase 1 (TOP1)
WO2022078260A1_ADC-2 linker
WO2022078260A1 ADC-3 [161]
Ln-D2
DNA topoisomerase 1 (TOP1)
WO2022078260A1_ADC-3 linker
WO2022078260A1 ADC-4 [161]
Ln-D4
DNA topoisomerase 1 (TOP1)
WO2022078260A1_ADC-4 linker
WO2022078260A1 ADC-5 [161]
Ln-D5
DNA topoisomerase 1 (TOP1)
WO2022078260A1_ADC-5 linker
WO2022078260A1 ADC-6 [161]
Ln-D6
DNA topoisomerase 1 (TOP1)
WO2022078260A1_ADC-6 linker
WO2022078260A1 ADC-7 [161]
Ln-D7
DNA topoisomerase 1 (TOP1)
WO2022078260A1_ADC-7 linker
WO2022078260A1 ADC-8 [161]
Ln-D8
DNA topoisomerase 1 (TOP1)
WO2022078260A1_ADC-8 linker
WO2021249228A1 ADC-1 [162]
WO2021249228A1_ADC-1 payload
Undisclosed
WO2021249228A1_ADC-1 linker
WO2021249228A1 ADC-2 [162]
WO2021249228A1_ADC-2 payload
Undisclosed
WO2021249228A1_ADC-2 linker
WO2021249228A1 ADC-3 [162]
WO2021249228A1_ADC-3 payload
Undisclosed
WO2021249228A1_ADC-3 linker
WO2021249228A1 ADC-4 [162]
WO2021249228A1_ADC-4 payload
Undisclosed
WO2021249228A1_ADC-4 linker
WO2021249228A1 ADC-5 [162]
WO2021249228A1_ADC-5 payload
Undisclosed
WO2021249228A1_ADC-5 linker
WO2021249228A1 ADC-6 [162]
WO2021249228A1_ADC-6 payload
Undisclosed
WO2021249228A1_ADC-6 linker
WO2021249228A1 ADC-7 [162]
WO2021249228A1_ADC-7 payload
Undisclosed
WO2021249228A1_ADC-7 linker
WO2021249228A1 ADC-8 [162]
WO2021249228A1_ADC-8 payload
Undisclosed
WO2021249228A1_ADC-8 linker
WO2021249228A1 ADC-9 [162]
WO2021249228A1_ADC-9 payload
Undisclosed
WO2021249228A1_ADC-9 linker
WO2021249228A1 ADC-10 [162]
WO2021249228A1_ADC-10 payload
Undisclosed
WO2021249228A1_ADC-10 linker
WO2021249228A1 ADC-11 [162]
WO2021249228A1_ADC-11 payload
Undisclosed
WO2021249228A1_ADC-11 linker
WO2021249228A1 ADC-12 [162]
WO2021249228A1_ADC-12 payload
Undisclosed
WO2021249228A1_ADC-12 linker
WO2021249228A1 ADC-13 [162]
WO2021249228A1_ADC-13 payload
Undisclosed
WO2021249228A1_ADC-13 linker
WO2021249228A1 ADC-14 [162]
WO2021249228A1_ADC-14 payload
Undisclosed
WO2021249228A1_ADC-14 linker
WO2021249228A1 ADC-15 [162]
WO2021249228A1_ADC-15 payload
Undisclosed
WO2021249228A1_ADC-15 linker
WO2021249228A1 ADC-16 [162]
WO2021249228A1_ADC-16 payload
Undisclosed
WO2021249228A1_ADC-16 linker
WO2021249228A1 ADC-17 [162]
WO2021249228A1_ADC-17 payload
Undisclosed
WO2021249228A1_ADC-17 linker
WO2021249228A1 ADC-18 [162]
WO2021249228A1_ADC-18 payload
Undisclosed
WO2021249228A1_ADC-18 linker
WO2021249228A1 ADC-19 [162]
WO2021249228A1_ADC-19 payload
Undisclosed
WO2021249228A1_ADC-19 linker
WO2021249228A1 ADC-20 [162]
WO2021249228A1_ADC-20 payload
Undisclosed
WO2021249228A1_ADC-20 linker
WO2021249228A1 ADC-21 [162]
WO2021249228A1_ADC-21 payload
Undisclosed
WO2021249228A1_ADC-21 linker
WO2021249228A1 ADC-22 [162]
WO2021249228A1_ADC-22 payload
Undisclosed
WO2021249228A1_ADC-22 linker
WO2021249228A1 ADC-23 [162]
WO2021249228A1_ADC-23 payload
Undisclosed
WO2021249228A1_ADC-23 linker
WO2021249228A1 ADC-24 [162]
WO2021249228A1_ADC-24 payload
Undisclosed
WO2021249228A1_ADC-24 linker
WO2021249228A1 ADC-25 [162]
WO2021249228A1_ADC-25 payload
Undisclosed
WO2021249228A1_ADC-25 linker
WO2021249228A1 ADC-26 [162]
WO2021249228A1_ADC-26 payload
Undisclosed
WO2021249228A1_ADC-26 linker
WO2021249228A1 ADC-27 [162]
WO2021249228A1_ADC-27 payload
Undisclosed
WO2021249228A1_ADC-27 linker
WO2021249228A1 ADC-28 [162]
WO2021249228A1_ADC-28 payload
Undisclosed
WO2021249228A1_ADC-28 linker
WO2021249228A1 ADC-29 [162]
WO2021249228A1_ADC-29 payload
Undisclosed
WO2021249228A1_ADC-29 linker
WO2021249228A1 ADC-30 [162]
WO2021249228A1_ADC-30 payload
Undisclosed
WO2021249228A1_ADC-30 linker
WO2021249228A1 ADC-31 [162]
WO2021249228A1_ADC-31 payload
Undisclosed
WO2021249228A1_ADC-31 linker
WO2021249228A1 ADC-32 [162]
WO2021249228A1_ADC-32 payload
Undisclosed
WO2021249228A1_ADC-32 linker
WO2021249228A1 ADC-33 [162]
WO2021249228A1_ADC-33 payload
Undisclosed
WO2021249228A1_ADC-33 linker
WO2021249228A1 ADC-34 [162]
WO2021249228A1_ADC-34 payload
Undisclosed
WO2021249228A1_ADC-34 linker
WO2021249228A1 ADC-35 [162]
WO2021249228A1_ADC-35 payload
Undisclosed
WO2021249228A1_ADC-35 linker
WO2021249228A1 ADC-36 [162]
WO2021249228A1_ADC-36 payload
Undisclosed
WO2021249228A1_ADC-36 linker
WO2021249228A1 ADC-37 [162]
WO2021249228A1_ADC-37 payload
Undisclosed
WO2021249228A1_ADC-37 linker
WO2021249228A1 ADC-38 [162]
WO2021249228A1_ADC-38 payload
Undisclosed
WO2021249228A1_ADC-38 linker
WO2021249228A1 ADC-39 [162]
WO2021249228A1_ADC-39 payload
Undisclosed
WO2021249228A1_ADC-39 linker
WO2021249228A1 ADC-40 [162]
WO2021249228A1_ADC-40 payload
Undisclosed
WO2021249228A1_ADC-40 linker
WO2021249228A1 ADC-41 [162]
WO2021249228A1_ADC-41 payload
Undisclosed
WO2021249228A1_ADC-41 linker
WO2021249228A1 ADC-42 [162]
WO2021249228A1_ADC-42 payload
Undisclosed
WO2021249228A1_ADC-42 linker
WO2021249228A1 ADC-43 [162]
WO2021249228A1_ADC-43 payload
Undisclosed
WO2021249228A1_ADC-43 linker
WO2021249228A1 ADC-44 [162]
WO2021249228A1_ADC-44 payload
Undisclosed
WO2021249228A1_ADC-44 linker
WO2021249228A1 ADC-45 [162]
WO2021249228A1_ADC-45 payload
Undisclosed
WO2021249228A1_ADC-45 linker
WO2021249228A1 ADC-46 [162]
WO2021249228A1_ADC-46 payload
Undisclosed
WO2021249228A1_ADC-46 linker
WO2021249228A1 ADC-47 [162]
WO2021249228A1_ADC-47 payload
Undisclosed
WO2021249228A1_ADC-47 linker
WO2021249228A1 ADC-48 [162]
WO2021249228A1_ADC-48 payload
Undisclosed
WO2021249228A1_ADC-48 linker
WO2021249228A1 ADC-49 [162]
WO2021249228A1_ADC-49 payload
Undisclosed
WO2021249228A1_ADC-49 linker
WO2021249228A1 ADC-50 [162]
WO2021249228A1_ADC-50 payload
Undisclosed
WO2021249228A1_ADC-50 linker
WO2021249228A1 ADC-51 [162]
WO2021249228A1_ADC-51 payload
Undisclosed
WO2021249228A1_ADC-51 linker
WO2021249228A1 ADC-52 [162]
WO2021249228A1_ADC-52 payload
Undisclosed
WO2021249228A1_ADC-52 linker
WO2021249228A1 ADC-53 [162]
WO2021249228A1_ADC-53 payload
Undisclosed
WO2021249228A1_ADC-53 linker
WO2021249228A1 ADC-54 [162]
WO2021249228A1_ADC-54 payload
Undisclosed
WO2021249228A1_ADC-54 linker
WO2021249228A1 ADC-55 [162]
WO2021249228A1_ADC-55 payload
Undisclosed
WO2021249228A1_ADC-55 linker
WO2021249228A1 ADC-56 [162]
WO2021249228A1_ADC-56 payload
Undisclosed
WO2021249228A1_ADC-56 linker
WO2021249228A1 ADC-57 [162]
WO2021249228A1_ADC-57 payload
Undisclosed
WO2021249228A1_ADC-57 linker
WO2021249228A1 ADC-58 [162]
WO2021249228A1_ADC-58 payload
Undisclosed
WO2021249228A1_ADC-58 linker
WO2021249228A1 ADC-59 [162]
WO2021249228A1_ADC-59 payload
Undisclosed
WO2021249228A1_ADC-59 linker
WO2021249228A1 ADC-60 [162]
WO2021249228A1_ADC-60 payload
Undisclosed
WO2021249228A1_ADC-60 linker
WO2021249228A1 ADC-61 [162]
WO2021249228A1_ADC-61 payload
Undisclosed
WO2021249228A1_ADC-61 linker
WO2022228495A1 ADC-67 [50]
WO2022228495A1 ADC-67 payload
Undisclosed
WO2022228495A1 ADC-67 linker
WO2022228495A1 ADC-68 [50]
WO2022228495A1 ADC-68 payload
Undisclosed
WO2022228495A1 ADC-68 linker
WO2022228495A1 ADC-69 [50]
WO2022228495A1 ADC-69 payload
Undisclosed
WO2022228495A1 ADC-69 linker
WO2022228495A1 ADC-70 [50]
WO2022228495A1 ADC-70 payload
Undisclosed
WO2022228495A1 ADC-70 linker
WO2022228495A1 ADC-71 [50]
WO2022228495A1 ADC-71 payload
Undisclosed
WO2022228495A1 ADC-71 linker
WO2022228495A1 ADC-74 [50]
WO2022228495A1 ADC-74 payload
Undisclosed
WO2022228495A1 ADC-74 linker
WO2022228495A1 ADC-75 [50]
WO2022228495A1 ADC-75 payload
Undisclosed
WO2022228495A1 ADC-75 linker
HER2-MMAU ADC [163]
Glucuronyl-monomethyl-auristatin E (MMAU)
Microtubule (MT)
Mc-Val-Cit-PABC
PF-06888667 [164]
SW-163D
Human Deoxyribonucleic acid (hDNA)
AcLys-Val-Cit-PABC-DMAE
TTZ-1-MMAE [165]
Monomethyl auristatin E
Microtubule (MT)
DSPh-Val-Ala-PABC
TTZ-2-MMAE [165]
Monomethyl auristatin E
Microtubule (MT)
DSPh-Val-Cit-PABC
TTZ-3-MMAE [165]
Monomethyl auristatin E
Microtubule (MT)
DSPh-PEG12-Val-Ala-PABC
TTZ-4-MMAE [165]
Monomethyl auristatin E
Microtubule (MT)
DSPh-PEG12-Val-Cit-PABC
Trastuzumab-DVP-linker-MMAE 1 [166]
Monomethyl auristatin E
Microtubule (MT)
DVP-based linker 1f
Trastuzumab-Val-Cit linker-MMAE 2 [166]
Monomethyl auristatin E
Microtubule (MT)
Val-Cit linker 2e
Trastuzumab-DVP-linker-MMAE 3 [166]
Monomethyl auristatin E
Microtubule (MT)
DVP-based linker 3
Trastuzumab-DVP-linker-MMAE 4 [166]
Monomethyl auristatin E
Microtubule (MT)
DVP-based linker 4
Trastuzumab-Me-PRX conjugate [167]
Methylated-beta-Cyclodextrin/Pluronic P103-based polyrotaxane (Me-PRX)
Undisclosed
Phenyl maleimide PEG2
T-PBA [168]
PBD-based payload 37b3
Human Deoxyribonucleic acid (hDNA)
Mc-Val-Ala
HER2-acetal-ADC 11 [169]
Monomethyl auristatin F
Microtubule (MT)
Clravable-acetal based linker 11
HER2-acetal-ADC 12 [169]
Monomethyl auristatin F
Microtubule (MT)
Clravable-TAMRA-acetal based linker 12
HER2-azide-alkyne MMAE conjugate [170]
Monomethyl auristatin E
Microtubule (MT)
Azide-alkyne based linker 10a
HER2-cyclopropene-tetrazine MMAE conjugate [170]
Monomethyl auristatin E
Microtubule (MT)
Cyclopropene-tetrazine based linker 10b
HER2-norbornene-tetrazine MMAE conjugate [170]
Monomethyl auristatin E
Microtubule (MT)
Norbornene-tetrazine based linker 10c
T-FcBP-DM1 [171]
Mertansine DM1
Microtubule (MT)
N-terminal norbornene group pFcBP linker
T-D8-1508 [172]
AZ-1508
Microtubule (MT)
Cysteine D8
T-D6-1508 [172]
AZ-1508
Microtubule (MT)
Cysteine D6
T-D4-1508 [172]
AZ-1508
Microtubule (MT)
Cysteine D4
T-D2-1508 [172]
AZ-1508
Microtubule (MT)
Cysteine D2
HER2 ADC-18 [173]
Monomethyl auristatin E
Microtubule (MT)
Vinylsulfonamide based linker 15
HER2 ADC-19 [173]
Monomethyl auristatin E
Microtubule (MT)
Vinylsulfonamide based linker 16
HER2 ADC-20 [173]
Monomethyl auristatin E
Microtubule (MT)
Vinylsulfonamide based linker 17
T-DM1-IR700 [174]
Mertansine DM1 plus IRDye700DX
Microtubule (MT)
Succinimidyl-4-(N-maleimidomethyl)cyclohexane-1-carboxylate (SMCC)
HER2-gsADC-46 [36]
Monomethyl auristatin E
Microtubule (MT)
ThioPz linker 6a
HER2-gsADC-47 [36]
Monomethyl auristatin E
Microtubule (MT)
Hydroxylamine derivative 6c
HER2-gsADC-48 [36]
Monomethyl auristatin E
Microtubule (MT)
2-Aminobenzamide oxime
HER2-gsADC-49 [36]
Monomethyl auristatin E
Microtubule (MT)
Azadibenzocylooctyne-amine derivative 6d
HER2-gsADC-50 [36]
Monomethyl auristatin E
Microtubule (MT)
2-Aminobenzamidoxime without core-fucosylation
T-DM1-2.6 [36]
Mertansine DM1
Microtubule (MT)
Succinimidyl-4-(N-maleimidomethyl)cyclohexane-1-carboxylate (SMCC)
Trastuzumab-amanitin 1 [175]
Beta-amanitin
DNA-directed RNA polymerase II subunit RPB2 (POLR2B); DNA-directed RNA polymerase III subunit RPC7 (POLR3G)
Trastuzumab-Amanitin1 linker
Trastuzumab-alpha-amanitin conjugate 3 [175]
Alpha-amanitin
DNA-directed RNA polymerase II subunit RPB2 (POLR2B); DNA-directed RNA polymerase III subunit RPC7 (POLR3G)
Trastuzumab-alpha-amanitin conjugate 3 linker
Trastuzumab-alpha-amanitin conjugate 4 [175]
Alpha-amanitin
DNA-directed RNA polymerase II subunit RPB2 (POLR2B); DNA-directed RNA polymerase III subunit RPC7 (POLR3G)
Trastuzumab-alpha-amanitin conjugate 4 linker
Trastuzumab-alpha-amanitin conjugate 7 [175]
Alpha-amanitin
DNA-directed RNA polymerase II subunit RPB2 (POLR2B); DNA-directed RNA polymerase III subunit RPC7 (POLR3G)
Trastuzumab-alpha-amanitin conjugate 7 linker
Trastuzumab-alpha-amanitin conjugate 10 [175]
Alpha-amanitin
DNA-directed RNA polymerase II subunit RPB2 (POLR2B); DNA-directed RNA polymerase III subunit RPC7 (POLR3G)
Trastuzumab-alpha-amanitin conjugate 10 linker
Trastuzumab-alpha-amanitin conjugate 11 [175]
Alpha-amanitin
DNA-directed RNA polymerase II subunit RPB2 (POLR2B); DNA-directed RNA polymerase III subunit RPC7 (POLR3G)
Trastuzumab-alpha-amanitin conjugate 11 linker
Trastuzumab-alpha-amanitin conjugate 14 [175]
Alpha-amanitin
DNA-directed RNA polymerase II subunit RPB2 (POLR2B); DNA-directed RNA polymerase III subunit RPC7 (POLR3G)
Trastuzumab-alpha-amanitin conjugate 14 linker
Trastuzumab-alpha-amanitin conjugate 15 [175]
Alpha-amanitin
DNA-directed RNA polymerase II subunit RPB2 (POLR2B); DNA-directed RNA polymerase III subunit RPC7 (POLR3G)
Trastuzumab-alpha-amanitin conjugate 15 linker
Trastuzumab-amanitin 3 [175]
Beta-amanitin
DNA-directed RNA polymerase II subunit RPB2 (POLR2B); DNA-directed RNA polymerase III subunit RPC7 (POLR3G)
Trastuzumab-Amanitin3 linker
Trastuzumab-amanitin 4 [175]
Beta-amanitin
DNA-directed RNA polymerase II subunit RPB2 (POLR2B); DNA-directed RNA polymerase III subunit RPC7 (POLR3G)
Trastuzumab-Amanitin4 linker
Her-30.0643 [176]
HDP 30.0643
DNA-directed RNA polymerase II subunit RPB2 (POLR2B); DNA-directed RNA polymerase III subunit RPC7 (POLR3G)
Her-30.0643 linker
Her-30.1033 [176]
HDP 30.1033
Undisclosed
Her-30.1033 linker
Her-30.1036 [176]
HDP 30.1036
Undisclosed
Her-30.1036 linker
Her-30.1165 [176]
HDP 30.1165
Undisclosed
Her-30.1165 linker
Her-30.0132 [176]
HDP 30.0132
Undisclosed
Her-30.0132 linker
Her-30.0134 [176]
HDP 30.0134
Undisclosed
Her-30.0134 linker
Her-30.0741 [176]
HDP 30.0741
Undisclosed
Her-30.0741 linker
Her-30.0743 [176]
HDP 30.0743
Undisclosed
Her-30.0743 linker
Trastuzumab-E-13 [177]
Trastuzumab-E-13 payload
Undisclosed
Trastuzumab-E-13 linker
Trastuzumab-G-13 [177]
Trastuzumab-G-13 payload
Undisclosed
Trastuzumab-G-13 linker
Trastuzumab-E-11 [177]
Trastuzumab-E-11 payload
Undisclosed
Trastuzumab-E-11 linker
Trastuzumab-E-12 [177]
Trastuzumab-E-12 payload
Undisclosed
Trastuzumab-E-12 payload
Trastuzumab-G-12 [177]
Trastuzumab-G-12 payload
Undisclosed
Trastuzumab-G-12E-11
Trastuzumab-F-13 [177]
Trastuzumab-F-13 payload
Undisclosed
Trastuzumab-F-13E-12
Trastuzumab-E-15 [177]
Trastuzumab-E-15 payload
Undisclosed
Trastuzumab-E-15G-12
Trastuzumab-G-15 [177]
Trastuzumab-G-15 payload
Undisclosed
Trastuzumab-G-15F-13
Trastuzumab-F-61 [177]
Trastuzumab-F-61 payload
Undisclosed
Trastuzumab-F-61E-15
Trastuzumab-F-62 [177]
Trastuzumab-F-62 payload
Undisclosed
Trastuzumab-F-62G-15
Trastuzumab-F-63 [177]
Trastuzumab-F-63 payload
Undisclosed
Trastuzumab-F-63F-61
WO2017089890A1 ADC1 [178]
Monomethyl auristatin E
Microtubule (MT)
WO2017089890A1_ADC1 linker
WO2017089890A1 ADC2 [178]
Monomethyl auristatin F
Microtubule (MT)
WO2017089890A1_ADC2 linker
WO2017089890A1 ADC3 [178]
Monomethyl auristatin E
Microtubule (MT)
WO2017089890A1_ADC3 linker
WO2017089890A1 ADC4 [178]
Monomethyl auristatin F
Microtubule (MT)
WO2017089890A1_ADC4 linker
WO2017089890A1 ADC5 [178]
Monomethyl auristatin E
Microtubule (MT)
WO2017089890A1_ADC5 linker
WO2017089890A1 ADC6 [178]
Monomethyl auristatin F
Microtubule (MT)
WO2017089890A1_ADC6 linker
WO2017089890A1 ADC7 [178]
Monomethyl auristatin E
Microtubule (MT)
WO2017089890A1_ADC7 linker
WO2017089890A1 ADC8 [178]
Monomethyl auristatin F
Microtubule (MT)
WO2017089890A1_ADC8 linker
WO2017089890A1 ADC9 [178]
Monomethyl auristatin E
Microtubule (MT)
WO2017089890A1_ADC9 linker
WO2017089890A1 ADC10 [178]
Monomethyl auristatin E
Microtubule (MT)
WO2017089890A1_ADC10 linker
WO2017089890A1 ADC11 [178]
Monomethyl auristatin E
Microtubule (MT)
WO2017089890A1_ADC11 linker
WO2017089890A1 ADC12 [178]
Monomethyl auristatin E
Microtubule (MT)
WO2017089890A1_ADC12 linker
WO2017089890A1 ADC13 [178]
Monomethyl auristatin E
Microtubule (MT)
WO2017089890A1_ADC13 linker
WO2017089890A1 ADC14 [178]
Monomethyl auristatin F
Microtubule (MT)
WO2017089890A1_ADC14 linker
WO2017089890A1 ADC15 [178]
Monomethyl auristatin E
Microtubule (MT)
WO2017089890A1_ADC15 linker
WO2017089890A1 ADC16 [178]
Monomethyl auristatin F
Microtubule (MT)
WO2017089890A1_ADC16 linker
WO2017089890A1 ADC17 [178]
Monomethyl auristatin E
Microtubule (MT)
WO2017089890A1_ADC17 linker
WO2017089890A1 ADC18 [178]
Monomethyl auristatin F
Microtubule (MT)
WO2017089890A1_ADC18 linker
WO2017089890A1 ADC19 [178]
Monomethyl auristatin E
Microtubule (MT)
WO2017089890A1_ADC19 linker
WO2017089890A1 ADC20 [178]
Monomethyl auristatin F
Microtubule (MT)
WO2017089890A1_ADC20 linker
WO2017089890A1 ADC86 [178]
Monomethyl auristatin F
Microtubule (MT)
WO2017089890A1_ADC86 linker
WO2017089890A1 ADC87 [178]
Monomethyl auristatin E
Microtubule (MT)
WO2017089890A1_ADC87 linker
WO2017089890A1 ADC23 [178]
Monomethyl auristatin F
Microtubule (MT)
WO2017089890A1_ADC23 linker
WO2017089890A1 ADC24 [178]
Monomethyl auristatin E
Microtubule (MT)
WO2017089890A1_ADC24 linker
WO2017089890A1 ADC25 [178]
Monomethyl auristatin E
Microtubule (MT)
WO2017089890A1_ADC25 linker
WO2017089890A1 ADC26 [178]
Monomethyl auristatin E
Microtubule (MT)
WO2017089890A1_ADC26 linker
WO2017089890A1 ADC27 [178]
Monomethyl auristatin E
Microtubule (MT)
WO2017089890A1_ADC27 linker
WO2017089890A1 ADC28 [178]
Monomethyl auristatin E
Microtubule (MT)
WO2017089890A1_ADC28 linker
WO2017089890A1 ADC29 [178]
Monomethyl auristatin E
Microtubule (MT)
WO2017089890A1_ADC29 linker
WO2017089890A1 ADC30 [178]
Monomethyl auristatin E
Microtubule (MT)
WO2017089890A1_ADC30 linker
WO2017089890A1 ADC31 [178]
Monomethyl auristatin E
Microtubule (MT)
WO2017089890A1_ADC31 linker
WO2017089890A1 ADC32 [178]
Monomethyl auristatin E
Microtubule (MT)
WO2017089890A1_ADC32 linker
WO2017089890A1 ADC33 [178]
Monomethyl auristatin E
Microtubule (MT)
WO2017089890A1_ADC33 linker
WO2017089890A1 ADC34 [178]
Monomethyl auristatin F
Microtubule (MT)
WO2017089890A1_ADC34 linker
WO2017089890A1 ADC35 [178]
Monomethyl auristatin E
Microtubule (MT)
WO2017089890A1_ADC35 linker
WO2017089890A1 ADC36 [178]
Monomethyl auristatin E
Microtubule (MT)
WO2017089890A1_ADC36 linker
WO2017089890A1 ADC37 [178]
Monomethyl auristatin E
Microtubule (MT)
WO2017089890A1_ADC37 linker
WO2017089890A1 ADC38 [178]
Monomethyl auristatin F
Microtubule (MT)
WO2017089890A1_ADC38 linker
WO2017089890A1 ADC39 [178]
Monomethyl auristatin E
Microtubule (MT)
WO2017089890A1_ADC39 linker
WO2017089890A1 ADC40 [178]
Monomethyl auristatin F
Microtubule (MT)
WO2017089890A1_ADC40 linker
WO2017089890A1 ADC41 [178]
Monomethyl auristatin E
Microtubule (MT)
WO2017089890A1_ADC41 linker
WO2017089890A1 ADC42 [178]
Monomethyl auristatin F
Microtubule (MT)
WO2017089890A1_ADC42 linker
WO2017089890A1 ADC43 [178]
Monomethyl auristatin E
Microtubule (MT)
WO2017089890A1_ADC43 linker
WO2017089890A1 ADC44 [178]
Monomethyl auristatin F
Microtubule (MT)
WO2017089890A1_ADC44 linker
WO2017089890A1 ADC45 [178]
Monomethyl auristatin E
Microtubule (MT)
WO2017089890A1_ADC45 linker
WO2017089890A1 ADC46 [178]
Monomethyl auristatin F
Microtubule (MT)
WO2017089890A1_ADC46 linker
WO2017089890A1 ADC47 [178]
Monomethyl auristatin E
Microtubule (MT)
WO2017089890A1_ADC47 linker
WO2017089890A1 ADC48 [178]
Monomethyl auristatin F
Microtubule (MT)
WO2017089890A1_ADC48 linker
WO2017089890A1 ADC49 [178]
Monomethyl auristatin E
Microtubule (MT)
WO2017089890A1_ADC49 linker
WO2017089890A1 ADC50 [178]
Monomethyl auristatin F
Microtubule (MT)
WO2017089890A1_ADC50 linker
WO2017089890A1 ADC51 [178]
Monomethyl auristatin E
Microtubule (MT)
WO2017089890A1_ADC51 linker
WO2017089890A1 ADC52 [178]
Monomethyl auristatin E
Microtubule (MT)
WO2017089890A1_ADC52 linker
WO2017089890A1 ADC53 [178]
Monomethyl auristatin E
Microtubule (MT)
WO2017089890A1_ADC53 linker
WO2017089890A1 ADC54 [178]
Monomethyl auristatin F
Microtubule (MT)
WO2017089890A1_ADC54 linker
WO2017089890A1 ADC55 [178]
Monomethyl auristatin E
Microtubule (MT)
WO2017089890A1_ADC55 linker
WO2017089890A1 ADC76 [178]
Monomethyl auristatin F
Microtubule (MT)
WO2017089890A1_ADC76 linker
WO2017089890A1 ADC88 [178]
Monomethyl auristatin F
Microtubule (MT)
WO2017089890A1_ADC88 linker
WO2017089890A1 ADC89 [178]
Monomethyl auristatin E
Microtubule (MT)
WO2017089890A1_ADC89 linker
WO2017089890A1 ADC90 [178]
Monomethyl auristatin F
Microtubule (MT)
WO2017089890A1_ADC90 linker
WO2017089890A1 ADC91 [178]
Monomethyl auristatin E
Microtubule (MT)
WO2017089890A1_ADC91 linker
WO2017089890A1 ADC60 [178]
Monomethyl auristatin F
Microtubule (MT)
WO2017089890A1_ADC60 linker
WO2017089890A1 ADC61 [178]
Monomethyl auristatin E
Microtubule (MT)
WO2017089890A1_ADC61 linker
WO2017089890A1 ADC62 [178]
Monomethyl auristatin F
Microtubule (MT)
WO2017089890A1_ADC62 linker
WO2017089890A1 ADC63 [178]
Monomethyl auristatin E
Microtubule (MT)
WO2017089890A1_ADC63 linker
WO2017089890A1 ADC77 [178]
Monomethyl auristatin F
Microtubule (MT)
WO2017089890A1_ADC77 linker
WO2017089890A1 ADC21 [178]
Alpha-amanitin
DNA-directed RNA polymerase II subunit RPB2 (POLR2B); DNA-directed RNA polymerase III subunit RPC7 (POLR3G)
WO2017089890A1_ADC21 linker
WO2017089890A1 ADC22 [178]
Alpha-amanitin
DNA-directed RNA polymerase II subunit RPB2 (POLR2B); DNA-directed RNA polymerase III subunit RPC7 (POLR3G)
WO2017089890A1_ADC22 linker
WO2017089890A1 ADC56 [178]
Alpha-amanitin
DNA-directed RNA polymerase II subunit RPB2 (POLR2B); DNA-directed RNA polymerase III subunit RPC7 (POLR3G)
WO2017089890A1_ADC56 linker
WO2017089890A1 ADC57 [178]
Alpha-amanitin
DNA-directed RNA polymerase II subunit RPB2 (POLR2B); DNA-directed RNA polymerase III subunit RPC7 (POLR3G)
WO2017089890A1_ADC57 linker
WO2017089890A1 ADC58 [178]
Alpha-amanitin+Monomethyl auristatin E
DNA-directed RNA polymerase II subunit RPB2 (POLR2B); DNA-directed RNA polymerase III subunit RPC7 (POLR3G); Microtubule (MT)
WO2017089890A1_ADC58 linker
WO2017089890A1 ADC59 [178]
Alpha-amanitin+Monomethyl auristatin E
DNA-directed RNA polymerase II subunit RPB2 (POLR2B); DNA-directed RNA polymerase III subunit RPC7 (POLR3G); Microtubule (MT)
WO2017089890A1_ADC59 linker
WO2017089890A1 ADC78 [178]
Alpha-amanitin+Monomethyl auristatin E
DNA-directed RNA polymerase II subunit RPB2 (POLR2B); DNA-directed RNA polymerase III subunit RPC7 (POLR3G); Microtubule (MT)
WO2017089890A1_ADC78 linker
WO2018098269A2 conjugate 25 [179]
WO2018098269A2_conjugate 25 payload
Undisclosed
WO2018098269A2_conjugate 25 linker
WO2018098269A2 conjugate 28 [179]
WO2018098269A2_conjugate 28 payload
Undisclosed
WO2018098269A2_conjugate 28 linker
WO2018098269A2 conjugate 31A [179]
WO2018098269A2_conjugate 31A payload
Undisclosed
WO2018098269A2_conjugate 31A linker
WO2018098269A2 conjugate 34A [179]
WO2018098269A2_conjugate 34A payload
Undisclosed
WO2018098269A2_conjugate 34A linker
WO2018098269A2 conjugate 43A [179]
WO2018098269A2_conjugate 43A payload
Undisclosed
WO2018098269A2_conjugate 43A linker
WO2018098269A2 conjugate 46A [179]
WO2018098269A2_conjugate 46A payload
Undisclosed
WO2018098269A2_conjugate 46A linker
WO2018098269A2 conjugate 48 [179]
WO2018098269A2_conjugate 48 payload
Undisclosed
WO2018098269A2_conjugate 48 linker
WO2018098269A2 conjugate 50 [179]
WO2018098269A2_conjugate 50 payload
Undisclosed
WO2018098269A2_conjugate 50 linker
WO2018098269A2 conjugate 52 [179]
WO2018098269A2_conjugate 52 payload
Undisclosed
WO2018098269A2_conjugate 52 linker
WO2018098269A2 conjugate 67 [179]
WO2018098269A2_conjugate 67 payload
Undisclosed
WO2018098269A2_conjugate 67 linker
WO2018098269A2 conjugate 68 [179]
WO2018098269A2_conjugate 68 payload
Undisclosed
WO2018098269A2_conjugate 68 linker
WO2018098269A2 conjugate 46B [179]
WO2018098269A2_conjugate 46B payload
Undisclosed
WO2018098269A2_conjugate 46B linker
WO2018098269A2 conjugate 43B [179]
WO2018098269A2_conjugate 43B payload
Undisclosed
WO2018098269A2_conjugate 43B linker
WO2018098269A2 conjugate 34B [179]
WO2018098269A2_conjugate 34B payload
Undisclosed
WO2018098269A2_conjugate 34B linker
WO2018098269A2 conjugate 31B [179]
WO2018098269A2_conjugate 31B payload
Undisclosed
WO2018098269A2_conjugate 31B linker
WO2015004400A1 ADC-1 [180]
WO2015004400A1 ADC-1 payload
Undisclosed
WO2015004400A1 ADC-1 linker
WO2015004400A1 ADC-2 [180]
WO2015004400A1 ADC-2 payload
Undisclosed
WO2015004400A1 ADC-2 linker
WO2015004400A1 ADC-3 [180]
WO2015004400A1 ADC-3 payload
Undisclosed
WO2015004400A1 ADC-3 linker
WO2015004400A1 ADC-4 [180]
WO2015004400A1 ADC-4 payload
Undisclosed
WO2015004400A1 ADC-4 linker
WO2015004400A1 ADC-5 [180]
WO2015004400A1 ADC-5 payload
Undisclosed
WO2015004400A1 ADC-5 linker
WO2015004400A1 ADC-6 [180]
WO2015004400A1 ADC-6 payload
Undisclosed
WO2015004400A1 ADC-6 linker
WO2015004400A1 ADC-7 [180]
WO2015004400A1 ADC-7 payload
Undisclosed
WO2015004400A1 ADC-7 linker
WO2015004400A1 ADC-8 [180]
WO2015004400A1 ADC-8 payload
Undisclosed
WO2015004400A1 ADC-8 linker
Trastuzumab-Compound 9 [23]
Mertansine DM1
Microtubule (MT)
Trastuzumab-Compound 9 linker
Trastuzumab-Compound 17 [23]
Mertansine DM4
Microtubule (MT)
Trastuzumab-Compound 17 linker
Trastuzumab-Compound 25 [23]
Monomethyl auristatin E
Microtubule (MT)
Trastuzumab-Compound 25 linker
Trastuzumab-Compound 31 [23]
Auristatin 0101
Microtubule (MT)
Trastuzumab-Compound 31 linker
Trastuzumab-Compound 36 [23]
Monomethyl auristatin E
Microtubule (MT)
Trastuzumab-Compound 36 linker
Trastuzumab-Compound 43 [23]
PBD dimer
Human Deoxyribonucleic acid (hDNA)
Trastuzumab-Compound 43 linker
Trastuzumab-Compound 49 [23]
PBD dimer
Human Deoxyribonucleic acid (hDNA)
Trastuzumab-Compound 49 linker
Trastuzumab-Compound 55 [23]
Mertansine DM1
Microtubule (MT)
Trastuzumab-Compound 55 linker
Trastuzumab-Compound 59 [23]
Mertansine DM4
Microtubule (MT)
Trastuzumab-Compound 59 linker
Trastuzumab-Compound 64 [23]
Monomethyl auristatin E
Microtubule (MT)
Trastuzumab-Compound 64 linker
Trastuzumab-Compound 69 [23]
Monomethyl auristatin E
Microtubule (MT)
Trastuzumab-Compound 69 linker
Trastuzumab-Compound 74 [23]
PBD dimer
Human Deoxyribonucleic acid (hDNA)
Trastuzumab-Compound 74 linker
Trastuzumab-Compound 75 [23]
Monomethyl auristatin E
Microtubule (MT)
Trastuzumab-Compound 75 linker
Trastuzumab-Compound 76 [23]
Monomethyl auristatin E
Microtubule (MT)
Trastuzumab-Compound 76 linker
Trastuzumab-Compound 77 [23]
Mertansine DM1
Microtubule (MT)
Trastuzumab-Compound 77 linker
Trastuzumab-Compound 78 [23]
Auristatin 0101
Microtubule (MT)
Trastuzumab-Compound 78 linker
Trastuzumab-Compound 79 [23]
Auristatin 0101
Microtubule (MT)
Trastuzumab-Compound 79 linker
Trastuzumab-Compound 80 [23]
Mertansine DM4
Microtubule (MT)
Trastuzumab-Compound 80 linker
CN114917361A ADC-2 [181]
CN114917361A ADC-2 payload
Undisclosed
CN114917361A ADC-2 linker
CN114917361A ADC-7 [181]
CN114917361A ADC-7 payload
Undisclosed
CN114917361A ADC-7 linker
CN114917361A ADC-14 [181]
CN114917361A ADC-14 payload
Undisclosed
CN114917361A ADC-14 linker
CN114917361A ADC-17 [181]
CN114917361A ADC-17 payload
Undisclosed
CN114917361A ADC-17 linker
CN114917361A ADC-22 [181]
CN114917361A ADC-22 payload
Undisclosed
CN114917361A ADC-22 linker
CN114917361A ADC-28 [181]
CN114917361A ADC-28 payload
Undisclosed
CN114917361A ADC-28 linker
CN114917361A ADC-31 [181]
CN114917361A ADC-31 payload
Undisclosed
CN114917361A ADC-31 linker
CN114917361A ADC-34 [181]
CN114917361A ADC-34 payload
Undisclosed
CN114917361A ADC-34 linker
CN114917361A ADC-37 [181]
CN114917361A ADC-37 payload
Undisclosed
CN114917361A ADC-37 linker
CN114917361A ADC-42 [181]
CN114917361A ADC-42 payload
Undisclosed
CN114917361A ADC-42 linker
CN114917361A ADC-45 [181]
CN114917361A ADC-45 payload
Undisclosed
CN114917361A ADC-45 linker
CN114917361A ADC-48 [181]
CN114917361A ADC-48 payload
Undisclosed
CN114917361A ADC-48 linker
CN114917361A ADC-51 [181]
CN114917361A ADC-51 payload
Undisclosed
CN114917361A ADC-51 linker
CN114917361A ADC-56 [181]
CN114917361A ADC-56 payload
Undisclosed
CN114917361A ADC-56 linker
CN114917361A ADC-59 [181]
CN114917361A ADC-59 payload
Undisclosed
CN114917361A ADC-59 linker
CN114917361A ADC-62 [181]
CN114917361A ADC-62 payload
Undisclosed
CN114917361A ADC-62 linker
CN114917361A ADC-65 [181]
CN114917361A ADC-65 payload
Undisclosed
CN114917361A ADC-65 linker
CN114917361A ADC-68 [181]
CN114917361A ADC-68 payload
Undisclosed
CN114917361A ADC-68 linker
CN114917361A ADC-71 [181]
CN114917361A ADC-71 payload
Undisclosed
CN114917361A ADC-71 linker
CN114917361A ADC-74 [181]
CN114917361A ADC-74 payload
Undisclosed
CN114917361A ADC-74 linker
CN114917361A ADC-77 [181]
CN114917361A ADC-77 payload
Undisclosed
CN114917361A ADC-77 linker
CN114917361A ADC-80 [181]
CN114917361A ADC-80 payload
Undisclosed
CN114917361A ADC-80 linker
CN114917361A ADC-83 [181]
CN114917361A ADC-83 payload
Undisclosed
CN114917361A ADC-83 linker
CN109641910A ADC-1 [182]
CN109641910A ADC-1 payload
Undisclosed
CN109641910A ADC-1 linker
CN109641910A ADC-2 [182]
CN109641910A ADC-2 payload
Undisclosed
CN109641910A ADC-2 linker
CN109641910A ADC-3 [182]
CN109641910A ADC-3 payload
Undisclosed
CN109641910A ADC-3 linker
CN109641910A ADC-4 [182]
CN109641910A ADC-4 payload
Undisclosed
CN109641910A ADC-4 linker
CN109641910A ADC-5 [182]
CN109641910A ADC-5 payload
Undisclosed
CN109641910A ADC-5 linker
CN109641910A ADC-6 [182]
CN109641910A ADC-6 payload
Undisclosed
CN109641910A ADC-6 linker
CN109641910A ADC-7 [182]
CN109641910A ADC-7 payload
Undisclosed
CN109641910A ADC-7 linker
CN109641910A ADC-8 [182]
CN109641910A ADC-8 payload
Undisclosed
CN109641910A ADC-8 linker
CN109641910A ADC-9 [182]
CN109641910A ADC-9 payload
Undisclosed
CN109641910A ADC-9 linker
CN109641910A ADC-10 [182]
CN109641910A ADC-10 payload
Undisclosed
CN109641910A ADC-10 linker
CN109641910A ADC-11 [182]
CN109641910A ADC-11 payload
Undisclosed
CN109641910A ADC-11 linker
CN109641910A ADC-12 [182]
CN109641910A ADC-12 payload
Undisclosed
CN109641910A ADC-12 linker
CN109641910A ADC-13 [182]
CN109641910A ADC-13 payload
Undisclosed
CN109641910A ADC-13 linker
CN109641910A ADC-14 [182]
CN109641910A ADC-14 payload
Undisclosed
CN109641910A ADC-14 linker
CN109641910A ADC-15 [182]
CN109641910A ADC-15 payload
Undisclosed
CN109641910A ADC-15 linker
CN109641910A ADC-16 [182]
CN109641910A ADC-16 payload
Undisclosed
CN109641910A ADC-16 linker
CN105051032B ADC-I-5 [183]
CN105051032B_ADC-I-5 payload
Undisclosed
CN105051032B_ADC-I-5 linker
CN105051032B ADC-I-6 [183]
CN105051032B_ADC-I-6 payload
Undisclosed
CN105051032B_ADC-I-6 linker
CN105051032B ADC-I-7 [183]
CN105051032B_ADC-I-7 payload
Undisclosed
CN105051032B_ADC-I-7 linker
CN105051032B ADC-I-8 [183]
CN105051032B_ADC-I-8 payload
Undisclosed
CN105051032B_ADC-I-8 linker
CN105051032B ADC-I-9 [183]
CN105051032B_ADC-I-9 payload
Undisclosed
CN105051032B_ADC-I-9 linker
CN105051032B ADC-I-10 [183]
CN105051032B_ADC-I-10 payload
Undisclosed
CN105051032B_ADC-I-10 linker
CN105051032B ADC-I-11 [183]
CN105051032B_ADC-I-11 payload
Undisclosed
CN105051032B_ADC-I-11 linker
CN105051032B ADC-I-12 [183]
CN105051032B_ADC-I-12 payload
Undisclosed
CN105051032B_ADC-I-12 linker
CN105051032B ADC-I-13 [183]
CN105051032B_ADC-I-13 payload
Undisclosed
CN105051032B_ADC-I-13 linker
CN105051032B ADC-I-14 [183]
CN105051032B_ADC-I-14 payload
Undisclosed
CN105051032B_ADC-I-14 linker
CN105051032B ADC-I-15 [183]
CN105051032B_ADC-I-15 payload
Undisclosed
CN105051032B_ADC-I-15 linker
CN105051032B ADC-I-16 [183]
CN105051032B_ADC-I-16 payload
Undisclosed
CN105051032B_ADC-I-16 linker
CN105051032B ADC-I-17 [183]
CN105051032B_ADC-I-17 payload
Undisclosed
CN105051032B_ADC-I-17 linker
CN105051032B ADC-I-18 [183]
CN105051032B_ADC-I-18 payload
Undisclosed
CN105051032B_ADC-I-18 linker
CN105051032B ADC-I-19 [183]
CN105051032B_ADC-I-19 payload
Undisclosed
CN105051032B_ADC-I-19 linker
CN105051032B ADC-I-20 [183]
CN105051032B_ADC-I-20 payload
Undisclosed
CN105051032B_ADC-I-20 linker
CN105051032B ADC-I-21 [183]
CN105051032B_ADC-I-21 payload
Undisclosed
CN105051032B_ADC-I-21 linker
CN105051032B ADC-I-22 [183]
CN105051032B_ADC-I-22 payload
Undisclosed
CN105051032B_ADC-I-22 linker
CN105051032B ADC-I-23 [183]
CN105051032B_ADC-I-23 payload
Undisclosed
CN105051032B_ADC-I-23 linker
CN105051032B ADC-I-24 [183]
CN105051032B_ADC-I-24 payload
Undisclosed
CN105051032B_ADC-I-24 linker
CN105051032B ADC-I-25 [183]
CN105051032B_ADC-I-25 payload
Undisclosed
CN105051032B_ADC-I-25 linker
CN105051032B ADC-I-26 [183]
CN105051032B_ADC-I-26 payload
Undisclosed
CN105051032B_ADC-I-26 linker
CN105051032B ADC-I-27 [183]
CN105051032B_ADC-I-27 payload
Undisclosed
CN105051032B_ADC-I-27 linker
CN105051032B ADC-I-28 [183]
CN105051032B_ADC-I-28 payload
Undisclosed
CN105051032B_ADC-I-28 linker
CN105051032B ADC-I-29 [183]
CN105051032B_ADC-I-29 payload
Undisclosed
CN105051032B_ADC-I-29 linker
CN105051032B ADC-I-30 [183]
CN105051032B_ADC-I-30 payload
Undisclosed
CN105051032B_ADC-I-30 linker
CN105051032B ADC-I-31 [183]
CN105051032B_ADC-I-31 payload
Undisclosed
CN105051032B_ADC-I-31 linker
CN105051032B ADC-I-32 [183]
CN105051032B_ADC-I-32 payload
Undisclosed
CN105051032B_ADC-I-32 linker
CN105051032B ADC-I-33 [183]
CN105051032B_ADC-I-33 payload
Undisclosed
CN105051032B_ADC-I-33 linker
CN105051032B ADC-I-34 [183]
CN105051032B_ADC-I-34 payload
Undisclosed
CN105051032B_ADC-I-34 linker
CN105051032B ADC-I-35 [183]
CN105051032B_ADC-I-35 payload
Undisclosed
CN105051032B_ADC-I-35 linker
CN105051032B ADC-I-36 [183]
CN105051032B_ADC-I-36 payload
Undisclosed
CN105051032B_ADC-I-36 linker
CN105051032B ADC-I-37 [183]
CN105051032B_ADC-I-37 payload
Undisclosed
CN105051032B_ADC-I-37 linker
CN105051032B ADC-I-38 [183]
CN105051032B_ADC-I-38 payload
Undisclosed
CN105051032B_ADC-I-38 linker
CN105051032B ADC-I-39 [183]
CN105051032B_ADC-I-39 payload
Undisclosed
CN105051032B_ADC-I-39 linker
CN105051032B ADC-I-40 [183]
CN105051032B_ADC-I-40 payload
Undisclosed
CN105051032B_ADC-I-40 linker
CN105051032B ADC-I-41 [183]
CN105051032B_ADC-I-41 payload
Undisclosed
CN105051032B_ADC-I-41 linker
WO2014068443A1 ADC1 [184]
WO2014068443A1_ADC1 payload
Undisclosed
WO2014068443A1_ADC1 linker
WO2014068443A1 ADC2 [184]
WO2014068443A1_ADC2 payload
Undisclosed
WO2014068443A1_ADC2 linker
WO2014068443A1 ADC3 [184]
WO2014068443A1_ADC3 payload
Undisclosed
WO2014068443A1_ADC3 linker
WO2014068443A1 ADC4 [184]
WO2014068443A1_ADC4 payload
Undisclosed
WO2014068443A1_ADC4 linker
WO2014068443A1 ADC5 [184]
WO2014068443A1_ADC5 payload
Undisclosed
WO2014068443A1_ADC5 linker
WO2014068443A1 ADC6 [184]
WO2014068443A1_ADC6 payload
Undisclosed
WO2014068443A1_ADC6 linker
WO2014068443A1 ADC7 [184]
WO2014068443A1_ADC7 payload
Undisclosed
WO2014068443A1_ADC7 linker
WO2014068443A1 ADC8 [184]
WO2014068443A1_ADC8 payload
Undisclosed
WO2014068443A1_ADC8 linker
WO2014068443A1 ADC9 [184]
WO2014068443A1_ADC9 payload
Undisclosed
WO2014068443A1_ADC9 linker
WO2014068443A1 ADC10 [184]
WO2014068443A1_ADC10 payload
Undisclosed
WO2014068443A1_ADC10 linker
WO2014068443A1 ADC11 [184]
WO2014068443A1_ADC11 payload
Undisclosed
WO2014068443A1_ADC11 linker
WO2014068443A1 ADC12 [184]
WO2014068443A1_ADC12 payload
Undisclosed
WO2014068443A1_ADC12 linker
WO2014068443A1 ADC13 [184]
WO2014068443A1_ADC13 payload
Undisclosed
WO2014068443A1_ADC13 linker
WO2014068443A1 ADC14 [184]
WO2014068443A1_ADC14 payload
Undisclosed
WO2014068443A1_ADC14 linker
WO2014068443A1 ADC15 [184]
WO2014068443A1_ADC15 payload
Undisclosed
WO2014068443A1_ADC15 linker
WO2014068443A1 ADC16 [184]
WO2014068443A1_ADC16 payload
Undisclosed
WO2014068443A1_ADC16 linker
WO2014068443A1 ADC17 [184]
WO2014068443A1_ADC17 payload
Undisclosed
WO2014068443A1_ADC17 linker
WO2014068443A1 ADC18 [184]
WO2014068443A1_ADC18 payload
Undisclosed
WO2014068443A1_ADC18 linker
WO2014068443A1 ADC19 [184]
WO2014068443A1_ADC19 payload
Undisclosed
WO2014068443A1_ADC19 linker
WO2014068443A1 ADC20 [184]
WO2014068443A1_ADC20 payload
Undisclosed
WO2014068443A1_ADC20 linker
WO2014068443A1 ADC21 [184]
WO2014068443A1_ADC21 payload
Undisclosed
WO2014068443A1_ADC21 linker
WO2014068443A1 ADC22 [184]
WO2014068443A1_ADC22 payload
Undisclosed
WO2014068443A1_ADC22 linker
WO2014068443A1 ADC23 [184]
WO2014068443A1_ADC23 payload
Undisclosed
WO2014068443A1_ADC23 linker
WO2014068443A1 ADC24 [184]
WO2014068443A1_ADC24 payload
Undisclosed
WO2014068443A1_ADC24 linker
WO2014068443A1 ADC25 [184]
WO2014068443A1_ADC25 payload
Undisclosed
WO2014068443A1_ADC25 linker
WO2014068443A1 ADC26 [184]
WO2014068443A1_ADC26 payload
Undisclosed
WO2014068443A1_ADC26 linker
WO2014068443A1 ADC27 [184]
WO2014068443A1_ADC27 payload
Undisclosed
WO2014068443A1_ADC27 linker
WO2014068443A1 ADC28 [184]
WO2014068443A1_ADC28 payload
Undisclosed
WO2014068443A1_ADC28 linker
WO2014068443A1 ADC29 [184]
WO2014068443A1_ADC29 payload
Undisclosed
WO2014068443A1_ADC29 linker
WO2014068443A1 ADC30 [184]
WO2014068443A1_ADC30 payload
Undisclosed
WO2014068443A1_ADC30 linker
WO2014068443A1 ADC31 [184]
WO2014068443A1_ADC31 payload
Undisclosed
WO2014068443A1_ADC31 linker
WO2014068443A1 ADC32 [184]
WO2014068443A1_ADC32 payload
Undisclosed
WO2014068443A1_ADC32 linker
WO2014068443A1 ADC33 [184]
WO2014068443A1_ADC33 payload
Undisclosed
WO2014068443A1_ADC33 linker
WO2014068443A1 ADC34 [184]
WO2014068443A1_ADC34 payload
Undisclosed
WO2014068443A1_ADC34 linker
WO2014068443A1 ADC35 [184]
WO2014068443A1_ADC35 payload
Undisclosed
WO2014068443A1_ADC35 linker
WO2014068443A1 ADC36 [184]
WO2014068443A1_ADC36 payload
Undisclosed
WO2014068443A1_ADC36 linker
WO2014068443A1 ADC37 [184]
WO2014068443A1_ADC37 payload
Undisclosed
WO2014068443A1_ADC37 linker
WO2014068443A1 ADC38 [184]
WO2014068443A1_ADC38 payload
Undisclosed
WO2014068443A1_ADC38 linker
WO2014068443A1 ADC39 [184]
WO2014068443A1_ADC39 payload
Undisclosed
WO2014068443A1_ADC39 linker
WO2014068443A1 ADC40 [184]
WO2014068443A1_ADC40 payload
Undisclosed
WO2014068443A1_ADC40 linker
WO2014068443A1 ADC41 [184]
WO2014068443A1_ADC41 payload
Undisclosed
WO2014068443A1_ADC41 linker
WO2014068443A1 ADC42 [184]
WO2014068443A1_ADC42 payload
Undisclosed
WO2014068443A1_ADC42 linker
WO2014068443A1 ADC43 [184]
WO2014068443A1_ADC43 payload
Undisclosed
WO2014068443A1_ADC43 linker
WO2014068443A1 ADC44 [184]
WO2014068443A1_ADC44 payload
Undisclosed
WO2014068443A1_ADC44 linker
WO2014068443A1 ADC45 [184]
WO2014068443A1_ADC45 payload
Undisclosed
WO2014068443A1_ADC45 linker
WO2014068443A1 ADC46 [184]
WO2014068443A1_ADC46 payload
Undisclosed
WO2014068443A1_ADC46 linker
WO2014068443A1 ADC47 [184]
WO2014068443A1_ADC47 payload
Undisclosed
WO2014068443A1_ADC47 linker
WO2014068443A1 ADC48 [184]
WO2014068443A1_ADC48 payload
Undisclosed
WO2014068443A1_ADC48 linker
WO2014068443A1 ADC49 [184]
WO2014068443A1_ADC49 payload
Undisclosed
WO2014068443A1_ADC49 linker
WO2014068443A1 ADC50 [184]
WO2014068443A1_ADC50 payload
Undisclosed
WO2014068443A1_ADC50 linker
WO2014068443A1 ADC51 [184]
WO2014068443A1_ADC51 payload
Undisclosed
WO2014068443A1_ADC51 linker
WO2014068443A1 ADC52 [184]
WO2014068443A1_ADC52 payload
Undisclosed
WO2014068443A1_ADC52 linker
WO2014068443A1 ADC53 [184]
WO2014068443A1_ADC53 payload
Undisclosed
WO2014068443A1_ADC53 linker
WO2014068443A1 ADC54 [184]
WO2014068443A1_ADC54 payload
Undisclosed
WO2014068443A1_ADC54 linker
WO2014068443A1 ADC55 [184]
WO2014068443A1_ADC55 payload
Undisclosed
WO2014068443A1_ADC55 linker
WO2014068443A1 ADC56 [184]
WO2014068443A1_ADC56 payload
Undisclosed
WO2014068443A1_ADC56 linker
WO2014068443A1 ADC57 [184]
WO2014068443A1_ADC57 payload
Undisclosed
WO2014068443A1_ADC57 linker
WO2014068443A1 ADC58 [184]
WO2014068443A1_ADC58 payload
Undisclosed
WO2014068443A1_ADC58 linker
WO2014068443A1 ADC59 [184]
WO2014068443A1_ADC59 payload
Undisclosed
WO2014068443A1_ADC59 linker
WO2014068443A1 ADC60 [184]
WO2014068443A1_ADC60 payload
Undisclosed
WO2014068443A1_ADC60 linker
WO2014068443A1 ADC61 [184]
WO2014068443A1_ADC61 payload
Undisclosed
WO2014068443A1_ADC61 linker
WO2014068443A1 ADC62 [184]
WO2014068443A1_ADC62 payload
Undisclosed
WO2014068443A1_ADC62 linker
WO2014068443A1 ADC63 [184]
WO2014068443A1_ADC63 payload
Undisclosed
WO2014068443A1_ADC63 linker
WO2014068443A1 ADC64 [184]
WO2014068443A1_ADC64 payload
Undisclosed
WO2014068443A1_ADC64 linker
WO2014068443A1 ADC65 [184]
WO2014068443A1_ADC65 payload
Undisclosed
WO2014068443A1_ADC65 linker
WO2014068443A1 ADC66 [184]
WO2014068443A1_ADC66 payload
Undisclosed
WO2014068443A1_ADC66 linker
WO2014068443A1 ADC67 [184]
WO2014068443A1_ADC67 payload
Undisclosed
WO2014068443A1_ADC67 linker
WO2014068443A1 ADC68 [184]
WO2014068443A1_ADC68 payload
Undisclosed
WO2014068443A1_ADC68 linker
WO2014068443A1 ADC69 [184]
WO2014068443A1_ADC69 payload
Undisclosed
WO2014068443A1_ADC69 linker
WO2014068443A1 ADC70 [184]
WO2014068443A1_ADC70 payload
Undisclosed
WO2014068443A1_ADC70 linker
WO2014068443A1 ADC71 [184]
WO2014068443A1_ADC71 payload
Undisclosed
WO2014068443A1_ADC71 linker
WO2014068443A1 ADC72 [184]
WO2014068443A1_ADC72 payload
Undisclosed
WO2014068443A1_ADC72 linker
WO2014068443A1 ADC73 [184]
WO2014068443A1_ADC73 payload
Undisclosed
WO2014068443A1_ADC73 linker
WO2014068443A1 ADC74 [184]
WO2014068443A1_ADC74 payload
Undisclosed
WO2014068443A1_ADC74 linker
WO2014068443A1 ADC75 [184]
WO2014068443A1_ADC75 payload
Undisclosed
WO2014068443A1_ADC75 linker
WO2014068443A1 ADC76 [184]
WO2014068443A1_ADC76 payload
Undisclosed
WO2014068443A1_ADC76 linker
WO2014068443A1 ADC77 [184]
WO2014068443A1_ADC77 payload
Undisclosed
WO2014068443A1_ADC77 linker
WO2014068443A1 ADC78 [184]
WO2014068443A1_ADC78 payload
Undisclosed
WO2014068443A1_ADC78 linker
WO2014068443A1 ADC79 [184]
WO2014068443A1_ADC79 payload
Undisclosed
WO2014068443A1_ADC79 linker
WO2014068443A1 ADC80 [184]
WO2014068443A1_ADC80 payload
Undisclosed
WO2014068443A1_ADC80 linker
WO2014068443A1 ADC81 [184]
WO2014068443A1_ADC81 payload
Undisclosed
WO2014068443A1_ADC81 linker
WO2014068443A1 ADC82 [184]
WO2014068443A1_ADC82 payload
Undisclosed
WO2014068443A1_ADC82 linker
WO2014068443A1 ADC83 [184]
WO2014068443A1_ADC83 payload
Undisclosed
WO2014068443A1_ADC83 linker
WO2014068443A1 ADC84 [184]
WO2014068443A1_ADC84 payload
Undisclosed
WO2014068443A1_ADC84 linker
Trastuzumab-dTSPEG-MMAF [185]
Monomethyl auristatin F
Microtubule (MT)
dTSPEG
Trastuzumab botidotin [186]
Duostatin 5
Microtubule (MT)
K-lock-Val-Cit-PABC
T-Ed9 [187]
Ed9
DNA topoisomerase I (TOP1)
Mc-Gly-Gly-Phe-Gly
T-VEd9 [187]
Ed9
DNA topoisomerase I (TOP1)
Mc-Val-Ala
Tras-DXd-MTL1 [188]
DX-8951 derivative (DXd); MTT5
Undisclosed
Gly-Mal-Gly-Gly-Phe-Gly
Trastuzumab-MMAU (DAR4) [189]
Glucuronyl-monomethyl-auristatin E (MMAU)
Microtubule (MT)
Val-Ser (beta-Glc) cleavable linker
Trastuzumab-MMAU (DAR8) [189]
Glucuronyl-monomethyl-auristatin E (MMAU)
Microtubule (MT)
Val-Ser (beta-Glc) cleavable linker
38850783 ADC 1 [190]
Mertansine DM1
Microtubule (MT)
Dimaleimide linker 1
38850783 ADC 2 [190]
Mertansine DM1
Microtubule (MT)
Dimaleimide linker 2
38850783 ADC 3 [190]
Mertansine DM1
Microtubule (MT)
Dimaleimide linker 3
38850783 ADC 4 [190]
Mertansine DM1
Microtubule (MT)
Dimaleimide linker 4
38850783 ADC 5 [190]
Mertansine DM1
Microtubule (MT)
Dimaleimide linker 5
39235949 anti-HER2-1 [191]
Undisclosed
Undisclosed
Undisclosed
39235949 anti-HER2-2 [191]
Undisclosed
Undisclosed
Undisclosed
39235949 anti-HER2-3 [191]
Undisclosed
Undisclosed
Undisclosed
39235949 anti-HER2-4 [191]
Undisclosed
Undisclosed
Undisclosed
39235949 anti-HER2-5 [191]
Undisclosed
Undisclosed
Undisclosed
39410752 ADC (1) [192]
Pyrene
Undisclosed
Mal-Exo-EVC
39410752 ADC (2) [192]
Pyrene
Undisclosed
Mal-Exo-EEVC
39410752 ADC (3) [192]
Pyrene
Undisclosed
Mc-Val-Cit-PABC
39410752 ADC (4) [192]
Pyrene
Undisclosed
Mc-EVC-PAB
39410752 ADC (5) [192]
Monomethyl auristatin E
Microtubule (MT)
Mal-Exo-EVC
39410752 ADC (6) [192]
Monomethyl auristatin E
Microtubule (MT)
Mal-Exo-EEVC
39410752 ADC (7) [192]
Exatecan
DNA topoisomerase 1 (TOP1)
Mal-Exo-EEVC
39410752 ADC (8) [192]
Monomethyl auristatin E
Microtubule (MT)
Mal-Exo-EEVC
39410752 ADC (9) [192]
Exatecan
DNA topoisomerase 1 (TOP1)
Mal-Exo-EEVC
39410752 ADC (10) [192]
Monomethyl auristatin E
Microtubule (MT)
Mc-Val-Cit-PABC
39410752 ADC (11) [192]
Monomethyl auristatin E
Microtubule (MT)
Mc-Val-Cit-PABC
39410752 ADC (12) [192]
Monomethyl auristatin E
Microtubule (MT)
Mc-EVC-PAB
37492000 ADC 6a (4h) [193]
Monomethyl auristatin E
Microtubule (MT)
TetraDVP based linker 1a
37492000 ADC 6b (4h) [193]
Monomethyl auristatin E
Microtubule (MT)
TetraDVP based linker 1b
37492000 ADC 6c (4h) [193]
Monomethyl auristatin E
Microtubule (MT)
TetraDVP based linker 1c
37492000 ADC 6d (4h) [193]
Monomethyl auristatin E
Microtubule (MT)
TetraDVP based linker 1d
37492000 ADC 7a (4h) [193]
Monomethyl auristatin E
Microtubule (MT)
TetraDVP based linker 2a
37492000 ADC 7b (4h) [193]
Monomethyl auristatin E
Microtubule (MT)
TetraDVP based linker 2b
37492000 ADC 7c (4h) [193]
Monomethyl auristatin E
Microtubule (MT)
TetraDVP based linker 2c
37492000 ADC 7d (4h) [193]
Monomethyl auristatin E
Microtubule (MT)
TetraDVP based linker 2d
37492000 ADC 6a (24h) [193]
Monomethyl auristatin E
Microtubule (MT)
TetraDVP based linker 1a
37492000 ADC 6b (24h) [193]
Monomethyl auristatin E
Microtubule (MT)
TetraDVP based linker 1b
37492000 ADC 6c (24h) [193]
Monomethyl auristatin E
Microtubule (MT)
TetraDVP based linker 1c
37492000 ADC 6d (24h) [193]
Monomethyl auristatin E
Microtubule (MT)
TetraDVP based linker 1d
37492000 ADC 7a (24h) [193]
Monomethyl auristatin E
Microtubule (MT)
TetraDVP based linker 2a
37492000 ADC 7b (24h) [193]
Monomethyl auristatin E
Microtubule (MT)
TetraDVP based linker 2b
37492000 ADC 7c (24h) [193]
Monomethyl auristatin E
Microtubule (MT)
TetraDVP based linker 2c
37492000 ADC 7d (24h) [193]
Monomethyl auristatin E
Microtubule (MT)
TetraDVP based linker 2d
Tras-Exa [194]
Exatecan
DNA topoisomerase 1 (TOP1)
AB2 self-immolative dendritic scaffold
Tras-Bel [194]
Belotecan
DNA topoisomerase 1 (TOP1)
AB2 self-immolative dendritic scaffold
DEVD ADC [195]
Exatecan
DNA topoisomerase 1 (TOP1)
MC-DEVD-PAB
36924655 ADC 28 [196]
Monomethyl auristatin E
Microtubule (MT)
Undisclosed
36924655 ADC 29 [196]
Monomethyl auristatin E
Microtubule (MT)
Undisclosed
36924655 ADC 30 [196]
Monomethyl auristatin E
Microtubule (MT)
Undisclosed
36924655 ADC 31 [196]
Monomethyl auristatin E
Microtubule (MT)
Undisclosed
36924655 ADC 5 [196]
Monomethyl auristatin E
Microtubule (MT)
Undisclosed
36924655 ADC 6 [196]
Monomethyl auristatin E
Microtubule (MT)
Undisclosed
36924655 ADC 7 [196]
Monomethyl auristatin E
Microtubule (MT)
Undisclosed
36924655 ADC 8 [196]
Monomethyl auristatin E
Microtubule (MT)
Undisclosed
36924655 ADC 9 [196]
Monomethyl auristatin E
Microtubule (MT)
Undisclosed
36924655 ADC 10 [196]
Monomethyl auristatin E
Microtubule (MT)
Undisclosed
36924655 ADC 11 [196]
Monomethyl auristatin E
Microtubule (MT)
Undisclosed
36924655 ADC 12 [196]
Monomethyl auristatin E
Microtubule (MT)
Undisclosed
36924655 ADC 13 [196]
Monomethyl auristatin E
Microtubule (MT)
Undisclosed
36924655 ADC 14 [196]
Monomethyl auristatin E
Microtubule (MT)
Undisclosed
36924655 ADC 15 [196]
Monomethyl auristatin E
Microtubule (MT)
Undisclosed
Trastuzumab-DXd (38003245) [197]
DX-8951 derivative (DXd)
DNA topoisomerase 1 (TOP1)
Undisclosed
37307297 ADC 1 [198]
FD-1
Undisclosed
Mc-Val-Cit-PABC
37307297 ADC 2 [198]
FD-1
Undisclosed
Undisclosed
37307297 ADC 3 [198]
FD-1
Undisclosed
Undisclosed
37307297 ADC 4 [198]
FD-1
Undisclosed
Undisclosed
37307297 ADC 5 [198]
FD-1
Undisclosed
Undisclosed
37307297 ADC 6 [198]
FD-1
Undisclosed
Undisclosed
37307297 ADC 7 [198]
FD-1
Undisclosed
Undisclosed
37307297 ADC 8 [198]
FD-1
Undisclosed
Undisclosed
37307297 ADC 9 [198]
FD-1
Undisclosed
Undisclosed
37307297 ADC 12 [198]
FD-2
Undisclosed
Undisclosed
37307297 ADC 13 [198]
FD-2
Undisclosed
Undisclosed
37307297 ADC 14 [198]
FD-3
Undisclosed
Undisclosed
Trastuzumab-LplA-MMAE [199]
Monomethyl auristatin E
Microtubule (MT)
DBCO-Val-Cit-PABC
H2-921 [200]
Undisclosed
Undisclosed
D5 linker
Tras-16a [201]
14a 39321689
Undisclosed
Mc-Gly-Gly-Phe-Gly
Tras-16b [201]
14b 39321689
Undisclosed
Mc-Gly-Gly-Phe-Gly
37486969 ADC 36 [202]
STING Agonist 6
Undisclosed
Undisclosed
37486969 ADC 37 [202]
STING Agonist 6
Undisclosed
Undisclosed
37486969 ADC 38 [202]
STING Agonist 6
Undisclosed
Undisclosed
37486969 ADC 39 [202]
STING Agonist 4
Undisclosed
Undisclosed
37486969 ADC 40 [202]
STING Agonist 4
Undisclosed
Undisclosed
37486969 ADC 42 [202]
STING Agonist 15
Undisclosed
Undisclosed
37486969 ADC 43 [202]
STING Agonist 15
Undisclosed
Undisclosed
37486969 ADC 44 [202]
STING Agonist 15
Undisclosed
Undisclosed
37486969 ADC 45 [202]
STING Agonist 15
Undisclosed
Undisclosed
37486969 ADC 46 [202]
STING Agonist 15
Undisclosed
Undisclosed
T-VCR 6a [203]
Vincristine (VCR)
Undisclosed
Mc-Val-Cit-PABC
T-VCR 6b [203]
Vincristine (VCR)
Undisclosed
Mc-Val-Cit-PABC
37217025 ADC-1 [204]
TLR7/8 agonist 1
Undisclosed
MT-VC-PABC
37217025 ADC-2 [204]
TLR7/8 agonist 20h
Undisclosed
MT-VC-PABC
37917829 ADC 2 [205]
RIPK2 PROTAC
Undisclosed
Undisclosed
37828728 ADC 1 [206]
Exatecan
DNA topoisomerase 1 (TOP1)
P5 (OEt)-VC-PAB
37828728 ADC 2 [206]
Exatecan
DNA topoisomerase 1 (TOP1)
P5 (PEG2)-VC-PAB
37828728 ADC 3 [206]
Exatecan
DNA topoisomerase 1 (TOP1)
P5 (PEG12)-VC-PAB
37828728 ADC 4 [206]
Exatecan
DNA topoisomerase 1 (TOP1)
P5 (PEG12)-VA-PAB
37828728 ADC 5 [206]
Exatecan
DNA topoisomerase 1 (TOP1)
P5 (PEG24)-VC-PAB
37828728 ADC 6 [206]
Exatecan
DNA topoisomerase 1 (TOP1)
Mc-Val-Cit-PABC
37828728 ADC 7 [206]
Exatecan
DNA topoisomerase 1 (TOP1)
P5 (PEG12)-VA
37828728 ADC 8 [206]
Exatecan
DNA topoisomerase 1 (TOP1)
P5- (PEG12)
HER2-14 [207]
CPTS-1
Undisclosed
Mal-Val-Ala-PAB
HER2-16 [207]
CPTS-1
Undisclosed
Mc-Val-Cit-PABC
HER2-17 [207]
WL-14
Undisclosed
Mal-Val-Ala-PAB
HER2-18 [207]
WL-14
Undisclosed
Mc-Val-Cit-PABC
Trastuzumab- (VC-PABC-MMAE)2 [208]
Monomethyl auristatin E
Microtubule (MT)
Undisclosed
Trastuzumab-DM1 (K248) [209]
Mertansine DM1
Microtubule (MT)
Undisclosed
Trastuzumab-MMAE (K248) [209]
Monomethyl auristatin E
Microtubule (MT)
Undisclosed
Trastuzumab-MMAE (K288) [209]
Monomethyl auristatin E
Microtubule (MT)
Undisclosed
38888299 ADC 1 [210]
Monomethyl auristatin E
Microtubule (MT)
Tuneable thiol exchange linker 1
38888299 ADC 2 [210]
Monomethyl auristatin E
Microtubule (MT)
Tuneable thiol exchange linker 2
38888299 ADC 3 [210]
Monomethyl auristatin E
Microtubule (MT)
Tuneable thiol exchange linker 3
Trastu-AzaNIRII-MMAE [211]
Monomethyl auristatin E
Microtubule (MT)
azaNIRII-BCN-PEG4-VAC-PAB
Tra-CL2A-FL118 (11) [212]
Undisclosed
Undisclosed
CL2A
39337633 2ICy7-Ab [213]
Diiodinated heptamethine cyanine
Undisclosed
Undisclosed
Cy7-Ab [213]
Heptamethine cyanine
Undisclosed
Undisclosed
[111In]In-ADCS [214]
Undisclosed
Undisclosed
Undisclosed
[111In]In-AD [214]
Undisclosed
Undisclosed
Undisclosed
HER2-25 [215]
Tolllike receptor 7/8 agonist 18
Undisclosed
Undisclosed
HER2-26 [215]
Tolllike receptor 7/8 agonist 18
Undisclosed
Undisclosed
37222285 ADC 1 [216]
Auri E
Undisclosed
sulfatase-responsive linker
Tras-DSPEK248 [217]
Undisclosed
Undisclosed
Undisclosed
Tmab-VcMMAE-SMCC-DM1 [218]
Monomethyl auristatin E; Maytansinoid DM1
Undisclosed
Mc-Val-Cit-PABC; Succinimidyl-4- (N-maleimidomethyl)cyclohexane-1-carboxylate (SMCC)
TZ-dSA3-2 [219]
diABZI STING agonist 3
Undisclosed
Undisclosed
TZ-dSA3-4 [219]
diABZI STING agonist 3
Undisclosed
Undisclosed
TZ-dSA3-8 [219]
diABZI STING agonist 3
Undisclosed
Undisclosed
TZ-dSA3-12 [219]
diABZI STING agonist 3
Undisclosed
Undisclosed
Anti-HER2_VCGP-Dex [220]
Dexamethasone
Glucocorticoid receptor (NR3C1)
Mal-ValCitGlyPro-OH
Tras-2C [87]
Undisclosed
Undisclosed
Undisclosed
Tras-5C [87]
Undisclosed
Undisclosed
Undisclosed
HC-A118C-1a [221]
Monomethyl auristatin E
Microtubule (MT)
Undisclosed
HC-A118C-1b [221]
Monomethyl auristatin E
Microtubule (MT)
Undisclosed
HC-A118C-2 [221]
Monomethyl auristatin E
Microtubule (MT)
Undisclosed
HC-A118C-3 [221]
Monomethyl auristatin E
Microtubule (MT)
Undisclosed
HC-A118C-4 [221]
Monomethyl auristatin E
Microtubule (MT)
Undisclosed
HC-A140C-1a [221]
Monomethyl auristatin E
Microtubule (MT)
Undisclosed
HC-A140C-1b [221]
Monomethyl auristatin E
Microtubule (MT)
Undisclosed
HC-A140C-2 [221]
Monomethyl auristatin E
Microtubule (MT)
Undisclosed
HC-A140C-3 [221]
Monomethyl auristatin E
Microtubule (MT)
Undisclosed
HC-A140C-4 [221]
Monomethyl auristatin E
Microtubule (MT)
Undisclosed
HC-E258C-1a [221]
Monomethyl auristatin E
Microtubule (MT)
Undisclosed
HC-E258C-1b [221]
Monomethyl auristatin E
Microtubule (MT)
Undisclosed
HC-E258C-2 [221]
Monomethyl auristatin E
Microtubule (MT)
Undisclosed
HC-E258C-3 [221]
Monomethyl auristatin E
Microtubule (MT)
Undisclosed
HC-E258C-4 [221]
Monomethyl auristatin E
Microtubule (MT)
Undisclosed
HC-S400C-1a [221]
Monomethyl auristatin E
Microtubule (MT)
Undisclosed
HC-S400C-1b [221]
Monomethyl auristatin E
Microtubule (MT)
Undisclosed
HC-S400C-2 [221]
Monomethyl auristatin E
Microtubule (MT)
Undisclosed
HC-S400C-3 [221]
Monomethyl auristatin E
Microtubule (MT)
Undisclosed
HC-S400C-4 [221]
Monomethyl auristatin E
Microtubule (MT)
Undisclosed
LC-K149C-1a [221]
Monomethyl auristatin E
Microtubule (MT)
Undisclosed
LC-K149C-1b [221]
Monomethyl auristatin E
Microtubule (MT)
Undisclosed
LC-K149C-2 [221]
Monomethyl auristatin E
Microtubule (MT)
Undisclosed
LC-K149C-3 [221]
Monomethyl auristatin E
Microtubule (MT)
Undisclosed
LC-K149C-4 [221]
Monomethyl auristatin E
Microtubule (MT)
Undisclosed
LC-V205C-1a [221]
Monomethyl auristatin E
Microtubule (MT)
Undisclosed
LC-V205C-1b [221]
Monomethyl auristatin E
Microtubule (MT)
Undisclosed
LC-V205C-2 [221]
Monomethyl auristatin E
Microtubule (MT)
Undisclosed
LC-V205C-3 [221]
Monomethyl auristatin E
Microtubule (MT)
Undisclosed
LC-V205C-4 [221]
Monomethyl auristatin E
Microtubule (MT)
Undisclosed
WT ADC [222]
Monomethyl auristatin E
Microtubule (MT)
Mc-Val-Cit-PABC
Trastuzumab-TCO-Pot-Tz [223]
Porphyrin (Por)-tetrazine (Tz)
Undisclosed
Undisclosed
Trastuzumab 20 [224]
PBD-butanamide derivative
Undisclosed
Mc-Val-Ala
Antibody-fluorophore conjugate FCY (11) [225]
Biorthogonal azide 9
Undisclosed
Undisclosed
CN119343374A ADC-S109 [93]
Undisclosed
Undisclosed
Undisclosed
CN119343374A ADC-S110 [93]
Undisclosed
Undisclosed
Undisclosed
CN119343374A ADC-S111 [93]
Undisclosed
Undisclosed
Undisclosed
CN119343374A ADC-S423 [93]
Undisclosed
Undisclosed
Undisclosed
CN119343374A ADC-S426 [93]
Undisclosed
Undisclosed
Undisclosed
CN119343374A ADC-TRA41C [93]
Undisclosed
Undisclosed
Undisclosed
Trastuzumab-Example 1 [226]
CN119343152A 1C1-Example1 Payload
Microtubule (MT)
CN119343152A 1C1-Example1 Linker
Trastuzumab-Example 2 [226]
CN119343152A 1C1-Example1 Payload
Microtubule (MT)
CN119343152A 1C1-Example2 Linker
Trastuzumab-Example 3 [226]
CN119343152A 1C1-Example3 Payload1; CN119343152A 1C1-Example3 Payload2
Undisclosed
CN119343152A 1C1-Example3 Linker
Trastuzumab-Example 4 [226]
CN119343152A 1C1-Example1 Payload; CN119343152A 1C1-Example4 Payload
Undisclosed
CN119343152A 1C1-Example4 Linker
Trastuzumab-Example 5 [226]
CN119343152A Trastuzumab-Example5 Payload
Microtubule (MT)
CN119343152A 1C1-Example1 Linker
Trastuzumab-Example 6 [226]
CN119343152A Trastuzumab-Example6 Payload
DNA topoisomerase I (TOP1)
CN119343152A 1C1-Example1 Linker
Trastuzumab-Example 7 [226]
CN119343152A Trastuzumab-Example6 Payload
DNA topoisomerase I (TOP1)
CN119343152A Trastuzumab-Example7 Linker
Trastuzumab-Example 8 [226]
DX-8951 derivative (DXd)
DNA topoisomerase 1 (TOP1)
CN119343152A Trastuzumab-Example8 Linker
Trastuzumab-GDP-D-P2/P4-P4-GGFG-Dxd [227]
DX-8951 derivative (DXd)
DNA topoisomerase 1 (TOP1)
CN119343152A Trastuzumab-GDP-D-P2/P4-P4-GGFG-Dxd Linker
Trastuzumab-GDP-K-P2/P4-P4-GGFG-Dxd [227]
DX-8951 derivative (DXd)
DNA topoisomerase 1 (TOP1)
CN119326907A Trastuzumab-GDP-D-P2/P4-P4-GGFG-Dxd Linker
Trastuzumab-GDP-D-P2/P8-P4-GGFG-Dxd [227]
DX-8951 derivative (DXd)
DNA topoisomerase 1 (TOP1)
CN119326907A Trastuzumab-GDP-D-P2/P8-P4-GGFG-Dxd Linker
Trastuzumab-GDP-D-P1/P2-P4-GGFG-Dxd [227]
DX-8951 derivative (DXd)
DNA topoisomerase 1 (TOP1)
CN119326907A Trastuzumab-GDP-D-P2/P4-P4-GGFG-Dxd Linker
Trastuzumab-GDP-D-P1/P1-P4-GGFG-Dxd [227]
DX-8951 derivative (DXd)
DNA topoisomerase 1 (TOP1)
CN119326907A Trastuzumab-GDP-D-P1/P1-P4-GGFG-Dxd Linker
Trastuzumab-GDP-D-P2/P4-P1-GGFG-Dxd [227]
DX-8951 derivative (DXd)
DNA topoisomerase 1 (TOP1)
CN119326907A Trastuzumab-GDP-D-P2/P4-P1-GGFG-Dxd Linker
Trastuzumab-GDP-D-P2/P4-P2-GGFG-Dxd [227]
DX-8951 derivative (DXd)
DNA topoisomerase 1 (TOP1)
CN119326907A Trastuzumab-GDP-D-P2/P4-P2-GGFG-Dxd Linker
Trastuzumab-GDP-D-P1/P1-P1-GGFG-Dxd [227]
DX-8951 derivative (DXd)
DNA topoisomerase 1 (TOP1)
CN119326907A Trastuzumab-GDP-D-P1/P1-P1-GGFG-Dxd Linker
Trastuzumab-GDP-D-P1/P1-P2-GGFG-Dxd [227]
DX-8951 derivative (DXd)
DNA topoisomerase 1 (TOP1)
CN119326907A Trastuzumab-GDP-D-P1/P1-P2-GGFG-Dxd Linker
Trastuzumab-GDP-D-P1/P1-C2-GGFG-Dxd [227]
DX-8951 derivative (DXd)
DNA topoisomerase 1 (TOP1)
CN119326907A Trastuzumab-GDP-D-P1/P1-C2-GGFG-Dxd Linker
Trastuzumab-GDP-D-P1/P2-C2-GGFG-Dxd [227]
DX-8951 derivative (DXd)
DNA topoisomerase 1 (TOP1)
CN119326907A Trastuzumab-GDP-D-P1/P2-C2-GGFG-Dxd Linker
Trastuzumab-GDP-D-P1/P2-P1-GGFG-Dxd [227]
DX-8951 derivative (DXd)
DNA topoisomerase 1 (TOP1)
CN119326907A Trastuzumab-GDP-D-P1/P2-P1-GGFG-Dxd Linker
Trastuzumab-GDP-N-P1/P2-P1-GGFG-Dxd [227]
DX-8951 derivative (DXd)
DNA topoisomerase 1 (TOP1)
CN119326907A Trastuzumab-GDP-N-P1/P2-P1-GGFG-Dxd Linker
Trastuzumab-GDP-N-P1/P1-P1-GGFG-Dxd [227]
DX-8951 derivative (DXd)
DNA topoisomerase 1 (TOP1)
CN119326907A Trastuzumab-GDP-N-P1/P1-P1-GGFG-Dxd Linker
Trastuzumab-GDP-D-P2/P2-P2-GGFG-Dxd [227]
DX-8951 derivative (DXd)
DNA topoisomerase 1 (TOP1)
Trastuzumab-GDP-D-P2/P2-P2-GGFG-Dxd Linker
AB185-ADL10-D8 [228]
D8 payload
Undisclosed
6-Maleimidocaproic acid
AB185-ADL10-D1 [228]
D1 payload
Undisclosed
6-Maleimidocaproic acid
AB185-ADL5-D17 [228]
D17 payload
Undisclosed
Mc-Val-Cit-PAB (Qamine) linker
AB185-ADL1-D16 [228]
D16 payload
Undisclosed
Mc-Val-Cit-PABC
AB185-ADL5-D26 [228]
D26 payload
Undisclosed
Mc-Val-Cit-PAB (Qamine) linker
AB185-ADL1-D14 [228]
D14 payload
Undisclosed
Mc-Val-Cit-PABC
AB185-ADL5-D15 [228]
D15 payload
Undisclosed
Mc-Val-Cit-PAB (Qamine) linker
AB185-ADL5-D11 [228]
D11 payload
Undisclosed
Mc-Val-Cit-PAB (Qamine) linker
AB185-ADL1-D33 [228]
D33 payload
Undisclosed
Mc-Val-Cit-PABC
AB185-ADL1-D22 [228]
D22 payload
Undisclosed
Mc-Val-Cit-PABC
AB185-ADL12-D2 [228]
D2 payload
Undisclosed
Mal- (CH2)6- linker
AB185-ADL1-D13 [228]
D13 payload
Undisclosed
Mc-Val-Cit-PABC
AB185-ADL5-D19 [228]
D19 payload
Undisclosed
Mc-Val-Cit-PAB (Qamine) linker
AB185-ADL5-D10 [228]
D10 payload
Undisclosed
Mc-Val-Cit-PAB (Qamine) linker
AB185-ADL6-D9 [228]
D9 payload
Undisclosed
Mc-Val-Cit-PABC
AB185-ADL5-D2 4.14 [228]
D2 payload
Undisclosed
Mc-Val-Cit-PAB (Qamine) linker
AB185-ADL1-D8 [228]
D8 payload
Undisclosed
Mc-Val-Cit-PABC
AB185-ADL15-D2 [228]
D2 payload
Undisclosed
Mal-CH2CH2-O-CH2CH2- linker
AB185-ADL12-D20 [228]
D20 payload
Undisclosed
Mal- (CH2)6- linker
AB185-ADL12-D1 3.3 [228]
D1 payload
Undisclosed
Mal- (CH2)6- linker
AB185-ADL5-D2 8.5 [228]
D2 payload
Undisclosed
Mc-Val-Cit-PAB (Qamine) linker
AB185-ADL6-D1 [228]
D1 payload
Undisclosed
Mc-Val-Cit-PABC
AB185-ADL12-D1 3 [228]
D1 payload
Undisclosed
Mal- (CH2)6- linker
AB185-ADL12-D22 [228]
D22 payload
Undisclosed
Mal- (CH2)6- linker
AB185-ADL1-D4 8 [228]
D4 payload
Undisclosed
Mc-Val-Cit-PABC
AB185-ADL15-D1 [228]
D1 payload
Undisclosed
Mal-CH2CH2-O-CH2CH2- linker
AB185-ADL14-D1 [228]
D14 payload
Undisclosed
Mal-CH2CH2- linker
AB185-ADL1-D4 2.8 [228]
undisclosed
Undisclosed
Mc-Val-Cit-PABC
AB185-ADL1-D1 [228]
D1 payload
Undisclosed
Mc-Val-Cit-PABC
AB185-ADL5-D25 [228]
D25 payload
Undisclosed
Mc-Val-Cit-PABC
AB185-ADL12-D21 [228]
D21 payload
Undisclosed
Mal- (CH2)6- linker
AB185-ADL1-D18 [228]
D18 payload
Undisclosed
Mc-Val-Cit-PABC
AB185-ADL1-D12 [228]
D12 payload
Undisclosed
Mc-Val-Cit-PABC
AB185-ADL13-D4 [228]
D4 payload
Undisclosed
B-glucuronide linker
AB185-ADL1-D5 [228]
D5 payload
Undisclosed
Mc-Val-Cit-PABC
AB185-ADL1-D3 [228]
D3 Payload payload
Undisclosed
Undisclosed
CN118924912A anti-HER2 ADC1 [229]
CN118924912A anti-HER2 ADC1 Payload
Undisclosed
CN118924912A anti-HER2 ADC1 Linker
CN118924912A anti-HER2 ADC2 [229]
CN118924912A anti-HER2 ADC2 Payload
Undisclosed
CN118924912A anti-HER2 ADC1 Linker
CN118924912A anti-HER2 ADC3 [229]
CN118924912A anti-HER2 ADC3 Payload
Undisclosed
CN118924912A anti-HER2 ADC1 Linker
CN118924912A anti-HER2 ADC4 [229]
CN118924912A anti-HER2 ADC4 Payload
Undisclosed
CN118924912A anti-HER2 ADC1 Linker
CN118924912A anti-HER2 ADC5 [229]
CN118924912A anti-HER2 ADC5 Payload
Undisclosed
CN118924912A anti-HER2 ADC1 Linker
CN118924912A anti-HER2 ADC6 [229]
CN118924912A anti-HER2 ADC6 Payload
Undisclosed
CN118924912A anti-HER2 ADC1 Linker
CN118924912A anti-HER2 ADC7 [229]
CN118924912A anti-HER2 ADC7 Payload
Undisclosed
CN118924912A anti-HER2 ADC1 Linker
CN118924912A anti-HER2 ADC8 [229]
CN118924912A anti-HER2 ADC8 Payload
Undisclosed
CN118924912A anti-HER2 ADC1 Linker
CN118924912A anti-HER2 ADC9 [229]
CN118924912A anti-HER2 ADC9 Payload
Undisclosed
CN118924912A anti-HER2 ADC1 Linker
CN118924912A anti-HER2 ADC10 [229]
CN118924912A anti-HER2 ADC10 Payload
Undisclosed
CN118924912A anti-HER2 ADC1 Linker
CN118924912A anti-HER2 ADC11 [229]
CN118924912A anti-HER2 ADC11 Payload
Undisclosed
CN118924912A anti-HER2 ADC1 Linker
CN118924912A anti-HER2 ADC12 [229]
CN118924912A anti-HER2 ADC12 Payload
Undisclosed
CN118924912A anti-HER2 ADC1 Linker
CN118924912A anti-HER2 ADC13 [229]
CN118924912A anti-HER2 ADC13 Payload
Undisclosed
CN118924912A anti-HER2 ADC1 Linker
CN118924912A anti-HER2 ADC14 [229]
CN118924912A anti-HER2 ADC14 Payload
Undisclosed
CN118924912A anti-HER2 ADC1 Linker
CN118924912A anti-HER2 ADC15 [229]
CN118924912A anti-HER2 ADC15 Payload
Undisclosed
CN118924912A anti-HER2 ADC1 Linker
CN118924912A anti-HER2 ADC16 [229]
CN118924912A anti-HER2 ADC16 Payload
Undisclosed
CN118924912A anti-HER2 ADC1 Linker
CN118924912A anti-HER2 ADC17 [229]
CN118924912A anti-HER2 ADC17 Payload
Undisclosed
CN118924912A anti-HER2 ADC1 Linker
CN118924912A anti-HER2 ADC18 [229]
CN118924912A anti-HER2 ADC18 Payload
Undisclosed
CN118924912A anti-HER2 ADC1 Linker
CN118924912A anti-HER2 ADC19 [229]
CN118924912A anti-HER2 ADC19 Payload
Undisclosed
CN118924912A anti-HER2 ADC1 Linker
CN118924912A anti-HER2 ADC20 [229]
CN118924912A anti-HER2 ADC20 Payload
Undisclosed
CN118924912A anti-HER2 ADC1 Linker
CN118401256A ADC 1 [230]
Monomethyl auristatin E
Microtubule (MT)
Allenamide-Amcap-Val-Cit-PABC
CN118401256A ADC 2 [230]
Monomethyl auristatin E
Microtubule (MT)
Maleimido-caproyl-Val-Cit-PABC
CN117750982A ADC58 [231]
CN117750982A ADC58 Payload
Undisclosed
CN117750982A ADC58 Linker
CN117750982A ADC59 [231]
CN117750982A ADC58 Payload
Undisclosed
CN117750982A ADC59 Linker
CN117750982A ADC60 [231]
CN117750982A ADC58 Payload
Undisclosed
CN117750982A ADC60 Linker
CN117750982A ADC61 [231]
CN117750982A ADC58 Payload
Undisclosed
CN117750982A ADC61 Linker
CN117750982A ADC62 [231]
CN117750982A ADC62 Payload
Undisclosed
CN117750982A ADC58 Linker
CN117750982A ADC63 [231]
CN117750982A ADC62 Payload
Undisclosed
CN117750982A ADC59 Linker
CN117750982A ADC64 [231]
CN117750982A ADC62 Payload
Undisclosed
CN117750982A ADC60 Linker
CN117750982A ADC65 [231]
CN117750982A ADC62 Payload
Undisclosed
CN117750982A ADC61 Linker
CN114615999B ADC-1 [232]
CN114615999B ADC-1 Payload
Undisclosed
CN114615999B ADC-1 Linker
CN114615999B ADC-2 [232]
CN114615999B ADC-1 Payload
Undisclosed
CN114615999B ADC-2 Linker
CN114615999B ADC-3 [232]
CN114615999B ADC-3 Payload
Undisclosed
CN114615999B ADC-2 Linker
CN114615999B ADC-4 [232]
CN114615999B ADC-1 Payload
Undisclosed
CN114615999B ADC-1 Linker
CN114615999B ADC-5 [232]
CN114615999B ADC-3 Payload
Undisclosed
CN114615999B ADC-2 Linker
T-PBA [233]
PBD-based payload 37b3
Undisclosed
MC-Val-Ala-OH linker
US20230109312A1 ADC with 4 MMAF [234]
Monomethyl auristatin F
Microtubule (MT)
US20230109312A1 ADC with 4 MMAF Linker
US20220226492A1 Immunoconjugate A [235]
undisclosed
Undisclosed
Undisclosed
US20220226492A1 Immunoconjugate B [235]
undisclosed
Undisclosed
Undisclosed
US20220226492A1 Immunoconjugate C [235]
undisclosed
Undisclosed
Undisclosed
US20220226492A1 Immunoconjugate D [235]
undisclosed
Undisclosed
Undisclosed
US20220226492A1 Immunoconjugate E [235]
undisclosed
Undisclosed
Undisclosed
US20220226492A1 Immunoconjugate F [235]
undisclosed
Undisclosed
Undisclosed
US20220226492A1 Immunoconjugate G [235]
undisclosed
Undisclosed
Undisclosed
US20220226492A1 Immunoconjugate H [235]
undisclosed
Undisclosed
Undisclosed
US20220226492A1 Immunoconjugate I [235]
undisclosed
Undisclosed
Undisclosed
US20220226492A1 Immunoconjugate J [235]
undisclosed
Undisclosed
Undisclosed
US20220226492A1 Immunoconjugate L [235]
undisclosed
Undisclosed
Undisclosed
US20220226492A1 Immunoconjugate M [235]
undisclosed
Undisclosed
Undisclosed
US20220226492A1 Immunoconjugate N [235]
undisclosed
Undisclosed
Undisclosed
US20220226492A1 Immunoconjugate O [235]
undisclosed
Undisclosed
Undisclosed
US20220226492A1 Immunoconjugate P [235]
undisclosed
Undisclosed
Undisclosed
US20220226492A1 Immunoconjugate Q [235]
undisclosed
Undisclosed
Undisclosed
US20220226492A1 Immunoconjugate R [235]
undisclosed
Undisclosed
Undisclosed
US20220226492A1 Immunoconjugate S [235]
undisclosed
Undisclosed
Undisclosed
US20220226492A1 Immunoconjugate T [235]
undisclosed
Undisclosed
Undisclosed
US20220226492A1 Immunoconjugate U [235]
undisclosed
Undisclosed
Undisclosed
US20220226492A1 Immunoconjugate V [235]
undisclosed
Undisclosed
Undisclosed
US20220226492A1 Immunoconjugate K1 [235]
undisclosed
Undisclosed
Undisclosed
US20220226492A1 Immunoconjugate R1 [235]
undisclosed
Undisclosed
Undisclosed
CN115515644A ADC-1-b [236]
CN115515644A ADC-1-a Payload
Undisclosed
CN115515644A ADC-1-a Linker
CN115515644A ADC-2-b [236]
CN115515644A ADC-1-a Payload
Undisclosed
CN115515644A ADC-2-a Linker
CN115515644A ADC-3-b [236]
CN115515644A ADC-1-a Payload
Undisclosed
CN115515644A ADC-3-a Linker
CN115515644A ADC-4-b [236]
CN115515644A ADC-1-a Payload
Undisclosed
CN115515644A ADC-4-a Linker
CN115515644A ADC-5-b [236]
CN115515644A ADC-1-a Payload
Undisclosed
CN115515644A ADC-5-a Linker
JP7623413B2 ExampleADC9 [237]
Undisclosed
Undisclosed
Undisclosed
JP7623413B2 ExampleADC45 [237]
Undisclosed
Undisclosed
Undisclosed
US12144865B2 1e [238]
Undisclosed
Undisclosed
Undisclosed
US12144865B2 2e [238]
Undisclosed
Undisclosed
Undisclosed
US12144865B2 5e [238]
Undisclosed
Undisclosed
Undisclosed
US12144865B2 6e [238]
Undisclosed
Undisclosed
Undisclosed
US12144865B2 8e [238]
Undisclosed
Undisclosed
Undisclosed
US12144865B2 11e [238]
Undisclosed
Undisclosed
Undisclosed
US12144865B2 12e [238]
Undisclosed
Undisclosed
Undisclosed
US12144865B2 13e [238]
Undisclosed
Undisclosed
Undisclosed
US12144865B2 14e [238]
Undisclosed
Undisclosed
Undisclosed
US12144865B2 16e [238]
Undisclosed
Undisclosed
Undisclosed
US12144865B2 17e [238]
Undisclosed
Undisclosed
Undisclosed
US12144865B2 18e [238]
Undisclosed
Undisclosed
Undisclosed
US12144865B2 19e [238]
Undisclosed
Undisclosed
Undisclosed
US12144865B2 21e [238]
Undisclosed
Undisclosed
Undisclosed
US12144865B2 22e [238]
Undisclosed
Undisclosed
Undisclosed
US12144865B2 23e [238]
Undisclosed
Undisclosed
Undisclosed
US12144865B2 24e [238]
Undisclosed
Undisclosed
Undisclosed
US12144865B2 25e [238]
Undisclosed
Undisclosed
Undisclosed
US12144865B2 26e [238]
Undisclosed
Undisclosed
Undisclosed
US12144865B2 27e [238]
Undisclosed
Undisclosed
Undisclosed
US12144865B2 28e [238]
Undisclosed
Undisclosed
Undisclosed
US12144865B2 29e [238]
Undisclosed
Undisclosed
Undisclosed
US12144865B2 30e [238]
Undisclosed
Undisclosed
Undisclosed
US12144865B2 35e [238]
Undisclosed
Undisclosed
Undisclosed
US12144865B2 36e [238]
Undisclosed
Undisclosed
Undisclosed
US12144865B2 37e [238]
Undisclosed
Undisclosed
Undisclosed
US12144865B2 38e [238]
Undisclosed
Undisclosed
Undisclosed
US12144865B2 39e [238]
Undisclosed
Undisclosed
Undisclosed
US12144865B2 40e [238]
Undisclosed
Undisclosed
Undisclosed
US12144865B2 41e [238]
Undisclosed
Undisclosed
Undisclosed
US12144865B2 42e [238]
Undisclosed
Undisclosed
Undisclosed
US12144865B2 43e [238]
Undisclosed
Undisclosed
Undisclosed
US12144865B2 44e [238]
Undisclosed
Undisclosed
Undisclosed
Trastuzumab-LD1 [242]
Seco-DUBA
Human Deoxyribonucleic acid (hDNA)
Trastuzumab-LD1-LINKER
Trastuzumab-LD3 [242]
Seco-DUBA
Human Deoxyribonucleic acid (hDNA)
Trastuzumab-LD3-LINKER
Trastuzumab-LD4 [242]
Seco-DUBA
Human Deoxyribonucleic acid (hDNA)
Trastuzumab-LD1-LINKER
Trastuzumab-LD5 [242]
Seco-DUBA
Human Deoxyribonucleic acid (hDNA)
Trastuzumab-LD1-LINKER
Trastuzumab-LD6 [242]
Seco-DUBA
Human Deoxyribonucleic acid (hDNA)
Trastuzumab-LD1-LINKER
Trastuzumab-LD7 [242]
Undisclosed
Undisclosed
Trastuzumab-LD7-LINKER
Trastuzumab-LD8 [242]
Undisclosed
Undisclosed
Trastuzumab-LD8-LINKER
AU2017363246B2 Conjugate28 [243]
AU2017363246B2+Conjugate28+Payload
Undisclosed
Undisclosed
AU2017363246B2 Conjugate31A [243]
AU2017363246B2+Conjugate31+Payload
Undisclosed
AU2017363246B2+Conjugate31+Linker
AU2017363246B2 Conjugate31B [243]
AU2017363246B2+Conjugate31+Payload
Undisclosed
AU2017363246B2+Conjugate31+Linker
AU2017363246B2 Conjugate34A [243]
AU2017363246B2+Conjugate34+Payload
Undisclosed
AU2017363246B2+Conjugate34+Linker
AU2017363246B2 Conjugate34B [243]
AU2017363246B2+Conjugate34+Payload
Undisclosed
AU2017363246B2+Conjugate34+Linker
AU2017363246B2 Conjugate43A [243]
AU2017363246B2+Conjugate43+Payload
Undisclosed
AU2017363246B2+Conjugate43+Linker
AU2017363246B2 Conjugate43B [243]
AU2017363246B2+Conjugate43+Payload
Undisclosed
AU2017363246B2+Conjugate43+Linker
AU2017363246B2 Conjugate46A [243]
AU2017363246B2+Conjugate46+Payload
Undisclosed
AU2017363246B2+Conjugate46+Linker
AU2017363246B2 Conjugate46B [243]
AU2017363246B2+Conjugate46+Payload
Undisclosed
AU2017363246B2+Conjugate46+Linker
AU2017363246B2 Conjugate48 [243]
AU2017363246B2+Conjugate48+Payload
Undisclosed
AU2017363246B2+Conjugate48+Linker
AU2017363246B2 Conjugate52 [243]
AU2017363246B2+Conjugate52+Payload
Undisclosed
AU2017363246B2+Conjugate52+Linker
AU2017363246B2 Conjugate67 [243]
AU2017363246B2+Conjugate67+Payload
Undisclosed
AU2017363246B2+Conjugate67+Linker
AU2017363246B2 Conjugate68 [243]
AU2017363246B2+Conjugate68+Payload
Undisclosed
AU2017363246B2+Conjugate68+Linker
AU2017363246B2 Conjugate25 [243]
AU2017363246B2+Conjugate25+Payload
Undisclosed
AU2017363246B2+Conjugate25+Linker
AU2023226367A1-1 [244]
RU20241285-1-payload
Undisclosed
RU20241285-1-linker
AU2023226367A1-2 [244]
U-030
DNA topoisomerase I (TOP1)
RU20241285-1-linker
AU2023226367A1-3 [244]
Auristatin E
Microtubule (MT)
RU20241285-3-linker
AU2023226367A1-4 [244]
RU20241285-4-payload
Undisclosed
RU20241285-4-linker
AU2023226367A1-5 [244]
RU20241285-5-payload
Undisclosed
RU20241285-1-linker
AU2023226367A1-6 [244]
RU20241285-6-payload
Undisclosed
RU20241285-6-linker
AU2023226367A1-7 [244]
Monomethyl auristatin E
Microtubule (MT)
RU20241285-7-linker
AU2023226367A1-8 [244]
Monomethyl auristatin E
Microtubule (MT)
RU20241285-8-linker
AU2023226367A1-9 [244]
RU20241285-9-payload
Undisclosed
RU20241285-9-linker
AU2023226367A1-10 [244]
RU20241285-10-payload
Undisclosed
RU20241285-10-linker
AU2023226367A1-11 [244]
DX-8951 derivative (DXd)
DNA topoisomerase 1 (TOP1)
RU20241285-10-linker
AU2023226367A1-12 [244]
DX-8951 derivative (DXd)
DNA topoisomerase 1 (TOP1)
RU20241285-12-linker
AU2023226367A1-13 [244]
DX-8951 derivative (DXd)
DNA topoisomerase 1 (TOP1)
RU20241285-13-linker
AU2023226367A1-14 [244]
Eribulin
Microtubule (MT)
RU20241285-8-linker
AU2023226367A1-15 [244]
RU20241285-15-payload
Undisclosed
RU20241285-15-linker
AU2023226367A1-16 [244]
Eribulin
Microtubule (MT)
EP4487874A1-18linker
AU2023226367A1-17 [244]
Eribulin
Microtubule (MT)
RU20241285-17-linker
AU2023226367A1-18 [244]
Eribulin
Microtubule (MT)
RU20241285-18-linker
AU2023226367A1-19 [244]
Auristatin E
Microtubule (MT)
RU20241285-19-linker
AU2023226367A1-20 [244]
Topo1 inhibitor A
DNA topoisomerase I (TOP1)
EP4487874A1-13linker
AU2023226367A1-21 [244]
RU20241285-21-payload
Undisclosed
RU20241285-21-linker
AU2023226367A1-22 [244]
RU20241285-22-payload
Undisclosed
RU20241285-22-linker
AU2023226367A1-23 [244]
RU20241285-23-payload
DNA topoisomerase I (TOP1)
RU20241285-23-linker
AU2023226367A1-24 [244]
RU20241285-23-payload
DNA topoisomerase I (TOP1)
RU20241285-24-linker
ZA202500114A-ADC-6 [245]
Undisclosed
Undisclosed
Undisclosed
ZA202500415A-ADC Example 1 [246]
NMT inhibitor 1
N-Myristoyltransferase (NMT)
ZA202500415A-ADC-Example-1-Linker
ZA202500415A-ADC Example 5 [246]
NMT inhibitor 26
N-Myristoyltransferase (NMT)
ZA202500415A-ADC-Example-1-Linker
ZA202500415A-ADC Example 6 [246]
ZA202500415A-ADC-Example-6-payload
N-Myristoyltransferase (NMT)
ZA202500415A-ADC-Example-1-Linker
ZA202500415A-ADC Example 7 [246]
NMT inhibitor 1
N-Myristoyltransferase (NMT)
Mc-Gly-Gly-Phe-Gly
HER2-ADC-001 [247]
DL001-payload; DL003-payload
Undisclosed
DL001-Linker; DL003-Linker
HER2-ADC-002 [247]
DL007-payload; DL003-payload
Undisclosed
DL007-Linker; DL003-Linker
HER2-ADC-003 [247]
DL007-payload; DL003-payload
Undisclosed
DL007-Linker; DL003-Linker
HER2-ADC-004 [247]
DL007-payload; DL002-payload
Undisclosed
DL007-Linker; DL002-Linker
HER2-ADC-005 [247]
DL012-payload; DL003-payload
Undisclosed
DL012-Linker; DL003-Linker
HER2-ADC-006 [247]
DL012-payload; DL003-payload
Undisclosed
DL012-Linker; DL003-Linker
HER2-ADC-007 [247]
DL012-payload; DL003-payload
Undisclosed
DL012-Linker; DL003-Linker
HER2-ADC-008 [247]
DL012-payload; DL003-payload
Undisclosed
DL012-Linker; DL003-Linker
HER2-ADC-009 [247]
DL012-payload; DL003-payload
Undisclosed
DL012-Linker; DL003-Linker
HER2-ADC-010 [247]
DL014-payload; DL003-payload
Undisclosed
DL014-Linker; DL003-Linker
HER2-ADC-011 [247]
DL014-payload; DL003-payload
Undisclosed
DL014-Linker; DL003-Linker
HER2-ADC-012 [247]
DL014-payload; DL003-payload
Undisclosed
DL014-Linker; DL003-Linker
HER2-ADC-013 [247]
DL012-payload; DL003-payload
Undisclosed
DL012-Linker; DL003-Linker
HER2-ADC-014 [247]
DL017-payload; DL003-payload
Undisclosed
DL017-Linker; DL003-Linker
HER2-ADC-015 [247]
DL017-payload; DL003-payload
Undisclosed
DL017-Linker; DL003-Linker
HER2-DL012-DAR2 [247]
DL012-payload
Undisclosed
DL012-Linker
HER2-DL003-DAR8 [247]
DL003-payload
Undisclosed
DL003-Linker
Trastuzumab N221 (WT)-MMAF #1 [248]
Monomethyl auristatin F
Microtubule (MT)
Undisclosed
Trastuzumab N221 (WT)-MMAF #2 [248]
Monomethyl auristatin F
Microtubule (MT)
Undisclosed
Trastuzumab N221 (GDLN)-MMAF [248]
Monomethyl auristatin F
Microtubule (MT)
Undisclosed
Tras-LN-MMAF [248]
Monomethyl auristatin F
Microtubule (MT)
Undisclosed
Tras.D221N-MMAF (HEK GDLN) [248]
Monomethyl auristatin F
Microtubule (MT)
Undisclosed
Tras.D221N-MMAF (HEK WT) [248]
Monomethyl auristatin F
Microtubule (MT)
Undisclosed
WO2023047090A1-MMAE ADC [97]
Monomethyl auristatin E
Microtubule (MT)
Undisclosed
WO2023047090A1-SN-38 reagent (11) ADC [97]
Undisclosed
Undisclosed
Undisclosed
WO2023047090A1-SN-38 reagent (13) ADC [97]
Undisclosed
Undisclosed
Undisclosed
AU2020291014A1 IC-1 [249]
AU2020291014A1-Payload-2
Undisclosed
Aminobenzazepine-linker Formula II-2
AU2020291014A1 IC-2 [249]
AU2020291014A1-Payload-3
Undisclosed
Aminobenzazepine-linker Formula II-3
AU2020291014A1 IC-3 [249]
AU2020291014A1-Payload-2
Undisclosed
Aminobenzazepine-linker Formula II-4
AU2020291014A1 IC-4 [249]
AU2020291014A1-Payload-2
Undisclosed
Aminobenzazepine-linker Formula II-5
AU2020291014A1 IC-5 [249]
Undisclosed
Undisclosed
Undisclosed
AU2020291014A1 IC-6 [249]
Undisclosed
Undisclosed
Undisclosed
AU2020291014A1 IC-7 [249]
Undisclosed
Undisclosed
Undisclosed
AU2020291014A1 IC-8 [249]
AU2020291014A1-Payload-70
Undisclosed
Aminobenzazepine-linker Formula II-15
AU2020291014A1 IC-10 [249]
AU2020291014A1-Payload-16
Undisclosed
Aminobenzazepine-linker Formula II-16
AU2020291014A1 IC-11 [249]
AU2020291014A1-Payload-17
Undisclosed
Aminobenzazepine-linker Formula II-17
AU2020291014A1 IC-12 [249]
AU2020291014A1-Payload-18
Undisclosed
Aminobenzazepine-linker Formula II-17
AU2020291014A1 IC-13 [249]
AU2020291014A1-Payload-19
Undisclosed
Aminobenzazepine-linker Formula II-17
AU2020291014A1 IC-14 [249]
AU2020291014A1-Payload-70
Undisclosed
Aminobenzazepine-linker Formula II-17
AU2020291014A1 IC-16 [249]
Undisclosed
Undisclosed
Undisclosed
AU2020291014A1 IC-17 [249]
AU2020291014A1-Payload-70
Undisclosed
Aminobenzazepine-linker Formula II-22
AU2020291014A1 IC-18 [249]
AU2020291014A1-Payload-25
Undisclosed
Aminobenzazepine-linker Formula II-25
AU2020291014A1 IC-19 [249]
AU2020291014A1-Payload-27
Undisclosed
Aminobenzazepine-linker Formula II-27
AU2020291014A1 IC-20 [249]
AU2020291014A1-Payload-70
Undisclosed
Aminobenzazepine-linker Formula II-31
AU2020291014A1 IC-21 [249]
Undisclosed
Undisclosed
Undisclosed
AU2020291014A1 IC-22 [249]
AU2020291014A1-Payload-33
Undisclosed
Aminobenzazepine-linker Formula II-33
AU2020291014A1 IC-23 [249]
AU2020291014A1-Payload-35
Undisclosed
Aminobenzazepine-linker Formula II-33
AU2020291014A1 IC-24 [249]
AU2020291014A1-Payload-36
Undisclosed
Aminobenzazepine-linker Formula II-36
AU2020291014A1 IC-25 [249]
Undisclosed
Undisclosed
Undisclosed
AU2020291014A1 IC-26 [249]
Undisclosed
Undisclosed
Undisclosed
AU2020291014A1 IC-27 [249]
AU2020291014A1-Payload-34
Undisclosed
Aminobenzazepine-linker Formula II-34
AU2020291014A1 IC-28 [249]
AU2020291014A1-Payload-39
Undisclosed
Undisclosed
AU2020291014A1 IC-29 [249]
AU2020291014A1-Payload-40
Undisclosed
Undisclosed
AU2020291014A1 IC-30 [249]
AU2020291014A1-Payload-41
Undisclosed
Undisclosed
AU2020291014A1 IC-31 [249]
AU2020291014A1-Payload-42
Undisclosed
Aminobenzazepine-linker Formula II-42
AU2020291014A1 IC-32 [249]
undisclosed
Undisclosed
Undisclosed
AU2020291014A1 IC-33 [249]
undisclosed
Undisclosed
Undisclosed
AU2020291014A1 IC-34 [249]
undisclosed
Undisclosed
Undisclosed
AU2020291014A1 IC-35 [249]
undisclosed
Undisclosed
Undisclosed
AU2020291014A1 IC-38 [249]
AU2020291014A1-Payload-49
Undisclosed
Undisclosed
AU2020291014A1 IC-40 [249]
undisclosed
Undisclosed
Undisclosed
AU2020291014A1 IC-41 [249]
undisclosed
Undisclosed
Undisclosed
AU2020291014A1 IC-42 [249]
undisclosed
Undisclosed
Undisclosed
AU2020291014A1 IC-43 [249]
undisclosed
Undisclosed
Undisclosed
AU2020291014A1 IC-44 [249]
undisclosed
Undisclosed
Undisclosed
AU2020291014A1 IC-45 [249]
undisclosed
Undisclosed
Undisclosed
AU2020291014A1 IC-50 [249]
undisclosed
Undisclosed
Undisclosed
AU2020291014A1 IC-52 [249]
undisclosed
Undisclosed
Undisclosed
AU2020291014A1 IC-53 [249]
undisclosed
Undisclosed
Undisclosed
AU2020291014A1 IC-54 [249]
undisclosed
Undisclosed
Undisclosed
AU2020291014A1 IC-55 [249]
undisclosed
Undisclosed
Undisclosed
AU2020291014A1 IC-56 [249]
undisclosed
Undisclosed
Undisclosed
AU2020291014A1 IC-59 [249]
undisclosed
Undisclosed
Undisclosed
AU2020291014A1 IC-60 [249]
undisclosed
Undisclosed
Undisclosed
AU2020291014A1 IC-61 [249]
undisclosed
Undisclosed
Undisclosed
AU2020291014A1 IC-62 [249]
AU2020291014A1-Payload-69
Undisclosed
Aminobenzazepine-linker Formula II-69
AU2020291014A1 IC-65 [249]
AU2020291014A1-Payload-70
Undisclosed
Aminobenzazepine-linker Formula II-69
AU2020291014A1 IC-66 [249]
AU2020291014A1-Payload-72
Undisclosed
Aminobenzazepine-linker Formula II-72
AU2020291014A1 IC-70 [249]
undisclosed
Undisclosed
Undisclosed
AU2020291014A1 IC-71 [249]
undisclosed
Undisclosed
Undisclosed
AU2020291014A1 IC-74 [249]
undisclosed
Undisclosed
Undisclosed
AU2020291014A1 IC-75 [249]
AU2020291014A1-Payload-74
Undisclosed
Undisclosed
AU2020291014A1 IC-76 [249]
AU2020291014A1-Payload-77
Undisclosed
Aminobenzazepine-linker Formula II-72
AU2020291014A1 IC-77 [249]
AU2020291014A1-Payload-35
Undisclosed
Aminobenzazepine-linker Formula II-75
AU2020291014A1 IC-78 [249]
AU2020291014A1-Payload-78
Undisclosed
Aminobenzazepine-linker Formula II-69
AU2020291014A1 IC-79 [249]
AU2020291014A1-Payload-70
Undisclosed
Aminobenzazepine-linker Formula II-75
AU2020291014A1 IC-86 [249]
AU2020291014A1-Payload-80
Undisclosed
Aminobenzazepine-linker Formula II-80
AU2020291014A1 IC-87 [249]
AU2020291014A1-Payload-82
Undisclosed
Aminobenzazepine-linker Formula II-82
AU2020291014A1 IC-90 [249]
undisclosed
Undisclosed
Undisclosed
AU2020291014A1 IC-91 [249]
AU2020291014A1-Payload-85
Undisclosed
Aminobenzazepine-linker Formula II-75
AU2020291014A1 IC-92 [249]
AU2020291014A1-Payload-69
Undisclosed
Aminobenzazepine-linker Formula II-69
Tra-25-4 [250]
PBX-7014
DNA topoisomerase I (TOP1)
Mc-Gly-Gly-Phe-Gly
Tra-25-6 [250]
PBX-7016
DNA topoisomerase I (TOP1)
Mc-Gly-Gly-Phe-Gly
EP4494656A1 DM-II [252]
DM-II Payload
Undisclosed
DM-II Linker
EP4494656A1 DM-III [252]
DM-III Payload
Undisclosed
DM-III Linker
EP4494656A1 DM-IV [252]
undisclosed
Undisclosed
Undisclosed
EP4494656A1 DM-V [252]
undisclosed
Undisclosed
Undisclosed
DS-24 [253]
DS-24 Payload
Undisclosed
DS-24 Linker
DS-26 [253]
DS-24 Payload
Undisclosed
DS-26 Linker
WO2019126691A1 Conjugate No.5 [254]
Conjugate No.5 Payload
Undisclosed
Conjugate No.5 Linker
WO2019126691A1 Conjugate No.10 [254]
Conjugate No.10 Payload
Undisclosed
Conjugate No.5 Linker
WO2019126691A1 Conjugate No.20 [254]
Conjugate No.20 Payload
Undisclosed
Conjugate No.20 Linker
WO2019126691A1 Conjugate No.26 [254]
Conjugate No.26 Payload
Undisclosed
Conjugate No.26 Linker
WO2019126691A1 Conjugate No.31 [254]
Conjugate No.31 Payload
Undisclosed
Conjugate No.20 Linker
WO2019126691A1 Conjugate No.36 [254]
Conjugate No.26 Payload
Undisclosed
Conjugate No.36 Linker
WO2019126691A1 Conjugate No.38 [254]
Conjugate No.26 Payload
Undisclosed
Conjugate No.38 Linker
WO2019126691A1 Conjugate No.46 [254]
Conjugate No.46 Payload
Undisclosed
Conjugate No.46 Linker
WO2019126691A1 Conjugate No.57 [254]
Conjugate No.57 Payload
Undisclosed
Conjugate No.57 Linker
WO2019126691A1 Conjugate No.60 [254]
Conjugate No.60 Payload
Undisclosed
Conjugate No.5 Linker
WO2019126691A1 Conjugate No.67 [254]
Conjugate No.67 Payload
Undisclosed
Conjugate No.67 Linker
WO2019126691A1 Conjugate No.71 [254]
Conjugate No.57 Payload
Undisclosed
Conjugate No.71 Linker
WO2019126691A1 Conjugate No.73 [254]
Conjugate No.67 Payload
Undisclosed
Conjugate No.73 Linker
WO2019126691A1 Conjugate No.79 [254]
Conjugate No.57 Payload
Undisclosed
Conjugate No.79 Linker
WO2019126691A1 Conjugate No.86 [254]
Conjugate No.67 Payload
Undisclosed
DL18 linker
WO2019126691A1 Conjugate No.94 [254]
Conjugate No.94 Payload
Undisclosed
Conjugate No.94 Linker
WO2019126691A1 Conjugate No.105 [254]
Conjugate No.105 Payload
Undisclosed
Conjugate No.105 Linker
WO2019126691A1 Conjugate No.112 [254]
Conjugate No.112 Payload
Undisclosed
Conjugate No.112 Linker
WO2019126691A1 Conjugate No.115 [254]
Conjugate No.112 Payload
Undisclosed
Conjugate No.115 Linker
WO2019126691A1 Conjugate No.119 [254]
Conjugate No.94 Payload
Undisclosed
Conjugate No.119 Linker
WO2019126691A1 Conjugate No.122 [254]
Conjugate No.94 Payload
Undisclosed
Conjugate No.122 Linker
WO2019126691A1 Conjugate No.130 [254]
Conjugate No.130 Payload
Undisclosed
Conjugate No.105 Linker
WO2019126691A1 Conjugate No.137 [254]
Conjugate No.137 Payload
Undisclosed
Conjugate No.105 Linker
CN115429893A ADC1 [255]
CN115429893A ADC1 Payload
Undisclosed
CB07 linker
CN115429893A ADC2 [255]
CN115429893A ADC2 Payload
Undisclosed
CB07 linker
CN115429893A ADC3 [255]
CN115429893A ADC3 Payload
Undisclosed
Mc-Gly-Gly-Phe-Gly
Trastuzumab-C-7 [256]
Undisclosed
Undisclosed
KR1020250002133A Trastuzumab-C-7 Linker
Trastuzumab-C-8 [256]
KR1020250002133A Trastuzumab-C-8 Payload
Undisclosed
KR1020250002133A Trastuzumab-C-8 Linker
Trastuzumab-C-9 [256]
Undisclosed
Undisclosed
KR1020250002133A Trastuzumab-C-9 Linker
Trastuzumab-C-10 [256]
undisclosed
Undisclosed
KR1020250002133A Trastuzumab-C-10 Linker
Trastuzumab-C-11 [256]
undisclosed
Undisclosed
KR1020250002133A Trastuzumab-C-11 Linker
Trastuzumab-C-15 [256]
undisclosed
Undisclosed
KR1020250002133A Trastuzumab-C-15 Linker
Trastuzumab-C-16 [256]
undisclosed
Undisclosed
KR1020250002133A Trastuzumab-C-16 Linker
Trastuzumab-C-17 [256]
undisclosed
Undisclosed
KR1020250002133A Trastuzumab-C-117 Linker
Trastuzumab-C-20 [256]
undisclosed
Undisclosed
KR1020250002133A Trastuzumab-C-20 Linker
Trastuzumab-C-21 [256]
undisclosed
Undisclosed
KR1020250002133A Trastuzumab-C-21 Linker
Trastuzumab-C-22 [256]
WO2023221971A1 NEC49-4 Payload
Undisclosed
KR1020250002133A Trastuzumab-C-22 Linker
HK40112172A Antibody-drug conjugate (2) [257]
HK40112172A+Antibody-drug conjugate (2)+payload
Undisclosed
HK40112172A+Antibody-drug conjugate (2)+Linker
HK40112172A Antibody-drug conjugate (3) [257]
HK40112172A+Antibody-drug conjugate (3)+payload
Undisclosed
Mc-Gly-Gly-Phe-Gly
HK40112172A Antibody-drug conjugate (4) [257]
HK40112172A+Antibody-drug conjugate (4)+payload
Undisclosed
HK40112172A+Antibody-drug conjugate (4)+Linker
HK40112172A Antibody-drug conjugate (5) [257]
LT4212552T ADC10 payload
DNA topoisomerase I (TOP1)
HK40112172A+Antibody-drug conjugate (4)+Linker
HK40112172A Antibody-drug conjugate (6) [257]
LT4212552T ADC10 payload
DNA topoisomerase I (TOP1)
HK40112172A+Antibody-drug conjugate (6)+Linker
HK40112172A Antibody-drug conjugate (7) [257]
LT4212552T ADC10 payload
DNA topoisomerase I (TOP1)
HK40112172A+Antibody-drug conjugate (7)+Linker
HK40112172A Antibody-drug conjugate (8) [257]
LT4212552T ADC10 payload
DNA topoisomerase I (TOP1)
HK40112172A+Antibody-drug conjugate (7)+Linker
HK40112172A Antibody-drug conjugate (9) [257]
LT4212552T ADC10 payload
DNA topoisomerase I (TOP1)
HK40112172A+Antibody-drug conjugate (7)+Linker
HK40112172A Antibody-drug conjugate (10) [257]
LT4212552T ADC10 payload
DNA topoisomerase I (TOP1)
HK40112172A+Antibody-drug conjugate (7)+Linker
HK40112172A Antibody-drug conjugate (12) [257]
LT4212552T ADC13 payload
DNA topoisomerase I (TOP1)
Mc-Gly-Gly-Phe-Gly
HK40112172A Antibody-drug conjugate (13) [257]
LT4212552T ADC13 payload
DNA topoisomerase I (TOP1)
Mc-Gly-Gly-Phe-Gly
HK40112172A Antibody-drug conjugate (15) [257]
LT4212552T ADC13 payload
DNA topoisomerase I (TOP1)
Mc-Gly-Gly-Phe-Gly
HK40112172A Antibody-drug conjugate (16) [257]
LT4212552T ADC13 payload
DNA topoisomerase I (TOP1)
Mc-Gly-Gly-Phe-Gly
HK40112172A Antibody-drug conjugate (17) [257]
HK40112172A+Antibody-drug conjugate (17)+payload
Undisclosed
HK40112172A+Antibody-drug conjugate (17)+Linker
HK40112172A Antibody-drug conjugate (18) [257]
HK40112172A+Antibody-drug conjugate (17)+payload
Undisclosed
HK40112172A+Antibody-drug conjugate (17)+Linker
HK40112172A Antibody-drug conjugate (19) [257]
HK40112172A+Antibody-drug conjugate (17)+payload
Undisclosed
HK40112172A+Antibody-drug conjugate (17)+Linker
HK40112172A Antibody-drug conjugate (20) [257]
HK40112172A+Antibody-drug conjugate (17)+payload
Undisclosed
HK40112172A+Antibody-drug conjugate (17)+Linker
HK40112172A Antibody-drug conjugate (21) [257]
LT4212552T ADC10 payload
DNA topoisomerase I (TOP1)
HK40112172A+Antibody-drug conjugate (7)+Linker
HK40112172A Antibody-drug conjugate (22) [257]
LT4212552T ADC10 payload
DNA topoisomerase I (TOP1)
HK40112172A+Antibody-drug conjugate (7)+Linker
HK40112172A Antibody-drug conjugate (24) [257]
LT4212552T ADC25 payload
DNA topoisomerase I (TOP1)
Mc-Gly-Gly-Phe-Gly
HK40112172A Antibody-drug conjugate (25) [257]
LT4212552T ADC25 payload
DNA topoisomerase I (TOP1)
Mc-Gly-Gly-Phe-Gly
HK40112172A Antibody-drug conjugate (26) [257]
LT4212552T ADC49 payload
DNA topoisomerase I (TOP1)
Mc-Gly-Gly-Phe-Gly
HK40112172A Antibody-drug conjugate (27) [257]
LT4212552T ADC49 payload
DNA topoisomerase I (TOP1)
Mc-Gly-Gly-Phe-Gly
HK40112172A Antibody-drug conjugate (28) [257]
LT4212552T ADC49 payload
DNA topoisomerase I (TOP1)
Mc-Gly-Gly-Phe-Gly
HK40112172A Antibody-drug conjugate (29) [257]
LT4212552T ADC49 payload
DNA topoisomerase I (TOP1)
Mc-Gly-Gly-Phe-Gly
HK40112172A Antibody-drug conjugate (30) [257]
LT4212552T ADC49 payload
DNA topoisomerase I (TOP1)
Mc-Gly-Gly-Phe-Gly
HK40112172A Antibody-drug conjugate (31) [257]
LT4212552T ADC49 payload
DNA topoisomerase I (TOP1)
Mc-Gly-Gly-Phe-Gly
HK40112172A Antibody-drug conjugate (36) [257]
LT4212552T ADC49 payload
DNA topoisomerase I (TOP1)
SCHEMBL17022441
HK40112172A Antibody-drug conjugate (37) [257]
LT4212552T ADC37 payload
DNA topoisomerase I (TOP1)
SCHEMBL17022441
HK40112172A Antibody-drug conjugate (39) [257]
HK40112172A+Antibody-drug conjugate (39)+payload
Undisclosed
HK40112172A+Antibody-drug conjugate (39)+Linker
HK40112172A Antibody-drug conjugate (40) [257]
HK40112172A+Antibody-drug conjugate (39)+payload
Undisclosed
HK40112172A+Antibody-drug conjugate (39)+Linker
HK40112172A Antibody-drug conjugate (41) [257]
Topo1 inhibitor B
DNA topoisomerase I (TOP1)
Mc-Gly-Gly-Phe-Gly
HK40112172A Antibody-drug conjugate (42) [257]
Topo1 inhibitor B
DNA topoisomerase I (TOP1)
Mc-Gly-Gly-Phe-Gly
HK40112172A Antibody-drug conjugate (43) [257]
LT4212552T ADC49 payload
DNA topoisomerase I (TOP1)
HK40112172A+Antibody-drug conjugate (43)+Linker
HK40112172A Antibody-drug conjugate (44) [257]
LT4212552T ADC49 payload
DNA topoisomerase I (TOP1)
HK40112172A+Antibody-drug conjugate (44)+Linker
HK40112172A Antibody-drug conjugate (46) [257]
LT4212552T ADC49 payload
DNA topoisomerase I (TOP1)
Mc-Gly-Gly-Phe-Gly
HK40112172A Antibody-drug conjugate (47) [257]
LT4212552T ADC49 payload
DNA topoisomerase I (TOP1)
Mc-Gly-Gly-Phe-Gly
HK40112172A Antibody-drug conjugate (48) [257]
LT4212552T ADC49 payload
DNA topoisomerase I (TOP1)
Mc-Gly-Gly-Phe-Gly
HK40112172A Antibody-drug conjugate (49) [257]
LT4212552T ADC49 payload
DNA topoisomerase I (TOP1)
Mc-Gly-Gly-Phe-Gly
HK40112172A Antibody-drug conjugate (50) [257]
Undisclosed
Undisclosed
Undisclosed
US20250018051A1 IaⅠ [258]
US20250018038A1+IaⅠ+payload
Undisclosed
Mc-Val-Cit-PABC
US20250018051A1 IaⅡ [258]
US20250018038A1+IaⅠ+payload
Undisclosed
TW202436324A+ADC-2+Linker
US20250018051A1 IaⅢ [258]
US20250018038A1+IaⅢ+payload
Undisclosed
Mc-Val-Cit-PABC
US20250018051A1 IaⅣ [258]
US20250018038A1+IaⅣ+payload
Undisclosed
Mc-Val-Ala-PABC
US20250018051A1 IaⅥ [258]
US20250018038A1+IaⅥ+payload
Undisclosed
Mc-Val-Cit-PABC
US20250018051A1 IaⅦ [258]
US20250018038A1+IaⅥ+payload
Undisclosed
Mc-Val-Ala-PABC
US20250018051A1 IaⅦ [258]
US20250018038A1+IaⅦ+payload
Undisclosed
Mc-Val-Cit-PABC
US20250018051A1 IaⅧ [258]
US20250018038A1+IaⅦ+payload
Undisclosed
TW202436324A+ADC-2+Linker
US20250018051A1 IaⅩ [258]
US20250018038A1+IaⅢ+payload
Undisclosed
Mc-Val-Cit-PABC
US20250018051A1 Iaⅰ [258]
US20250018038A1+IaⅣ+payload
Undisclosed
Mc-Val-Ala-PABC
US20250018051A1 IaⅰⅠ [258]
US20250018038A1+IaⅥ+payload
Undisclosed
Mc-Val-Cit-PABC
US20250018051A1 IaⅰⅡ [258]
US20250018038A1+IaⅦ+payload
Undisclosed
Mc-Val-Ala-PABC
US20250018051A1 IaⅰⅢ [258]
US20250018038A1+IaⅣ+payload
Undisclosed
Mc-Val-Cit-PABC
US20250018051A1 IaⅰⅣ [258]
US20250018038A1+IaⅰⅣ+payload
Undisclosed
Mc-Val-Ala-PABC
US20250018051A1 IaⅰⅥ [258]
US20250018038A1+IaⅣ+payload
Undisclosed
Mc-Val-Cit-PABC
US20250018051A1 IaⅰⅦ [258]
US20250018038A1+IaⅣ+payload
Undisclosed
Mc-Val-Ala-PABC
US11903948B2 I-1 [259]
Dolicatatin 5
Microtubule (MT)
Undisclosed
US11903948B2 I-2 [259]
Undisclosed
Undisclosed
Undisclosed
US11903948B2 I-3 [259]
Undisclosed
Undisclosed
Undisclosed
HER-E-36 [260]
WO2024020536A1+HER-E-36+payload
Undisclosed
WO2024020536A1+HER-E-36+Linker
HER-E-37 [260]
WO2024020536A1+HER-E-37+payload
Undisclosed
Mc-Gly-Gly-Phe-Gly
HER-E-39 [260]
WO2024020536A1+HER-E-37+payload
Undisclosed
Mc-Gly-Gly-Phe-Gly
HER-E-40 [260]
WO2024020536A1+HER-E-37+payload
Undisclosed
Mc-Gly-Gly-Phe-Gly
HER-E-44 [260]
WO2024020536A1+HER-E-44+payload
Undisclosed
WO2024020536A1+HER-E-44+Linker
HER-E-46 [260]
WO2024020536A1+HER-E-44+payload
Undisclosed
Mc-Gly-Gly-Phe-Gly
HER-E-48 [260]
WO2024020536A1+HER-E-48+payload
Undisclosed
WO2024020536A1+HER-E-48+Linker
HER-E-49 [260]
WO2024020536A1+HER-E-37+payload
Undisclosed
WO2024020536A1+HER-E-49+Linker
Trastuzumab-DXD (EP4183421A1) [261]
Exatecan
DNA topoisomerase 1 (TOP1)
EP4183421A1+Trastuzumab-DXD+Linker
Trastuzumab-DDDXD [261]
Exatecan
DNA topoisomerase 1 (TOP1)
EP4183421A1+Trastuzumab-DDDXD+Linker
JP2025004232A ADC9 [262]
undisclosed
Undisclosed
Undisclosed
EP4227309A4 ADC-1 [263]
undisclosed
Undisclosed
Undisclosed
EP4227309A4 ADC-2 [263]
undisclosed
Undisclosed
Undisclosed
EP4227309A4 ADC-3 [263]
undisclosed
Undisclosed
Undisclosed
EP4227309A4 ADC-4 [263]
undisclosed
Undisclosed
Undisclosed
EP4227309A4 ADC-5 [263]
undisclosed
Undisclosed
Undisclosed
EP4227309A4 ADC-6 [263]
undisclosed
Undisclosed
Undisclosed
EP4227309A4 ADC-7 [263]
undisclosed
Undisclosed
Undisclosed
EP4227309A4 ADC-8 [263]
undisclosed
Undisclosed
Undisclosed
EP4227309A4 ADC-9 [263]
undisclosed
Undisclosed
Undisclosed
EP4227309A4 ADC-10 [263]
undisclosed
Undisclosed
Undisclosed
EP4227309A4 ADC-11 [263]
undisclosed
Undisclosed
Undisclosed
EP4227309A4 ADC-12 [263]
undisclosed
Undisclosed
Undisclosed
EP4227309A4 ADC-13 [263]
undisclosed
Undisclosed
Undisclosed
EP4227309A4 ADC-14 [263]
undisclosed
Undisclosed
Undisclosed
EP4227309A4 ADC-15 [263]
undisclosed
Undisclosed
Undisclosed
EP4227309A4 ADC-16 [263]
undisclosed
Undisclosed
Undisclosed
EP4227309A4 ADC-17 [263]
undisclosed
Undisclosed
Undisclosed
EP4227309A4 ADC-18 [263]
undisclosed
Undisclosed
Undisclosed
US11850287B2 IIIa [265]
Undisclosed
Undisclosed
Undisclosed
US11850287B2 IIIb [265]
Undisclosed
Undisclosed
Undisclosed
US11850287B2 IIIc [265]
Undisclosed
Undisclosed
Undisclosed
US11850287B2 IIId [265]
Undisclosed
Undisclosed
Undisclosed
WO2023232144A1ADC-6 [15]
WO2023232144A1, ADC-2, Payload
DNA topoisomerase I (TOP1)
WO2023232144A1, ADC-2, linker
WO2023232144A1ADC22 [82]
WO2025015586A1, ADC22, Payload
DNA topoisomerase I (TOP1)
Mc-Val-Cit-PABC
WO2023232144A1ADC23 [82]
WO2025015586A1, ADC23, Payload
Toll-like receptor 7 (TLR7); Toll-like receptor 8 (TLR8)
Mc-Val-Cit-PABC
WO2023232144A1ADC24 [82]
WO2025015586A1, ADC24, Payload
Toll-like receptor 7 (TLR7); Toll-like receptor 8 (TLR8)
Mc-Val-Cit-PABC
WO2023232144A1ADC25 [82]
WO2025015586A1, ADC25, Payload
Toll-like receptor 7 (TLR7); Toll-like receptor 8 (TLR8)
Mc-Val-Cit-PABC
WO2023232144A1ADC30 [82]
WO2025015586A1, ADC25, Payload
Toll-like receptor 7 (TLR7); Toll-like receptor 8 (TLR8)
SMCC
WO2023232144A1ADC32 [82]
WO2025015586A1, ADC22, Payload
DNA topoisomerase I (TOP1)
SMCC
AU2023308528A1 ADC3 [266]
Exatecan
DNA topoisomerase 1 (TOP1)
Mal-amido-PEG8-acid
AU2023308528A1 ADC5 [266]
4- ((S)-2- ((S)-2-amino-3-methylbutanamido)propanamido)benzyl ((1S,9S)-9-ethyl-5-fluoro-9-hydroxy-4-methyl-10,13-dioxo-2,3,9,10,13,15-hexahydro-1H,12H-benzo[de]pyrano[3',4':6,7]indolizino[1,2-b]quinolin-1-yl)carbamate
DNA topoisomerase I (TOP1)
Mal-amido-PEG8-acid
AU2023308528A1 ADC1 [266]
PBD aromatic-amide derivative
DNA topoisomerase I (TOP1)
6-Maleimidocaproic acid
AU2023308528A1 ADC2 [266]
PBD-butanamide derivative
DNA topoisomerase I (TOP1)
6-Maleimidocaproic acid
AU2023308528A1 ADC7 [266]
N- (4- ((S)-2- ((S)-2-amino-3- methylbutanamido)propanamido)phenyl)-4- (4- (4- (4- (( (S)-2-methoxy-12-oxo-6a,7,8,9,10,12-hexahydrobenzo[e]pyrido[1,2-a][1,4]diazepin-3-yl)oxy)butanamido)-1-methyl-1H-pyrrole-2-carboxamido)phenyl)-1-methyl-1H-pyrrole-2-carboxamide
DNA topoisomerase I (TOP1)
(S)-75-oxo-76- (4- (3-tosyl-2- (tosylmethyl)propanoyl)benzamido) 2,5,8,11,14,17,20,23,26,29,32,35,38,41,44,47,50,53,56,59,62,65,68,71-tetracosaoxa-74 azanonaheptacontan-79-oic acid
AU2023308528A1 ADC2 (DAR of 4) [266]
PBD-butanamide derivative
DNA topoisomerase I (TOP1)
6-Maleimidocaproic acid
Trastuzumab-Compound 30 [266]
Exatecan
DNA topoisomerase 1 (TOP1)
Mal-amido-PEG8-acid
AU2023279443A1 Example 1 [267]
U-030; Ac-Exatecan
Undisclosed
AU2023279443A1, Example 1, Linker
AU2023279443A1 Example 2 [267]
U-031
Microtubule (MT)
AU2023279443A1, Example 3, Linker
AU2023279443A1 Example 3 [267]
U-030
DNA topoisomerase I (TOP1)
AU2023279443A1, Example 4, Linker
AU2023279443A1 Example 4 [267]
U-031
Microtubule (MT)
AU2023279443A1, Example 4, Linker
AU2023279443A1 Example 5 [267]
U-031
Microtubule (MT)
AU2023279443A1, Example 5, Linker
AU2023279443A1 Example 6 [267]
U-031; AU2023279443A1, Example 6, Paylaod
Undisclosed
AU2023279443A1, Example 4, Linker
AU2023279443A1 Example 7 [267]
U-031; U-033
Undisclosed
AU2023279443A1, Example 4, Linker
AU2023279443A1 Example A1 [267]
Monomethyl auristatin E
Microtubule (MT)
Undisclosed
AU2023279443A1 Example A2 [267]
U-030
DNA topoisomerase I (TOP1)
Undisclosed
AU2023279443A1 Example A3 [267]
U-031
Microtubule (MT)
AU2023279443A1, Example A3, Linker
AU2023279443A1 Example A4 [267]
U-003
Microtubule (MT)
Undisclosed
AU2023279443A1 Example A5 [267]
U-029
Microtubule (MT)
Undisclosed
AU2023279443A1 Example A6 [267]
Monomethyl auristatin E
Microtubule (MT)
AU2023279443A1, Example A6, Linker
AU2023279443A1 Example A7 [267]
Monomethyl auristatin E
Microtubule (MT)
AU2023279443A1, Example A7, Linker
AU2023279443A1 Example A8 [267]
Monomethyl auristatin E
Microtubule (MT)
RU20241285-9-linker
AU2023279443A1 Example A9 [267]
U-036
Microtubule (MT)
RU20241285-9-linker
AU2023279443A1 Example A10 [267]
Ac-Exatecan
DNA topoisomerase I (TOP1)
AU2023279443A1, Example A10, Linker
AU2023279443A1 Example A11 [267]
DX-8951 derivative (DXd)
DNA topoisomerase 1 (TOP1)
AU2023279443A1, Example A10, Linker
AU2023279443A1 Example A12 [267]
U-035
Microtubule (MT)
AU2023279443A1, Example A12, Linker
AU2023279443A1 Example A13 [267]
DX-8951 derivative (DXd)
DNA topoisomerase 1 (TOP1)
AU2023279443A1, Example A13, Linker
AU2023279443A1 Example A14 [267]
Eribulin
Microtubule (MT)
RU20241285-9-linker
AU2023279443A1Example A15 [267]
U-031
Microtubule (MT)
AU2023279443A1, Example A15, Linker
AU2023279443A1 Example A16 [267]
Eribulin
Microtubule (MT)
AU2023279443A1, Example A16, Linker
AU2023279443A1 Example A17 [267]
Eribulin
Microtubule (MT)
AU2023279443A1, Example A17, Linker
AU2023279443A1 Example A18 [267]
Eribulin
Microtubule (MT)
AU2023279443A1, Example A18, Linker
AU2023279443A1 Example A19 [267]
U-031
Microtubule (MT)
AU2023279443A1, Example A19, Linker
AU2023279443A1 Example A20 [267]
Topo1 inhibitor A
DNA topoisomerase I (TOP1)
AU2023279443A1, Example A12, Linker
AU2023279443A1 Example A21 [267]
Eribulin
Microtubule (MT)
AU2023279443A1, Example A21, Linker
AU2023279443A1 Example A22 [267]
Eribulin
Microtubule (MT)
AU2023279443A1, Example A22, Linker
AU2023279443A1 Example A23 [267]
RU20241285-23-payload
DNA topoisomerase I (TOP1)
AU2023279443A1, Example A10, Linker
AU2023279443A1 Example A24 [267]
RU20241285-23-payload
DNA topoisomerase I (TOP1)
AU2023279443A1, Example A24, Linker
AU2023279443A1 Comparative Control Compound-1 [267]
Monomethyl auristatin E
Microtubule (MT)
Mc-Val-Cit-PABC
AU2023279443A1 Comparative Control Compound-2 [267]
Eribulin
Microtubule (MT)
Mal-PEG2-Val-Cit-PAB
CN113943310A ADC-1 [268]
D-D9 payload
DNA topoisomerase I (TOP1)
CN113943310A, ADC-1, Linker
CN113943310A ADC-2 [268]
D-D10 payload
DNA topoisomerase I (TOP1)
CN113943310A, ADC-1, Linker
CN113943310A ADC-3 [268]
D-D3 payload
DNA topoisomerase I (TOP1)
CN113943310A, ADC-1, Linker
CN113943310A ADC-4 [268]
D-D4 payload
DNA topoisomerase I (TOP1)
CN113943310A, ADC-1, Linker
CN113943310A ADC-5 [268]
D-D5 payload
DNA topoisomerase I (TOP1)
CN113943310A, ADC-1, Linker
CN113943310A ADC-6 [268]
D-D6 payload
DNA topoisomerase I (TOP1)
CN113943310A, ADC-1, Linker
CN113943310A ADC-7 [268]
D-D11 payload
DNA topoisomerase I (TOP1)
CN113943310A, ADC-1, Linker
CN113943310A ADC-8 [268]
D-D12 payload
DNA topoisomerase I (TOP1)
CN113943310A, ADC-1, Linker
CN113943310A ADC-9 [268]
D-D14 payload
DNA topoisomerase I (TOP1)
CN113943310A, ADC-1, Linker
CN113943310A ADC-10 [268]
D-D1 payload
DNA topoisomerase I (TOP1)
CN113943310A, ADC-1, Linker
CN113943310A ADC-11 [268]
WO2025015586A1, ADC25, Payload
Toll-like receptor 7 (TLR7); Toll-like receptor 8 (TLR8)
Mc-Gly-Gly-Phe-Gly
CN113943310A ADC-12 [268]
WO2025015586A1, ADC25, Payload
Toll-like receptor 7 (TLR7); Toll-like receptor 8 (TLR8)
CN113943310A, ADC-12, Linker
CN113943310A ADC-13 [268]
WO2025015586A1, ADC23, Payload
Toll-like receptor 7 (TLR7); Toll-like receptor 8 (TLR8)
CN113943310A, ADC-12, Linker
CN113943310A ADC-14 [268]
compound 4
DNA topoisomerase I (TOP1)
CN113943310A, ADC-12, Linker
CN113943310A ADC-15 [268]
compound 5
DNA topoisomerase I (TOP1)
CN113943310A, ADC-12, Linker
CN113943310A ADC-16 [268]
WO2025015586A1, ADC24, Payload
Toll-like receptor 7 (TLR7); Toll-like receptor 8 (TLR8)
CN113943310A, ADC-12, Linker
CN113943310A ADC-17 [268]
WO2025015586A1, ADC35, Payload
Toll-like receptor 7 (TLR7); Toll-like receptor 8 (TLR8)
CN113943310A, ADC-12, Linker
CN113943310A ADC-18 [268]
WO2025015586A1, ADC34, Payload
Toll-like receptor 7 (TLR7); Toll-like receptor 8 (TLR8)
CN113943310A, ADC-12, Linker
H2-921 [269]
SB743921
Kinesin spindle protein (KSP)
CN118987256A, H2-921, Linker
CN106714844B ADC-141 [3]
Mertansine DM1
Microtubule (MT)
Succinimidyl-4- (N-maleimidomethyl)cyclohexane-1-carboxylate (SMCC)
Tras-1 [270]
US11141490B2-Tras-1-payload
Undisclosed
US11141490B2-Tras-1-linker
Tras-4 [270]
US11141490B2-Tras-4-payload
Undisclosed
Ethylmaleimide linker
CN110974975B C-01 [271]
Exatecan
DNA topoisomerase 1 (TOP1)
Coumpound7
CN110974975B C-06 [271]
Exatecan
DNA topoisomerase 1 (TOP1)
Coumpound15
CN110974975B C-07 [271]
Active metabolite of irinotecan SN38
DNA topoisomerase 1 (TOP1)
Coumpound17
CN110974975B C-00 [271]
Monomethyl auristatin E
Microtubule (MT)
CN110974975B-C-00-linker
CN116888123A ADC-1 [272]
D2 payload
Undisclosed
Mc-Gly-Gly-Phe-Gly
CN116888123A ADC-2 [272]
D2 payload
Undisclosed
LA2 linker
CN116888123A ADC-3 [272]
D2 payload
Undisclosed
LA2 linker
CN116888123A ADC-4 [272]
D3 payload
Undisclosed
Mc-Gly-Gly-Phe-Gly
CN116888123A ADC-5 [272]
D1 payload
Undisclosed
B1-b linker
CN116888123A ADC-6 [272]
D1-SH payload
Undisclosed
LC1 linker
CN116888123A ADC-7 [272]
D2 payload
Undisclosed
LD1 linker
BCN-linker-Dxd1 [273]
DX-8951 derivative (DXd)
DNA topoisomerase 1 (TOP1)
BCN-linker
BCN-linker-Dxd2 [273]
DX-8951 derivative (DXd)
DNA topoisomerase 1 (TOP1)
BCN-linker
BCN-linker-Dxd3 [273]
DX-8951 derivative (DXd)
DNA topoisomerase 1 (TOP1)
BCN-linker
BCN-linker-Dxd4 [273]
DX-8951 derivative (DXd)
DNA topoisomerase 1 (TOP1)
BCN-linker
SMCC-calicheamicin-ADC [274]
Calicheamicin
Undisclosed
Succinimidyl-4- (N-maleimidomethyl)cyclohexane-1-carboxylate (SMCC)
SMPB-calicheamicin-ADC [274]
Calicheamicin
Undisclosed
Undisclosed
AU2016292759A1 ADC-1 [275]
AU2016292759A1-ADC-1-payload
Undisclosed
AU2016292759A1-ADC-1-linker
TrastuzumabA132TCO*A [276]
Undisclosed
Undisclosed
CN118574641A-TrastuzumabA132TCO*A-linker
Trastuzumab-TCO*A-5 [276]
Undisclosed
Undisclosed
CN118574641A-Trastuzumab-TCO*A-5-linker
Trastuzumab-TCO*A-11 [276]
Undisclosed
Undisclosed
CN118574641A-Trastuzumab-TCO*A-11-linker
US20240148889A1 ADC-1 [277]
US20240148889A1-ADC-1-payload
Undisclosed
US20240148889A1-ADC-1-linker
TWI870307BAntibody-drug conjugate (2) [278]
LT4212552T ADC10 payload
DNA topoisomerase I (TOP1)
Mc-Gly-Gly-Phe-Gly
TWI870307BAntibody-drug conjugate (3) [278]
LT4212552T ADC10 payload
DNA topoisomerase I (TOP1)
Mc-Gly-Gly-Phe-Gly
TWI870307BAntibody-drug conjugate (4) [278]
LT4212552T ADC10 payload
DNA topoisomerase I (TOP1)
TWI870307BAntibody-drug conjugate (4)Linker
TWI870307BAntibody-drug conjugate (5) [278]
LT4212552T ADC10 payload
DNA topoisomerase I (TOP1)
TWI870307BAntibody-drug conjugate (4)Linker
TWI870307BAntibody-drug conjugate (6) [278]
LT4212552T ADC10 payload
DNA topoisomerase I (TOP1)
TWI870307BAntibody-drug conjugate (6)Linker
TWI870307BAntibody-drug conjugate (7) [278]
LT4212552T ADC10 payload
DNA topoisomerase I (TOP1)
TWI870307BAntibody-drug conjugate (6)Linker
TWI870307BAntibody-drug conjugate (8) [278]
LT4212552T ADC10 payload
DNA topoisomerase I (TOP1)
TWI870307BAntibody-drug conjugate (6)Linker
TWI870307BAntibody-drug conjugate (9) [278]
LT4212552T ADC10 payload
DNA topoisomerase I (TOP1)
TWI870307BAntibody-drug conjugate (9)Linker
TWI870307BAntibody-drug conjugate (10) [278]
LT4212552T ADC10 payload
DNA topoisomerase I (TOP1)
TWI870307BAntibody-drug conjugate (9)Linker
TWI870307BAntibody-drug conjugate (12) [278]
TWI870307BAntibody-drug conjugate (12)Payload
Undisclosed
Mc-Gly-Gly-Phe-Gly
TWI870307BAntibody-drug conjugate (13) [278]
TWI870307BAntibody-drug conjugate (12)Payload
Undisclosed
Mc-Gly-Gly-Phe-Gly
TWI870307BAntibody-drug conjugate (15) [278]
TWI870307BAntibody-drug conjugate (12)Payload
Undisclosed
Mc-Gly-Gly-Phe-Gly
TWI870307BAntibody-drug conjugate (16) [278]
TWI870307BAntibody-drug conjugate (12)Payload
Undisclosed
Mc-Gly-Gly-Phe-Gly
TWI870307BAntibody-drug conjugate (17) [278]
TWI870307BAntibody-drug conjugate (12)Payload
Undisclosed
LT4212552T-ADC-5-LINKER
TWI870307BAntibody-drug conjugate (18) [278]
TWI870307BAntibody-drug conjugate (12)Payload
Undisclosed
LT4212552T-ADC-5-LINKER
TWI870307BAntibody-drug conjugate (19) [278]
TWI870307BAntibody-drug conjugate (12)Payload
Undisclosed
HK40112172A+Antibody-drug conjugate (19)+Linker
TWI870307BAntibody-drug conjugate (20) [278]
TWI870307BAntibody-drug conjugate (12)Payload
Undisclosed
HK40112172A+Antibody-drug conjugate (19)+Linker
TWI870307BAntibody-drug conjugate (21) [278]
TWI870307BAntibody-drug conjugate (12)Payload
Undisclosed
TWI870307BAntibody-drug conjugate (21)Linker
TWI870307BAntibody-drug conjugate (22) [278]
TWI870307BAntibody-drug conjugate (12)Payload
Undisclosed
TWI870307BAntibody-drug conjugate (21)Linker
TWI870307BAntibody-drug conjugate (24) [278]
LT4212552T ADC25 payload
DNA topoisomerase I (TOP1)
Mc-Gly-Gly-Phe-Gly
TWI870307BAntibody-drug conjugate (25) [278]
LT4212552T ADC25 payload
DNA topoisomerase I (TOP1)
Mc-Gly-Gly-Phe-Gly
TWI870307BAntibody-drug conjugate (26) [278]
TWI870307BAntibody-drug conjugate (26)Payload
Undisclosed
TWI870307BAntibody-drug conjugate (26)Linker
TWI870307BAntibody-drug conjugate (27) [278]
TWI870307BAntibody-drug conjugate (26)Payload
Undisclosed
TWI870307BAntibody-drug conjugate (26)Linker
TWI870307BAntibody-drug conjugate (28) [278]
TWI870307BAntibody-drug conjugate (26)Payload
Undisclosed
TWI870307BAntibody-drug conjugate (26)Linker
TWI870307BAntibody-drug conjugate (29) [278]
TWI870307BAntibody-drug conjugate (26)Payload
Undisclosed
TWI870307BAntibody-drug conjugate (26)Linker
TWI870307BAntibody-drug conjugate (30) [278]
TWI870307BAntibody-drug conjugate (26)Payload
Undisclosed
TWI870307BAntibody-drug conjugate (26)Linker
TWI870307BAntibody-drug conjugate (31) [278]
TWI870307BAntibody-drug conjugate (26)Payload
Undisclosed
TWI870307BAntibody-drug conjugate (26)Linker
TWI870307BAntibody-drug conjugate (36) [278]
LT4212552T ADC37 payload
DNA topoisomerase I (TOP1)
TWI870307BAntibody-drug conjugate (36)Linker
TWI870307BAntibody-drug conjugate (37) [278]
LT4212552T ADC37 payload
DNA topoisomerase I (TOP1)
TWI870307BAntibody-drug conjugate (36)Linker
TWI870307BAntibody-drug conjugate (39) [278]
TWI870307BAntibody-drug conjugate (39)Payload
Undisclosed
TWI870307BAntibody-drug conjugate (39)Linker
TWI870307BAntibody-drug conjugate (40) [278]
TWI870307BAntibody-drug conjugate (39)Payload
Undisclosed
TWI870307BAntibody-drug conjugate (39)Linker
TWI870307BAntibody-drug conjugate (41) [278]
Topo1 inhibitor B
DNA topoisomerase I (TOP1)
Mc-Gly-Gly-Phe-Gly
TWI870307BAntibody-drug conjugate (42) [278]
Topo1 inhibitor B
DNA topoisomerase I (TOP1)
Mc-Gly-Gly-Phe-Gly
TWI870307BAntibody-drug conjugate (43) [278]
LT4212552T ADC49 payload
DNA topoisomerase I (TOP1)
TWI870307BAntibody-drug conjugate (6)Linker
TWI870307BAntibody-drug conjugate (44) [278]
TWI870307BAntibody-drug conjugate (44)Payload
Undisclosed
TWI870307BAntibody-drug conjugate (44)Linker
TWI870307BAntibody-drug conjugate (46) [278]
Undisclosed
Undisclosed
Mc-Gly-Gly-Phe-Gly
TWI870307BAntibody-drug conjugate (47) [278]
Undisclosed
Undisclosed
Mc-Gly-Gly-Phe-Gly
TWI870307BAntibody-drug conjugate (48) [278]
Undisclosed
Undisclosed
Mc-Gly-Gly-Phe-Gly
TWI870307BAntibody-drug conjugate (49) [278]
Undisclosed
Undisclosed
Mc-Gly-Gly-Phe-Gly
TWI870307BAntibody-drug conjugate (50) [278]
Undisclosed
Undisclosed
Mc-Gly-Gly-Phe-Gly
KR102754055B1 ADCProductionexampleNo.1 [92]
ADCProductionexampleNo.1Payload
Undisclosed
Mc-Val-Cit-PABC
KR102754055B1 ADCProductionexampleNo.2 [92]
ADCProductionexampleNo.2Payload
Undisclosed
ADCProductionexampleNo.2Linker
KR102754055B1 ADCProductionexampleNo.3a [92]
ADCProductionexampleNo.3aPayload
Undisclosed
ADCProductionexampleNo.3aLinker
KR102754055B1 ADCProductionexampleNo.3b [92]
ADCProductionexampleNo.3bPayload
Undisclosed
ADCProductionexampleNo.3aLinker
KR102754055B1 ADCProductionexampleNo.3c [92]
ADCProductionexampleNo.3cPayload
Undisclosed
ADCProductionexampleNo.3aLinker
KR102754055B1 ADCProductionexampleNo.4 [92]
ADCProductionexampleNo.4Payload
Undisclosed
ADCProductionexampleNo.4Linker
KR102754055B1 ADCProductionexampleNo.5 [92]
ADCProductionexampleNo.5Payload
Undisclosed
RU20241285-4-linker
KR102754055B1 ADCProductionexampleNo.6 [92]
ADCProductionexampleNo.6Payload
Undisclosed
ADCProductionexampleNo.6Linker
KR102754055B1 ADCProductionexampleNo.7 [92]
ADCProductionexampleNo.7Payload
Undisclosed
ADCProductionexampleNo.7Linker
KR102754055B1 ADCProductionexampleNo.8 [92]
ADCProductionexampleNo.8Payload
Undisclosed
ADCProductionexampleNo.8Linker
KR102754055B1 ADCProductionexampleNo.9 [92]
ADCProductionexampleNo.9Payload
Undisclosed
ADCProductionexampleNo.9Linker
KR102754055B1 ADCProductionexampleNo.10 [92]
ADCProductionexampleNo.10Payload
Undisclosed
ADCProductionexampleNo.10Linker
KR102754055B1 ADCProductionexampleNo.11 [92]
ADCProductionexampleNo.11Payload
Undisclosed
ADCProductionexampleNo.11Linker
KR102754055B1 ADCProductionexampleNo.12 [92]
ADCProductionexampleNo.12Payload
Undisclosed
ADCProductionexampleNo.8Linker
KR102754055B1 ADCProductionexampleNo.13 [92]
ADCProductionexampleNo.13Payload
Undisclosed
ADCProductionexampleNo.13Linker
KR102754055B1 ADCProductionexampleNo.14 [92]
Undisclosed
Undisclosed
ADCProductionexampleNo.15Linker
KR102754055B1 ADCProductionexampleNo.15 [92]
ADCProductionexampleNo.15Payload
Undisclosed
ADCProductionexampleNo.15Linker
KR102754055B1 ADCProductionexampleNo.16 [92]
ADCProductionexampleNo.16Payload
Undisclosed
ADCProductionexampleNo.16Linker
KR102754055B1 ADCProductionexampleNo.17 [92]
ADCProductionexampleNo.17Payload
Undisclosed
ADCProductionexampleNo.17Linker
KR102754055B1 ADCProductionexampleNo.18 [92]
ADCProductionexampleNo.18Payload
Undisclosed
ADCProductionexampleNo.18Linker
KR102754055B1 ADCProductionexampleNo.19 [92]
ADCProductionexampleNo.19Payload
Undisclosed
ADCProductionexampleNo.19Linker
KR102754055B1 ADCProductionexampleNo.20 [92]
ADCProductionexampleNo.20Payload
Undisclosed
ADCProductionexampleNo.20Linker
KR102754055B1 ADCProductionexampleNo.21 [92]
ADCProductionexampleNo.20Payload
Undisclosed
ADCProductionexampleNo.20Linker
KR102754055B1 ADCProductionexampleNo.22 [92]
ADCProductionexampleNo.20Payload
Undisclosed
ADCProductionexampleNo.20Linker
KR102754055B1 ADCProductionexampleNo.23 [92]
Undisclosed
Undisclosed
Undisclosed
KR102754055B1 ADCProductionexampleNo.24 [92]
Undisclosed
Undisclosed
Undisclosed
CH-2-589 [92]
Undisclosed
Undisclosed
Undisclosed
CH-2-593 [279]
Undisclosed
Undisclosed
Undisclosed
CH-2-518 [279]
Undisclosed
Undisclosed
Undisclosed
LC302-2-1 [279]
Undisclosed
Undisclosed
Undisclosed
LC302-2-4 (4) 3.41 [279]
Undisclosed
Undisclosed
Undisclosed
IN202417100055A Reference Example A1 [280]
Undisclosed
Undisclosed
Undisclosed
IN202417100055A Reference Example A2 [280]
Undisclosed
Undisclosed
Undisclosed
IN202417100055A Reference Example A3 [280]
Undisclosed
Undisclosed
Undisclosed
IN202417100055A Reference Example A3b [280]
Undisclosed
Undisclosed
Undisclosed
IN202417100055A Reference Example A3c [280]
Undisclosed
Undisclosed
Undisclosed
IN202417100055A Reference Example A4 [280]
Undisclosed
Undisclosed
Undisclosed
IN202417100055A Reference Example A5 [280]
Undisclosed
Undisclosed
Undisclosed
IN202417100055A Reference Example A6 [280]
Undisclosed
Undisclosed
Undisclosed
IN202417100055A Reference Example A7 [280]
Undisclosed
Undisclosed
Undisclosed
IN202417100055A Reference Example A8 [280]
Undisclosed
Undisclosed
Undisclosed
IN202417100055A Reference Example A9 [280]
Undisclosed
Undisclosed
Undisclosed
IN202417100055A Reference Example A10 [280]
Undisclosed
Undisclosed
Undisclosed
IN202417100055A Reference Example A11 [280]
Undisclosed
Undisclosed
Undisclosed
IN202417100055A Reference Example A12 [280]
Undisclosed
Undisclosed
Undisclosed
IN202417100055A Reference Example A13 [280]
Undisclosed
Undisclosed
Undisclosed
IN202417100055A Reference Example A14 [280]
Undisclosed
Undisclosed
Undisclosed
IN202417100055A Reference Example A15 [280]
Undisclosed
Undisclosed
Undisclosed
IN202417100055A Reference Example A16 [280]
Undisclosed
Undisclosed
Undisclosed
IN202417100055A Reference Example A17 [280]
Undisclosed
Undisclosed
Undisclosed
IN202417100055A Reference Example A18 [280]
Undisclosed
Undisclosed
Undisclosed
IN202417100055A Reference Example A19 [280]
Undisclosed
Undisclosed
Undisclosed
IN202417100055A Reference Example A20 [280]
Undisclosed
Undisclosed
Undisclosed
IN202417100055A Reference Example A21 [280]
Undisclosed
Undisclosed
Undisclosed
IN202417100055A Reference Example A22 [280]
Undisclosed
Undisclosed
Undisclosed
IN202417100055A Reference Example A23 [280]
Undisclosed
Undisclosed
Undisclosed
IN202417100055A Reference Example A24 [280]
Undisclosed
Undisclosed
Undisclosed
IN202417100055A Reference Example A25 [280]
Undisclosed
Undisclosed
Undisclosed
IN202417100055A Reference Example A26 [280]
Undisclosed
Undisclosed
Undisclosed
IN202417100055A Reference Example 1 [280]
Undisclosed
Undisclosed
Undisclosed
IN202417100055A Reference Example 2 [280]
Undisclosed
Undisclosed
Undisclosed
IN202417100055A Reference Example 3 [280]
Undisclosed
Undisclosed
Undisclosed
IN202417100055A Reference Example 4 [280]
Undisclosed
Undisclosed
Undisclosed
IN202417100055A Reference Example 5 [280]
Undisclosed
Undisclosed
Undisclosed
IN202417100055A Reference Example 6 [280]
Undisclosed
Undisclosed
Undisclosed
IN202417100055A Reference Example 7 [281]
Undisclosed
Undisclosed
Undisclosed
CN115594732A I-LD011 [282]
undisclosed
Undisclosed
Undisclosed
CN115594732A I-LD012 [282]
undisclosed
Undisclosed
Undisclosed
CN115594732A I-LD013 [282]
undisclosed
Undisclosed
Undisclosed
CN115594732A I-LD014 [282]
undisclosed
Undisclosed
Undisclosed
CN115594732A I-LD015 [282]
undisclosed
Undisclosed
Undisclosed
CN115594732A I-LD016 [282]
undisclosed
Undisclosed
Undisclosed
CN115594732A I-LD017 [282]
undisclosed
Undisclosed
Undisclosed
CN115594732A I-LD018A [282]
undisclosed
Undisclosed
Undisclosed
CN115594732A I-LD018B [282]
undisclosed
Undisclosed
Undisclosed
CN115594732A I-LD019 [282]
undisclosed
Undisclosed
Undisclosed
CN115594732A I-LD020 [282]
undisclosed
Undisclosed
Undisclosed
CN115594732A I-LD021 [282]
undisclosed
Undisclosed
Undisclosed
CN115594732A II-LD-011 [282]
undisclosed
Undisclosed
Undisclosed
CN115594732A II-LD-012 [282]
undisclosed
Undisclosed
Undisclosed
CN115594732A II-LD-013 [282]
undisclosed
Undisclosed
Undisclosed
CN115594732A II-LD-014 [282]
undisclosed
Undisclosed
Undisclosed
CN115594732A II-LD-015 [282]
undisclosed
Undisclosed
Undisclosed
CN115594732A II-LD-016 [282]
undisclosed
Undisclosed
Undisclosed
CN115594732A II-LD-017 [282]
undisclosed
Undisclosed
Undisclosed
CN115594732A II-LD-018 [282]
undisclosed
Undisclosed
Undisclosed
CN115594732A II-LD-019 [282]
undisclosed
Undisclosed
Undisclosed
CN118873678A ADC-1 [283]
undisclosed
Undisclosed
Undisclosed
CN118873678A ADC-2 [283]
Undisclosed
Undisclosed
Undisclosed
CN118873678A ADC-3 [283]
Undisclosed
Undisclosed
Undisclosed
CN118873678A ADC-4 [283]
undisclosed
Undisclosed
Undisclosed
CN118873678A ADC-5 [283]
Undisclosed
Undisclosed
Undisclosed
CN118873678A ADC-6 [283]
Undisclosed
Undisclosed
Undisclosed
CN118873678A ADC-7 [283]
Undisclosed
Undisclosed
Undisclosed
CN118873678A ADC-8 [283]
Undisclosed
Undisclosed
Undisclosed
CN118873678A ADC-9 [283]
Undisclosed
Undisclosed
Undisclosed
CN118873678A ADC-10 [283]
Undisclosed
Undisclosed
Undisclosed
CN118873678A ADC-11 [283]
undisclosed
Undisclosed
Undisclosed
CN118873678A ADC-12 [283]
undisclosed
Undisclosed
Undisclosed
CN118873678A ADC-13 [283]
undisclosed
Undisclosed
Undisclosed
CN118873678A ADC-14 [283]
undisclosed
Undisclosed
Undisclosed
LT4212552T ADC-2 [284]
LT4212552T-ADC-2-PAYLOAD
Undisclosed
Mc-Gly-Gly-Phe-Gly
LT4212552T ADC-3 [284]
LT4212552T ADC10 payload
DNA topoisomerase I (TOP1)
Mc-Gly-Gly-Phe-Gly
LT4212552T ADC4 [284]
LT4212552T-ADC-4-PAYLOAD
Undisclosed
Mc-Gly-Gly-Phe-Gly
LT4212552T ADC5 [284]
LT4212552T ADC10 payload
DNA topoisomerase I (TOP1)
LT4212552T-ADC-5-LINKER
LT4212552T ADC6 [284]
LT4212552T-ADC-6-PAYLOAD
Undisclosed
LT4212552T-ADC-6-LINKER
LT4212552T ADC7 [284]
LT4212552T ADC10 payload
DNA topoisomerase I (TOP1)
LT4212552T-ADC-7-LINKER
LT4212552T ADC8 [284]
LT4212552T ADC10 payload
DNA topoisomerase I (TOP1)
LT4212552T-ADC-8-LINKER
LT4212552T ADC9 [284]
LT4212552T ADC10 payload
DNA topoisomerase I (TOP1)
LT4212552T-ADC-9-LINKER
LT4212552T ADC10 [284]
LT4212552T ADC10 payload
DNA topoisomerase I (TOP1)
LT4212552T-ADC-10-LINKER
LT4212552T ADC12 [284]
LT4212552T-ADC-12-PAYLOAD
Undisclosed
Mc-Gly-Gly-Phe-Gly
LT4212552T ADC13 [284]
LT4212552T ADC13 payload
DNA topoisomerase I (TOP1)
Mc-Gly-Gly-Phe-Gly
LT4212552T ADC15 [284]
LT4212552T ADC37 payload
DNA topoisomerase I (TOP1)
Undisclosed
LT4212552T ADC16 [284]
LT4212552T ADC37 payload
DNA topoisomerase I (TOP1)
Undisclosed
LT4212552T ADC17 [284]
LT4212552T ADC37 payload
DNA topoisomerase I (TOP1)
LT4212552T-ADC-17-LINKER
LT4212552T ADC18 [284]
LT4212552T ADC37 payload
DNA topoisomerase I (TOP1)
LT4212552T-ADC-17-LINKER
LT4212552T ADC19 [284]
LT4212552T ADC37 payload
DNA topoisomerase I (TOP1)
LT4212552T-ADC-19-LINKER
LT4212552T ADC20 [284]
LT4212552T ADC37 payload
DNA topoisomerase I (TOP1)
LT4212552T-ADC-19-LINKER
LT4212552T ADC21 [284]
LT4212552T ADC37 payload
DNA topoisomerase I (TOP1)
LT4212552T-ADC-21-LINKER
LT4212552T ADC22 [284]
LT4212552T ADC37 payload
DNA topoisomerase I (TOP1)
LT4212552T-ADC-21-LINKER
LT4212552T ADC24 [284]
LT4212552T ADC25 payload
DNA topoisomerase I (TOP1)
LT4212552T-ADC-24-LINKER
LT4212552T ADC25 [284]
LT4212552T ADC25 payload
DNA topoisomerase I (TOP1)
LT4212552T-ADC-24-LINKER
LT4212552T ADC26 [284]
LT4212552T ADC49 payload
DNA topoisomerase I (TOP1)
Mc-Gly-Gly-Phe-Gly
LT4212552T ADC27 [284]
LT4212552T ADC49 payload
DNA topoisomerase I (TOP1)
Mc-Gly-Gly-Phe-Gly
LT4212552T ADC28 [284]
LT4212552T ADC49 payload
DNA topoisomerase I (TOP1)
Mc-Gly-Gly-Phe-Gly
LT4212552T ADC29 [284]
LT4212552T ADC49 payload
DNA topoisomerase I (TOP1)
Mc-Gly-Gly-Phe-Gly
LT4212552T ADC30 [284]
LT4212552T ADC49 payload
DNA topoisomerase I (TOP1)
Mc-Gly-Gly-Phe-Gly
LT4212552T ADC31 [284]
LT4212552T ADC49 payload
DNA topoisomerase I (TOP1)
Mc-Gly-Gly-Phe-Gly
LT4212552T ADC36 [284]
LT4212552T ADC37 payload
DNA topoisomerase I (TOP1)
LT4212552T-ADC-36-LINKER
LT4212552T ADC37 [284]
LT4212552T ADC37 payload
DNA topoisomerase I (TOP1)
LT4212552T-ADC-36-LINKER
LT4212552T ADC39 [284]
LT4212552T-ADC-39-PAYLOAD
Undisclosed
Mc-Gly-Gly-Phe-Gly
LT4212552T ADC40 [284]
LT4212552T-ADC-39-PAYLOAD
Undisclosed
Mc-Gly-Gly-Phe-Gly
LT4212552T ADC41 [284]
Topo1 inhibitor B
DNA topoisomerase I (TOP1)
Mc-Gly-Gly-Phe-Gly
LT4212552T ADC42 [284]
Topo1 inhibitor B
DNA topoisomerase I (TOP1)
Mc-Gly-Gly-Phe-Gly
LT4212552T ADC43 [284]
LT4212552T ADC49 payload
DNA topoisomerase I (TOP1)
LT4212552T-ADC-6-LINKER
LT4212552T ADC44 [284]
LT4212552T ADC49 payload
DNA topoisomerase I (TOP1)
HK40112172A+Antibody-drug conjugate (44)+Linker
LT4212552T ADC46 [284]
LT4212552T ADC49 payload
DNA topoisomerase I (TOP1)
Mc-Gly-Gly-Phe-Gly
LT4212552T ADC47 [284]
LT4212552T ADC49 payload
DNA topoisomerase I (TOP1)
Mc-Gly-Gly-Phe-Gly
LT4212552T ADC49 [284]
LT4212552T ADC49 payload
DNA topoisomerase I (TOP1)
Mc-Gly-Gly-Phe-Gly
Herceptin-RTX-5007 [285]
Undisclosed
Undisclosed
Undisclosed
IGAC-1 [286]
IG-L-1 Payload
Undisclosed
IG-L-1 linker
IGAC-3 [286]
Smol006
Eukaryotic peptide chain release factor GTP-binding subunit ERF3A (GSPT1)
MP-Ala-Ala-PAB
IGAC-5 [286]
IG-L-2 Payload
Undisclosed
MP-Ala-Ala-PAB
IGAC-7 [286]
Smol006
Eukaryotic peptide chain release factor GTP-binding subunit ERF3A (GSPT1)
MP-Ala-Ala-PAB
IGAC-9 [286]
IG-L-1 Payload
Undisclosed
IG-L-1 linker
IGAC-11 [286]
IG-L-3 Payload
Undisclosed
IG-L-3 linker
IGAC-13 [286]
IG-L-7 Payload
Undisclosed
MP-Ala-Ala-PAB
IGAC-15 [286]
IG-L-4 Payload
Undisclosed
MP-Ala-Ala-PAB
IGAC-17 [286]
IG-L-5 Payload
Undisclosed
MP-Ala-Ala-PAB
IGAC-19 [286]
IG-L-9 Payload
Undisclosed
MP-Ala-Ala-PAB
IGAC-21 [286]
IG-L-10 Payload
Undisclosed
MP-Ala-Ala-PAB
IGAC-23 [286]
IG-L-11 Payload
Undisclosed
MP-Ala-Ala-PAB
IGAC-29 [286]
IG-L-12 Payload
Undisclosed
MP-Ala-Ala-PAB
IGAC-31 [286]
Smol006
Eukaryotic peptide chain release factor GTP-binding subunit ERF3A (GSPT1)
IG-L-14 linker
IGAC-33 [286]
IG-L-16 Payload
Undisclosed
IG-L-16 linker
IGAC-35 [286]
IG-L-17 Payload
Undisclosed
MP-Ala-Ala-PAB
IGAC-36 [286]
IG-L-13 Payload
Undisclosed
IG-L-13 linker
IGAC-37 [286]
IG-L-15 Payload
Undisclosed
DL18 linker
IGAC-39 [286]
Smol006
Eukaryotic peptide chain release factor GTP-binding subunit ERF3A (GSPT1)
MP-Ala-Ala-PAB
IGAC-40 [286]
IG-L-18 Payload
Undisclosed
IG-L-18 linker
IGAC-41 [286]
undisclosed
Undisclosed
IG-L-19 linker
IGAC-42 [286]
IG-L-18 Payload
Undisclosed
IG-L-20 linker
IGAC-43 [286]
IG-L-18 Payload
Undisclosed
IG-L-21 linker
IGAC-44 [286]
IG-L-18 Payload
Undisclosed
IG-L-22 linker
IGAC-47 [286]
IG-L-26 Payload
Undisclosed
IG-L-26 linker
IGAC-48 [286]
IG-L-23 Payload
Undisclosed
IG-L-3 linker
IGAC-49 [286]
IG-L-18 Payload
Undisclosed
IG-L-25 linker
IGAC-50 [286]
IG-L-36 Payload
Undisclosed
IG-L-36 linker
IGAC-52 [286]
IG-L-36 Payload
Undisclosed
IG-L-37 linker
IGAC-54 [286]
IG-L-38 Payload
Undisclosed
IG-L-38 linker
IGAC-55 [286]
IG-L-39 Payload
Undisclosed
IG-L-38 linker
IGAC-56 [286]
IG-L-79 Payload
Undisclosed
IG-L-47 linker
IGAC-57 [286]
Smol006
Eukaryotic peptide chain release factor GTP-binding subunit ERF3A (GSPT1)
IG-L-16 linker
IGAC-58 [286]
Smol006
Eukaryotic peptide chain release factor GTP-binding subunit ERF3A (GSPT1)
IG-L-63 linker
IGAC-60 [286]
CC-885
Undisclosed
IG-L-54 linker
IGAC-61 [286]
CC-885
Undisclosed
IG-L-58 linker
IGAC-63 [286]
IG-L-79 Payload
Undisclosed
IG-L-46 linker
IGAC-65 [286]
Smol006
Eukaryotic peptide chain release factor GTP-binding subunit ERF3A (GSPT1)
IG-L-65 linker
IGAC-68 [286]
IG-L-71 Payload
Undisclosed
IG-L-71 linker
IGAC-69 [286]
Smol006
Eukaryotic peptide chain release factor GTP-binding subunit ERF3A (GSPT1)
IG-L-68 linker
IGAC-71 [286]
IG-L-70 Payload
Undisclosed
IG-L-70 linker
IGAC-73 [286]
IG-L-48 Payload
Undisclosed
IG-L-36 linker
IGAC-75 [286]
IG-L-45 Payload
Undisclosed
IG-L-45 linker
IGAC-77 [286]
IG-L-40 Payload
Undisclosed
IG-L-40 linker
IGAC-79 [286]
CC-885
Undisclosed
IG-L-42 linker
IGAC-81 [286]
IG-L-41 Payload
Undisclosed
IG-L-41 linker
IGAC-84 [286]
IG-L-43 Payload
Undisclosed
IG-L-43 linker
IGAC-85 [286]
IG-L-44 Payload
Undisclosed
IG-L-44 linker
IGAC-93 [286]
IG-L-18 Payload
Undisclosed
IG-L-25 linker
IGAC-96 [286]
CC-885
Undisclosed
IG-L-73 linker
IGAC-97 [286]
Smol006
Eukaryotic peptide chain release factor GTP-binding subunit ERF3A (GSPT1)
IG-L-74 linker
IGAC-98 [286]
IG-L-79 Payload
Undisclosed
IG-L-75 linker
IGAC-99 [286]
IG-L-76 Payload
Undisclosed
IG-L-76 linker
IGAC-100 [286]
IG-L-79 Payload
Undisclosed
IG-L-77 linker
IGAC-101 [286]
CC-885
Undisclosed
IG-L-74 linker
IGAC-102 [286]
IG-L-79 Payload
Undisclosed
IG-L-74 linker
IGAC-103 [286]
IG-L-80 Payload
Undisclosed
IG-L-74 linker
IGAC-104 [286]
IG-L-81 Payload
Undisclosed
IG-L-81 linker
IGAC-105 [286]
IG-L-82 Payload
Undisclosed
IG-L-82 linker
JP7560255B2 ControlADC45 [287]
Undisclosed
Undisclosed
Undisclosed
CN113874046B ADC-1 [288]
Monomethyl auristatin E
Microtubule (MT)
CN113874046B-ADC-1-LINKER
CN113874046B ADC-2 [288]
CN113874046B-ADC-2-PAYLOAD
Undisclosed
CN113874046B-ADC-2-LINKER
CN113874046B ADC-3 [288]
CN113874046B-ADC-3-PAYLOAD
Undisclosed
CN113874046B-ADC-3-LINKER
CN113874046B ADC-4 [288]
Monomethyl auristatin E
Microtubule (MT)
CN113874046B-ADC-4-LINKER
CN113874046B ADC-5 [288]
CN113874046B-ADC-5-PAYLOAD
Undisclosed
CN113874046B-ADC-5-LINKER
CN113874046B ADC-6 [288]
CN113874046B-ADC-6-PAYLOAD
Undisclosed
CN113874046B-ADC-6-LINKER
CN113874046B ADC-7 [288]
Monomethyl auristatin E
Microtubule (MT)
CN113874046B-ADC-7-LINKER
CN113453724B ADC-A [289]
CN113453724B-ADCA-PAYLOAD
Undisclosed
CN113453724B-ADCA-LINKER
CN119630431A ADC-90 [290]
CN119630431A-ADC-82-PAYLOAD
Undisclosed
CN119630431A-ADC-82-LINKER
TWI857167B IC-1 [291]
TWI857167B-IC-1-PAYLOAD
Undisclosed
TWI857167B-IC-1-LINKER
TWI857167B IC-2 2.4 [291]
TWI857167B-IC-2-PAYLOAD
Undisclosed
TWI857167B-IC-1-LINKER
TWI857167B IC-2 4.2 [291]
TWI857167B-IC-2-PAYLOAD
Undisclosed
TWI857167B-IC-1-LINKER
TWI857167B IC-3 [291]
TWI857167B-IC-3-PAYLOAD
Undisclosed
Aminobenzazepine-linker Formula II-3
TWI857167B IC-6 [291]
TWI857167B-IC-6-PAYLOAD
Undisclosed
Aminobenzazepine-linker Formula II-3
TWI857167B IC-7 [291]
TWI857167B-IC-7-PAYLOAD
Undisclosed
Aminobenzazepine-linker Formula II-3
TWI857167B IC-10 [291]
TWI857167B-IC-10-PAYLOAD
Undisclosed
TWI857167B-IC-1-LINKER
TWI857167B IC-11 [291]
TWI857167B-IC-11-PAYLOAD
Undisclosed
Aminobenzazepine-linker Formula II-3
TWI857167B IC-13 [291]
TWI857167B-IC-13-PAYLOAD
Undisclosed
Aminobenzazepine-linker Formula II-3
TWI857167B IC-14 [291]
TWI857167B-IC-14-PAYLOAD
Undisclosed
Aminobenzazepine-linker Formula II-3
TWI857167B IC-15 [291]
TWI857167B IC-74 payload
Undisclosed
Aminobenzazepine-linker Formula II-3
TWI857167B IC-16 [291]
TWI857167B-IC-16-PAYLOAD
Undisclosed
Aminobenzazepine-linker Formula II-3
TWI857167B IC-17 [291]
TWI857167B-IC-17-PAYLOAD
Undisclosed
Aminobenzazepine-linker Formula II-3
TWI857167B IC-18 [291]
TWI857167B-IC-18-PAYLOAD
Undisclosed
Aminobenzazepine-linker Formula II-3
TWI857167B IC-19 [291]
TWI857167B-IC-19-PAYLOAD
Undisclosed
Aminobenzazepine-linker Formula II-3
TWI857167B IC-20 [291]
TWI857167B-IC-20-PAYLOAD
Undisclosed
Aminobenzazepine-linker Formula II-3
TWI857167B IC-21 [291]
TWI857167B-IC-21-PAYLOAD
Undisclosed
Aminobenzazepine-linker Formula II-3
TWI857167B IC-22 [291]
TWI857167B-IC-22-PAYLOAD
Undisclosed
Aminobenzazepine-linker Formula II-3
TWI857167B IC-23 [291]
TWI857167B-IC-23-PAYLOAD
Undisclosed
Aminobenzazepine-linker Formula II-3
TWI857167B IC-24 [291]
TWI857167B-IC-24-PAYLOAD
Undisclosed
Aminobenzazepine-linker Formula II-3
TWI857167B IC-25 [291]
TWI857167B-IC-25-PAYLOAD
Undisclosed
Aminobenzazepine-linker Formula II-3
TWI857167B IC-26 [291]
TWI857167B-IC-26-PAYLOAD
Undisclosed
Aminobenzazepine-linker Formula II-3
TWI857167B IC-27 [291]
TWI857167B-IC-27-PAYLOAD
Undisclosed
Aminobenzazepine-linker Formula II-3
TWI857167B IC-28 [291]
TWI857167B-IC-28-PAYLOAD
Undisclosed
Aminobenzazepine-linker Formula II-3
TWI857167B IC-29 [291]
TWI857167B IC-67 payload
Undisclosed
TWI857167B-IC-29-LINKER
TWI857167B IC-30 [291]
TWI857167B IC-38 payload
Undisclosed
TWI857167B-IC-30-LINKER
TWI857167B IC-31 [291]
TWI857167B-IC-31-PAYLOAD
Undisclosed
Aminobenzazepine-linker Formula II-3
TWI857167B IC-32 [291]
TWI857167B-IC-32-PAYLOAD
Undisclosed
TWI857167B-IC-32-LINKER
TWI857167B IC-34 [291]
TWI857167B-IC-34-PAYLOAD
Undisclosed
Aminobenzazepine-linker Formula II-3
TWI857167B IC-35 [291]
TWI857167B-IC-35-PAYLOAD
Undisclosed
TWI857167B-IC-35-LINKER
TWI857167B IC-36 [291]
TWI857167B-IC-36-PAYLOAD
Undisclosed
Aminobenzazepine-linker Formula II-3
TWI857167B IC-37 [291]
TWI857167B-IC-37-PAYLOAD
Undisclosed
Undisclosed
TWI857167B IC-38 [291]
TWI857167B IC-38 payload
Undisclosed
Aminobenzazepine-linker Formula II-72
TWI857167B IC-39 [291]
TWI857167B-IC-39-PAYLOAD
Undisclosed
Undisclosed
TWI857167B IC-40 [291]
TWI857167B-IC-39-PAYLOAD
Undisclosed
Aminobenzazepine-linker Formula II-72
TWI857167B IC-41 [291]
TWI857167B-IC-41-PAYLOAD
Undisclosed
Aminobenzazepine-linker Formula II-72
TWI857167B IC-42 [291]
TWI857167B-IC-42-PAYLOAD
Undisclosed
Aminobenzazepine-linker Formula II-72
TWI857167B IC-43 [291]
TWI857167B-IC-43-PAYLOAD
Undisclosed
Aminobenzazepine-linker Formula II-72
TWI857167B IC-44 [291]
TWI857167B-IC-44-PAYLOAD
Undisclosed
Aminobenzazepine-linker Formula II-3
TWI857167B IC-45 [291]
TWI857167B-IC-45-PAYLOAD
Undisclosed
Aminobenzazepine-linker Formula II-72
TWI857167B IC-46 [291]
TWI857167B-IC-45-PAYLOAD
Undisclosed
Aminobenzazepine-linker Formula II-72
TWI857167B IC-47 [291]
TWI857167B-IC-47-PAYLOAD
Undisclosed
Aminobenzazepine-linker Formula II-72
TWI857167B IC-48 [291]
TWI857167B-IC-48-PAYLOAD
Undisclosed
Aminobenzazepine-linker Formula II-3
TWI857167B IC-49 [291]
TWI857167B-IC-49-PAYLOAD
Undisclosed
Aminobenzazepine-linker Formula II-3
TWI857167B IC-50 [291]
TWI857167B-IC-50-PAYLOAD
Undisclosed
Aminobenzazepine-linker Formula II-3
TWI857167B IC-51 [291]
TWI857167B-IC-51-PAYLOAD
Undisclosed
Aminobenzazepine-linker Formula II-3
TWI857167B IC-52 [291]
TWI857167B-IC-52-PAYLOAD
Undisclosed
Aminobenzazepine-linker Formula II-72
TWI857167B IC-53 [291]
TWI857167B-IC-53-PAYLOAD
Undisclosed
Aminobenzazepine-linker Formula II-72
TWI857167B IC-54 [291]
TWI857167B-IC-54-PAYLOAD
Undisclosed
Aminobenzazepine-linker Formula II-72
TWI857167B IC-55 [291]
TWI857167B-IC-55-PAYLOAD
Undisclosed
Aminobenzazepine-linker Formula II-72
TWI857167B IC-56 [291]
TWI857167B-IC-56-PAYLOAD
Undisclosed
Aminobenzazepine-linker Formula II-72
TWI857167B IC-57 [291]
TWI857167B-IC-55-PAYLOAD
Undisclosed
Aminobenzazepine-linker Formula II-3
TWI857167B IC-58 [291]
TWI857167B-IC-58-PAYLOAD
Undisclosed
Aminobenzazepine-linker Formula II-3
TWI857167B IC-59 [291]
TWI857167B-IC-59-PAYLOAD
Undisclosed
Aminobenzazepine-linker Formula II-72
TWI857167B IC-60 [291]
TWI857167B-IC-60-PAYLOAD
Undisclosed
Aminobenzazepine-linker Formula II-72
TWI857167B IC-61 [291]
TWI857167B IC-67 payload
Undisclosed
TWI857167B-IC-61-LINKER
TWI857167B IC-62 [291]
TWI857167B-IC-62-PAYLOAD
Undisclosed
Aminobenzazepine-linker Formula II-72
TWI857167B IC-63 [291]
TWI857167B-IC-63-PAYLOAD
Undisclosed
Aminobenzazepine-linker Formula II-72
TWI857167B IC-64 [291]
TWI857167B IC-74 payload
Undisclosed
Aminobenzazepine-linker Formula II-72
TWI857167B IC-65 [291]
TWI857167B-IC-65-PAYLOAD
Undisclosed
Aminobenzazepine-linker Formula II-3
TWI857167B IC-66 [291]
TWI857167B-IC-65-PAYLOAD
Undisclosed
TWI857167B-IC-66-LINKER
TWI857167B IC-67 [291]
TWI857167B IC-67 payload
Undisclosed
Aminobenzazepine-linker Formula II-72
TWI857167B IC-68 [291]
TWI857167B-IC-67-PAYLOAD
Undisclosed
Aminobenzazepine-linker Formula II-3
TWI857167B IC-69 [291]
TWI857167B-IC-68-PAYLOAD
Undisclosed
Aminobenzazepine-linker Formula II-3
TWI857167B IC-70 [291]
TWI857167B-IC-69-PAYLOAD
Undisclosed
Aminobenzazepine-linker Formula II-3
TWI857167B IC-71 [291]
TWI857167B-IC-70-PAYLOAD
Undisclosed
TWI857167B-IC-70-LINKER
TWI857167B IC-72 [291]
undisclosed
Undisclosed
TWI857167B-IC-71-LINKER
TWI857167B IC-73 [291]
TWI857167B-IC-69-PAYLOAD
Undisclosed
TWI857167B-IC-72-LINKER
TWI857167B IC-74 [291]
TWI857167B IC-74 payload
Undisclosed
Aminobenzazepine-linker Formula II-82
TWI857167B IC-75 [291]
TWI857167B-IC-74-PAYLOAD
Undisclosed
TWI857167B-IC-70-LINKER
TWI857167B IC-76 [291]
TWI857167B-IC-75-PAYLOAD
Undisclosed
Aminobenzazepine-linker Formula II-3
TWI857167B IC-77 [291]
TWI857167B-IC-50-PAYLOAD
Undisclosed
Aminobenzazepine-linker Formula II-82
TWI857167B IC-78 [291]
TWI857167B-IC-77-PAYLOAD
Undisclosed
Aminobenzazepine-linker Formula II-3
TWI857167B IC-79 [291]
TWI857167B-IC-78-PAYLOAD
Undisclosed
Aminobenzazepine-linker Formula II-3
TWI857167B IC-80 [291]
TWI857167B-IC-79-PAYLOAD
Undisclosed
Aminobenzazepine-linker Formula II-3
TWI857167B IC-81 [291]
TWI857167B-IC-80-PAYLOAD
Undisclosed
Aminobenzazepine-linker Formula II-3
TWI857167B IC-82 [291]
TWI857167B-IC-81-PAYLOAD
Undisclosed
Aminobenzazepine-linker Formula II-3
TWI857167B IC-83 [291]
TWI857167B IC-84 payload
Undisclosed
Aminobenzazepine-linker Formula II-3
TWI857167B IC-84 [291]
TWI857167B IC-84 payload
Undisclosed
TWI857167B-IC-82-LINKER
TWI857167B IC-85 [291]
TWI857167B-IC-85-PAYLOAD
Undisclosed
TWI857167B-IC-82-LINKER
TWI857167B IC-86 [291]
TWI857167B-IC-85-PAYLOAD
Undisclosed
Aminobenzazepine-linker Formula II-82
TWI857167B IC-87 [291]
TWI857167B-IC-86-PAYLOAD
Undisclosed
TWI857167B-IC-85-LINKER
TWI857167B IC-88 [291]
TWI857167B-IC-78-PAYLOAD
Undisclosed
TWI857167B-IC-82-LINKER
TWI857167B IC-89 [291]
TWI857167B-IC-88-PAYLOAD
Undisclosed
Undisclosed
TWI857167B IC-90 [291]
TWI857167B-IC-88-PAYLOAD
Undisclosed
TWI857167B-IC-82-LINKER
TWI857167B IC-91 [291]
TWI857167B-IC-90-PAYLOAD
Undisclosed
Undisclosed
TWI857167B IC-92 [291]
TWI857167B-IC-91-PAYLOAD
Undisclosed
TWI857167B-IC-90-LINKER
TWI857167B IC-93 [291]
TWI857167B-IC-92-PAYLOAD
Undisclosed
TWI857167B-IC-82-LINKER
TWI857167B IC-94 [291]
TWI857167B-IC-93-PAYLOAD
Undisclosed
TWI857167B-IC-82-LINKER
TWI857167B IC-95 [291]
TWI857167B-IC-86-PAYLOAD
Undisclosed
Undisclosed
TWI857167B IC-96 [291]
TWI857167B-IC-95-PAYLOAD
Undisclosed
Undisclosed
TWI857167B IC-97 [291]
TWI857167B-IC-96-PAYLOAD
Undisclosed
TWI857167B-IC-95-LINKER
TWI857167B IC-98 [291]
TWI857167B-IC-63-PAYLOAD
Undisclosed
TWI857167B-IC-96-LINKER
TWI857167B IC-99 [291]
TWI857167B-IC-98-PAYLOAD
Undisclosed
TWI857167B-IC-97-LINKER
TWI857167B IC-100 [291]
TWI857167B-IC-99-PAYLOAD
Undisclosed
Undisclosed
TWI857167B IC-101 [291]
TWI857167B-IC-99-PAYLOAD
Undisclosed
Undisclosed
TWI857167B IC-102 [291]
TWI857167B-IC-101-PAYLOAD
Undisclosed
Undisclosed
TWI857167B IC-103 [291]
TWI857167B-IC-102-PAYLOAD
Undisclosed
TWI857167B-IC-101-LINKER
TWI857167B IC-104 [291]
TWI857167B-IC-95-PAYLOAD
Undisclosed
Undisclosed
TWI857167B IC-105 [291]
TWI857167B-IC-104-PAYLOAD
Undisclosed
Undisclosed
TWI857167B IC-106 [291]
TWI857167B-IC-105-PAYLOAD
Undisclosed
Undisclosed
TWI857167B IC-107 [291]
TWI857167B-IC-106-PAYLOAD
Undisclosed
TWI857167B-IC-105-LINKER
TWI857167B IC-108 [291]
TWI857167B-IC-107-PAYLOAD
Undisclosed
TWI857167B-IC-95-LINKER
TWI857167B IC-109 [291]
TWI857167B-IC-108-PAYLOAD
Undisclosed
Undisclosed
TWI857167B IC-110 [291]
TWI857167B-IC-101-PAYLOAD
Undisclosed
TWI857167B-IC-108-LINKER
TWI857167B IC-111 [291]
TWI857167B-IC-110-PAYLOAD
Undisclosed
Undisclosed
TWI857167B IC-112 [291]
TWI857167B-IC-111-PAYLOAD
Undisclosed
Undisclosed
TWI857167B IC-113 [291]
TWI857167B-IC-111-PAYLOAD
Undisclosed
Undisclosed
TWI857167B IC-114 [291]
TWI857167B-IC-113-PAYLOAD
Undisclosed
Undisclosed
TWI857167B IC-115 [291]
undisclosed
Undisclosed
Undisclosed
TWI857167B IC-116 [291]
TWI857167B-IC-115-PAYLOAD
Undisclosed
Undisclosed
TWI857167B IC-117 [291]
TWI857167B-IC-116-PAYLOAD
Undisclosed
Undisclosed
TWI857167B IC-118 [291]
TWI857167B-IC-117-PAYLOAD
Undisclosed
Undisclosed
TWI857167B IC-119 [291]
TWI857167B-IC-118-PAYLOAD
Undisclosed
Undisclosed
TWI857167B IC-120 [291]
undisclosed
Undisclosed
Undisclosed
TWI857167B IC-121 [291]
TWI857167B-IC-115-PAYLOAD
Undisclosed
Undisclosed
TWI857167B IC-122 [291]
undisclosed
Undisclosed
Undisclosed
TWI857167B IC-123 [291]
undisclosed
Undisclosed
Undisclosed
EP4487874A1-2 [72]
EP4487874A1-2payload
Undisclosed
RU20241285-1-linker
EP4487874A1-3 [72]
undisclosed
Undisclosed
EP4487874A1-3linker
EP4487874A1-5 [72]
EP4487874A1-5payload
Undisclosed
RU20241285-4-linker
EP4487874A1-6 [72]
EP4487874A1-6payload
Undisclosed
RU20241285-4-linker
EP4487874A1-7 [72]
EP4487874A1-7payload
Undisclosed
EP4487874A1-7linker
EP4487874A1-8 [72]
EP4487874A1-8payload
Undisclosed
EP4487874A1-8linker
EP4487874A1-9 [72]
EP4487874A1-9payload
Undisclosed
EP4487874A1-9linker
EP4487874A1-10 [72]
EP4487874A1-10payload
Undisclosed
EP4487874A1-10linker
EP4487874A1-11 [72]
EP4487874A1-11payload
Undisclosed
RU20241285-9-linker
EP4487874A1-12 [72]
DX-8951 derivative (DXd)
DNA topoisomerase 1 (TOP1)
EP4487874A1-12linker
EP4487874A1-13 [72]
EP4487874A1-13payload
Undisclosed
EP4487874A1-13linker
EP4487874A1-14 [72]
DX-8951 derivative (DXd)
DNA topoisomerase 1 (TOP1)
EP4487874A1-14linker
EP4487874A1-15 [72]
EP4487874A1-15payload
Undisclosed
EP4487874A1-15linker
EP4487874A1-16 [72]
EP4487874A1-16payload
Undisclosed
EP4487874A1-10linker
EP4487874A1-17 [72]
EP4487874A1-17payload
Undisclosed
EP4487874A1-17linker
EP4487874A1-18 [72]
Topo1 inhibitor A
DNA topoisomerase I (TOP1)
EP4487874A1-18linker
EP4487874A1-19 [72]
RU20241285-23-payload
DNA topoisomerase I (TOP1)
EP4487874A1-19linker
EP4487874A1-20 [72]
undisclosed
Undisclosed
EP4487874A1-20linker
EP4487874A1-21 [72]
RU20241285-23-payload
DNA topoisomerase I (TOP1)
RU20241285-19-linker
EP4487874A1-22 [72]
Topo1 inhibitor A
DNA topoisomerase I (TOP1)
EP4487874A1-22linker
EP4487874A1-23 [72]
EP4487874A1-16payload
Undisclosed
EP4487874A1-23linker
EP4487874A1-24 [72]
EP4487874A1-16payload
Undisclosed
EP4487874A1-24linker
EP4487874A1-25 [72]
RU20241285-23-payload
DNA topoisomerase I (TOP1)
EP4487874A1-23linker
EP4487874A1-26 [72]
RU20241285-23-payload
DNA topoisomerase I (TOP1)
EP4487874A1-24linker
38354417 T-DL1 [292]
FD1
DNA topoisomerase I (TOP1)
MT-GGFG-AM
38354417 T-DL3 [292]
FD2
DNA topoisomerase I (TOP1)
MT-GGFG-AM
38354417 T-DL4 [292]
FD3
DNA topoisomerase I (TOP1)
MT-GGFG-AM
38354417 T-DL9 [292]
10NH2-11F-Camptothecin
DNA topoisomerase I (TOP1)
MT-GGFG-AM
38354417 T-DL5 [292]
FD5
DNA topoisomerase I (TOP1)
MT-GGFG-AM
38354417 T-DL6 [292]
FD5
DNA topoisomerase I (TOP1)
Mc-Gly-Gly-Phe-Gly
38354417 T-DL11 [292]
FD5
DNA topoisomerase I (TOP1)
MT-GGFG-AM
38354417 T-DL13 [292]
FD6
DNA topoisomerase I (TOP1)
MT-GGFG-AM
38354417 T-DL14 [292]
FD7
DNA topoisomerase I (TOP1)
MT-GGFG-AM
38354417 T-DL7 [292]
DX-8951 derivative (DXd)
DNA topoisomerase 1 (TOP1)
MT-GGFG-AM
AZO-ADC-0 [293]
Monomethyl auristatin E
Microtubule (MT)
Solubilizing group-PEG0-Hypoxia sensitive linker-Azobenzene
AZO-ADC-2 [293]
Monomethyl auristatin E
Microtubule (MT)
Solubilizing group-PEG2-Hypoxia sensitive linker-Azobenzene
AZO-ADC-4 [293]
Monomethyl auristatin E
Microtubule (MT)
Solubilizing group-PEG4-Hypoxia sensitive linker-Azobenzene
AZO-ADC-6 [293]
Monomethyl auristatin E
Microtubule (MT)
Solubilizing group-PEG6-Hypoxia sensitive linker-Azobenzene
AZO-ADC-8 [293]
Monomethyl auristatin E
Microtubule (MT)
Solubilizing group-PEG8-Hypoxia sensitive linker-Azobenzene
IgG (8)-m- (b-PEG12)-VC-MMAE [80]
Monomethyl auristatin E
Microtubule (MT)
IgG (8)-m- (b-PEG12)-VC-MMAE
WO2024169913A1 ADC01-01-8 [89]
Smol006
Eukaryotic peptide chain release factor GTP-binding subunit ERF3A (GSPT1)
Mc-Val-Cit-PABC
WO2024169913A1 ADC01-01-4 [89]
B19
Eukaryotic peptide chain release factor GTP-binding subunit ERF3A (GSPT1)
Mc-Val-Cit-PABC
WO2024169913A1 ADC01-02-8 [89]
B19
Eukaryotic peptide chain release factor GTP-binding subunit ERF3A (GSPT1)
Mc-Val-Cit-PABC
WO2024169913A1 ADC01-02-4 [89]
B19
Eukaryotic peptide chain release factor GTP-binding subunit ERF3A (GSPT1)
Mc-Val-Ala-PABC
WO2024169913A1 ADC01-06-8 [89]
B19
Eukaryotic peptide chain release factor GTP-binding subunit ERF3A (GSPT1)
Mc-Val-Ala-PABC
WO2024169913A1 ADC01-06-4 [89]
B63
Eukaryotic peptide chain release factor GTP-binding subunit ERF3A (GSPT1)
Mc-Val-Ala-PABC
WO2024169913A1 ADC01-07-4 [89]
B63
Eukaryotic peptide chain release factor GTP-binding subunit ERF3A (GSPT1)
Mc-Val-Ala-PABC
WO2024169913A1 ADC01-08-8 [89]
B19
Eukaryotic peptide chain release factor GTP-binding subunit ERF3A (GSPT1)
(Linker-02)MC-PEG-VA-PAB
WO2024169913A1 ADC01-08-4 [89]
B19
Eukaryotic peptide chain release factor GTP-binding subunit ERF3A (GSPT1)
(Linker-03)SMCC-TAZ-PEG-VC-PAB
WO2024222841A1 ADC38 [294]
(S)B19
Eukaryotic peptide chain release factor GTP-binding subunit ERF3A (GSPT1)
OXDc-VA-PAB (PEG)
WO2024222841A1 ADC38-4 [294]
(S)B19
Eukaryotic peptide chain release factor GTP-binding subunit ERF3A (GSPT1)
OXDc-VA-PAB (PEG)
WO2024222841A1 ADC39 [294]
(S)B19
Eukaryotic peptide chain release factor GTP-binding subunit ERF3A (GSPT1)
OXD-VA-PAB (PEG)
WO2024222841A1 ADC40 [294]
(S)B19
Eukaryotic peptide chain release factor GTP-binding subunit ERF3A (GSPT1)
OXDc-VA-PAB (Glu)
WO2024222841A1 ADC41 [294]
(S)B19
Eukaryotic peptide chain release factor GTP-binding subunit ERF3A (GSPT1)
OXD-VA-PAB (Glu)
WO2024222841A1 ADC42 [294]
B19
Eukaryotic peptide chain release factor GTP-binding subunit ERF3A (GSPT1)
OXDc-VA-PAB (PEG)
WO2024222841A1 ADC43 [294]
(R)B19
Eukaryotic peptide chain release factor GTP-binding subunit ERF3A (GSPT1)
OXDc-VA-PAB (PEG)
WO2024222841A1 ADC44 [294]
B61
Eukaryotic peptide chain release factor GTP-binding subunit ERF3A (GSPT1)
OXDc-VA-PAB (PEG)
WO2024222841A1 ADC45 [294]
B63
Eukaryotic peptide chain release factor GTP-binding subunit ERF3A (GSPT1)
OXDc-VA-PAB (PEG)
T-ADC-2 [294]
(S)B19
Eukaryotic peptide chain release factor GTP-binding subunit ERF3A (GSPT1)
OXDc-VA-PAB (PEG)
T-ADC [294]
(S)B19
Eukaryotic peptide chain release factor GTP-binding subunit ERF3A (GSPT1)
OXDc-VA-PAB (PEG)
WO2024222841A1 ADC39-4 [294]
(S)B19
Eukaryotic peptide chain release factor GTP-binding subunit ERF3A (GSPT1)
OXD-VA-PAB (PEG)
WO2024222841A1 ADC40-4 [294]
(S)B19
Eukaryotic peptide chain release factor GTP-binding subunit ERF3A (GSPT1)
OXDc-VA-PAB (Glu)
WO2024222841A1 ADC41-4 [294]
(S)B19
Eukaryotic peptide chain release factor GTP-binding subunit ERF3A (GSPT1)
OXD-VA-PAB (Glu)
WO2024222841A1 ADC42-4 [294]
B19
Eukaryotic peptide chain release factor GTP-binding subunit ERF3A (GSPT1)
OXDc-VA-PAB (PEG)
WO2024222841A1 ADC43-4 [294]
(R)B19
Eukaryotic peptide chain release factor GTP-binding subunit ERF3A (GSPT1)
OXDc-VA-PAB (PEG)
WO2024222841A1 ADC44-4 [294]
B61
Eukaryotic peptide chain release factor GTP-binding subunit ERF3A (GSPT1)
OXDc-VA-PAB (PEG)
CN119343374A ADC-S108 [93]
Undisclosed
Undisclosed
Undisclosed
CN119343374A ADC-S105 [93]
Undisclosed
Undisclosed
Undisclosed
NC18
AF-HEA
Microtubule (MT)
PHF polymer linker
trastuzumab
ADC Name Payload Target Linker ADC Info
WO2024230301A1 ADC-1 [239]
Undisclosed
Undisclosed
Undisclosed
WO2024230301A1 ADC-2 [239]
Undisclosed
Undisclosed
Undisclosed
WO2024230301A1 ADC-3 [239]
Undisclosed
Undisclosed
Undisclosed
WO2024230301A1 ADC-4 [239]
Undisclosed
Undisclosed
Undisclosed
WO2024230301A1 ADC-5 [239]
Undisclosed
Undisclosed
Undisclosed
WO2024230301A1 ADC-6 [239]
Undisclosed
Undisclosed
Undisclosed
WO2024230301A1 ADC-7 [239]
Undisclosed
Undisclosed
Undisclosed
WO2024230301A1 ADC-8 [239]
Undisclosed
Undisclosed
Undisclosed
WO2024230301A1 ADC-9 [239]
Undisclosed
Undisclosed
Undisclosed
WO2024230301A1 ADC-10 [239]
Undisclosed
Undisclosed
Undisclosed
WO2024230301A1 ADC-11 [239]
Undisclosed
Undisclosed
Undisclosed
WO2024230301A1 ADC-12 [239]
Undisclosed
Undisclosed
Undisclosed
WO2024230301A1 ADC-13 [239]
Undisclosed
Undisclosed
Undisclosed
WO2024230301A1 ADC-14 [239]
Undisclosed
Undisclosed
Undisclosed
WO2024230301A1 ADC-15 [239]
Undisclosed
Undisclosed
Undisclosed
WO2024230301A1 ADC-16 [239]
Undisclosed
Undisclosed
Undisclosed
WO2024230301A1 ADC-17 [239]
Undisclosed
Undisclosed
Undisclosed
WO2024230301A1 ADC-18 [239]
Undisclosed
Undisclosed
Undisclosed
WO2024230301A1 ADC-19 [239]
Undisclosed
Undisclosed
Undisclosed
WO2024230301A1 ADC-20 [239]
Undisclosed
Undisclosed
Undisclosed
WO2024230301A1 ADC1a-DAR4 [239]
Undisclosed
Undisclosed
Undisclosed
CN116782954A ADC2-DAR4 [240]
Undisclosed
Undisclosed
Undisclosed
CN116782954A ADC3-DAR4 [240]
Undisclosed
Undisclosed
Undisclosed
CN116782954A ADC4a-DAR4 [240]
Undisclosed
Undisclosed
Undisclosed
CN116782954A ADC4b-DAR4 [240]
Undisclosed
Undisclosed
Undisclosed
CN116782954A ADC5-DAR2 [240]
Undisclosed
Undisclosed
Undisclosed
Trastuzumab-ZY-889 [241]
Undisclosed
Undisclosed
Undisclosed
Trastuzumab-ZY-948 [241]
Undisclosed
Undisclosed
Undisclosed
Trastuzumab-ZY-894 [241]
Undisclosed
Undisclosed
Undisclosed
EP4090377A1 EP4090377A1 221 [41]
Undisclosed
Undisclosed
Undisclosed
Trast-v8-XL06 [41]
Undisclosed
Undisclosed
Undisclosed
Trast-v4- (201)2 [41]
Undisclosed
Undisclosed
Undisclosed
US20240245795A1 Antibody Conjugate 1 [251]
Exatecan
DNA topoisomerase 1 (TOP1)
Mc-Val-Cit-PABC
US20240245795A1 Antibody Conjugate 2 [251]
Undisclosed
Undisclosed
Undisclosed
US20240245795A1 Antibody Conjugate 3 [251]
Undisclosed
Undisclosed
Undisclosed
US20240245795A1 Antibody Conjugate 4 [251]
Undisclosed
Undisclosed
Undisclosed
US20240245795A1 Antibody Conjugate 5 [251]
Exatecan
DNA topoisomerase 1 (TOP1)
Undisclosed
US20240245795A1 Antibody Conjugate 6 [251]
Exatecan
DNA topoisomerase 1 (TOP1)
Undisclosed
US20240245795A1 Antibody Conjugate 7 [251]
Antibody Conjugate 7 +Payload
DNA topoisomerase I (TOP1)
Undisclosed
US20240245795A1 Antibody Conjugate 8 [251]
Undisclosed
Undisclosed
Undisclosed
US20240245795A1 Antibody Conjugate 11 [251]
Undisclosed
Undisclosed
Undisclosed
US20240245795A1 Antibody Conjugate 12 [251]
Undisclosed
Undisclosed
Undisclosed
Trastuzumab-DXD (CN114569739A) [264]
Undisclosed
Undisclosed
Undisclosed
CN114569739A ADC-1 (trastuzumab) [264]
Undisclosed
Undisclosed
Undisclosed
CN114569739A ADC-2 (trastuzumab) [264]
Undisclosed
Undisclosed
Undisclosed
CN114569739A ADC-3 (trastuzumab) [264]
Undisclosed
Undisclosed
Undisclosed
CN114569739A ADC-4 (trastuzumab) [264]
Undisclosed
Undisclosed
Undisclosed
CN114569739A ADC-7 (trastuzumab) [264]
Undisclosed
Undisclosed
Undisclosed
trastuzumab (6-N3-GalNAc)2
ADC Name Payload Target Linker ADC Info
EP4090377A1 EP4090377A1 210 [41]
Undisclosed
Undisclosed
Undisclosed
Trastuzumab (C2)
ADC Name Payload Target Linker ADC Info
Tras (C2)-Cp [295]
Cryptophycin-uD[Dap (Me)]
Undisclosed
Mc-Val-Cit-PABC
Trastuzumab (C4)
ADC Name Payload Target Linker ADC Info
Tras (C4)-Cp [295]
Cryptophycin-uD[Dap (Me)]
Undisclosed
Mc-Val-Cit-PABC
Trastuzumab (C8)
ADC Name Payload Target Linker ADC Info
Tras (C8)-Cp [295]
Cryptophycin-uD[Dap (Me)]
Undisclosed
Mc-Val-Cit-PABC
Tras (C8)-MMAE [295]
Monomethyl auristatin E
Microtubule (MT)
Mc-Val-Cit-PABC
Trastuzumab (Positively Charged)
ADC Name Payload Target Linker ADC Info
Positively Charged ADC [222]
Monomethyl auristatin E
Microtubule (MT)
Mc-Val-Cit-PABC
Trastuzumab A114C
ADC Name Payload Target Linker ADC Info
Neolymphostin ADC 21 [296]
Neolymphostin A
3-Phosphoinositide-dependent protein kinase 1 (PDPK1)
Mc-Val-Cit-PABC-DMEA
Neolymphostin ADC 22 [296]
Neolymphostin A
3-Phosphoinositide-dependent protein kinase 1 (PDPK1)
PEG4-DMEA
Neolymphostin ADC 23 [296]
Neolymphostin A
3-Phosphoinositide-dependent protein kinase 1 (PDPK1)
Mc-Val-Cit-PABC
Neolymphostin ADC 24 [296]
Neolymphostin A
3-Phosphoinositide-dependent protein kinase 1 (PDPK1)
N-Methoxycarbonylmaleimide
Trastuzumab D265C
ADC Name Payload Target Linker ADC Info
T-D265C-CN-Pro-amanitin [297]
CN-Pro-dideoxy-alpha-amanitin
DNA-directed RNA polymerase II subunit RPB2 (POLR2B); DNA-directed RNA polymerase III subunit RPC7 (POLR3G)
Mal-Val-Ala-PAB
T-D265C-NH2-Pro-amanitin [297]
NH2-Pro-dideoxy-alpha-amanitin
DNA-directed RNA polymerase II subunit RPB2 (POLR2B); DNA-directed RNA polymerase III subunit RPC7 (POLR3G)
Mc-Val-Ala-PABC
T-D265C-OH-Pro-amanitin [297]
OH-Pro-dideoxy-alpha-amanitin
DNA-directed RNA polymerase II subunit RPB2 (POLR2B); DNA-directed RNA polymerase III subunit RPC7 (POLR3G)
Mc-Val-Ala-PABC
trastuzumab GalNProSSMe trast-v5a
ADC Name Payload Target Linker ADC Info
Trast-v5b-XL02 [41]
Undisclosed
Undisclosed
Undisclosed
Trastuzumab I253Q
ADC Name Payload Target Linker ADC Info
Trastuzumab I253Q-MMAE [298]
Monomethyl auristatin E
Microtubule (MT)
Dansylcadaverine-BCN based linker
Trastuzumab deglycosylated WT-MMAE [298]
Monomethyl auristatin E
Microtubule (MT)
Dansylcadaverine deglycosylated-BCN based linker
Trastuzumab N297A
ADC Name Payload Target Linker ADC Info
ADC MMAE/F 4+2 [299]
Monomethyl auristatin E+Monomethyl auristatin F
Microtubule (MT)
DBCO-PEG3-Glu-Val-Cit-PABC; TCO-PEG3-Glu-Val-Cit-PABC
ADC MMAE/F 2+4 [299]
Monomethyl auristatin E+Monomethyl auristatin F
Microtubule (MT)
DBCO-PEG3-Glu-Val-Cit-PABC; TCO-PEG3-Glu-Val-Cit-PABC
ADC MMAE/F 2+2 [299]
Monomethyl auristatin E+Monomethyl auristatin F
Microtubule (MT)
DBCO-PEG3-Glu-Val-Cit-PABC; TCO-PEG3-Glu-Val-Cit-PABC
trastuzumab S239C mutant trast-v6
ADC Name Payload Target Linker ADC Info
Trast-v6-XL02 [41]
Undisclosed
Undisclosed
Undisclosed
Trast-v6-XL03 [41]
Undisclosed
Undisclosed
C-lock-azide linker
Trast-v6- (XL05)2 [41]
Undisclosed
Undisclosed
Maleimide linker
Trastuzumab scFv
ADC Name Payload Target Linker ADC Info
scFv (Herceptin)-PE [300]
Pseudomonas exotoxin PE38
Eukaryotic elongation factor 2 kinase (EEF2K)
Undisclosed
scFv(Herceptin)-PE-STXA [300]
PE15-Stx 2a
Eukaryotic elongation factor 2 kinase (EEF2K)
Undisclosed
ScFv(trastuzumab)-PE38KDEL [19]
Pseudomonas exotoxin PE38
Eukaryotic elongation factor 2 kinase (EEF2K)
Undisclosed
trastuzumab trast-v1a
ADC Name Payload Target Linker ADC Info
TCO-trastuzumab trast-v1a-XL11 [41]
Undisclosed
Undisclosed
Undisclosed
trastuzumab trast-v7
ADC Name Payload Target Linker ADC Info
Trast-v7-XL01 [41]
Undisclosed
Undisclosed
Undisclosed
Trastuzumab variant
ADC Name Payload Target Linker ADC Info
GQ1005
DXd
DNA topoisomerase 1 (TOP1)
Mc-Gly-Gly-Phe-Gly (ring-opening derivative)
GQ1001
DM1
Microtubule (MT)
K'-MCC'
ALT-P7
Monomethyl auristatin E
Microtubule (MT)
Val-Cit dipeptide linker
ADCT-502
SG3199 (SC-DR002)
Human deoxyribonucleic acid (hDNA)
Mal-PEG8-Val-Ala-PABC
trastuzumab- (azide)2
ADC Name Payload Target Linker ADC Info
EP4090377A1 EP4090377A1 211 [41]
Undisclosed
Undisclosed
linker105
EP4090377A1 EP4090377A1 212 [41]
Undisclosed
Undisclosed
Undisclosed
EP4090377A1 EP4090377A1 213 [41]
Undisclosed
Undisclosed
Undisclosed
EP4090377A1 EP4090377A1 214 [41]
Undisclosed
Undisclosed
Undisclosed
EP4090377A1 EP4090377A1 215 [41]
Undisclosed
Undisclosed
Undisclosed
EP4090377A1 EP4090377A1 216 [41]
Undisclosed
Undisclosed
Undisclosed
EP4090377A1 EP4090377A1 217 [41]
Undisclosed
Undisclosed
linker145
Trastuzumab-(κK183C+K290C)
ADC Name Payload Target Linker ADC Info
PF-06804103
Auristatin 0101 (Aur0101)
Microtubule (MT)
Mc-Val-Cit-PABC
Trastuzumab-A111
ADC Name Payload Target Linker ADC Info
AU2022395626A1 ADC-L2-P2 [301]
Monomethyl auristatin E
Microtubule (MT)
H-Tet-Glucuronide
Trastuzumab-A121
ADC Name Payload Target Linker ADC Info
AU2022395626A1 ADC-H8-P3 [301]
Undisclosed
Undisclosed
Undisclosed
Trastuzumab-A51
ADC Name Payload Target Linker ADC Info
AU2022395626A1 ADC-L1-P2 [301]
Monomethyl auristatin E
Microtubule (MT)
H-Tet-Glucuronide
Trastuzumab-AL1
ADC Name Payload Target Linker ADC Info
IgG1 (trastuzumab)-AL1-MMAE [19]
Monomethyl auristatin E
Microtubule (MT)
Undisclosed
Trastuzumab-BUPY
ADC Name Payload Target Linker ADC Info
Trastuzumab-BUPY-DM1 [302]
Mertansine DM1
Microtubule (MT)
N3-SMCC
Trastuzumab-BUPY-TAMRA [302]
TAMRA
Undisclosed
N3-PEG3
Trastuzumab-CpHK
ADC Name Payload Target Linker ADC Info
T-CpHK-Tet-ADC [303]
Monomethyl auristatin E
Microtubule (MT)
Tetrazine-PEG5-Val-Ala-PABC
T-CpHK-Mal-ADC [303]
Monomethyl auristatin E
Microtubule (MT)
Mc-Val-Cit-PABC
Trastuzumab-Fab-cd38
ADC Name Payload Target Linker ADC Info
38501590 Anti-HER2 ARC-FDC (1) [304]
Monomethyl auristatin F
Microtubule (MT)
2'-Cl-araNAD linker
38501590 Anti-HER2 ARC-FDC (2) [304]
Monomethyl auristatin F
Microtubule (MT)
2'-Cl-araNAD linker
Trastuzumab-Flexmab
ADC Name Payload Target Linker ADC Info
Trastuzumab-Flexmab-SG3710 [114]
SG3199
Human Deoxyribonucleic acid (hDNA)
Mal-PEG8-Val-Ala-PABC
Trastuzumab-G41
ADC Name Payload Target Linker ADC Info
AU2022395626A1 ADC-L4-P2 [301]
Monomethyl auristatin E
Microtubule (MT)
H-Tet-Glucuronide
Trastuzumab-G42
ADC Name Payload Target Linker ADC Info
AU2022395626A1 ADC-H7-P2 [301]
Monomethyl auristatin E
Microtubule (MT)
H-Tet-Glucuronide
trastuzumab-GalNProSSMe trast-v5a
ADC Name Payload Target Linker ADC Info
Trast-v5b-XL01 [41]
Undisclosed
Undisclosed
Undisclosed
Trast-v5b- (XL05)2 2 [41]
Undisclosed
Undisclosed
Undisclosed
Trastuzumab-H16-K222R-Hg1
ADC Name Payload Target Linker ADC Info
US11365263B2 ADC#2 [305]
US11365263B2 ADC#2 payload
Undisclosed
US11365263B2 ADC#3 linker
US11365263B2 ADC#3 [305]
US11365263B2 ADC#3 payload
Undisclosed
US11365263B2 ADC#3 linker
Trastuzumab-K169
ADC Name Payload Target Linker ADC Info
AU2022395626A1 ADC-L3-P2 [301]
Monomethyl auristatin E
Microtubule (MT)
H-Tet-Glucuronide
Trastuzumab-K249
ADC Name Payload Target Linker ADC Info
AU2022395626A1 ADC-H1-P1 [301]
Monomethyl auristatin E
Microtubule (MT)
H-Tet-PEG9-Val-Ala-PAB
AU2022395626A1 ADC-H1-P2 [301]
Monomethyl auristatin E
Microtubule (MT)
H-Tet-Glucuronide
GlyADC-H1-P2 [301]
Monomethyl auristatin E
Microtubule (MT)
H-Tet-Glucuronide
Trastuzumab-K249&G41
ADC Name Payload Target Linker ADC Info
AU2022395626A1 ADC-H1L4-P2 [301]
Monomethyl auristatin E
Microtubule (MT)
H-Tet-Glucuronide
Trastuzumab-K249&K169
ADC Name Payload Target Linker ADC Info
AU2022395626A1 ADC-H1L3-P2 [301]
Monomethyl auristatin E
Microtubule (MT)
H-Tet-Glucuronide
Trastuzumab-K249&K320
ADC Name Payload Target Linker ADC Info
AU2022395626A1 ADC-H1H4-P2 [301]
Monomethyl auristatin E
Microtubule (MT)
H-Tet-Glucuronide
Trastuzumab-K249&K343
ADC Name Payload Target Linker ADC Info
AU2022395626A1 ADC-H1H5-P2 [301]
Monomethyl auristatin E
Microtubule (MT)
H-Tet-Glucuronide
Trastuzumab-K251
ADC Name Payload Target Linker ADC Info
AU2022395626A1 ADC-H2-P1 [301]
Monomethyl auristatin E
Microtubule (MT)
H-Tet-PEG9-Val-Ala-PAB
Trastuzumab-K291
ADC Name Payload Target Linker ADC Info
AU2022395626A1 ADC-H3-P1 [301]
Monomethyl auristatin E
Microtubule (MT)
H-Tet-PEG9-Val-Ala-PAB
Trastuzumab-K320
ADC Name Payload Target Linker ADC Info
AU2022395626A1 ADC-H4-P1 [301]
Monomethyl auristatin E
Microtubule (MT)
H-Tet-PEG9-Val-Ala-PAB
AU2022395626A1 ADC-H4-P2 [301]
Monomethyl auristatin E
Microtubule (MT)
H-Tet-Glucuronide
GlyADC-H4-P2 [301]
Monomethyl auristatin E
Microtubule (MT)
H-Tet-Glucuronide
Trastuzumab-K320&G41
ADC Name Payload Target Linker ADC Info
AU2022395626A1 ADC-H4L4-P2 [301]
Monomethyl auristatin E
Microtubule (MT)
H-Tet-Glucuronide
Trastuzumab-K320&K169
ADC Name Payload Target Linker ADC Info
AU2022395626A1 ADC-H4L3-P2 [301]
Monomethyl auristatin E
Microtubule (MT)
H-Tet-Glucuronide
Trastuzumab-K343
ADC Name Payload Target Linker ADC Info
AU2022395626A1 ADC-H5-P1 [301]
Monomethyl auristatin E
Microtubule (MT)
H-Tet-PEG9-Val-Ala-PAB
Trastuzumab-P41
ADC Name Payload Target Linker ADC Info
AU2022395626A1 ADC-H6-P2 [301]
Monomethyl auristatin E
Microtubule (MT)
H-Tet-Glucuronide
Trastuzumab-P41&G41
ADC Name Payload Target Linker ADC Info
AU2022395626A1 ADC-H6L4-P2 [301]
Monomethyl auristatin E
Microtubule (MT)
H-Tet-Glucuronide
Trastuzumab-P59
ADC Name Payload Target Linker ADC Info
AU2022395626A1 ADC-L5-P2 [301]
Monomethyl auristatin E
Microtubule (MT)
H-Tet-Glucuronide
Trastuzumab-Qtag2
ADC Name Payload Target Linker ADC Info
Trastuzumab-Qtag2-Alexa 488-cadaverine [306]
Alexa 488-cadaverine
Undisclosed
Undisclosed
Trastuzumab-Qtag2-MMAE [306]
Monomethyl auristatin E
Microtubule (MT)
PEG4-VC-PAB
Trastuzumab-Qtag2-DM1 [306]
Mertansine DM1
Microtubule (MT)
PEG4-SMCC
37341172 13d [307]
NAMPT inhibitor 1b
Undisclosed
Undisclosed
37341172 13f [307]
NAMPT inhibitor 1b
Undisclosed
Undisclosed
trastuzumab-S239C mutant trast-v6
ADC Name Payload Target Linker ADC Info
Trast-v6-XL01 [41]
Undisclosed
Undisclosed
Undisclosed
Trast-v6-XL12 [41]
Undisclosed
Undisclosed
Undisclosed
Trastuzumabk453del-Qtag2
ADC Name Payload Target Linker ADC Info
Trastuzumabk453del-Qtag2-MMAE [306]
Monomethyl auristatin E
Microtubule (MT)
PEG4-VC-PAB
Tratuzumab (P41C)
ADC Name Payload Target Linker ADC Info
KR1020250011922A ADC-TRA41C [308]
Undisclosed
Undisclosed
Undisclosed
KR1020250011922A ADC-S105 masked [308]
Undisclosed
Undisclosed
Undisclosed
KR1020250011922A ADC-S105 demasked [308]
Undisclosed
Undisclosed
Undisclosed
KR1020250011922A ADC-S105 [308]
Undisclosed
Undisclosed
Undisclosed
KR1020250011922A ADC-S108 [308]
Undisclosed
Undisclosed
Undisclosed
KR1020250011922A ADC-S109 [308]
Undisclosed
Undisclosed
Undisclosed
KR1020250011922A ADC-S110 [308]
Undisclosed
Undisclosed
Undisclosed
KR1020250011922A ADC-S111 [308]
Undisclosed
Undisclosed
Undisclosed
KR1020250011922A ADC-TRA41C MMP2-treated [308]
Undisclosed
Undisclosed
Undisclosed
KR1020250011922A ADC-S423 masked [308]
Undisclosed
Undisclosed
Undisclosed
KR1020250011922A ADC-S423 demasked [308]
Undisclosed
Undisclosed
Undisclosed
KR1020250011922A ADC-S426 masked [308]
Undisclosed
Undisclosed
Undisclosed
KR1020250011922A ADC-S426 MMP2-treated [308]
Undisclosed
Undisclosed
Undisclosed
KR1020250011922A ADC-S424 masked [308]
Undisclosed
Undisclosed
Undisclosed
KR1020250011922A ADC-S424 demasked [308]
Undisclosed
Undisclosed
Undisclosed
KR1020250011922A ADC-S425 masked [308]
Undisclosed
Undisclosed
Undisclosed
KR1020250011922A ADC-S425 demasked [308]
Undisclosed
Undisclosed
Undisclosed
KR1020250011922A ADC-S424 MMP2 treated [308]
Undisclosed
Undisclosed
Undisclosed
KR1020250011922A ADC-S425 MMP2 treated [308]
Undisclosed
Undisclosed
Undisclosed
Trz-HC:p67
ADC Name Payload Target Linker ADC Info
Trz-HC:p67-MMAE [309]
Monomethyl auristatin E
Microtubule (MT)
Undisclosed
Trz-LC:p67
ADC Name Payload Target Linker ADC Info
Trz-LC:p67-MMAE [309]
Monomethyl auristatin E
Microtubule (MT)
Undisclosed
WO2015095301A2 ADC-1 antibody
ADC Name Payload Target Linker ADC Info
WO2015095301A2 ADC-1 [12]
WO2015095301A2 ADC-1 payload
Undisclosed
WO2015095301A2 ADC-1 linker
WO2015095301A2 ADC-10 antibody
ADC Name Payload Target Linker ADC Info
WO2015095301A2 ADC-10 [12]
WO2015095301A2 ADC-10 payload
Undisclosed
WO2015095301A2 ADC-10 linker
WO2015095301A2 ADC-11 antibody
ADC Name Payload Target Linker ADC Info
WO2015095301A2 ADC-11 [12]
WO2015095301A2 ADC-11 payload
Undisclosed
WO2015095301A2 ADC-11 linker
WO2015095301A2 ADC-12 antibody
ADC Name Payload Target Linker ADC Info
WO2015095301A2 ADC-12 [12]
WO2015095301A2 ADC-12 payload
Undisclosed
WO2015095301A2 ADC-12 linker
WO2015095301A2 ADC-13 antibody
ADC Name Payload Target Linker ADC Info
WO2015095301A2 ADC-13 [12]
WO2015095301A2 ADC-13 payload
Undisclosed
WO2015095301A2 ADC-13 linker
WO2015095301A2 ADC-14 antibody
ADC Name Payload Target Linker ADC Info
WO2015095301A2 ADC-14 [12]
WO2015095301A2 ADC-14 payload
Undisclosed
WO2015095301A2 ADC-14 linker
WO2015095301A2 ADC-15 antibody
ADC Name Payload Target Linker ADC Info
WO2015095301A2 ADC-15 [12]
WO2015095301A2 ADC-15 payload
Undisclosed
WO2015095301A2 ADC-15 linker
WO2015095301A2 ADC-16 antibody
ADC Name Payload Target Linker ADC Info
WO2015095301A2 ADC-16 [12]
WO2015095301A2 ADC-16 payload
Undisclosed
WO2015095301A2 ADC-16 linker
WO2015095301A2 ADC-17 antibody
ADC Name Payload Target Linker ADC Info
WO2015095301A2 ADC-17 [12]
WO2015095301A2 ADC-17 payload
Undisclosed
WO2015095301A2 ADC-17 linker
WO2015095301A2 ADC-18 antibody
ADC Name Payload Target Linker ADC Info
WO2015095301A2 ADC-18 [12]
WO2015095301A2 ADC-18 payload
Undisclosed
WO2015095301A2 ADC-18 linker
WO2015095301A2 ADC-19 antibody
ADC Name Payload Target Linker ADC Info
WO2015095301A2 ADC-19 [12]
WO2015095301A2 ADC-19 payload
Undisclosed
WO2015095301A2 ADC-19 linker
WO2015095301A2 ADC-2 antibody
ADC Name Payload Target Linker ADC Info
WO2015095301A2 ADC-2 [12]
WO2015095301A2 ADC-2 payload
Undisclosed
WO2015095301A2 ADC-2 linker
WO2015095301A2 ADC-20 antibody
ADC Name Payload Target Linker ADC Info
WO2015095301A2 ADC-20 [12]
WO2015095301A2 ADC-20 payload
Undisclosed
WO2015095301A2 ADC-20 linker
WO2015095301A2 ADC-21 antibody
ADC Name Payload Target Linker ADC Info
WO2015095301A2 ADC-21 [12]
WO2015095301A2 ADC-21 payload
Undisclosed
WO2015095301A2 ADC-21 linker
WO2015095301A2 ADC-22 antibody
ADC Name Payload Target Linker ADC Info
WO2015095301A2 ADC-22 [12]
WO2015095301A2 ADC-22 payload
Undisclosed
WO2015095301A2 ADC-22 linker
WO2015095301A2 ADC-23 antibody
ADC Name Payload Target Linker ADC Info
WO2015095301A2 ADC-23 [12]
WO2015095301A2 ADC-23 payload
Undisclosed
WO2015095301A2 ADC-23 linker
WO2015095301A2 ADC-24 antibody
ADC Name Payload Target Linker ADC Info
WO2015095301A2 ADC-24 [12]
WO2015095301A2 ADC-24 payload
Undisclosed
WO2015095301A2 ADC-24 linker
WO2015095301A2 ADC-25 antibody
ADC Name Payload Target Linker ADC Info
WO2015095301A2 ADC-25 [12]
WO2015095301A2 ADC-25 payload
Undisclosed
WO2015095301A2 ADC-25 linker
WO2015095301A2 ADC-26 antibody
ADC Name Payload Target Linker ADC Info
WO2015095301A2 ADC-26 [12]
WO2015095301A2 ADC-26 payload
Undisclosed
WO2015095301A2 ADC-26 linker
WO2015095301A2 ADC-27 antibody
ADC Name Payload Target Linker ADC Info
WO2015095301A2 ADC-27 [12]
WO2015095301A2 ADC-27 payload
Undisclosed
WO2015095301A2 ADC-27 linker
WO2015095301A2 ADC-3 antibody
ADC Name Payload Target Linker ADC Info
WO2015095301A2 ADC-3 [12]
WO2015095301A2 ADC-3 payload
Undisclosed
WO2015095301A2 ADC-3 linker
WO2015095301A2 ADC-4 antibody
ADC Name Payload Target Linker ADC Info
WO2015095301A2 ADC-4 [12]
WO2015095301A2 ADC-4 payload
Undisclosed
WO2015095301A2 ADC-4 linker
WO2015095301A2 ADC-5 antibody
ADC Name Payload Target Linker ADC Info
WO2015095301A2 ADC-5 [12]
WO2015095301A2 ADC-5 payload
Undisclosed
WO2015095301A2 ADC-5 linker
WO2015095301A2 ADC-6 antibody
ADC Name Payload Target Linker ADC Info
WO2015095301A2 ADC-6 [12]
WO2015095301A2 ADC-6 payload
Undisclosed
WO2015095301A2 ADC-6 linker
WO2015095301A2 ADC-7 antibody
ADC Name Payload Target Linker ADC Info
WO2015095301A2 ADC-7 [12]
WO2015095301A2 ADC-7 payload
Undisclosed
WO2015095301A2 ADC-7 linker
WO2015095301A2 ADC-8 antibody
ADC Name Payload Target Linker ADC Info
WO2015095301A2 ADC-8 [12]
WO2015095301A2 ADC-8 payload
Undisclosed
WO2015095301A2 ADC-8 linker
WO2015095301A2 ADC-9 antibody
ADC Name Payload Target Linker ADC Info
WO2015095301A2 ADC-9 [12]
WO2015095301A2 ADC-9 payload
Undisclosed
WO2015095301A2 ADC-9 linker
WO2015189791A1 ADC-1 antibody
ADC Name Payload Target Linker ADC Info
WO2015189791A1 ADC-1 [13]
WO2015189791A1 ADC-1 payload
Undisclosed
WO2015189791A1 ADC-1 linker
WO2015189791A1 ADC-10 antibody
ADC Name Payload Target Linker ADC Info
WO2015189791A1 ADC-10 [13]
WO2015189791A1 ADC-10 payload
Undisclosed
WO2015189791A1 ADC-10 linker
WO2015189791A1 ADC-11 antibody
ADC Name Payload Target Linker ADC Info
WO2015189791A1 ADC-11 [13]
WO2015189791A1 ADC-11 payload
Undisclosed
WO2015189791A1 ADC-11 linker
WO2015189791A1 ADC-12 antibody
ADC Name Payload Target Linker ADC Info
WO2015189791A1 ADC-12 [13]
WO2015189791A1 ADC-12 payload
Undisclosed
WO2015189791A1 ADC-12 linker
WO2015189791A1 ADC-13 antibody
ADC Name Payload Target Linker ADC Info
WO2015189791A1 ADC-13 [13]
WO2015189791A1 ADC-13 payload
Undisclosed
WO2015189791A1 ADC-13 linker
WO2015189791A1 ADC-14 antibody
ADC Name Payload Target Linker ADC Info
WO2015189791A1 ADC-14 [13]
WO2015189791A1 ADC-14 payload
Undisclosed
WO2015189791A1 ADC-14 linker
WO2015189791A1 ADC-15 antibody
ADC Name Payload Target Linker ADC Info
WO2015189791A1 ADC-15 [13]
WO2015189791A1 ADC-15 payload
Undisclosed
WO2015189791A1 ADC-15 linker
WO2015189791A1 ADC-16 antibody
ADC Name Payload Target Linker ADC Info
WO2015189791A1 ADC-16 [13]
WO2015189791A1 ADC-16 payload
Undisclosed
WO2015189791A1 ADC-16 linker
WO2015189791A1 ADC-17 antibody
ADC Name Payload Target Linker ADC Info
WO2015189791A1 ADC-17 [13]
WO2015189791A1 ADC-17 payload
Undisclosed
WO2015189791A1 ADC-17 linker
WO2015189791A1 ADC-18 antibody
ADC Name Payload Target Linker ADC Info
WO2015189791A1 ADC-18 [13]
WO2015189791A1 ADC-18 payload
Undisclosed
WO2015189791A1 ADC-18 linker
WO2015189791A1 ADC-19 antibody
ADC Name Payload Target Linker ADC Info
WO2015189791A1 ADC-19 [13]
WO2015189791A1 ADC-19 payload
Undisclosed
WO2015189791A1 ADC-19 linker
WO2015189791A1 ADC-2 antibody
ADC Name Payload Target Linker ADC Info
WO2015189791A1 ADC-2 [13]
WO2015189791A1 ADC-2 payload
Undisclosed
WO2015189791A1 ADC-2 linker
WO2015189791A1 ADC-20 antibody
ADC Name Payload Target Linker ADC Info
WO2015189791A1 ADC-20 [13]
WO2015189791A1 ADC-20 payload
Undisclosed
WO2015189791A1 ADC-20 linker
WO2015189791A1 ADC-21 antibody
ADC Name Payload Target Linker ADC Info
WO2015189791A1 ADC-21 [13]
WO2015189791A1 ADC-21 payload
Undisclosed
WO2015189791A1 ADC-21 linker
WO2015189791A1 ADC-22 antibody
ADC Name Payload Target Linker ADC Info
WO2015189791A1 ADC-22 [13]
WO2015189791A1 ADC-22 payload
Undisclosed
WO2015189791A1 ADC-22 linker
WO2015189791A1 ADC-23 antibody
ADC Name Payload Target Linker ADC Info
WO2015189791A1 ADC-23 [13]
WO2015189791A1 ADC-23 payload
Undisclosed
WO2015189791A1 ADC-23 linker
WO2015189791A1 ADC-24 antibody
ADC Name Payload Target Linker ADC Info
WO2015189791A1 ADC-24 [13]
WO2015189791A1 ADC-24 payload
Undisclosed
WO2015189791A1 ADC-24 linker
WO2015189791A1 ADC-25 antibody
ADC Name Payload Target Linker ADC Info
WO2015189791A1 ADC-25 [13]
WO2015189791A1 ADC-25 payload
Undisclosed
WO2015189791A1 ADC-25 linker
WO2015189791A1 ADC-26 antibody
ADC Name Payload Target Linker ADC Info
WO2015189791A1 ADC-26 [13]
WO2015189791A1 ADC-26 payload
Undisclosed
WO2015189791A1 ADC-26 linker
WO2015189791A1 ADC-3 antibody
ADC Name Payload Target Linker ADC Info
WO2015189791A1 ADC-3 [13]
WO2015189791A1 ADC-3 payload
Undisclosed
WO2015189791A1 ADC-3 linker
WO2015189791A1 ADC-38 antibody
ADC Name Payload Target Linker ADC Info
WO2015189791A1 ADC-38 [13]
WO2015189791A1 ADC-38 payload
Undisclosed
WO2015189791A1 ADC-38 linker
WO2015189791A1 ADC-39 antibody
ADC Name Payload Target Linker ADC Info
WO2015189791A1 ADC-39 [13]
WO2015189791A1 ADC-39 payload
Undisclosed
WO2015189791A1 ADC-39 linker
WO2015189791A1 ADC-4 antibody
ADC Name Payload Target Linker ADC Info
WO2015189791A1 ADC-4 [13]
WO2015189791A1 ADC-4 payload
Undisclosed
WO2015189791A1 ADC-4 linker
WO2015189791A1 ADC-41 antibody
ADC Name Payload Target Linker ADC Info
WO2015189791A1 ADC-41 [13]
WO2015189791A1 ADC-41 payload
Undisclosed
WO2015189791A1 ADC-41 linker
WO2015189791A1 ADC-42 antibody
ADC Name Payload Target Linker ADC Info
WO2015189791A1 ADC-42 [13]
WO2015189791A1 ADC-42 payload
Undisclosed
WO2015189791A1 ADC-42 linker
WO2015189791A1 ADC-43 antibody
ADC Name Payload Target Linker ADC Info
WO2015189791A1 ADC-43 [13]
WO2015189791A1 ADC-43 payload
Undisclosed
WO2015189791A1 ADC-43 linker
WO2015189791A1 ADC-44 antibody
ADC Name Payload Target Linker ADC Info
WO2015189791A1 ADC-44 [13]
WO2015189791A1 ADC-44 payload
Undisclosed
WO2015189791A1 ADC-44 linker
WO2015189791A1 ADC-45 antibody
ADC Name Payload Target Linker ADC Info
WO2015189791A1 ADC-45 [13]
WO2015189791A1 ADC-45 payload
Undisclosed
WO2015189791A1 ADC-45 linker
WO2015189791A1 ADC-46 antibody
ADC Name Payload Target Linker ADC Info
WO2015189791A1 ADC-46 [13]
WO2015189791A1 ADC-46 payload
Undisclosed
WO2015189791A1 ADC-46 linker
WO2015189791A1 ADC-47 antibody
ADC Name Payload Target Linker ADC Info
WO2015189791A1 ADC-47 [13]
WO2015189791A1 ADC-47 payload
Undisclosed
WO2015189791A1 ADC-47 linker
WO2015189791A1 ADC-48 antibody
ADC Name Payload Target Linker ADC Info
WO2015189791A1 ADC-48 [13]
WO2015189791A1 ADC-48 payload
Undisclosed
WO2015189791A1 ADC-48 linker
WO2015189791A1 ADC-49 antibody
ADC Name Payload Target Linker ADC Info
WO2015189791A1 ADC-49 [13]
WO2015189791A1 ADC-49 payload
Undisclosed
WO2015189791A1 ADC-49 linker
WO2015189791A1 ADC-5 antibody
ADC Name Payload Target Linker ADC Info
WO2015189791A1 ADC-5 [13]
WO2015189791A1 ADC-5 payload
Undisclosed
WO2015189791A1 ADC-5 linker
WO2015189791A1 ADC-50 antibody
ADC Name Payload Target Linker ADC Info
WO2015189791A1 ADC-50 [13]
WO2015189791A1 ADC-50 payload
Undisclosed
WO2015189791A1 ADC-50 linker
WO2015189791A1 ADC-51 antibody
ADC Name Payload Target Linker ADC Info
WO2015189791A1 ADC-51 [13]
WO2015189791A1 ADC-51 payload
Undisclosed
WO2015189791A1 ADC-51 linker
WO2015189791A1 ADC-52 antibody
ADC Name Payload Target Linker ADC Info
WO2015189791A1 ADC-52 [13]
WO2015189791A1 ADC-52 payload
Undisclosed
WO2015189791A1 ADC-52 linker
WO2015189791A1 ADC-53 antibody
ADC Name Payload Target Linker ADC Info
WO2015189791A1 ADC-53 [13]
WO2015189791A1 ADC-53 payload
Undisclosed
WO2015189791A1 ADC-53 linker
WO2015189791A1 ADC-54 antibody
ADC Name Payload Target Linker ADC Info
WO2015189791A1 ADC-54 [13]
WO2015189791A1 ADC-54 payload
Undisclosed
WO2015189791A1 ADC-54 linker
WO2015189791A1 ADC-55 antibody
ADC Name Payload Target Linker ADC Info
WO2015189791A1 ADC-55 [13]
WO2015189791A1 ADC-55 payload
Undisclosed
WO2015189791A1 ADC-55 linker
WO2015189791A1 ADC-56 antibody
ADC Name Payload Target Linker ADC Info
WO2015189791A1 ADC-56 [13]
WO2015189791A1 ADC-56 payload
Undisclosed
WO2015189791A1 ADC-56 linker
WO2015189791A1 ADC-57 antibody
ADC Name Payload Target Linker ADC Info
WO2015189791A1 ADC-57 [13]
WO2015189791A1 ADC-57 payload
Undisclosed
WO2015189791A1 ADC-57 linker
WO2015189791A1 ADC-58 antibody
ADC Name Payload Target Linker ADC Info
WO2015189791A1 ADC-58 [13]
WO2015189791A1 ADC-58 payload
Undisclosed
WO2015189791A1 ADC-58 linker
WO2015189791A1 ADC-59 antibody
ADC Name Payload Target Linker ADC Info
WO2015189791A1 ADC-59 [13]
WO2015189791A1 ADC-59 payload
Undisclosed
WO2015189791A1 ADC-59 linker
WO2015189791A1 ADC-6 antibody
ADC Name Payload Target Linker ADC Info
WO2015189791A1 ADC-6 [13]
WO2015189791A1 ADC-6 payload
Undisclosed
WO2015189791A1 ADC-6 linker
WO2015189791A1 ADC-60 antibody
ADC Name Payload Target Linker ADC Info
WO2015189791A1 ADC-60 [13]
WO2015189791A1 ADC-60 payload
Undisclosed
WO2015189791A1 ADC-60 linker
WO2015189791A1 ADC-62 antibody
ADC Name Payload Target Linker ADC Info
WO2015189791A1 ADC-62 [13]
WO2015189791A1 ADC-62 payload
Undisclosed
WO2015189791A1 ADC-62 linker
WO2015189791A1 ADC-65 antibody
ADC Name Payload Target Linker ADC Info
WO2015189791A1 ADC-65 [13]
WO2015189791A1 ADC-65 payload
Undisclosed
WO2015189791A1 ADC-65 linker
WO2015189791A1 ADC-7 antibody
ADC Name Payload Target Linker ADC Info
WO2015189791A1 ADC-7 [13]
WO2015189791A1 ADC-7 payload
Undisclosed
WO2015189791A1 ADC-7 linker
WO2015189791A1 ADC-8 antibody
ADC Name Payload Target Linker ADC Info
WO2015189791A1 ADC-8 [13]
WO2015189791A1 ADC-8 payload
Undisclosed
WO2015189791A1 ADC-8 linker
WO2015189791A1 ADC-9 antibody
ADC Name Payload Target Linker ADC Info
WO2015189791A1 ADC-9 [13]
WO2015189791A1 ADC-9 payload
Undisclosed
WO2015189791A1 ADC-9 linker
ADC Name Payload Target Linker ADC Info
XMT-1522
AF-HPA
Microtubule (MT)
Fleximer polymer
XMT-1519 Conjugate 1 [4]
Undisclosed
Undisclosed
Undisclosed
ZA202500114A-mAb-1
ADC Name Payload Target Linker ADC Info
ZA202500114A-ADC-1 [245]
Monomethyl auristatin E
Microtubule (MT)
Undisclosed
ZA202500114A-ADC-2 [245]
Undisclosed
Undisclosed
Undisclosed
Zanidatamab
ADC Name Payload Target Linker ADC Info
Zanidatamab-ADC-Tb3-1 [7]
Zanidatamab-ADC-Tb3-1 payload
Undisclosed
Zanidatamab-ADC-Tb3-1 linker
Zanidatamab-ADC-Tb3-2 [7]
Zanidatamab-ADC-Tb3-2 payload
Undisclosed
Zanidatamab-ADC-Tb3-2 linker
Zanidatamab-ADC-Tb3-3 [7]
Zanidatamab-ADC-Tb3-3 payload
Undisclosed
Zanidatamab-ADC-Tb3-3 linker
Zanidatamab-ADC-Tb3-4 [7]
Zanidatamab-ADC-Tb3-4 payload
Undisclosed
Zanidatamab-ADC-Tb3-4 linker
Zanidatamab-ADC-Tb3-5 [7]
Zanidatamab-ADC-Tb3-5 payload
Undisclosed
Zanidatamab-ADC-Tb3-5 linker
Zanidatamab-ADC-Tb3-6 [7]
Zanidatamab-ADC-Tb3-6 payload
Undisclosed
Zanidatamab-ADC-Tb3-6 linker
Zanidatamab-ADC-Tb3-7 [7]
Zanidatamab-ADC-Tb3-7 payload
Undisclosed
Zanidatamab-ADC-Tb3-7 linker
Zanidatamab-ADC-Tb3-8 [7]
Zanidatamab-ADC-Tb3-8 payload
Undisclosed
Zanidatamab-ADC-Tb3-8 linker
Zanidatamab-ADC-Tb3-9 [7]
Zanidatamab-ADC-Tb3-9 payload
Undisclosed
Zanidatamab-ADC-Tb3-9 linker
Zanidatamab-ADC-Tb3-10 [7]
Zanidatamab-ADC-Tb3-10 payload
Undisclosed
Zanidatamab-ADC-Tb3-10 linker
ADC Name Payload Target Linker ADC Info
ZHER2-Gly3-VC-PAB-MMAF [310]
Monomethyl auristatin F
Microtubule (MT)
Gly3-VC-PAB
ZHER2-Gly3-VC-PAB-MMAE [310]
Monomethyl auristatin E
Microtubule (MT)
Gly3-VC-PAB
ZHER2-ABD
ADC Name Payload Target Linker ADC Info
ZHER2-ABD-mcMMAF [311]
Monomethyl auristatin F
Microtubule (MT)
Maleimido-caproyl
ZHER2-ABD-mcMMAE [311]
Monomethyl auristatin E
Microtubule (MT)
Maleimido-caproyl
ZHER2:342-Cupid-His
ADC Name Payload Target Linker ADC Info
ZHER2:342-Cupid-His-Ax-SiPc [312]
Silicon Phthalocyanine
Undisclosed
Psyche-Ax
Zr-labeled trastuzumab
ADC Name Payload Target Linker ADC Info
89Zr-DFO-T-DM1 [152]
Mertansine DM1
Microtubule (MT)
Undisclosed
Undisclosed
ADC Name Payload Target Linker ADC Info
Recombinant anti-HER2 humanized mAb-DM1
Mertansine DM1
Microtubule (MT)
Undisclosed
MT-5111
Shiga toxin B subunit (StxB)
Ribosome (RB)
Undisclosed
KM254-ADC [313]
Undisclosed
Undisclosed
Undisclosed
Xl-250 [314]
Undisclosed
Undisclosed
Undisclosed
Anti-HER2 antibody-drug conjugate (XDCExplorer) [315]
Undisclosed
Undisclosed
Undisclosed
YB1-ADC-HER2 [316]
Undisclosed
Undisclosed
Undisclosed
Biparatopic HER2/HER2 antibody drug conjugate [317]
Undisclosed
Undisclosed
Undisclosed
Anti-HER2-4AP ADC [318]
Undisclosed
Undisclosed
Undisclosed
Anti-HER2 antibody drug conjugate (NBE-Therapeutics) [319]
Undisclosed
Undisclosed
Undisclosed
Anti-HER2 antibody-drug conjugate (Mersana Therapeutics/Genentech) [320]
Undisclosed
Undisclosed
Undisclosed
Mabion-HER2 ADC [321]
Undisclosed
Undisclosed
Undisclosed
Antibody drug conjugate targeting HER2 (IntoCell) [322]
Undisclosed
Undisclosed
Undisclosed
TE-1218 [323]
Undisclosed
Undisclosed
Undisclosed
TE-1112 [324]
Undisclosed
Undisclosed
Undisclosed
Second Generation HER2-Directed Antibody-Drug conjugate [325]
Undisclosed
Undisclosed
Undisclosed
Chloromethylbenz-Indoline Dimer Antibody Drug conjugate [326]
Undisclosed
Undisclosed
Undisclosed
XB3-001 [327]
Undisclosed
Undisclosed
Undisclosed
ANT-043 [328]
Undisclosed
Undisclosed
Undisclosed
AbGn-110 [329]
Undisclosed
Undisclosed
Undisclosed
CTAT-ADC [330]
Mertansine DM1
Microtubule (MT)
Undisclosed
Humanized Anti-HER2 Mab-Maytansine Conjugate [331]
Mertansine DM1
Microtubule (MT)
Undisclosed
DAN-311 [332]
Camptothecin
DNA topoisomerase 1 (TOP1)
Undisclosed
JAB-BX400 [333]
STING agonist
Stimulator of interferon genes protein (STING1)
Undisclosed
QBK249-G [334]
Undisclosed
Undisclosed
Undisclosed
Antibody-drug conjugate (Scripps) [335]
Undisclosed
Undisclosed
Undisclosed
FS-1502
Monomethyl auristatin F
Microtubule (MT)
Undisclosed
ZV-0203 [336]
Undisclosed
Undisclosed
Undisclosed
FDA022-BB05 [337]
Undisclosed
Undisclosed
Undisclosed
HS630 [338]
Mertansine DM1
Microtubule (MT)
Undisclosed
Anti-Her2_ (Q295)_AsnAsnPABC_MMAE [339]
Monomethyl auristatin E
Microtubule (MT)
AsnAsnPABC
Anti-Her2_ (Q295)_AsnAlaPABC_MMAE [339]
Monomethyl auristatin E
Microtubule (MT)
AsnAlaPABC
Antl-Her2_ (0295)_ValAlaPABC_MMAE [339]
Monomethyl auristatin E
Microtubule (MT)
Mc-Val-Ala-PABC
Anti-Her2_AsnAsnPABC_MMAE [339]
Monomethyl auristatin E
Microtubule (MT)
AsnAsnPABC
Anti-Her2_AsnAlaPABC_MMAE [339]
Monomethyl auristatin E
Microtubule (MT)
AsnAlaPABC
Anti-Her2_ValCitPABC_MMAE [339]
Monomethyl auristatin E
Microtubule (MT)
Mc-Val-Cit-PABC
HER2-11 [340]
WL-14
Undisclosed
Undisclosed
HER2-STINGa [341]
STINGa
Undisclosed
Undisclosed
HER2-B [342]
TLR7/8 agonist B
Undisclosed
Succinimidyl-4- (N-maleimidomethyl)cyclohexane-1-carboxylate (SMCC)
HER2-A [342]
TLR7/8 agonist A
Undisclosed
Succinimidyl-4- (N-maleimidomethyl)cyclohexane-1-carboxylate (SMCC)
HER2-A (Fc null) [342]
TLR7/8 agonist A
Undisclosed
Succinimidyl-4- (N-maleimidomethyl)cyclohexane-1-carboxylate (SMCC)
HLX91-048 ADC (DAR 4) [343]
HLX91-048
Undisclosed
Undisclosed
HLX91-048 ADC (DAR 8) [343]
HLX91-048
Undisclosed
Undisclosed
aHer2- (AL6-LP1)n [344]
DX-8951 derivative (DXd)
DNA topoisomerase 1 (TOP1)
US20240269308A1 aHer2- (AL6-LP1)n Linker
aHer2- (AL6-LP15)n [344]
DX-8951 derivative (DXd)
DNA topoisomerase 1 (TOP1)
US20240269308A1 aHer2- (AL6-LP15)n Linker
aHer2- (AL6-LP13)n [344]
DX-8951 derivative (DXd)
DNA topoisomerase 1 (TOP1)
US20240269308A1 aHer2- (AL6-LP13)n Linker
aHer2- (AL7-LP1)n [344]
DX-8951 derivative (DXd)
DNA topoisomerase 1 (TOP1)
US20240269308A1 aHer2- (AL6-LP1)n Linker
aHer2- (AL7-LP13)n [344]
DX-8951 derivative (DXd)
DNA topoisomerase 1 (TOP1)
US20240269308A1 aHer2- (AL6-LP13)n Linker
aHer2- (AL7-LP2)n [344]
CP1412
Undisclosed
US20240269308A1 aHer2- (AL6-LP1)n Linker
aHer2- (AL7-LP3)n [344]
CP1408
Undisclosed
US20240269308A1 aHer2- (AL6-LP1)n Linker
aHer2- (AL7-LP4)n [344]
CP1409
Undisclosed
US20240269308A1 aHer2- (AL6-LP1)n Linker
aHer2- (AL7-LP5)n [344]
CP1436
DNA topoisomerase I (TOP1)
US20240269308A1 aHer2- (AL7-LP5)n Linker
aHer2- (AL7-LP7)n [344]
CP1411
Undisclosed
US20240269308A1 aHer2- (AL6-LP1)n Linker
aHer2- (AL7-LP9)n [344]
CP1422
Undisclosed
US20240269308A1 aHer2- (AL7-LP5)n Linker
aHer2- (AL7-LP12)n [344]
CP1436
DNA topoisomerase I (TOP1)
US20240269308A1 aHer2- (AL7-LP5)n Linker
aHer2- (AL7-LP5D)n [344]
CP1436
DNA topoisomerase I (TOP1)
US20240269308A1 aHer2- (AL7-LP5D)n Linker
aHer2- (AL4c-LP1B)n [344]
DX-8951 derivative (DXd)
DNA topoisomerase 1 (TOP1)
US20240269308A1 aHer2- (AL4c-LP1B)n Linker
aHer2- (AL4c-LP13C)n [344]
DX-8951 derivative (DXd)
DNA topoisomerase 1 (TOP1)
US20240269308A1 aHer2- (AL4c-LP13C)n Linker
aHer2- (AL11a-LP1)n [344]
DX-8951 derivative (DXd)
DNA topoisomerase 1 (TOP1)
US20240269308A1 aHer2- (AL6-LP1)n Linker
aHer2- (AL11a-LP13)n [344]
DX-8951 derivative (DXd)
DNA topoisomerase 1 (TOP1)
US20240269308A1 aHer2- (AL6-LP13)n Linker
aHer2- (AL11a-LP15)n [344]
DX-8951 derivative (DXd)
DNA topoisomerase 1 (TOP1)
US20240269308A1 aHer2- (AL6-LP15)n Linker
aHer2- (BL1-LP1)n [344]
DX-8951 derivative (DXd)
DNA topoisomerase 1 (TOP1)
US20240269308A1 aHer2- (AL6-LP1)n Linker
aHer2- (BL1-LP13)n [344]
DX-8951 derivative (DXd)
DNA topoisomerase 1 (TOP1)
US20240269308A1 aHer2- (AL6-LP13)n Linker
aHer2- (BL3b-LP1)n [344]
DX-8951 derivative (DXd)
DNA topoisomerase 1 (TOP1)
US20240269308A1 aHer2- (AL6-LP1)n Linker
HK40112818A Anti-Her2-AL1- LP9 [345]
US12209180B2 P3
Undisclosed
Anti-Her2-AL1- LP9 LINKER
HK40112818A Anti-Her2-AL1- LP4 [345]
US12209180B2 P3
Undisclosed
Anti-Her2-AL1- LP4 LINKER
HK40112818A Anti-Her2-AL1- LP3 [345]
US12209180B2 P3
Undisclosed
Anti-Her2-AL1- LP3 LINKER
HK40112818A Anti-Her2-AL1- LP1 [345]
US12209180B2 P3
Undisclosed
Anti-Her2-AL1- LP1 LINKER
HK40112818A Anti-Her2-BL2- LP1 [345]
US12209180B2 P3
Undisclosed
Anti-Her2-AL1- LP1 LINKER
HK40112818A Anti-Her2-AL1- LP2 [345]
US12209180B2 P3
Undisclosed
Anti-Her2-AL1- LP2 LINKER
HK40112818A Anti-Her2-AL1- LP20 [345]
US12209180B2 P3
Undisclosed
Anti-Her2-AL1- LP20 LINKER
HK40112818A Anti-Her2-AL1- LP22 [345]
US12209180B2 P3
Undisclosed
Anti-Her2-AL1- LP22 linker
HK40112818A Anti-Her2-BL2- LP22 [345]
US12209180B2 P3
Undisclosed
Anti-Her2-AL1- LP22 linker
HK40112818A Anti-Her2-AL1- LP10 [345]
US12209180B2 P3
Undisclosed
Anti-Her2-AL1- LP10 linker
HK40112818A Anti-Her2-AL1- LP11 [345]
US12209180B2 P3
Undisclosed
Anti-Her2-AL1- LP11 linker
HK40112818A Anti-Her2-AL1- LP12 [345]
US12209180B2 P3
Undisclosed
Anti-Her2-AL1- LP12 linker
HK40112818A Anti-Her2-AL1- LP23 [345]
Undisclosed
Undisclosed
Anti-Her2-AL1- LP23 linker
HK40112818A Anti-Her2-AL1- LP24 [345]
Undisclosed
Undisclosed
Anti-Her2-AL1- LP24 linker
HK40112818A Anti-Her2-AL1- LP25 [345]
Undisclosed
Undisclosed
Anti-Her2-AL1- LP25 linker
HK40112818A Anti-Her2-AL1- LP26 [345]
Undisclosed
Undisclosed
Anti-Her2-AL1- LP26 linker
HK40112818A Anti-Her2-AL1- LP28 [345]
Undisclosed
Undisclosed
Anti-Her2-AL1- LP28 linker
Control-AL1- LP28 [345]
Undisclosed
Undisclosed
Anti-Her2-AL1- LP28 linker
HK40112818A Anti-Her2-BL21- LP28 [345]
Undisclosed
Undisclosed
Anti-Her2-AL1- LP28 linker
HK40112818A Anti-Her2-AL1- LP30 [345]
Undisclosed
Undisclosed
Anti-Her2-AL1- LP30 linker
HK40112818A Anti-Her2-AL1- LP32 [345]
Undisclosed
Undisclosed
Anti-Her2-AL1- LP32 linker
HK40112818A Anti-Her2-BL2- LP32 [345]
Undisclosed
Undisclosed
Anti-Her2-AL1- LP32 linker
HK40112818A Anti-Her2-AL1- LP34 [345]
Undisclosed
Undisclosed
Anti-Her2-AL1- LP32 linker
HK40112818A Anti-Her2-AL1- LP35 [345]
Undisclosed
Undisclosed
Anti-Her2-AL1- LP35 LINKER linker
HK40112818A Anti-Her2-AL1- LP36 [345]
Undisclosed
Undisclosed
Anti-Her2-AL1- LP36 linker
HK40112818A Anti-Her2-AL1- LP37 [345]
Undisclosed
Undisclosed
Anti-Her2-AL1- LP37 linker
HK40112818A Anti-Her2-AL1- LP38 [345]
Undisclosed
Undisclosed
Anti-Her2-AL1- LP38 linker
HK40112818A Anti-Her2-BL2- LP38 [345]
Undisclosed
Undisclosed
Anti-Her2-AL1- LP38 linker
HK40112818A Anti-Her2-AL1- LP39 [345]
Undisclosed
Undisclosed
Anti-Her2-AL1- LP41 linker
HK40112818A Anti-Her2-BL2- LP39 [345]
Undisclosed
Undisclosed
Undisclosed
HK40112818A Anti-Her2-AL1- LP41 [345]
Undisclosed
Undisclosed
Anti-Her2-AL1- LP40 linker
HK40112818A Anti-Her2-BL2- LP41 [345]
Undisclosed
Undisclosed
Anti-Her2-AL1- LP41 linker
HK40112818A Anti-Her2-LP16 [345]
US12209180B2 P3
Undisclosed
Anti-Her2-LP16 linker
HK40112818A Anti-Her2-LP21 [345]
Undisclosed
Undisclosed
Anti-Her2-LP21 linker
HK40112818A Anti-Her2-LP27 [345]
Undisclosed
Undisclosed
Anti-Her2-LP27 linker
HK40112818A Anti-Her2-LP31 [345]
Undisclosed
Undisclosed
Anti-Her2-LP31 linker
HK40112818A Anti-Her2-qLP18 [345]
Undisclosed
Undisclosed
Undisclosed
CA2975383C example16 [346]
Tubulin inhibitor A
Undisclosed
Undisclosed
CA2975383C example17 [346]
Tubulin inhibitor A
Undisclosed
Undisclosed
CA2975383C example19 [346]
Tubulin inhibitor C
Undisclosed
Undisclosed
CA2975383C example64 [346]
CA2975383C example64 payload
Undisclosed
Undisclosed
CA2975383C example21 [346]
Tubulin inhibitor A
Undisclosed
Undisclosed
CA2975383C example22 [346]
Tubulin inhibitor A
Undisclosed
Undisclosed
CA2975383C example23 [346]
Tubulin inhibitor A
Undisclosed
Undisclosed
CA2975383C example24 [346]
CA2975383C example24 payload
Undisclosed
Undisclosed
CA2975383C example28 [346]
Tubulin inhibitor C
Undisclosed
Undisclosed
CA2975383C example65 [346]
Tubulin inhibitor C
Undisclosed
Undisclosed
WO2024043319A1 78 [347]
Undisclosed
Undisclosed
Undisclosed
H-1-VcMMAE [348]
Undisclosed
Undisclosed
Undisclosed
H-1-MMAF [348]
Undisclosed
Undisclosed
Undisclosed
H-3-VcMMAE [348]
Undisclosed
Undisclosed
Undisclosed
H-3-MMAF [348]
Undisclosed
Undisclosed
Undisclosed
H-4-VcMMAE [348]
Undisclosed
Undisclosed
Undisclosed
H-4-MMAF [348]
Undisclosed
Undisclosed
Undisclosed
Maa-C6-Val-Ala-PAB-MMAE [79]
Monomethyl auristatin E
Microtubule (MT)
Maa-C6-Val-Ala-PAB
Maa-C6-Val-Cit-PAB-MMAE [79]
Monomethyl auristatin E
Microtubule (MT)
Maa-C6-Val-Cit-PAB
Mf-C6-Val-Ala-PAB-MMAE [79]
Monomethyl auristatin E
Microtubule (MT)
Mm-C6-Val-Ala-PAB
Mf-C3-Val-Ala-PAB-MMAE [79]
Monomethyl auristatin E
Microtubule (MT)
Mm-C3-Val-Ala-PAB
Mf-C6-Val-Cit-PAB-MMAE [79]
Monomethyl auristatin E
Microtubule (MT)
Mf-C6-Val-Cit-PAB
Mm-C6-Val-Ala-PAB-MMAE [79]
Monomethyl auristatin E
Microtubule (MT)
Mm-C6-Val-Ala-PAB
Mm-C3-Val-Ala-PAB-MMAE [79]
Monomethyl auristatin E
Microtubule (MT)
Mm-C3-Val-Ala-PAB
Mm-C6-Val-Cit-PAB-MMAE [79]
Monomethyl auristatin E
Microtubule (MT)
Mm-C6-Val-Cit-PAB
JY201 [89]
Undisclosed
Undisclosed
Mc-Val-Cit-PABC
JY201b [89]
Undisclosed
Undisclosed
Mc-Val-Cit-PABC
Ab[AL- LP1] 4 [349]
Exatecan
DNA topoisomerase 1 (TOP1)
Undisclosed
Ab[AL- LP2] 4 [349]
Exatecan
DNA topoisomerase 1 (TOP1)
Undisclosed
Ab[AL- LP3] 4 [349]
Exatecan
DNA topoisomerase 1 (TOP1)
Undisclosed
Ab[AL- LP4] 4 [349]
Exatecan
DNA topoisomerase 1 (TOP1)
Undisclosed
Ab[AL- LP8] 4 [349]
Exatecan
DNA topoisomerase 1 (TOP1)
Undisclosed
Ab[AL- LP9] 4 [349]
Exatecan
DNA topoisomerase 1 (TOP1)
Undisclosed
Ab[AL- LP3] [349]
Exatecan
DNA topoisomerase 1 (TOP1)
Undisclosed
Ab[AL- LP8] [349]
Exatecan
DNA topoisomerase 1 (TOP1)
Undisclosed
Ab[AL- LP9] [349]
DX-8951 derivative (DXd)
DNA topoisomerase 1 (TOP1)
Undisclosed
Ab[AL2- LP1] 4 [349]
Exatecan
DNA topoisomerase 1 (TOP1)
Undisclosed
Ab[AL2- LP17]n [349]
DX-8951 derivative (DXd)
DNA topoisomerase 1 (TOP1)
Undisclosed
Ab[AL2- LP17] [349]
DX-8951 derivative (DXd)
DNA topoisomerase 1 (TOP1)
Undisclosed
JP2025502147A aHer2 Ab [349]
Undisclosed
Undisclosed
Undisclosed
Isotype Control Ab [349]
Undisclosed
Undisclosed
Undisclosed
aHer2 (Handle)n [349]
Undisclosed
Undisclosed
Undisclosed
Isotype Control- (Handle)n [349]
Undisclosed
Undisclosed
Undisclosed
JP2025502147A ADC1 [349]
undisclosed
Undisclosed
Undisclosed
JP2025502147A ADC2 [349]
Undisclosed
Undisclosed
Undisclosed
JP2025502147A ADC3 [349]
undisclosed
Undisclosed
Undisclosed
Isotype Control ADC [349]
Undisclosed
Undisclosed
Undisclosed
JP2025502147A ADC4 [349]
Undisclosed
Undisclosed
Undisclosed
JP2025502147A ADC5 [349]
Exatecan
DNA topoisomerase 1 (TOP1)
Undisclosed
JP2025502147A ADC6 [349]
Exatecan
DNA topoisomerase 1 (TOP1)
Undisclosed
JP2025502147A ADC7 [349]
Exatecan
DNA topoisomerase 1 (TOP1)
Undisclosed
JP2025502147A ADC8 [349]
Exatecan
DNA topoisomerase 1 (TOP1)
Undisclosed
HER2-L078-055 [350]
Undisclosed
Undisclosed
Undisclosed
HER2-L078-056 [350]
Undisclosed
Undisclosed
Undisclosed
HER2-L078-062 [350]
Undisclosed
Undisclosed
Undisclosed
HER2-L078-063 [350]
Undisclosed
Undisclosed
Undisclosed
HER2-SET0218 (1) [350]
Undisclosed
Undisclosed
Undisclosed
STI1499-SET0218 6.2-6.4 [350]
Undisclosed
Undisclosed
Undisclosed
HER2-L078-030-LT [350]
Undisclosed
Undisclosed
Undisclosed
HER2-L078-044 [350]
Undisclosed
Undisclosed
Undisclosed
HER2-L078-045 [350]
Undisclosed
Undisclosed
Undisclosed
HER2-L078-057 [350]
Undisclosed
Undisclosed
Undisclosed
HER2-L078-058 [350]
Undisclosed
Undisclosed
Undisclosed
HER2-L078-059 [350]
Undisclosed
Undisclosed
Undisclosed
HER2-L078-064 [350]
Undisclosed
Undisclosed
Undisclosed
HER2-L078-065LT [350]
Undisclosed
Undisclosed
Undisclosed
HER2-L078-066LT [350]
Undisclosed
Undisclosed
Undisclosed
HER2-SET0218 (2) [350]
Undisclosed
Undisclosed
Undisclosed
STI1499-SET0218 3.8-4.1 [350]
Undisclosed
Undisclosed
Undisclosed
HER2-L079-018 [350]
Undisclosed
Undisclosed
Undisclosed
HER2-L079-019 [350]
Undisclosed
Undisclosed
Undisclosed
HER2-L079-027 [350]
Undisclosed
Undisclosed
Undisclosed
HER2-L079-034 [350]
Undisclosed
Undisclosed
Undisclosed
HER2-L079-035 [350]
Undisclosed
Undisclosed
Undisclosed
HER2-L079-040 [350]
Undisclosed
Undisclosed
Undisclosed
HER2-L078-121 [350]
Undisclosed
Undisclosed
Undisclosed
HER2-L078-118 [350]
Undisclosed
Undisclosed
Undisclosed
HER2-L078-119 [350]
Undisclosed
Undisclosed
Undisclosed
HER2-L078-120 [350]
Undisclosed
Undisclosed
Undisclosed
HER2-L078-177 [350]
Undisclosed
Undisclosed
Undisclosed
HER2-L078-130 [350]
Undisclosed
Undisclosed
Undisclosed
HER2-L078-123 [350]
Undisclosed
Undisclosed
Undisclosed
HER2-L078-163 [350]
Undisclosed
Undisclosed
Undisclosed
HER2-L078-164 [350]
Undisclosed
Undisclosed
Undisclosed
HER2-L078-173 [350]
Undisclosed
Undisclosed
Undisclosed
HER2-L078-170 [350]
Undisclosed
Undisclosed
Undisclosed
HER2-L078-171 [350]
Undisclosed
Undisclosed
Undisclosed
HER2-L078-178 [350]
Undisclosed
Undisclosed
Undisclosed
HER2-L078-182 [350]
Undisclosed
Undisclosed
Undisclosed
HER2-L081-034 [350]
Undisclosed
Undisclosed
Undisclosed
HER2-L081-036 [350]
Undisclosed
Undisclosed
Undisclosed
HER2-L081-038 [350]
Undisclosed
Undisclosed
Undisclosed
HER2-Dxd [350]
DX-8951 derivative (DXd)
DNA topoisomerase 1 (TOP1)
Undisclosed
US20230233540A1+ADC [351]
Undisclosed
Undisclosed
Mc-Gly-Gly-Phe-Gly
Her2-E380C-L443C [352]
Undisclosed
Undisclosed
Undisclosed
Her2-L443C 1 [352]
Undisclosed
Undisclosed
Undisclosed
Her2-E380C 1.9 [352]
Undisclosed
Undisclosed
Undisclosed
Her2-Q347C 2 [352]
Undisclosed
Undisclosed
Undisclosed
Her2-Q347C [352]
Undisclosed
Undisclosed
Undisclosed
Her2-Y373C 1.6 [352]
Undisclosed
Undisclosed
Undisclosed
Her2-Y373C 1.9 [352]
Undisclosed
Undisclosed
Undisclosed
Her2-E380C 2 [352]
Undisclosed
Undisclosed
Undisclosed
Her2-E380C+L443C [352]
Undisclosed
Undisclosed
Undisclosed
Her2-K392C 2 [352]
Undisclosed
Undisclosed
Undisclosed
Her2-K392C 1.9 [352]
Undisclosed
Undisclosed
Undisclosed
Her2-K392C+L443C [352]
Undisclosed
Undisclosed
Undisclosed
Her2-L398C+L443C [352]
Undisclosed
Undisclosed
Undisclosed
Her2-N421C 2 [352]
Undisclosed
Undisclosed
Undisclosed
Her2-N421C 2.1 [352]
Undisclosed
Undisclosed
Undisclosed
Her2-L443C 2 [352]
Undisclosed
Undisclosed
Undisclosed
Her2-L443C 3 [352]
Undisclosed
Undisclosed
Undisclosed
Her2-kappa-A111C [352]
Undisclosed
Undisclosed
Undisclosed
Her2-kappa-A111C+Q347C [352]
Undisclosed
Undisclosed
Undisclosed
Her2-kappa-A111C+K392C [352]
Undisclosed
Undisclosed
Undisclosed
Her2-kappa-A111C+L443C [352]
Undisclosed
Undisclosed
Undisclosed
Her2-kappa-K149C [352]
Undisclosed
Undisclosed
Undisclosed
Her2-kappa-K183C [352]
Undisclosed
Undisclosed
Undisclosed
Her2-kappa-K183C+L443C [352]
Undisclosed
Undisclosed
Undisclosed
Her2-kappa-K207C [352]
Undisclosed
Undisclosed
Undisclosed
Her2-kappa-K207C+L443C [352]
Undisclosed
Undisclosed
Undisclosed
WO2024138000A1 aHer2 Ab [353]
Undisclosed
Undisclosed
Undisclosed
aHer2- (AL11a)4 [353]
Undisclosed
Undisclosed
Undisclosed
aHer2- (AL2a)4 [353]
Undisclosed
Undisclosed
Undisclosed
aHer2- (AL3a)3.94 [353]
Undisclosed
Undisclosed
Undisclosed
aHer2- (AL7)4 [353]
Undisclosed
Undisclosed
Undisclosed
aHer2- (AL6)3.6 [353]
Undisclosed
Undisclosed
Undisclosed
aHer2- (BL1)3.9 [353]
Undisclosed
Undisclosed
Undisclosed
aHer2- (BL3b)3.8 [353]
Undisclosed
Undisclosed
Undisclosed
aHer2- (AL6-LP1)3.6 [353]
aHer2- (AL6-LP1)3.6 Payload
Undisclosed
aHer2- (AL6-LP1)3.6 Linker
aHer2- (AL6-LP13D)6.2 [353]
DX-8951 derivative (DXd)
DNA topoisomerase 1 (TOP1)
aHer2- (AL6-LP13D)6.2 Linker
aHer2- (AL6-LP13)6.5 [353]
aHer2- (AL6-LP1)3.6 Payload
Undisclosed
aHer2- (AL6-LP13)6.5 Linker
aHer2- (AL7-LP1)3.7 [353]
aHer2- (AL6-LP1)3.6 Payload
Undisclosed
aHer2- (AL7-LP1)3.7 Linker
aHer2- (AL7-LP13)7.3 [353]
aHer2- (AL6-LP1)3.6 Payload
Undisclosed
aHer2- (AL7-LP13)7.3 Linker
aHer2- (AL7-LP2)3.83 [353]
aHer2- (AL7-LP2)3.83 Payload
Undisclosed
aHer2- (AL7-LP2)3.83 Linker
aHer2- (AL7-LP3)3.88 [353]
DX-8951 derivative (DXd)
DNA topoisomerase 1 (TOP1)
aHer2- (AL7-LP2)3.83 Linker
aHer2- (AL7-LP4)3.84 [353]
DX-8951 derivative (DXd)
DNA topoisomerase 1 (TOP1)
aHer2- (AL7-LP2)3.83 Linker
aHer2- (AL7-LP5)3.80 [353]
aHer2- (AL7-LP5)3.80 Payload
Undisclosed
aHer2- (AL7-LP5)3.80 Linker
aHer2- (AL7-LP7)3.70 [353]
aHer2- (AL7-LP7)3.70 Payload
Undisclosed
aHer2- (AL7-LP2)3.83 Linker
aHer2- (AL7-LP9)3.81 [353]
undisclosed
Undisclosed
aHer2- (AL7-LP2)3.83 Linker
aHer2- (AL7-LP12)3.82 [353]
aHer2- (AL7-LP12)3.82 Payload
Undisclosed
aHer2- (AL7-LP12)3.82 Linker
aHer2- (AL7-LP5D)3.89 [353]
aHer2- (AL7-LP5D)3.89 Payload
Undisclosed
aHer2- (AL7-LP12)3.82 Linker
aHer2- (AL7-LP5D)3.90 [353]
aHer2- (AL7-LP5D)3.89 Payload
Undisclosed
aHer2- (AL7-LP12)3.82 Linker
aHer2- (AL4c-LP1B)3.49 [353]
aHer2- (AL4c-LP1B)3.49 Payload
Undisclosed
aHer2- (AL4c-LP1B)3.49 Linker
aHer2- (AL4c-LP13C)7.07 [353]
undisclosed
Undisclosed
aHer2- (AL4c-LP13C)7.07 Linker
aHer2- (AL4c-LP13C)7.11 [353]
undisclosed
Undisclosed
aHer2- (AL4c-LP13C)7.07 Linker
aHer2- (AL11a-LP1)4 [353]
aHer2- (AL6-LP1)3.6 Payload
Undisclosed
aHer2- (AL7-LP2)3.83 Linker
aHer2- (AL11a-LP13)7.8 [353]
aHer2- (AL6-LP1)3.6 Payload
Undisclosed
aHer2- (AL11a-LP13)7.8 Linker
aHer2- (AL11a-LP15)7.6 [353]
DX-8951 derivative (DXd)
DNA topoisomerase 1 (TOP1)
aHer2- (AL11a-LP15)7.6 Linker
aHer2- (BL1-LP1)7.7 [353]
aHer2- (AL6-LP1)3.6 Payload
Undisclosed
aHer2- (BL1-LP1)7.7 Linker
aHer2- (BL1-LP13)14.88 [353]
aHer2- (AL6-LP1)3.6 Payload
Undisclosed
aHer2- (BL1-LP13)14.88 Linker
aHer2- (BL3b-LP1)7.5 [353]
aHer2- (AL4c-LP1B)3.49 Payload
Undisclosed
aHer2- (BL3b-LP1)7.5 Linker
aHer2 1- (Mc-GGFG-DXD)7.7 [353]
DX-8951 derivative (DXd)
DNA topoisomerase 1 (TOP1)
Mc-Gly-Gly-Phe-Gly
aHer2 2- (Mc-GGFG-DXD)7.7 [353]
DX-8951 derivative (DXd)
DNA topoisomerase 1 (TOP1)
Mc-Gly-Gly-Phe-Gly
aHer2 3- (Mc-GGFG-DXD)7.7 [353]
DX-8951 derivative (DXd)
DNA topoisomerase 1 (TOP1)
Mc-Gly-Gly-Phe-Gly
aHer2 1- (Mc-GGFG-DXD)7.1 [353]
DX-8951 derivative (DXd)
DNA topoisomerase 1 (TOP1)
Mc-Gly-Gly-Phe-Gly
aHer2 2- (Mc-GGFG-DXD)7.1 [353]
DX-8951 derivative (DXd)
DNA topoisomerase 1 (TOP1)
Mc-Gly-Gly-Phe-Gly
aHer2 3- (Mc-GGFG-DXD)7.1 [353]
DX-8951 derivative (DXd)
DNA topoisomerase 1 (TOP1)
Mc-Gly-Gly-Phe-Gly
AU2017341000B2 ADC (1) [354]
DX-8951 derivative (DXd)
DNA topoisomerase 1 (TOP1)
Mc-Gly-Gly-Phe-Gly
TW202500135A-1 [355]
TW202500135A-1 payload
Undisclosed
Mc-Gly-Gly-Phe-Gly
CN114106088A ADC6 [356]
Tubulin inhibitor B
Microtubule (MT)
CN114106088A+ADC1+Linker
CN114106088A ADC7 [356]
Tubulin inhibitor B
Microtubule (MT)
CN114106088A+ADC2+Linker
CN114106088A ADC8 [356]
Tubulin inhibitor B
Microtubule (MT)
CN114106088A+ADC3+Linker
CN114106088A ADC9 [356]
Tubulin inhibitor B
Microtubule (MT)
CN114106088A+ADC4+Linker
CN114106088A ADC10 [356]
Tubulin inhibitor B
Microtubule (MT)
CN114106088A+ADC5+Linker
LN401-31-1 [356]
Tubulin inhibitor B
Microtubule (MT)
CN114106088A+ADC1+Linker
LN401-31-2 [356]
Tubulin inhibitor B
Microtubule (MT)
CN114106088A+ADC2+Linker
LN401-90-5 [356]
Tubulin inhibitor B
Microtubule (MT)
CN114106088A+ADC3+Linker
LN401-90-6 [356]
Tubulin inhibitor B
Microtubule (MT)
CN114106088A+ADC4+Linker
LN401-90-4 [356]
Tubulin inhibitor B
Microtubule (MT)
CN114106088A+ADC5+Linker
US12195552B2 ADC1 [262]
Undisclosed
Undisclosed
Undisclosed
US12195552B2 ADC2 [357]
Undisclosed
Undisclosed
Undisclosed
US12195552B2 ADC3 [357]
Undisclosed
Undisclosed
Undisclosed
US12195552B2 ADC4 [357]
Undisclosed
Undisclosed
Undisclosed
US12195552B2 ADC5 [357]
Undisclosed
Undisclosed
Undisclosed
US12195552B2 ADC6 [357]
Undisclosed
Undisclosed
Undisclosed
US12195552B2 ADC7 [357]
Undisclosed
Undisclosed
Undisclosed
US12195552B2 ADC8 [357]
Undisclosed
Undisclosed
Undisclosed
US12195552B2 ADC9 [357]
Undisclosed
Undisclosed
Undisclosed
US12195552B2 ADC10 [357]
Undisclosed
Undisclosed
Undisclosed
US12195552B2 ADC11 [357]
Undisclosed
Undisclosed
Undisclosed
US12195552B2 ADC12 [357]
Undisclosed
Undisclosed
Undisclosed
US12195552B2 ADC13 [357]
Undisclosed
Undisclosed
Undisclosed
US12195552B2 ADC14 [357]
Undisclosed
Undisclosed
Undisclosed
US12195552B2 ADC15 [357]
Undisclosed
Undisclosed
Undisclosed
US12195552B2 ADC16 [357]
Undisclosed
Undisclosed
Undisclosed
US12195552B2 ADC17 [357]
Undisclosed
Undisclosed
Undisclosed
US12195552B2 ADC18 [357]
Undisclosed
Undisclosed
Undisclosed
US12195552B2 ADC19 [357]
Undisclosed
Undisclosed
Undisclosed
US12195552B2 ADC20 [357]
Undisclosed
Undisclosed
Undisclosed
US12195552B2 ADC21 [357]
Undisclosed
Undisclosed
Undisclosed
US12195552B2 ADC22 [357]
Undisclosed
Undisclosed
Undisclosed
US12195552B2 ADC23 [357]
Undisclosed
Undisclosed
Undisclosed
US12195552B2 ADC24 [357]
Undisclosed
Undisclosed
Undisclosed
US12195552B2 ADC25 [357]
Undisclosed
Undisclosed
Undisclosed
US12195552B2 ADC26 [357]
Undisclosed
Undisclosed
Undisclosed
US12195552B2 ADC27 [357]
Undisclosed
Undisclosed
Undisclosed
US12195552B2 ADC28 [357]
Undisclosed
Undisclosed
Undisclosed
US12195552B2 ADC29 [357]
Undisclosed
Undisclosed
Undisclosed
US12195552B2 ADC30 [357]
Undisclosed
Undisclosed
Undisclosed
US12195552B2 ADC31 [357]
Undisclosed
Undisclosed
Undisclosed
US12195552B2 ADC32 [357]
Undisclosed
Undisclosed
Undisclosed
US12195552B2 ADC33 [357]
Undisclosed
Undisclosed
Undisclosed
US12195552B2 ADC34 [357]
Undisclosed
Undisclosed
Undisclosed
US12195552B2 ADC35 [357]
Undisclosed
Undisclosed
Undisclosed
US12195552B2 ADC36 [357]
Undisclosed
Undisclosed
Undisclosed
US12195552B2 ADC37 [357]
Undisclosed
Undisclosed
Undisclosed
US12195552B2 ADC38 [357]
Undisclosed
Undisclosed
Undisclosed
US12195552B2 ADC39 [357]
Undisclosed
Undisclosed
Undisclosed
US12195552B2 ADC40 [357]
Undisclosed
Undisclosed
Undisclosed
US12195552B2 ADC41 [357]
undisclosed
Undisclosed
Undisclosed
US12195552B2 ADC42 [357]
undisclosed
Undisclosed
Undisclosed
US12195552B2 ADC43 [357]
undisclosed
Undisclosed
Undisclosed
US12195552B2 ADC44 [357]
undisclosed
Undisclosed
Undisclosed
US12195552B2 ADC45 [357]
undisclosed
Undisclosed
Undisclosed
US12195552B2 ADC46 [357]
undisclosed
Undisclosed
Undisclosed
US12195552B2 ADC47 [357]
undisclosed
Undisclosed
Undisclosed
US12195552B2 ADC48 [357]
undisclosed
Undisclosed
Undisclosed
BR122024023391 antibody-drug conjugate (1) [358]
undisclosed
Undisclosed
Undisclosed
30kmPEG (SCAHer2 (1)xSCAHer2 (2))-2 (Val-Cit-PAB-DEA-SN38) [359]
Active metabolite of irinotecan SN38
DNA topoisomerase 1 (TOP1)
Undisclosed
30kmPEG (SCAHer2 (1)xSCAHer2 (2))-3 (Val-Cit-PAB-DEA-SN38) [359]
Active metabolite of irinotecan SN38
DNA topoisomerase 1 (TOP1)
Undisclosed
WO2024118785A3 Lot1 [69]
Undisclosed
Undisclosed
Undisclosed
WO2024118785A3 Lot8 [69]
Undisclosed
Undisclosed
Undisclosed
WO2024118785A3 Lot9 [69]
Undisclosed
Undisclosed
Undisclosed
WO2024118785A3 Lot13 [69]
Undisclosed
Undisclosed
Undisclosed
WO2024118785A3 Lot15 [69]
Undisclosed
Undisclosed
Undisclosed
WO2024118785A3 Lot16 [69]
Undisclosed
Undisclosed
Undisclosed
WO2024118785A3 Lot17 [69]
Undisclosed
Undisclosed
Undisclosed
WO2024118785A3 Lot25 [69]
Undisclosed
Undisclosed
Undisclosed
WO2024118785A3 Lot26 [69]
Undisclosed
Undisclosed
Undisclosed
WO2024118785A3 Lot27 [69]
Undisclosed
Undisclosed
Undisclosed
WO2024118785A3 Lot28 [69]
P9
Undisclosed
Undisclosed
WO2024118785A3 Lot29 [69]
Undisclosed
Undisclosed
Undisclosed
WO2024118785A3 Lot30 [69]
Undisclosed
Undisclosed
Undisclosed
WO2024118785A3 Lot31 [69]
Undisclosed
Undisclosed
Undisclosed
WO2024118785A3 Lot32 [69]
Undisclosed
Undisclosed
Undisclosed
WO2024118785A3 Lot37 [69]
Undisclosed
Undisclosed
Undisclosed
WO2024118785A3 Lot44 [69]
Undisclosed
Undisclosed
Undisclosed
WO2024118785A3 Lot45 [69]
Undisclosed
Undisclosed
Undisclosed
WO2024118785A3 Lot46 [69]
Undisclosed
Undisclosed
Undisclosed
WO2024118785A3 Lot47 [69]
P9
Undisclosed
Undisclosed
WO2024118785A3 Lot51 [69]
Undisclosed
Undisclosed
Undisclosed
WO2024118785A3 Lot60 [69]
P9
Undisclosed
Undisclosed
WO2024118785A3 Lot63 [69]
P9
Undisclosed
Undisclosed
WO2024118785A3 Lot72 [69]
Undisclosed
Undisclosed
Undisclosed
WO2024118785A3 Lot73 [69]
Undisclosed
Undisclosed
Undisclosed
WO2024118785A3 Lot81 [69]
Undisclosed
Undisclosed
Undisclosed
WO2024118785A3 Lot82 [69]
P9
Undisclosed
Undisclosed
WO2024118785A3 Lot83 [69]
P9
Undisclosed
Undisclosed
WO2024118785A3 Lot84 [69]
Undisclosed
Undisclosed
Undisclosed
WO2024118785A3 Lot85 [69]
Undisclosed
Undisclosed
Undisclosed
WO2024118785A3 Lot86 [69]
P9
Undisclosed
Undisclosed
WO2024118785A3 Lot87 [69]
P9
Undisclosed
Undisclosed
WO2024118785A3 Lot88 [69]
Undisclosed
Undisclosed
Undisclosed
WO2024118785A3 Lot89 [69]
Undisclosed
Undisclosed
Undisclosed
WO2024118785A3 Lot90 [69]
Undisclosed
Undisclosed
Undisclosed
Anti-HER-N297Q-Ex18 [360]
Undisclosed
Undisclosed
Undisclosed
Anti-HER-N297Q-Ex27 [360]
Undisclosed
Undisclosed
Undisclosed
SG11202200215QA ADC1 [361]
Ceritinib
Undisclosed
SG11202200215QA ADC5 linker
SG11202200215QA ADC2 [361]
MK4827
Undisclosed
SG11202200215QA ADC5 linker
SG11202200215QA ADC3 [361]
Active metabolite of irinotecan SN38
DNA topoisomerase 1 (TOP1)
SG11202200215QA ADC3 linker
SG11202200215QA ADC4 [361]
Exatecan
DNA topoisomerase 1 (TOP1)
SG11202200215QA ADC5 linker
SG11202200215QA ADC5 [361]
DX-8951 derivative (DXd)
DNA topoisomerase 1 (TOP1)
SG11202200215QA ADC5 linker
WO2021260582A1 ADC-1 [362]
Exatecan
DNA topoisomerase 1 (TOP1)
Mc-Gly-Gly-Phe-Gly
Production of the antibody-drug conjugate (1) [363]
undisclosed
Undisclosed
Undisclosed
References
Ref 1 Antibody-drug conjugates (A2DCs) with enzymatically cleavable groups
Ref 2 A HER2 Specific Nanobody-Drug Conjugate: Site-Selective Bioconjugation and In Vitro Evaluation in Breast Cancer Models
Ref 3 Anthracycline disulfide intermediates, antibody-drug conjugates and methods
Ref 4 Antibody drug conjugates comprising STING agonists, combinations and methods of use
Ref 5 Pharmaceutical composition of antibody-drug conjugates
Ref 6 Targeting HER2 Expressing Tumors with a Potent Drug Conjugate Based on an Albumin Binding Domain-Derived Affinity Protein. Pharmaceutics. 2021 Nov 3;13(11):1847.
Ref 7 Bioactive substance conjugate, preparation method therefor and use thereof; 2022-08-18.
Ref 8 Utilization of the Angiopep platform to enable brain penetration of therapeutic mAbs or Antibody-Drug Conjugates for treatment of brain tumors. Cancer Res (2014) 74 (19_Supplement): 2657.
Ref 9 Effect of vitamin D analog (1alpha hydroxy D5) immunoconjugated to Her-2 antibody on breast cancer. Int J Cancer. 2004 Mar 1;108(6):922-9. doi: 10.1002/ijc.11590.
Ref 10 Heteroaryl sulfone-based conjugation handles, methods for their preparation, and their use in synthesizing antibody drug conjugates
Ref 11 Antibody Conjugation of a Chimeric BET Degrader Enables in?vivo Activity. ChemMedChem. 2020 Jan 7;15(1):17-25. doi: 10.1002/cmdc.201900497. Epub 2019 Nov 14.
Ref 12 Cytotoxic peptides and conjugates thereof.
Ref 13 Auristatin derivatives and conjugates thereof.
Ref 14 Cysteine engineered antibodies and conjugates.
Ref 15 Oligosaccharide linkers, linker-payloads comprising the linkers, and glycan chain-remodeled antibody-drug conjugates, preparation methods and uses thereof
Ref 16 Sculpting a Uniquely Reactive Cysteine Residue for Site-Specific Antibody Conjugation. Bioconjug Chem. 2022 Jun 15;33(6):1192-1200.
Ref 17 Application of a Biocatalytic Strategy for the Preparation of Tiancimycin-Based Antibody-Drug Conjugates Revealing Key Insights into Structure-Activity Relationships. J Med Chem. 2023 Jan 26;66(2):1562-1573. doi: 10.1021/acs.jmedchem.2c01771.
Ref 18 A single-chain fab derived drug conjugate for HER2 specific delivery
Ref 19 Antibody-drug conjugates with HER2-targeting antibodies from synthetic antibody libraries are highly potent against HER2-positive human gastric tumor in xenograft models. MAbs. 2019 Jan;11(1):153-165. doi: 10.1080/19420862.2018.1541370. Epub 2018 Nov 8.
Ref 20 Introduction to basic information on ADC drug ADC2202
Ref 21 Phosphate based linkers for intracellular delivery of drug conjugates; 2015-10-08.
Ref 22 Intratumoral Payload Concentration Correlates with the Activity of Antibody-Drug Conjugates. Mol Cancer Ther. 2018 Mar;17(3):677-685. doi: 10.1158/1535-7163.MCT-17-0697. Epub 2018 Jan 18.
Ref 23 Covalent linkers in antibody-drug conjugates and methods of making and using the same.
Ref 24 Antibody drug conjugate and application thereof.
Ref 25 Site-specific antibody-drug conjugation through glycoengineering.
Ref 26 Glutamic acid-valine-citrulline linkers ensure stability and efficacy of antibody-drug conjugates in mice. Nat Commun. 2018 Jun 28;9(1):2512. doi: 10.1038/s41467-018-04982-3.
Ref 27 Tridentate connexon and use thereof.
Ref 28 Preparation and characterization of antibody-drug conjugates acting on HER2-positive cancer cells. PLoS One. 2020 Sep 28;15(9):e0239813. doi: 10.1371/journal.pone.0239813. eCollection 2020.
Ref 29 Stable and Potent Selenomab-Drug Conjugates. Cell Chem Biol. 2017 Apr 20;24(4):433-442.e6. doi: 10.1016/j.chembiol.2017.02.012.
Ref 30 Site-specific antibody-drug conjugation through glycoengineering
Ref 31 Amatoxin antibody-drug conjugates and uses thereof; 2020-10-29.
Ref 32 Genetically Encoded Azide Containing Amino Acid in Mammalian Cells Enables Site-Specific Antibody-Drug Conjugates Using Click Cycloaddition Chemistry. Bioconjug Chem. 2015 Nov 18;26(11):2249-60. doi: 10.1021/acs.bioconjchem.5b00359.
Ref 33 Antibody-drug conjugates for removing hematopoietic stem cells
Ref 34 A Novel NAMPT Inhibitor-Based Antibody-Drug Conjugate Payload Class for Cancer Therapy. Bioconjug Chem. 2022 Jun 15;33(6):1210-1221.
Ref 35 Introduction to basic information on ADC Anvatabart pactil.
Ref 36 Hiding Payload Inside the IgG Fc Cavity Significantly Enhances the Therapeutic Index of Antibody-Drug Conjugates. J Med Chem. 2023 Jan 12;66(1):1011-1026. doi: 10.1021/acs.jmedchem.2c01812. Epub 2022 Dec 30.
Ref 37 A novel anti-HER2/EGFR bispecific antibody-drug conjugate demonstrates promising antitumor efficacy and overcomes resistance to HER2- or EGFR-targeted ADCs
Ref 38 Conditionally active anti-her2 antibodies, antibody fragments their immunoconjugates and uses thereof; 2021-07-29.
Ref 39 Antibody-Drug Conjugates with Pyrrole-Based KSP Inhibitors as the Payload Class. Angew Chem Int Ed Engl. 2018 Nov 12;57(46):15243-15247. doi: 10.1002/anie.201807619. Epub 2018 Oct 15.
Ref 40 Tetravalent antibody-drug conjugates and uses thereof
Ref 41 Conjugates of antibodies and immune cell engagers
Ref 42 1-(chloromethyl)-2,3-dihydro-1h-benzo[e]indole dimer antibody-drug conjugate compounds, and methods of use and treatment.
Ref 43 Nickel-Catalyzed Antibody Bioconjugation
Ref 44 Selenium antibody conjugates
Ref 45 Leveraging a Dual Variable Domain Immunoglobulin to Create a Site-Specifically Modified Radioimmunoconjugate. Mol Pharm. 2023 Jan 2;20(1):775-782. doi: 10.1021/acs.molpharmaceut.2c00700. Epub 2022 Nov 15.
Ref 46 Antibody-drug conjugates for delivering cytotoxic agents using MATE technology
Ref 47 Synthesis and evaluation of pyrrolobenzodiazepine dimer antibody-drug conjugates with dual -glucuronide and dipeptide triggers. Eur J Med Chem. 2019 Oct 1;179:591-607.
Ref 48 Synthesis and in vitro evaluation of SG3227, a pyrrolobenzodiazepine dimer antibody-drug conjugate payload based on sibiromycin. Bioorg Med Chem Lett. 2017 Mar 1;27(5):1154-1158.
Ref 49 Antibody-drug conjugate comprising modified antibody
Ref 50 Preparation method for antibody-drug conjugate, and application; 2022-11-03.
Ref 51 Uses of antibody-drug conjugates
Ref 52 Antibody compositions comprising Fc mutations and site-specific conjugation properties for use in treating cancer, immunological disorders, and methods thereof
Ref 53 Linkers for use in antibody drug conjugates; 2023-03-16.
Ref 54 Calicheamicin derivatives and antibody drug conjugates thereof
Ref 55 Antibody-Drug Conjugates Used in Breast Cancers. J Oncol. 2021 Jun 24;2021:9927433. doi: 10.1155/2021/9927433. eCollection 2021.
Ref 56 Antibody-drug conjugates of N-haloalkyl substituted camptothecin derivatives
Ref 57 Antibody-drug conjugates of N-alkoxyalkyl substituted camptothecin derivatives
Ref 58 Antibody-drug conjugates of N-azidoalkyl substituted camptothecin derivatives
Ref 59 2'-deoxy-2',2'-difluorocytidine ProTides and antibody-drug conjugates and their preparation and uses
Ref 60 Bifunctional linker compounds, antibody-drug conjugates, and their preparation methods and uses
Ref 61 An auristatin-based antibody-drug conjugate targeting EphA2 in pancreatic cancer treatment
Ref 62 Antibody-drug conjugates of N-oxacycloalkyl substituted camptothecin derivatives
Ref 63 Antibody-drug conjugates, their preparation methods and applications
Ref 64 An Elaborate New Linker System Significantly Enhances the Efficacy of an HER2-Antibody-Drug Conjugate against Refractory HER2-Positive Cancers. Adv Sci (Weinh). 2021 Dec;8(23):e2102414. doi: 10.1002/advs.202102414. Epub 2021 Oct 18.
Ref 65 Antibody-drug conjugate intermediates and preparation methods thereof
Ref 66 Oligosaccharide linker, linker-payload comprising the same and glycan chain-remodeled antibody-drug conjugate, preparation methods and uses thereof
Ref 67 Use of hydroxypropyl-β-cyclodextrin in stabilizing antibody-drug conjugate formulations
Ref 68 Antibody-drug conjugates and production thereof
Ref 69 TLR7 agonists and antibody-drug conjugates thereof
Ref 70 Antibody-drug conjugates and uses thereof
Ref 71 Introduction to basic information on ADC drug trastuzumab vedotin.
Ref 72 Antibody-drug conjugate precursor and intermediate for synthesis thereof
Ref 73 Coumarin-containing linkers and antibody-drug conjugates comprising the linkers
Ref 74 Development of applicable thiol-linked antibody-drug conjugates with improved stability and therapeutic index. Drug Deliv. 2022 Dec;29(1):754-766.
Ref 75 Synthesis and evaluation of highly releasable and structurally stable antibody-SN-38-conjugates. Drug Deliv. 2021 Dec;28(1):2603-2617.
Ref 76 Antibody-Drug Conjugate Using Ionized Cys-Linker-MMAE as the Potent Payload Shows Optimal Therapeutic Safety. Cancers (Basel). 2020 Mar 21;12(3):744. doi: 10.3390/cancers12030744.
Ref 77 Novel Silyl Ether-Based Acid-Cleavable Antibody-MMAE Conjugates with Appropriate Stability and Efficacy. Cancers (Basel). 2019 Jul 8;11(7):957. doi: 10.3390/cancers11070957.
Ref 78 Development of applicable thiol-linked antibody-drug conjugates with improved stability and therapeutic index. Drug Deliv. 2022 Dec;29(1):754-766. doi: 10.1080/10717544.2022.2039807.
Ref 79 Linker, antibody-drug conjugate including same, and uses thereof
Ref 80 Branched pegylated linker-auristatin to control hydrophobicity for the production of homogeneous minibody-drug conjugate against HER2-positive breast cancer
Ref 81 Anti-HER2 Affibody-Conjugated Photosensitizer for Tumor Targeting Photodynamic Therapy. Mol Pharm. 2020 May 4;17(5):1546-1557. doi: 10.1021/acs.molpharmaceut.9b01247. Epub 2020 Apr 16.
Ref 82 Drug conjugates of imidazoquinoline amine derivatives, compositions and methods thereof
Ref 83 Abstract 3933: ORM-5029: A first-in-class targeted protein degradation therapy using antibody neodegrader conjugate (AnDC) for HER2-expressing breast cancer
Ref 84 Ligand-drug conjugate of exatecan analogue, preparation method therefor and application thereof; 2020-04-02.
Ref 85 Neodegrader conjugates; 2021-10-07.
Ref 86 Introduction to basic information on ADC drug ZV203; 6 Jan 2020.
Ref 87 Shifting the Antibody-Drug Conjugate Paradigm: A Trastuzumab-Gold-Based Conjugate Demonstrates High Efficacy against Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer Mouse Model
Ref 88 Preparation method for doubly substituted bridge-linked antibody-drug conjugates
Ref 89 Domide molecular glue derivative and use thereof
Ref 90 Computational-aided rational mutation design of pertuzumab to overcome active HER2 mutation S310F through antibody-drug conjugates
Ref 91 Regression of established breast carcinoma xenografts with antibody-directed enzyme prodrug therapy against c-erbB2 p185. Cancer Res. 1994 Oct 1;54(19):5171-7.
Ref 92 Pharmaceutical compositions of anti-HER2 antibody-drug conjugate
Ref 93 Novel masked antibodies
Ref 94 Production of site-specific antibody conjugates using metabolic glycoengineering and novel Fc glycovariants
Ref 95 Targeted delivery of dual payloads of MMAF or MMAE and TLR7 agonists for the treatment of cancer
Ref 96 PEGylated antibody hydroxyl-bearing drug conjugates
Ref 97 Antibody-drug conjugates
Ref 98 Pyrrolobenzodiazepine antibody drug conjugates and methods of use; 2017-04-06.
Ref 99 PROTAC antibody conjugates and methods of use
Ref 100 Pyrrolobenzodiazepines and conjugates thereof; 2015-04-09.
Ref 101 Silvestrol antibody-drug conjugates and methods of use; 2017-12-14.
Ref 102 Antibody-drug conjugates cleavable in a tumor microenvironment
Ref 103 Copper assisted sequence-specific chemical protein conjugation at a single backbone amide
Ref 104 Site-Selective Tyrosine Reaction for Antibody-Cell Conjugation and Targeted Immunotherapy
Ref 105 Trastuzumab emtansine: first global approval
Ref 106 Trastuzumab Deruxtecan in Previously Treated HER2-Low Advanced Breast Cancer
Ref 107 Introduction to basic information on ADC drug Trastuzumab rezetecan.
Ref 108 Spotlight on Trastuzumab Deruxtecan (DS-8201,T-DXd) for HER2 Mutation Positive Non-Small Cell Lung Cancer
Ref 109 Enzymatic glycan remodeling-metal free click (GlycoConnect) provides homogenous antibody-drug conjugates with improved stability and therapeutic index without sequence engineering. MAbs. 2022 Jan-Dec;14(1):2078466.
Ref 110 Transient Inhibition of Trastuzumab-Tumor Binding to Overcome the "Binding-Site Barrier" and Improve the Efficacy of a Trastuzumab-Gelonin Immunotoxin. Mol Cancer Ther. 2022 Oct 7;21(10):1573-1582.
Ref 111 Design and Characterization of Immune-Stimulating Imidazo[4,5-c]quinoline Antibody-Drug Conjugates. Mol Pharm. 2022 Sep 5;19(9):3228-3241.
Ref 112 Targeting HER2-positive breast cancer with trastuzumab-DM1, an antibody-cytotoxic drug conjugate. Cancer Res. 2008 Nov 15;68(22):9280-90.
Ref 113 Biological Evaluation of Maytansinoid-Based Site-Specific Antibody-Drug Conjugate Produced by Fully Chemical Conjugation Approach: AJICAP. Front Biosci (Landmark Ed). 2022 Aug 5;27(8):234.
Ref 114 Design and characterization of homogenous antibody-drug conjugates with a drug-to-antibody ratio of one prepared using an engineered antibody and a dual-maleimide pyrrolobenzodiazepine dimer. MAbs. 2019 Apr;11(3):500-515.
Ref 115 Highly Potent, Anthracycline-based Antibody-Drug Conjugates Generated by Enzymatic, Site-specific Conjugation. Mol Cancer Ther. 2017 May;16(5):879-892.
Ref 116 A new immunochemical strategy for triple-negative breast cancer therapy. Sci Rep. 2021 Jul 21;11(1):14875.
Ref 117 Synthesis and Evaluation of Three Azide-Modified Disaccharide Oxazolines as Enzyme Substrates for Single-Step Fc Glycan-Mediated Antibody-Drug Conjugation. Bioconjug Chem. 2022 Jun 15;33(6):1179-1191.
Ref 118 General and Robust Chemoenzymatic Method for Glycan-Mediated Site-Specific Labeling and Conjugation of Antibodies: Facile Synthesis of Homogeneous Antibody-Drug Conjugates. ACS Chem Biol. 2021 Nov 19;16(11):2502-2514.
Ref 119 The first ADC bearing the ferroptosis inducer RSL3 as a payload with conservation of the fragile electrophilic warhead. Eur J Med Chem. 2022 Dec 15;244:114863.
Ref 120 Design and Synthesis of Tesirine, a Clinical Antibody-Drug Conjugate Pyrrolobenzodiazepine Dimer Payload. ACS Med Chem Lett. 2016 May 24;7(11):983-987.
Ref 121 Introduction to basic information on ADC drug LIN-002.
Ref 122 Introduction to basic information on ADC drug trastuzumab imbotolimod.
Ref 123 HER2-targeted DEP SN-38 ADC outperforms in HER2+ human cancer model (ASX announcement); 2023
Ref 124 BN 80245: An E-ring modified camptothecin with potent antiproliferative and topoisomerase I inhibitory activities. Bioorg Med Chem Lett. 1997;7(17):2235-2238.
Ref 125 Fluorescence Imaging of Tumor-Accumulating Antibody-IR700 Conjugates Prior to Near-Infrared Photoimmunotherapy (NIR-PIT) Using a Commercially Available Camera Designed for Indocyanine Green. Mol Pharm. 2021 Mar 1;18(3):1238-1246. doi: 10.1021/acs.molpharmaceut.0c01107. Epub 2021 Jan 27.
Ref 126 Spirea secures more capital to develop nextgeneration ADC cancer therapeutics; 2020
Ref 127 Develop highly specific cell engager constructs with improved function and safety by understanding target-effector cell avidity.
Ref 128 Adcitmer , a new CD56-targeting monomethyl auristatin E-conjugated antibody, is a potential therapeutic approach in Merkel cell carcinoma. Br J Dermatol. 2022 Feb;186(2):295-306. doi: 10.1111/bjd.20770.
Ref 129 Therapeutic Potential of MF-TTZ-MMAE, a Site-Specifically Conjugated Antibody-Drug Conjugate, for the Treatment of HER2-Overexpressing Breast Cancer. Bioconjug Chem. 2022 Feb 16;33(2):418-426. doi: 10.1021/acs.bioconjchem.2c00015. Epub 2022 Feb 1.
Ref 130 Divinylpyrimidine reagents generate antibody-drug conjugates with excellent in vivo efficacy and tolerability. Chem Commun (Camb). 2022 Feb 8;58(12):1962-1965. doi: 10.1039/d1cc06766d.
Ref 131 N-terminal selective conjugation method widens the therapeutic window of antibody-drug conjugates by improving tolerability and stability. MAbs. 2021 Jan-Dec;13(1):1914885. doi: 10.1080/19420862.2021.1914885.
Ref 132 A novel anti-HER2 anthracycline-based antibody-drug conjugate induces adaptive anti-tumor immunity and potentiates PD-1 blockade in breast cancer. J Immunother Cancer. 2019 Jan 21;7(1):16. doi: 10.1186/s40425-018-0464-1.
Ref 133 Non-Genetic Generation of Antibody Conjugates Based on Chemoenzymatic Tyrosine Click Chemistry. Bioconjug Chem. 2021 Oct 20;32(10):2167-2172. doi: 10.1021/acs.bioconjchem.1c00351. Epub 2021 Sep 14.
Ref 134 The preclinical pharmacology of PRO1102, a novel exatecan-based HER2-directed antibody-drug conjugate with robust anti-tumor activity. Cancer Res (2022) 82 (12_Supplement): 1758.
Ref 135 Exatecan Antibody Drug Conjugates Based on a Hydrophilic Polysarcosine Drug-Linker Platform. Pharmaceuticals (Basel). 2021 Mar 9;14(3):247. doi: 10.3390/ph14030247.
Ref 136 Harnessing the power of antibodies to fight bone metastasis. Sci Adv. 2021 Jun 23;7(26):eabf2051. doi: 10.1126/sciadv.abf2051.
Ref 137 Payload diversification: a key step in the development of antibody-drug conjugates. J Hematol Oncol. 2023 Jan 17;16(1):3. doi: 10.1186/s13045-022-01397-y.
Ref 138 CRD5500: A versatile small molecule STING agonist amenable to bioconjugation as an ADC. Cancer Res (2019) 79 (13_Supplement): LB-061.
Ref 139 Trastuzumab-deBouganin Conjugate Overcomes Multiple Mechanisms of T-DM1 Drug Resistance. J Immunother. 2016 Apr;39(3):117-26. doi: 10.1097/CJI.0000000000000115.
Ref 140 N-Myristolytransferase (NMT) inhibitors as novel potent payloads for antibody drug conjugates. Cancer Res (2023) 83 (7_Supplement): 2635.
Ref 141 MI130004, a Novel Antibody-Drug Conjugate Combining Trastuzumab with a Molecule of Marine Origin, Shows Outstanding In Vivo Activity against HER2-Expressing Tumors. Mol Cancer Ther. 2018 Apr;17(4):786-794. doi: 10.1158/1535-7163.MCT-17-0795. Epub 2018 Feb 13.
Ref 142 Internalization of Foldamer-Based DNA Mimics through a Site-Specific Antibody Conjugate to Target HER2-Positive Cancer Cells. Pharmaceuticals (Basel). 2021 Jun 28;14(7):624. doi: 10.3390/ph14070624.
Ref 143 ErbB2 Targeted Epigenetic Modulation: Anti-tumor Efficacy of the ADC Trastuzumab-HDACi ST8176AA1. Front Oncol. 2020 Jan 23;9:1534. doi: 10.3389/fonc.2019.01534.
Ref 144 Site-specific construction of triptolide-based antibody-drug conjugates. Bioorg Med Chem. 2021 Dec 1;51:116497. doi: 10.1016/j.bmc.2021.116497. Epub 2021 Nov 10.
Ref 145 A HER2-targeted antibody-novel DNA topoisomerase I inhibitor conjugate induces durable adaptive antitumor immunity by activating dendritic cells. MAbs. 2023 Jan-Dec;15(1):2220466. doi: 10.1080/19420862.2023.2220466.
Ref 146 Generation of DAR1 Antibody-Drug Conjugates for Ultrapotent Payloads Using Tailored GlycoConnect Technology. Bioconjug Chem. 2023 Mar 15;34(3):538-548. doi: 10.1021/acs.bioconjchem.2c00611. Epub 2023 Mar 1.
Ref 147 Antibody conjugates for targeted delivery of Toll-like receptor 9 agonist to the tumor tissue. PLoS One. 2023 Mar 13;18(3):e0282831. doi: 10.1371/journal.pone.0282831. eCollection 2023.
Ref 148 Antibody-Exatecan Conjugates with a Novel Self-immolative Moiety Overcome Resistance in Colon and Lung Cancer. Cancer Discov. 2023 Apr 3;13(4):950-973. doi: 10.1158/2159-8290.CD-22-1368.
Ref 149 Antibody-PROTAC Conjugates Enable HER2-Dependent Targeted Protein Degradation of BRD4. ACS Chem Biol. 2020 Jun 19;15(6):1306-1312. doi: 10.1021/acschembio.0c00285. Epub 2020 Apr 30.
Ref 150 Antibody-Drug Conjugate that Exhibits Synergistic Cytotoxicity with an Endosome-Disruptive Peptide. ACS Omega. 2019 Jul 31;4(7):12955-12968. doi: 10.1021/acsomega.9b01585. eCollection 2019 Jul 31.
Ref 151 Aptamer-Directed Conjugation of DNA to Therapeutic Antibodies. Bioconjug Chem. 2019 Aug 21;30(8):2127-2135. doi: 10.1021/acs.bioconjchem.9b00363. Epub 2019 Jul 12.
Ref 152 Aryl Sulfate is a Useful Motif for Conjugating and Releasing Phenolic Molecules: Sulfur Fluorine Exchange Click Chemistry Enables Discovery of Ortho-Hydroxy-Protected Aryl Sulfate Linker. Bioconjug Chem. 2019 Jul 17;30(7):1957-1968. doi: 10.1021/acs.bioconjchem.9b00340. Epub 2019 Jun 28.
Ref 153 Antibody-nanoparticle conjugate constructed with trastuzumab and nanoparticle albumin-bound paclitaxel for targeted therapy of human epidermal growth factor receptor?2-positive gastric cancer. Oncol Rep. 2018 Mar;39(3):1396-1404. doi: 10.3892/or.2018.6201. Epub 2018 Jan 9.
Ref 154 Tumor uptake and associated greater efficacy of anti-Her2 immunoliposome does not rely on Her2 expression status: study of a docetaxel-trastuzumab immunoliposome on Her2+ breast cancer model (SKBR3). Anticancer Drugs. 2020 Jun;31(5):463-472. doi: 10.1097/CAD.0000000000000878.
Ref 155 A light-responsive, self-immolative linker for controlled drug delivery via peptide- and protein-drug conjugates. Chem Sci. 2019 Aug 19;10(39):8973-8980. doi: 10.1039/c9sc03016f. eCollection 2019 Oct 21.
Ref 156 Binding protein drug conjugates comprising anthracycline derivatives; 2016-06-30.
Ref 157 Antibody drug conjugates; 2023-07-06.
Ref 158 Antibody-drug conjugates comprising branched linkers and methods related thereto; 2017-06-01.
Ref 159 Pyrrolobenzodiazepines and conjugates thereof; 2013-04-18.
Ref 160 Antitumor compound, and preparation method therefor and use thereof; 2022-04-07.
Ref 161 Camptothecin derivative and ligand-drug conjugate thereof; 2022-04-21.
Ref 162 Camptothecin drug having high-stability hydrophilic connecting unit and conjugate thereof; 2021-12-16.
Ref 163 Hydrophilic Auristatin Glycoside Payload Enables Improved Antibody-Drug Conjugate Efficacy and Biocompatibility. Antibodies (Basel). 2018 Mar 22;7(2):15. doi: 10.3390/antib7020015.
Ref 164 Natural Product Bis-Intercalator Depsipeptides as a New Class of Payloads for Antibody-Drug Conjugates. Bioconjug Chem. 2019 Jan 16;30(1):200-209. doi: 10.1021/acs.bioconjchem.8b00843. Epub 2018 Dec 13.
Ref 165 Impact of cathepsin B-sensitive triggers and hydrophilic linkers on in vitro efficacy of novel site-specific antibody-drug conjugates. Org Biomol Chem. 2018 Mar 14;16(11):1882-1889. doi: 10.1039/c7ob02780j.
Ref 166 Peroxide-cleavable linkers for antibody-drug conjugates. Chem Commun (Camb). 2023 Feb 9;59(13):1841-1844. doi: 10.1039/d2cc06677g.
Ref 167 An antibody-supermolecule conjugate for tumor-specific targeting of tumoricidal methylated -cyclodextrin-threaded polyrotaxanes. J Mater Chem B. 2020 Aug 21;8(31):6975-6987. doi: 10.1039/d0tb00575d. Epub 2020 Jun 23.
Ref 168 Design, Synthesis, and Bioevaluation of a Novel Hybrid Molecular Pyrrolobenzodiazepine-Anthracenecarboxyimide as a Payload for Antibody-Drug Conjugate. J Med Chem. 2022 Sep 8;65(17):11679-11702. doi: 10.1021/acs.jmedchem.2c00471. Epub 2022 Aug 18.
Ref 169 A Novel Family of Acid-Cleavable Linker Based on Cyclic Acetal Motifs for the Production of Antibody-Drug Conjugates with High Potency and Selectivity. Bioconjug Chem. 2022 Oct 19;33(10):1860-1866. doi: 10.1021/acs.bioconjchem.2c00314. Epub 2022 Sep 15.
Ref 170 One-Pot Conversion of Free Sialoglycans to Functionalized Glycan Oxazolines and Efficient Synthesis of Homogeneous Antibody-Drug Conjugates through Site-Specific Chemoenzymatic Glycan Remodeling. Bioconjug Chem. 2021 Aug 18;32(8):1888-1897. doi: 10.1021/acs.bioconjchem.1c00314. Epub 2021 Aug 5.
Ref 171 Photoconjugation of an Fc-Specific Peptide Enables Efficient DAR 2 Antibody-Drug Conjugate Formation. Org Lett. 2020 Nov 6;22(21):8419-8423. doi: 10.1021/acs.orglett.0c03049. Epub 2020 Oct 19.
Ref 172 Design and Validation of Linkers for Site-Specific Preparation of Antibody-Drug Conjugates Carrying Multiple Drug Copies Per Cysteine Conjugation Site. Int J Mol Sci. 2020 Sep 19;21(18):6882. doi: 10.3390/ijms21186882.
Ref 173 Divinylsulfonamides enable the construction of homogeneous antibody-drug conjugates. Bioorg Med Chem. 2020 Dec 1;28(23):115793. doi: 10.1016/j.bmc.2020.115793. Epub 2020 Oct 6.
Ref 174 Near-infrared-induced drug release from antibody-drug double conjugates exerts a cytotoxic photo-bystander effect. Bioeng Transl Med. 2022 Aug 21;7(3):e10388. doi: 10.1002/btm2.10388. eCollection 2022 Sep.
Ref 175 Amatoxin-armed therapeutic cell surface binding components designed for tumour therapy.
Ref 176 Amatoxin derivatives.
Ref 177 Antibody-drug-conjugate and its use for the treatment of cancer.
Ref 178 Conjugates comprising self-immolative groups and methods related thereto.
Ref 179 Peptide-containing linkers for antibody-drug conjugates.
Ref 180 Novel antibody-drug conjugates and the use of same in therapy.
Ref 181 Binder-wirkstoff-konjugate (adcs) und binder-prodrug-konjugate (apdcs) mit enzymatisch spaltbaren gruppen.
Ref 182 Pyrrolobenzodiazepines and conjugates thereof.
Ref 183 Antibody-linker-drug conjugate, preparation method therefor, and anticancer drug composition containing same.
Ref 184 Spliceostatin analogs.
Ref 185 Antibody-drug conjugates and related compounds, compositions, and methods.
Ref 186 Introduction to basic information on ADC drug trastuzumab botidotin.
Ref 187 Rational Identification of Novel Antibody-Drug Conjugate with High Bystander Killing Effect against Heterogeneous Tumors
Ref 188 A DXd/TLR7-Agonist Dual-Conjugate Anti-HER2 ADC Exerts Robust Antitumor Activity Through Tumor Cell Killing and Immune Activation
Ref 189 Trastuzumab-MMAU Antibody-Auristatin Conjugates: Valine-Glucoserine Linker with Stabilized Maleimide Conjugation Improves In Vivo Efficacy and Tolerability
Ref 190 Synthesis and evaluation of antibody-drug conjugates with high drug-to-antibody ratio using dimaleimide-DM1 as a linker- payload
Ref 191 Discovery and Evaluation of TLR-Targeted Immune Agonists
Ref 192 Exo-Cleavable Linkers: Enhanced Stability and Therapeutic Efficacy in Antibody-Drug Conjugates
Ref 193 Disulfide re-bridging reagents for single-payload antibody-drug conjugates
Ref 194 Potent antitumor activity of anti-HER2 antibody-topoisomerase I inhibitor conjugate based on self-immolative dendritic dimeric-linker
Ref 195 Enhancing the bystander effect of antibody-drug conjugate by using a novel caspase-3 cleavable peptide linker to overcome tumor heterogeneity
Ref 196 Phenyldivinylsulfonamides for the construction of antibody-drug conjugates with controlled four payloads
Ref 197 Generation of a Novel SORT1×HER2 Bispecific Antibody-Drug Conjugate Targeting HER2-Low-Expression Tumor
Ref 198 Structure-Activity Relationships of Bis-Intercalating Peptides and Their Application as Antibody-Drug Conjugate Payloads
Ref 199 Biological Evaluation of Antibody-Drug Conjugates Produced by Tag-Free Lipoate Ligase A Modification
Ref 200 A novel antibody-KSP inhibitor conjugate improves KSP inhibitor efficacy in vitro and in vivo
Ref 201 Synthesis and evaluation of homocamptothecin antibody-drug conjugates for cancer treatment
Ref 202 Discovery and Optimization of a STING Agonist Platform for Application in Antibody Drug Conjugates
Ref 203 Antibody-Vincristine Conjugates as Potent Anticancer Therapeutic Agents
Ref 204 Generation and structure-activity relationships of novel imidazo-thienopyridine based TLR7 agonists: application as payloads for immunostimulatory antibody drug-conjugates
Ref 205 Antibody-Proteolysis Targeting Chimera Conjugate Enables Selective Degradation of Receptor-Interacting Serine/Threonine-Protein Kinase 2 in HER2+ Cell Lines
Ref 206 Design and Evaluation of Phosphonamidate-Linked Exatecan Constructs for Highly Loaded, Stable, and Efficacious Antibody-Drug Conjugates
Ref 207 Synthesis and biological evaluation of novel quaternary ammonium antibody drug conjugates based on camptothecin derivatives
Ref 208 Affinity-Directed Site-Specific Protein Labeling and Its Application to Antibody-Drug Conjugates
Ref 209 AJICAP-M: Traceless Affinity Peptide Mediated Conjugation Technology for Site-Selective Antibody-Drug Conjugate Synthesis
Ref 210 Tuneable thiol exchange linkers for traceless drug release applications in prodrugs and ADCs
Ref 211 NIR-II aza-BODIPY Platform for the Development of a Fluorescent Antibody Drug Conjugate
Ref 212 Design, synthesis and biological evaluation of camptothecin analogue FL118 as a payload for antibody-drug conjugates in targeted cancer therapy
Ref 213 Sonodynamic Therapy for HER2+ Breast Cancer with Iodinated Heptamethine Cyanine-Trastuzumab Conjugate
Ref 214 Synthesis and Evaluation of a Cathepsin B-Recognizing Trifunctional Chelating Agent to Improve Tumor Retention of Radioimmunoconjugates
Ref 215 Design and Optimization of Selectivity-Tunable Toll-like Receptor 7/8 Agonists as Novel Antibody-Drug Conjugate Payloads
Ref 216 Targeted delivery of alcohol-containing payloads with antibody-drug conjugates
Ref 217 Site-selective antibody-lipid conjugates for surface functionalization of red blood cells and targeted drug delivery
Ref 218 A Novel Dual-Payload ADC for the Treatment of HER2+ Breast and Colon Cancer
Ref 219 Novel Quaternary Ammonium Salt-Linked STING Agonist Antibody-Drug Conjugate: Synergistic Activation of Tumor Immunity with Mitigated Off-Target Toxicity
Ref 220 ValCitGlyPro-dexamethasone antibody conjugates selectively suppress the activation of human monocytes
Ref 221 Linker and Conjugation Site Synergy in Antibody-Drug Conjugates: Impacts on Biological Activity
Ref 222 PK/PD of Positively Charged ADC in Mice
Ref 223 Positron Emission Tomography and Optical Imaging to Monitor Bioorthogonal Diels-Alder Click Chemistry of Trastuzumab with a Porphyrin
Ref 224 A novel DNA sequence-selective, guanine mono-alkylating ADC payload suitable for solid tumour treatment
Ref 225 Effective synthesis, development and application of a highly fluorescent cyanine dye for antibody conjugation and microscopy imaging
Ref 226 Antibody-drug conjugates
Ref 227 A drug conjugate and its preparation method and application
Ref 228 Splicing modulator antibody-drug conjugates and methods of use
Ref 229 An antibody-drug conjugate and its uses
Ref 230 Allenamide linkers for antibody-drug conjugates
Ref 231 Conjugation reagents and conjugates thereof
Ref 232 Drug-antibody conjugates
Ref 233 Pyrrolobenzodiazepine-anthraceneimide hybrid molecules and their preparation methods and uses
Ref 234 Novel linkers for antibody-drug conjugates and related compounds, compositions, and methods of use
Ref 235 Immunoconjugates targeting HER2
Ref 236 An antibody-drug conjugate, its preparation method and applications
Ref 237 Antibody-drug complexes containing hemiasterlin derivatives
Ref 238 Antibody drug conjugates with enzymatically cleavable groups
Ref 239 An antibody-drug conjugate and its uses
Ref 240 Antibody-irinotecan conjugates
Ref 241 Linkers containing o-phthalaldehyde and their use in preparing antibody-drug conjugates
Ref 242 Non-linear self-immolative linkers and conjugates thereof
Ref 243 Peptide-containing linkers for antibody-drug conjugates
Ref 244 Antibody-drug conjugate
Ref 245 Oligosaccharide linker, linker-payload comprising the same and glycan chain-remodeled antibody-drug conjugate, preparation methods and uses thereof
Ref 246 Antibody drug conjugate comprising NMT inhibitor and its use
Ref 247 Multi-payload antibody-drug conjugates and their preparation methods and uses
Ref 248 Glyco-engineered antibody-drug conjugates comprising an oxime linker
Ref 249 Aminobenzazepine compounds, immunoconjugates, and uses thereof
Ref 250 DDX5 protein-binding camptothecin derivatives and prodrugs thereof
Ref 251 Preparation method and application of antibody drug conjugate
Ref 252 Organic cytotoxin oligomers and uses thereof as a payload in antibody-drug conjugates
Ref 253 Benzoselenophene compounds, pharmaceutical compositions containing them and antibody-drug conjugates
Ref 254 Pyrrolobenzodiazepine antibody conjugates
Ref 255 Drug conjugates and uses thereof
Ref 256 Anticipate-drug zygotes, pharmacological compositions and Uses
Ref 257 Anti-HER2 antibody-drug conjugate
Ref 258 Anthracycline derivative linker reagents, antibody-drug conjugates and methods
Ref 259 Anti-ErbB2 antibody-drug conjugate and composition thereof, preparation method therefor, and use thereof
Ref 260 Hexacyclic topoisomerase inhibitors having cytotoxic activity on cancer cells
Ref 261 Antibody drug conjugate
Ref 262 Antibody-drug complexes containing hemiasterlin derivatives
Ref 263 Deuterated camptothecin derivatives and antibody-drug conjugates thereof
Ref 264 Antibody-drug conjugates
Ref 265 Heterocyclic acyl hydrazone linkers, methods and uses thereof
Ref 266 Antibody-drug conjugates
Ref 267 Antibody-multidrug conjugate
Ref 268 Deuterated camptothecin derivatives and their antibody-drug conjugates
Ref 269 Antibody-drug conjugates and their preparation methods and uses
Ref 270 Antibody-drug conjugates based on gold compounds
Ref 271 Rapid-release antibody-drug conjugates
Ref 272 Camptothecin derivatives for ADC preparation
Ref 273 Acetal-based cleavable linkers
Ref 274 Compositions and methods for reducing off-target toxicity of antibody drug conjugates
Ref 275 Compositions comprising antibody-duocarmycin drug conjugates
Ref 276 Hydrophilic tetrazine-functionalized payloads for preparing targeted conjugates
Ref 277 Stabilized trioxacarcin antibody drug conjugates and uses thereof
Ref 278 Uses of antibody-drug conjugates
Ref 279 Exatecan derivatives, linker-payloads and conjugates thereof
Ref 280 Antibody-multidrug conjugate
Ref 281 Antibody-drug conjugate binding to human PTK7 and method for preparation and use thereof
Ref 282 Linker-drug conjugates, their preparation methods and applications
Ref 283 Antibody-drug conjugates and uses thereof
Ref 284 Anti-HER2 antibody-drug conjugate
Ref 285 Oxazaphosphorine antibody drug conjugates and methods of use
Ref 286 Isoindolinone-glutarimide antibody conjugates, and uses thereof
Ref 287 Pharmaceuticals containing antibody-drug complexes containing hemiasterin derivatives
Ref 288 Peptide linkers containing glycosides for antibody-drug conjugates
Ref 289 Sulfonyl maleimide-based linkers and corresponding conjugates
Ref 290 Antibody-drug conjugates
Ref 291 Thienobenzodiazepine immunoconjugates and uses thereof
Ref 292 Design and Evaluation of ZD06519, a Novel Camptothecin Payload for Antibody Drug Conjugates
Ref 293 Azobenzene-Based Linker Strategy for Selective Activation of Antibody-Drug Conjugates
Ref 294 Antibody-drug conjugate
Ref 295 Evaluation of Potency and Specificity of Cryptophycin-Loaded Antibody-Drug Conjugates
Ref 296 Novel PIKK inhibitor antibody-drug conjugates: Synthesis and anti-tumor activity. Bioorg Med Chem Lett. 2019 Apr 1;29(7):943-947. doi: 10.1016/j.bmcl.2019.01.009. Epub 2019 Jan 11.
Ref 297 Design, Synthesis, and Biochemical Evaluation of Alpha-Amanitin Derivatives Containing Analogs of the trans-Hydroxyproline Residue for Potential Use in Antibody-Drug Conjugates. Chemistry. 2021 Jul 16;27(40):10282-10292. doi: 10.1002/chem.202101373. Epub 2021 Jun 18.
Ref 298 Tag-free, specific conjugation of glycosylated IgG1 antibodies using microbial transglutaminase. RSC Adv. 2022 Nov 22;12(52):33510-33515. doi: 10.1039/d2ra05630e. eCollection 2022 Nov 22.
Ref 299 Antibody-drug conjugates with dual payloads for combating breast tumor heterogeneity and drug resistance. Nat Commun. 2021 Jun 10;12(1):3528.
Ref 300 Breast cancer targeted/ therapeutic with double and triple fusion Immunotoxins. J Steroid Biochem Mol Biol. 2020 Jun;200:105651. doi: 10.1016/j.jsbmb.2020.105651. Epub 2020 Mar 5.
Ref 301 Improved antibody-payload conjugates (APCs) prepared by site-specific conjugation utilizing genetic code expansion
Ref 302 Site-Selective Antibody Conjugation with Dibromopyrazines
Ref 303 Cyclopentadiene as a Multifunctional Reagent for Normal- and Inverse-Electron Demand Diels-Alder Bioconjugation. Bioconjug Chem. 2022 Sep 21;33(9):1609-1619.
Ref 304 Synthesis of site-specific Fab-drug conjugates using ADP-ribosyl cyclases
Ref 305 Bifunctional cytotoxic agents containing the CTI pharmacophore
Ref 306 Antibody and antibody fragments site-specific conjugation using new Q-tag substrate of bacterial transglutaminase
Ref 307 Chemical Tagging of Bioactive Amides by Cooperative Catalysis: Applications in the Syntheses of Drug Conjugates
Ref 308 New shielded antibody
Ref 309 A Recognition Tag of Human Origin for Bioorthogonal Generation of Antibody-Drug Conjugates using Microbial Biotin Ligase
Ref 310 Methods for preparing protein-small-molecule drug conjugates and applications thereof
Ref 311 Comparison of HER2-targeted affibody conjugates loaded with auristatin- and maytansine-derived drugs. J Control Release. 2023 Mar;355:515-527. doi: 10.1016/j.jconrel.2023.02.005. Epub 2023 Feb 14.
Ref 312 Pathological complete remission of relapsed tumor by photo-activating antibody-mimetic drug conjugate treatment. Cancer Sci. 2022 Dec;113(12):4350-4362.
Ref 313 Sihuan pharmaceutical holdings group annual presentation; 2020
Ref 314 Introduction to basic information on ADC drug xl-250.
Ref 315 Introduction to basic information on ADC drug Anti-HER2 antibody-drug conjugate(XDCExplorer)
Ref 316 YB1 pharmaceutical company product pipeline
Ref 317 Introduction to basic information on biparatopic HER2 x HER2 antibody drug conjugate(Regeneron Pharmaceuticals).
Ref 318 Introduction to basic information on ADC drug Anti-HER2-4AP ADC(Catalent Biologics)
Ref 319 Introduction to basic information on anti-HER2 antibody drug conjugates(NBE-Therapeutics).
Ref 320 Introduction to basic information on anti-HER2 antibody-drug conjugate(Mersana Therapeutics/Genentech).
Ref 321 Introduction to basic information on ADC drug Mabion-HER2 ADC
Ref 322 Intocell biotechnology company product pipeline
Ref 323 Introduction to basic information on ADC drug TE-1218.
Ref 324 Introduction to basic information on ADC drug TE-1112.
Ref 325 A second-generation antibody-drug conjugate to treat HER2-positive breast cancer. Lancet. 2023 Jan 14;401(10371):80-81. doi: 10.1016/S0140-6736(22)02534-X. Epub 2022 Dec 7.
Ref 326 Introduction to basic information on ADC drug Chloromethylbenz-Indoline Dimer Antibody Drug conjugate
Ref 327 Bioasis and wuxi biologics announce initial strategic collaboration for the development and manufacturing of xB3-001, the companys lead investigational candidate to treat brain cancer; 2018
Ref 328 Antibody fragment drug-conjugates (FDCs)-application of ANT-043 and ANT-045 in solid tumors. Cancer Res (2021) 81 (13_Supplement): 909.
Ref 329 ADC review: basic information about ABGN-110.
Ref 330 Antibody drug conjugate using CTAT linker technology shows superior efficacy in xenograft trial; 2015
Ref 331 Introduction to basic information on humanized anti-HER2 mab-maytansine conjugate(Anhui Anke Biotechnology/Wuxi Pharmatech).
Ref 332 An investigational next generation ADC (DAN-311) is highly effective in HER2-low breast cancer models. Cancer Res (2022) 82 (4_Supplement): P2-13-09.
Ref 333 A JAB-X1800/JAB-BX400 introduction by Jacobio Pharmaceuticals.
Ref 334 Quadira Biosciences AG company product pipeline
Ref 335 Introduction to basic information on ADC drug Antibody-drug conjugate (Scripps).
Ref 336 Study of ZV0203 in Patients With HER2-Positive Advanced Solid Tumors; NCT05423977.
Ref 337 Fudan-zhangjiang bio-pharmaceutic company indicative announcement
Ref 338 Novel development strategies and challenges for anti-Her2 antibody-drug conjugates. Antib Ther. 2022 Jan 27;5(1):18-29. doi: 10.1093/abt/tbac001.
Ref 339 A comparison of the activity, lysosomal stability, and efficacy of legumain-cleavable and cathepsin-cleavable ADC linkers
Ref 340 Comparison of quaternary ammonium-based linkers for antibody-drug conjugates based on camptothecin derivatives
Ref 341 Tumor cell-directed STING agonist antibody-drug conjugates induce type III interferons and anti-tumor innate immune responses
Ref 342 Development and application of an in vitro assay to assess target-independent B-cell activation by targeted TLR7 immune agonists
Ref 343 Discovery of a novel antibody-drug conjugate linker-payload with a distinct killing mechanism via prolonged unfolded protein response activation
Ref 344 Prodrugs of topoisomerase I inhibitor for ADC conjugations and methods of use thereof
Ref 345 Protein-drug conjugates comprising camptothecin analogs and methods of use thereof
Ref 346 Antibody drug conjugates comprising dolastatin derivatives
Ref 347 Antibody-drug complexes
Ref 348 Trident-type linkers and applications thereof
Ref 349 Camptothecin analogs conjugated to glutamine residues in proteins and their uses
Ref 350 Antibody-drug conjugates and uses thereof
Ref 351 Combination of antibody-drug conjugate and CDK9 inhibitor
Ref 352 Engineered antibody constant regions for site-specific conjugation and methods and uses therefor
Ref 353 Prodrugs of topoisomerase I inhibitor for ADC conjugations and methods of use thereof
Ref 354 Therapy for drug-resistant cancer by administration of anti-HER2 antibody/drug conjugate
Ref 355 Antibody-drug conjugates comprising antibodies against human TROP2 and uses thereof
Ref 356 Bromomethylpyrazine-based drug conjugates and ADCs
Ref 357 Linkers for antibody-drug conjugates and uses thereof
Ref 358 Use of an antibody-drug conjugate, pharmaceutical composition and pharmaceutical combination
Ref 359 PEGylated antibody hydroxyl-bearing drug conjugates
Ref 360 Hydrophilic linkers for antibody-drug conjugates
Ref 361 Antibody drug conjugate loaded with binary toxins and its application
Ref 362 Combination of antibody-drug conjugate and Aurora B inhibitor
Ref 363 Combination of antibody-drug conjugate with anti-SIRPα antibody